data_2kra_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kra _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 121.803 0.811 . . . . 0.0 110.008 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.19 128.16 1.08 Allowed Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.878 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . . . -90.57 -33.73 15.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.279 0.562 . . . . 0.0 110.158 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 5.0 p -152.0 -165.0 2.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.152 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.453 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 27.4 t70 -141.72 -40.45 0.37 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.311 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -105.61 128.41 53.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.436 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.439 ' HB2' ' HB3' ' A' ' 49' ' ' PRO . 12.9 m-20 -54.84 -24.56 23.58 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.591 0.557 . . . . 0.0 111.069 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.53 -31.42 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.834 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -69.27 -29.59 67.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.287 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.451 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 59.7 m -93.49 -119.09 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.048 0.451 . . . . 0.0 110.545 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.96 157.8 30.39 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 m -53.39 117.29 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.068 0.461 . . . . 0.0 110.481 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.22 -23.98 5.41 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.9 p -128.34 142.13 51.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.601 -0.3 . . . . 0.0 110.211 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.416 ' HB3' HD12 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -123.05 154.48 38.47 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.2 m -91.51 38.58 0.98 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.932 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -88.69 -173.02 3.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.766 0.317 . . . . 0.0 110.558 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.33 140.56 29.58 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.462 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 93.6 p -67.75 144.46 55.4 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.467 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.07 65.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.354 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 41.7 p90 -87.65 -32.21 19.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.4 m -149.93 127.38 11.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.401 0.619 . . . . 0.0 112.287 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.85 5.34 1.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.725 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -88.58 -24.68 22.8 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.323 0.582 . . . . 0.0 109.895 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.4 mp -87.38 122.89 39.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.534 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 31.9 mtp180 -140.64 46.08 1.8 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.269 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.472 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 0.3 OUTLIER -98.53 -172.91 2.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 38.3 m -71.67 78.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.659 HG13 ' SG ' ' A' ' 59' ' ' CYS . 17.0 pt -88.75 142.7 30.9 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.739 0.304 . . . . 0.0 110.583 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.79 150.33 71.81 Favored 'Trans proline' 0 N--CA 1.475 0.409 0 C-N-CA 123.413 2.742 . . . . 0.0 114.834 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 59' ' ' CYS . 8.1 mp -87.11 167.3 14.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.164 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.98 141.2 32.52 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.882 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 68.9 m-80 -102.46 -168.13 1.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.856 0.36 . . . . 0.0 110.893 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 m -62.2 125.59 24.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.056 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.18 1.68 86.24 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.569 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 20.8 mm-40 -88.92 150.44 22.85 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.853 0.359 . . . . 0.0 110.748 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.486 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -73.64 139.39 45.42 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.371 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.9 p -138.4 148.44 44.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.275 0.56 . . . . 0.0 110.388 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -89.25 122.63 68.45 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.76 -31.56 95.28 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.825 2.35 . . . . 0.0 111.929 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.83 -22.3 62.34 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.641 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.461 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 46.7 m -79.9 125.79 30.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.907 0.384 . . . . 0.0 110.219 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.417 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 34.9 m170 -86.41 168.92 13.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.477 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 149.0 23.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.42 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 42.7 t -87.71 136.65 32.53 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.057 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 15.9 Cg_exo -69.31 136.98 40.51 Favored 'Cis proline' 0 C--N 1.35 0.623 0 C-N-CA 123.871 -1.304 . . . . 0.0 112.819 0.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.439 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 53.9 t80 -63.72 127.96 33.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.866 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.16 58.03 1.95 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.373 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 158.92 -143.05 8.85 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.026 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -136.19 136.72 40.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.439 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 1.7 tpt180 -157.85 126.62 5.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.0 mp -89.1 52.89 2.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.337 0.589 . . . . 0.0 110.764 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 54.7 m -88.82 138.64 31.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.399 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 13.4 m -89.92 32.35 0.91 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.457 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.6 tp -154.62 127.81 8.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.985 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.659 ' SG ' HG13 ' A' ' 32' ' ' ILE . 54.8 m -74.97 145.03 80.5 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.461 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 17.0 Cg_exo -67.59 -168.34 0.18 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.496 2.131 . . . . 0.0 111.704 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 81.5 m -72.17 140.46 48.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.651 0.262 . . . . 0.0 111.04 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.409 ' HA ' HD22 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -63.97 152.89 38.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.073 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.9 m -49.28 123.95 8.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.51 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.05 -32.4 6.73 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.261 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.402 HD12 ' HG3' ' A' ' 62' ' ' LYS . 28.3 mt -89.8 151.39 21.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.068 0.461 . . . . 0.0 112.147 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -111.63 134.45 53.2 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.388 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.503 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 46.2 t -88.45 120.07 29.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.6 t -150.44 155.86 40.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 32.8 ttpt -61.63 114.38 3.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.08 0.467 . . . . 0.0 110.015 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.533 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 14.7 m -123.74 50.15 1.65 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.296 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.1 -112.29 0.84 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.66 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.84 ' HG2' ' HG3' ' A' ' 73' ' ' LYS . 2.7 pm0 -86.68 -37.63 17.79 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.29 0.567 . . . . 0.0 109.912 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.84 ' HG3' ' HG2' ' A' ' 72' ' ' GLU . 9.8 mtmp? -131.31 -165.02 1.51 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.987 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 3.5 m-85 -89.67 139.45 30.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.672 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 51.0 mttp -137.9 154.92 49.39 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 63.2 m -78.94 134.41 36.85 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.72 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.0 m . . . . . 0 C--O 1.245 0.835 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.354 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 121.744 0.783 . . . . 0.0 109.919 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.85 97.66 0.68 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.375 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.964 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -78.0 -12.31 59.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.836 0.35 . . . . 0.0 111.573 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 p -150.83 152.12 33.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.928 0.394 . . . . 0.0 111.524 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.446 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 7.6 t70 -106.23 -50.2 3.21 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -89.66 130.34 35.96 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.514 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 34.4 t70 -55.51 -28.46 54.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.619 0.724 . . . . 0.0 110.081 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.59 ' HA ' ' CB ' ' A' ' 49' ' ' PRO . 42.9 t -54.79 -29.35 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.24 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -65.59 -26.71 67.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.463 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 76.7 m -89.95 132.5 35.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.128 0.49 . . . . 0.0 111.175 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.37 158.78 53.42 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.911 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.1 m -52.95 107.92 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.307 0.575 . . . . 0.0 110.995 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.06 -30.88 2.0 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 35.5 p -132.35 149.25 52.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.291 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -136.03 162.81 31.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.861 0.3 . . . . 0.0 110.807 -178.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.514 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 65.3 m -87.82 85.99 7.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.043 0.449 . . . . 0.0 110.031 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.501 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . . . -130.97 157.45 42.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.562 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.667 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -85.81 144.34 27.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.295 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.702 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -65.58 140.89 58.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.035 0.445 . . . . 0.0 111.003 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.549 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -66.81 -24.67 66.2 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -87.06 -36.08 18.36 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.1 m -151.53 138.93 19.44 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -80.31 35.29 0.33 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.919 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -89.86 -38.47 13.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.266 0.555 . . . . 0.0 109.885 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.702 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.4 mp -88.33 126.77 41.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.446 ' NH2' ' HA ' ' A' ' 8' ' ' ASP . 0.8 OUTLIER -150.93 57.17 0.91 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.964 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.6 p90 -138.69 -169.32 2.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.234 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.8 m -58.47 98.16 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 O-C-N 124.028 0.83 . . . . 0.0 112.236 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.606 HG13 ' SG ' ' A' ' 59' ' ' CYS . 33.1 pt -116.68 149.48 43.98 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.74 144.63 53.19 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.629 2.886 . . . . 0.0 115.434 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 59' ' ' CYS . 7.4 mp -88.11 173.85 8.59 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.915 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.01 143.54 23.2 Favored Glycine 0 C--O 1.239 0.429 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.771 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.558 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 71.4 m-80 -99.65 -169.77 1.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.909 0.385 . . . . 0.0 111.057 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.7 m -61.0 128.06 34.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.101 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.26 8.77 85.65 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.834 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 2.2 mm-40 -88.89 161.64 16.57 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.807 0.337 . . . . 0.0 110.972 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.46 ' CG ' ' HZ1' ' A' ' 73' ' ' LYS . 2.0 t70 -71.3 137.36 48.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.909 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.83 142.56 28.96 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -89.95 124.23 64.09 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -56.36 -39.95 87.91 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.794 2.33 . . . . 0.0 112.147 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.56 -38.98 77.65 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.373 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.4 m -66.29 101.37 0.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.325 0.583 . . . . 0.0 109.954 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.483 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 66.0 m-70 -68.6 148.27 50.73 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.053 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' A' ' 63' ' ' SER . 52.0 tttm -54.15 163.72 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.493 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.501 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 44.5 t -85.01 143.08 39.35 Favored Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.629 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.59 ' CB ' ' HA ' ' A' ' 11' ' ' VAL . 18.9 Cg_endo -91.99 129.85 6.53 Favored 'Cis proline' 0 N--CA 1.461 -0.415 0 C-N-CA 124.013 -1.245 . . . . 0.0 114.495 1.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.5 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 20.4 t80 -87.15 128.57 35.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.838 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -82.69 61.56 5.85 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.463 -0.773 . . . . 0.0 110.789 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.13 176.62 44.48 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.81 126.05 35.54 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.403 HH12 ' CG ' ' A' ' 10' ' ' ASP . 22.6 ttm105 -75.19 120.24 20.42 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.3 -2.19 58.44 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.223 0.535 . . . . 0.0 110.594 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.4 m -87.31 142.73 27.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.579 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 30.2 m -88.0 34.76 0.73 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.901 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.7 tp -154.31 130.73 10.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.709 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.606 ' SG ' HG13 ' A' ' 32' ' ' ILE . 9.8 m -76.06 148.79 81.83 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -72.92 -166.15 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.425 2.083 . . . . 0.0 111.792 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 72.2 m -76.46 140.59 41.32 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.335 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.435 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 11.1 ptmm? -60.88 148.17 40.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.997 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.507 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 68.1 m -51.04 131.77 27.26 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.142 0.496 . . . . 0.0 110.551 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.95 -28.68 10.18 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 mt -102.51 150.58 23.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.359 -0.42 . . . . 0.0 110.871 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.9 m -118.92 131.64 56.05 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.23 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 52.5 t -78.14 125.67 29.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.889 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.8 t -150.52 155.99 40.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 80.7 tttt -65.79 123.17 19.04 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.989 0.423 . . . . 0.0 110.266 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 m -128.0 41.6 3.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.255 0.55 . . . . 0.0 110.24 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 144.97 -112.72 0.67 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.03 -45.65 10.0 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.104 0.478 . . . . 0.0 109.748 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.46 ' HZ1' ' CG ' ' A' ' 40' ' ' ASP . 46.4 mtmt -110.98 -158.64 0.65 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.162 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 5.4 m-85 -107.38 137.24 45.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.81 0.338 . . . . 0.0 110.949 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 5.5 mptp? -126.83 159.44 33.87 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 70.1 m -81.17 131.99 35.33 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.824 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.244 0.783 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.842 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.424 HG23 ' N ' ' A' ' 5' ' ' GLY . 9.0 t . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.714 0.292 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.424 ' N ' HG23 ' A' ' 4' ' ' THR . . . 159.82 124.77 0.76 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.009 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.997 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.88 -13.22 34.06 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.0 p -150.97 -159.92 1.1 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.784 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -153.15 -53.31 0.11 Allowed 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 52' ' ' GLY . 29.9 mmtp -89.83 132.97 34.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 50' ' ' TYR . 45.1 m-20 -53.86 -30.66 46.67 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.551 0.532 . . . . 0.0 110.622 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.1 t -54.94 -31.47 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.794 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.403 ' NE2' ' H ' ' A' ' 9' ' ' LYS . 73.6 mt-30 -67.26 -27.78 67.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.407 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 75.4 m -89.67 138.51 31.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.019 0.437 . . . . 0.0 111.171 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.99 154.15 52.82 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.056 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 m -49.49 108.66 0.21 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.033 0.49 . . . . 0.0 110.755 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.22 -18.37 4.21 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.304 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.5 p -135.11 161.46 35.26 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.385 0.274 . . . . 0.0 110.934 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.636 ' SG ' ' HB1' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -145.87 167.63 22.77 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.1 m -88.91 58.63 4.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.02 0.438 . . . . 0.0 111.268 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.815 ' HA ' ' HB2' ' A' ' 54' ' ' ARG . . . -90.08 152.81 20.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.26 0.552 . . . . 0.0 111.871 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -82.91 147.69 28.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.833 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.518 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -63.22 137.76 58.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.028 0.442 . . . . 0.0 111.092 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.612 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -67.09 -22.99 65.8 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -87.38 -40.03 14.78 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.89 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.0 m -152.32 148.42 27.5 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -78.09 48.36 0.73 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.936 0.398 . . . . 0.0 111.522 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -98.27 -43.14 7.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.417 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.8 mp -88.18 131.87 34.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.818 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -148.6 55.67 1.02 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.997 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.4 p90 -138.43 -173.8 3.64 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.2 m -57.6 98.31 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.915 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.478 HG13 ' SG ' ' A' ' 59' ' ' CYS . 44.8 pt -119.13 155.59 53.22 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 32' ' ' ILE . 10.1 Cg_endo -52.0 143.59 39.88 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.409 2.739 . . . . 0.0 115.152 -177.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.512 ' CD2' ' HB3' ' A' ' 18' ' ' CYS . 70.0 mt -87.19 159.74 18.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.689 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -52.98 141.53 29.11 Favored Glycine 0 C--O 1.242 0.614 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.268 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.624 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 66.1 m-20 -95.65 176.37 6.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.322 -0.439 . . . . 0.0 110.997 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.5 m -64.38 128.11 34.38 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.17 5.52 90.02 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.357 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.522 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 3.2 mm-40 -92.56 152.81 19.42 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.833 0.349 . . . . 0.0 111.497 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -68.72 145.1 54.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.426 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.45 179.0 7.05 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -116.12 122.75 31.82 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -47.9 -44.12 28.03 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.425 2.75 . . . . 0.0 113.407 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.94 80.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.281 0.563 . . . . 0.0 110.984 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.498 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 19.6 m -78.17 83.15 4.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.172 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -61.59 146.47 48.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.957 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.8 143.21 10.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.796 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.498 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 99.7 t -87.93 144.3 34.56 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.938 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 48' ' ' VAL . 34.4 Cg_exo -62.53 142.45 40.82 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 124.634 -0.986 . . . . 0.0 114.144 1.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.41 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 87.8 t80 -166.36 137.59 3.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.621 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -84.66 113.82 21.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.687 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 9' ' ' LYS . . . 169.7 -174.2 43.95 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.225 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.568 ' HZ1' ' HB3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -132.86 142.58 49.01 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.242 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.815 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . 3.6 mmp_? -86.67 110.53 19.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.247 0.546 . . . . 0.0 112.076 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 55' ' ' LEU . 3.1 mm? -88.42 -21.94 23.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.6 m -88.7 153.82 20.79 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.27 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.612 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 43.6 m -87.69 46.04 1.34 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.044 0.45 . . . . 0.0 111.044 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.6 tp -153.08 127.0 8.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.078 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.568 ' SG ' ' HB1' ' A' ' 20' ' ' ALA . 1.6 m -77.86 141.58 64.02 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.262 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.498 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 20.4 Cg_exo -65.57 -178.31 0.9 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.677 2.251 . . . . 0.0 111.499 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 72.7 m -62.4 140.43 58.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.313 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -64.11 155.56 31.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.073 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.4 m -51.78 127.4 20.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.211 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.72 -30.48 9.06 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.695 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.611 HD11 ' HG2' ' A' ' 62' ' ' LYS . 26.3 mt -88.98 145.77 25.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.109 0.481 . . . . 0.0 112.081 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.2 m -119.85 125.02 47.5 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.791 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.616 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 4.4 t -81.82 135.55 35.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.858 0.361 . . . . 0.0 111.242 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.4 m -137.53 148.33 45.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.438 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' A' ' 72' ' ' GLU . 16.0 ttmt -64.54 114.26 4.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.471 0.653 . . . . 0.0 110.962 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.493 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 11.1 m -97.75 83.37 3.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.985 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.07 -62.47 4.17 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.46 ' OE1' ' HA ' ' A' ' 72' ' ' GLU . 35.6 tp10 -150.11 -43.67 0.13 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.928 0.394 . . . . 0.0 109.957 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.621 ' HB2' ' HZ2' ' A' ' 73' ' ' LYS . 9.0 mtmp? -87.79 153.68 21.15 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.565 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 11.8 m-85 -89.39 129.57 35.89 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.89 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.493 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 45.8 mttm -125.81 150.28 47.94 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.137 0.494 . . . . 0.0 110.027 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 59.2 m -75.03 141.33 43.9 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.125 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.253 1.241 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.214 179.6 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.2 t . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 121.673 0.749 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . 167.91 69.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.142 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.792 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -71.3 -17.33 62.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.7 p -150.06 144.99 26.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.826 0.345 . . . . 0.0 111.192 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.561 ' O ' ' HD2' ' A' ' 53' ' ' LYS . 11.6 t70 -86.91 -47.7 8.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.672 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.527 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 36.7 mttm -117.88 146.41 43.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.573 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' A' ' 53' ' ' LYS . 1.8 m-20 -51.24 -28.17 10.98 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.873 0.733 . . . . 0.0 111.529 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.853 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 22.0 t -55.25 -31.17 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.763 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -69.94 -17.98 63.34 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.1 m -89.42 -139.61 0.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.7 -141.84 4.77 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 119.395 -1.383 . . . . 0.0 113.777 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m -50.68 115.71 1.61 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.913 -0.644 . . . . 0.0 112.646 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 33' ' ' PRO . . . 60.45 31.45 74.36 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 114.928 -1.033 . . . . 0.0 114.907 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.539 ' O ' HG13 ' A' ' 48' ' ' VAL . 6.0 p -148.57 143.06 26.36 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.149 0.974 . . . . 0.0 111.685 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.549 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 0.7 OUTLIER -142.43 167.67 21.55 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.016 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.2 m -89.67 45.19 1.26 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.523 ' HB3' ' SG ' ' A' ' 59' ' ' CYS . . . -79.81 159.87 26.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.405 0.621 . . . . 0.0 111.407 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -88.27 152.68 21.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.945 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.621 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -63.33 136.5 57.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.048 0.452 . . . . 0.0 110.694 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.677 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -66.91 -22.43 65.96 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -86.99 -37.36 17.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.895 0.379 . . . . 0.0 111.674 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.0 m -152.01 145.92 25.18 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -80.14 38.84 0.42 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.47 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -89.93 -41.66 11.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.511 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.621 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.0 mp -87.35 130.76 36.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.569 ' O ' ' HA2' ' A' ' 5' ' ' GLY . 88.4 mtm180 -148.44 65.63 1.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.86 0.725 . . . . 0.0 109.304 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.792 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.4 p90 -150.84 -170.6 3.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.816 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 94.6 m -58.76 102.8 0.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.804 0.69 . . . . 0.0 112.539 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.492 HG13 ' SG ' ' A' ' 59' ' ' CYS . 47.1 pt -123.85 157.62 62.57 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 14.4 Cg_endo -56.0 147.7 62.13 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.235 2.623 . . . . 0.0 115.061 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 59' ' ' CYS . 78.5 mt -87.15 160.43 18.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.501 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.74 144.76 45.85 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 114.156 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.449 ' H ' ' CD ' ' A' ' 39' ' ' GLU . 35.1 m-80 -99.69 159.89 14.71 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.34 0.656 . . . . 0.0 110.685 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.2 m -56.39 128.58 36.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.883 0.373 . . . . 0.0 110.437 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.5 -21.69 36.31 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.966 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 36' ' ' ASN . 7.2 pt-20 -96.44 155.34 16.81 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 117.561 0.68 . . . . 0.0 110.648 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.413 ' CG ' ' HZ1' ' A' ' 75' ' ' LYS . 1.5 m-20 -60.71 145.32 49.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.998 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.2 p -144.7 156.13 43.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.079 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.452 ' CD2' ' HB3' ' A' ' 58' ' ' LEU . 84.0 m-70 -90.61 126.9 54.54 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.93 -34.67 99.21 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.708 2.272 . . . . 0.0 112.387 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.93 98.95 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.543 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.643 ' HB2' ' HB3' ' A' ' 60' ' ' PRO . 3.4 p -74.31 133.39 42.58 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -112.88 -150.31 0.46 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.947 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.615 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -70.02 155.19 40.95 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -179.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.606 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 92.0 t -111.99 137.77 21.49 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.114 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.853 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 37.9 Cg_exo -59.13 126.26 2.5 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 124.193 -1.17 . . . . 0.0 113.383 1.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.561 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 57.2 t80 -75.16 146.65 41.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.732 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.473 ' CG ' ' HZ3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -74.51 56.31 0.67 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.266 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.15 -136.54 6.38 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.643 ' HE3' HD23 ' A' ' 55' ' ' LEU . 29.7 pttt -150.38 138.24 20.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.731 0.3 . . . . 0.0 110.256 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 29.9 mmt180 -114.87 115.3 26.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.059 0.457 . . . . 0.0 111.224 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.643 HD23 ' HE3' ' A' ' 53' ' ' LYS . 3.1 mm? -89.23 32.75 0.82 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.931 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 p -89.2 157.38 18.28 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.703 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.677 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 68.0 m -88.02 30.21 0.87 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.044 0.45 . . . . 0.0 111.595 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.452 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 60.9 tp -154.5 123.65 6.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.382 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 20' ' ' ALA . 1.7 m -73.94 146.75 85.51 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.643 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 57.0 Cg_endo -70.16 -173.31 0.75 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.843 1.695 . . . . 0.0 111.339 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . 80.0 m -67.69 142.35 56.37 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.995 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.472 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . 46.8 mtpt -55.24 145.41 21.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.182 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.8 m -47.16 117.39 1.71 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.427 0.454 . . . . 0.0 110.966 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.26 -27.53 8.93 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.496 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 61' ' ' CYS . 56.2 mt -88.3 156.64 19.07 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.781 0.324 . . . . 0.0 111.04 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.7 m -123.15 130.57 52.94 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.496 -0.482 . . . . 0.0 112.163 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.438 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 35.6 t -78.06 119.23 21.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.5 m -131.99 145.02 51.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.638 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 54.2 tttp -65.37 107.8 1.75 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.277 0.56 . . . . 0.0 110.332 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.44 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 14.4 m -95.02 83.73 3.99 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.855 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.51 -69.75 3.27 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.449 ' OE1' ' HA ' ' A' ' 72' ' ' GLU . 36.4 tp10 -135.58 -49.46 0.71 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -88.15 157.87 18.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.438 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 12.8 m-85 -89.83 130.83 36.02 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.677 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 34.5 mttp -131.39 150.62 52.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.247 0.546 . . . . 0.0 109.906 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 62.1 m -67.23 134.29 51.38 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.983 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.254 1.295 0 CA-C-O 117.747 -1.12 . . . . 0.0 108.54 179.092 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 15.4 t . . . . . 0 CA--C 1.532 0.284 0 CA-C-O 120.638 0.256 . . . . 0.0 111.426 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.5 117.55 0.4 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 1.103 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.71 -7.93 51.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.709 0.29 . . . . 0.0 111.776 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.498 ' SG ' ' HA ' ' A' ' 30' ' ' PHE . 6.0 p -132.3 139.13 48.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.024 0.44 . . . . 0.0 111.801 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.525 ' HB3' ' NE2' ' A' ' 12' ' ' GLN . 0.2 OUTLIER -71.55 -46.01 60.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.697 178.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -139.87 153.99 47.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.996 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.469 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 6.6 t70 -50.09 -30.87 11.9 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.155 0.91 . . . . 0.0 111.688 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.567 ' HA ' ' CB ' ' A' ' 49' ' ' PRO . 46.3 t -53.94 -30.15 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.512 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.525 ' NE2' ' HB3' ' A' ' 8' ' ' ASP . 72.3 mt-30 -76.36 -15.17 60.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 92.0 m -89.32 132.14 35.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.128 0.49 . . . . 0.0 111.088 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.51 156.83 51.39 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.095 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.1 m -52.14 108.9 0.32 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.135 0.493 . . . . 0.0 110.632 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.31 -21.18 3.3 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.1 p -136.3 156.34 48.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.136 -0.532 . . . . 0.0 110.077 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.672 ' SG ' ' HB2' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -145.17 161.69 38.9 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.325 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 62.1 m -87.01 59.41 5.62 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.078 0.465 . . . . 0.0 111.26 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.672 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . . . -93.33 144.5 25.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.97 0.414 . . . . 0.0 110.821 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.591 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -78.6 143.12 36.72 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.65 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 66.0 m -65.46 133.66 51.76 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.883 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.62 -24.71 67.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.901 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -86.68 -37.08 18.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 110.623 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.627 ' O ' ' HB2' ' A' ' 22' ' ' SER . 23.1 t -152.06 128.1 10.39 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.483 ' HD3' ' N ' ' A' ' 26' ' ' ARG . 1.7 mpp_? -77.22 37.87 0.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 4' ' ' THR . 13.4 p-10 -89.23 -37.69 14.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.65 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 42.9 mt -89.02 124.33 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.6 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.422 ' HG2' ' HB2' ' A' ' 21' ' ' ALA . 89.0 mtm180 -145.99 53.74 1.15 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 1.103 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.6 p90 -131.51 -171.0 2.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.478 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.7 m -61.56 77.3 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.19 0.931 . . . . 0.0 113.266 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.434 HG13 ' SG ' ' A' ' 59' ' ' CYS . 44.7 pt -93.54 154.6 41.17 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -55.29 151.63 35.37 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.222 2.615 . . . . 0.0 114.442 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.496 ' HA ' ' HB3' ' A' ' 59' ' ' CYS . 75.7 mt -86.91 159.68 18.96 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.12 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.53 138.25 44.17 Favored Glycine 0 C--O 1.238 0.353 0 O-C-N 124.059 0.849 . . . . 0.0 114.145 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.49 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 44.7 m-80 -105.75 162.51 13.48 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.238 0.615 . . . . 0.0 110.161 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.539 ' HG ' HD22 ' A' ' 65' ' ' LEU . 5.4 m -55.95 121.02 8.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.729 0.3 . . . . 0.0 110.63 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.77 -25.84 13.94 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.422 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 13.6 pt-20 -93.71 152.89 18.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.873 0.836 . . . . 0.0 110.769 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -59.69 153.64 19.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.537 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 27.2 p -144.72 154.85 43.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.775 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 56.8 m170 -90.2 126.14 57.87 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.531 ' HG3' ' CG ' ' A' ' 74' ' ' PHE . 36.5 Cg_exo -59.52 -53.45 3.39 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 123.15 2.566 . . . . 0.0 113.721 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.41 30.62 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.626 ' HG ' ' HG3' ' A' ' 60' ' ' PRO . 23.1 t -90.54 120.86 31.98 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.561 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 83.8 m-70 -68.65 144.32 54.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.186 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.571 ' HE3' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -54.16 154.98 3.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.969 -178.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' A' ' 49' ' ' PRO . 95.8 t -88.71 135.46 32.22 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.567 ' CB ' ' HA ' ' A' ' 11' ' ' VAL . 60.7 Cg_endo -73.21 140.77 69.08 Favored 'Cis proline' 0 C--O 1.237 0.469 0 C-N-CA 123.881 -1.3 . . . . 0.0 113.08 0.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.561 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 68.7 t80 -62.25 133.75 55.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.112 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.04 60.22 1.39 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.725 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.72 -133.9 4.26 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.92 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -117.89 124.76 49.08 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -90.63 111.91 23.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.215 0.531 . . . . 0.0 112.181 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.408 ' N ' HD23 ' A' ' 55' ' ' LEU . 4.0 mm? -111.65 18.43 19.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.14 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -89.34 142.3 27.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.37 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 15.8 m -89.25 30.51 0.97 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.7 tp -154.46 130.22 10.05 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.263 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 34' ' ' LEU . 1.7 m -80.51 140.31 51.81 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.626 ' HG3' ' HG ' ' A' ' 45' ' ' SER . 16.8 Cg_exo -66.35 171.06 11.01 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.539 2.159 . . . . 0.0 111.139 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.3 m -60.35 139.91 57.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.772 0.32 . . . . 0.0 110.937 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.428 ' HG2' HD11 ' A' ' 65' ' ' LEU . 14.6 ptmt -62.37 153.14 32.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.482 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.6 m -47.81 124.68 7.63 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.417 0.448 . . . . 0.0 111.294 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.18 -32.04 6.98 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.539 HD22 ' HG ' ' A' ' 37' ' ' SER . 28.2 mt -89.29 156.9 18.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 0.0 111.565 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.1 m -124.87 133.28 53.14 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.332 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 48.1 t -79.16 122.49 26.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 m -151.0 151.98 32.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.658 0.266 . . . . 0.0 111.08 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 83.0 tttt -62.25 116.29 4.88 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.7 m -115.97 49.02 1.15 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.775 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.413 ' O ' ' HE2' ' A' ' 69' ' ' LYS . . . 131.26 -102.59 0.52 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.039 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.17 -49.61 7.17 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.062 0.458 . . . . 0.0 110.683 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -121.42 -167.29 1.49 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.673 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 5.5 m-85 -91.38 134.96 34.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.889 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -133.75 155.83 49.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.537 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 60.6 m -75.61 137.64 40.89 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.946 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.667 -0.683 . . . . 0.0 109.158 179.684 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.461 ' O ' ' HD2' ' A' ' 29' ' ' ARG . 3.1 t . . . . . 0 CA--C 1.534 0.333 0 CA-C-O 121.577 0.704 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.788 ' HA2' ' HB2' ' A' ' 29' ' ' ARG . . . 132.03 126.55 2.75 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.463 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 30' ' ' PHE . . . -91.71 -35.67 14.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.224 0.535 . . . . 0.0 110.597 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -127.58 150.02 49.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.064 -177.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -77.1 -44.03 32.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.842 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 1.012 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 32.0 mttm -131.48 152.04 51.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.789 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . 41.8 m-20 -54.87 -22.68 15.47 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.723 0.639 . . . . 0.0 110.586 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.92 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 2.2 p -54.22 -28.4 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.956 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.444 ' N ' HG11 ' A' ' 11' ' ' VAL . 62.0 mt-30 -77.55 -24.13 49.93 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 73.4 m -89.55 136.94 32.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.941 0.4 . . . . 0.0 110.979 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.63 154.86 53.39 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.869 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -53.66 100.34 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.141 0.496 . . . . 0.0 110.966 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.33 -23.71 1.55 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.3 p -133.41 147.88 51.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.639 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.459 ' HB3' HD12 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -134.87 167.97 19.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.994 0.361 . . . . 0.0 110.186 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.7 m -89.83 31.83 0.93 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.424 ' O ' HD12 ' A' ' 32' ' ' ILE . . . -73.99 148.67 41.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.974 0.416 . . . . 0.0 110.936 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.726 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -76.7 132.19 39.21 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.506 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 78.3 p -60.04 138.95 57.75 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.927 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.53 -24.73 63.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.375 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.3 p90 -87.39 -27.32 22.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.45 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 27' ' ' ASN . 67.9 m -150.8 122.8 8.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.038 0.447 . . . . 0.0 110.904 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.487 ' HE ' ' HB3' ' A' ' 21' ' ' ALA . 46.1 mmm-85 -74.75 10.94 1.18 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.78 0.324 . . . . 0.0 110.92 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 25' ' ' SER . 78.9 m-20 -89.75 -26.37 20.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.694 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.726 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.2 mp -85.97 115.95 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.788 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 62.0 mtt180 -140.52 43.8 1.86 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.486 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 0.8 OUTLIER -101.83 -178.12 3.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.99 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 89.1 m -68.64 79.64 0.28 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.573 0.546 . . . . 0.0 110.918 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 20' ' ' ALA . 43.9 pt -89.18 150.54 45.2 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.06 151.72 40.88 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.54 2.827 . . . . 0.0 114.896 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' A' ' 59' ' ' CYS . 5.2 mp -87.99 166.5 14.44 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.958 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.93 142.41 47.41 Favored Glycine 0 C--O 1.245 0.838 0 CA-C-N 114.714 -1.13 . . . . 0.0 114.496 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.487 ' O ' ' HB3' ' A' ' 39' ' ' GLU . 57.1 m-80 -91.23 173.08 8.12 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.396 -0.902 . . . . 0.0 111.316 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.6 m -63.0 128.83 37.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.395 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.57 11.38 85.27 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.651 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 36' ' ' ASN . 15.4 tt0 -100.56 155.35 17.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.43 140.23 58.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.175 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.7 p -143.12 145.5 32.9 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 52.7 m170 -89.5 123.5 66.59 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 9.6 Cg_endo -54.14 -34.11 77.13 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.244 2.629 . . . . 0.0 112.513 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.95 85.72 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.861 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 m -72.11 136.62 46.61 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -119.58 -142.21 0.35 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.639 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -68.49 166.37 17.05 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.618 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 72.3 t -133.8 130.63 20.74 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.92 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 52.4 Cg_exo -57.03 131.24 4.63 Favored 'Cis proline' 0 C--N 1.348 0.529 0 C-N-CA 124.278 -1.134 . . . . 0.0 113.197 0.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.789 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 69.1 t80 -77.57 150.93 34.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.226 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -74.17 52.06 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.096 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.53 -135.13 5.63 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 1.012 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 3.6 pptp? -151.48 127.73 10.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.988 0.394 . . . . 0.0 110.132 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -86.4 125.67 33.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.951 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.455 HD21 ' HD2' ' A' ' 53' ' ' LYS . 3.0 mm? -94.72 24.09 4.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.592 0.711 . . . . 0.0 109.395 178.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 m -89.84 158.79 17.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.476 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.682 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 4.6 m -89.24 24.34 2.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.726 0.298 . . . . 0.0 111.303 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.1 tp -154.07 130.15 10.31 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.79 -0.186 . . . . 0.0 111.42 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.501 ' HB3' HD12 ' A' ' 34' ' ' LEU . 16.7 m -76.26 156.7 83.57 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.72 -166.75 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 121.728 1.619 . . . . 0.0 111.229 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.436 ' O ' HD23 ' A' ' 34' ' ' LEU . 73.2 m -74.16 140.02 44.89 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.604 0.24 . . . . 0.0 111.296 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -64.55 157.64 26.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.715 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.9 m -44.05 125.26 4.3 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.736 0.647 . . . . 0.0 112.08 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.26 -30.58 10.07 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.514 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.12 140.98 28.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.095 0.474 . . . . 0.0 112.13 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.0 m -107.25 131.73 53.86 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.818 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 45.2 t -85.06 117.74 24.21 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.2 t -150.57 154.01 36.77 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 15.7 ttpp -65.4 119.67 11.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.945 0.402 . . . . 0.0 110.801 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -137.12 45.39 2.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 122.08 0.943 . . . . 0.0 108.921 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.7 -121.17 1.02 Allowed Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.5 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.18 -44.04 12.52 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -120.06 -161.01 0.85 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.593 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.576 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 3.5 m-85 -89.75 141.6 28.47 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.885 0.374 . . . . 0.0 111.196 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -131.02 160.14 35.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.274 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 81.7 m -84.76 129.2 34.86 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.715 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 C--O 1.252 1.192 0 CA-C-O 117.626 -1.178 . . . . 0.0 109.367 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.971 0.415 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.27 116.47 0.69 Allowed Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.779 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 1.005 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -89.89 -11.66 41.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.506 -0.347 . . . . 0.0 111.437 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.2 p -151.03 159.41 44.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.765 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -104.53 -54.69 2.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.309 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.59 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 21.9 ttmm -108.03 146.01 33.15 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.279 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 50' ' ' TYR . 76.7 m-20 -51.41 -22.43 2.99 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.947 0.779 . . . . 0.0 110.731 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.7 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -57.11 -27.2 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.501 179.273 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.49 ' N ' HG11 ' A' ' 11' ' ' VAL . 53.0 mt-30 -81.11 -19.62 43.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.811 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.4 m -89.95 -138.26 0.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.115 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.3 -138.24 3.62 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 119.676 -1.25 . . . . 0.0 113.3 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 m -49.86 112.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.991 -0.604 . . . . 0.0 112.582 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.452 ' HA2' HD21 ' A' ' 34' ' ' LEU . . . 57.52 34.32 68.9 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.017 -0.992 . . . . 0.0 114.83 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.3 p -145.44 140.56 27.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.914 0.857 . . . . 0.0 111.113 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.492 ' HB3' HD13 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -145.03 162.18 37.58 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.7 m -88.32 57.58 4.32 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.169 0.509 . . . . 0.0 111.73 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.795 ' HB3' HH12 ' A' ' 54' ' ' ARG . . . -93.19 168.95 10.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.006 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -85.16 152.04 23.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.938 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.506 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -59.44 134.35 56.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.524 0.202 . . . . 0.0 111.068 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.91 37.2 0.08 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -151.48 -36.68 0.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.008 0.433 . . . . 0.0 110.485 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.7 m -151.05 149.54 29.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -83.4 43.99 0.93 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.342 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -97.35 -45.05 6.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.067 0.46 . . . . 0.0 110.231 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.6 mp -89.39 135.44 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.772 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.67 54.58 0.89 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 1.005 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.4 p90 -130.74 -166.91 1.75 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.986 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.2 m -62.08 80.69 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.988 0.805 . . . . 0.0 112.959 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.497 HG13 ' SG ' ' A' ' 59' ' ' CYS . 48.8 pt -96.74 154.21 38.46 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.46 151.82 80.74 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 122.785 2.323 . . . . 0.0 114.528 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 61' ' ' CYS . 5.8 mp -87.23 164.34 16.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.874 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.9 140.01 26.09 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.111 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 58.2 m-80 -95.63 -164.64 1.18 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.181 0.515 . . . . 0.0 111.124 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.441 ' HA ' HD13 ' A' ' 65' ' ' LEU . 6.1 m -61.43 123.79 18.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.315 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.1 -6.56 82.58 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.465 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.78 150.96 22.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.376 0.588 . . . . 0.0 111.343 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.13 146.86 49.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.533 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.542 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 24.5 p -143.58 145.45 32.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.093 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 39.9 m170 -90.11 122.68 67.38 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 9.9 Cg_endo -54.15 -38.78 87.78 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.219 2.613 . . . . 0.0 112.904 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.53 65.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.86 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.516 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 17.2 m -81.33 121.01 25.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.915 0.388 . . . . 0.0 110.47 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -93.05 -172.31 2.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.196 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -72.69 165.65 24.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 49' ' ' PRO . 60.4 t -87.09 139.92 32.54 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.7 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 2.6 Cg_exo -77.12 133.11 29.61 Favored 'Cis proline' 0 C--N 1.346 0.415 0 C-N-CA 123.845 -1.314 . . . . 0.0 113.505 1.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.482 ' HB3' ' OD2' ' A' ' 10' ' ' ASP . 48.8 t80 -113.64 149.25 34.88 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.59 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 25.8 t70 -58.63 -23.67 59.52 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.394 0.616 . . . . 0.0 111.3 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.13 33.31 57.57 Favored Glycine 0 C--N 1.318 -0.426 0 N-CA-C 115.409 0.924 . . . . 0.0 115.409 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.2 pttm -88.3 56.74 3.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.035 0.917 . . . . 0.0 109.739 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.795 HH12 ' HB3' ' A' ' 20' ' ' ALA . 4.0 ppt_? -150.32 130.04 13.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.619 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 55' ' ' LEU . 94.8 mt -88.48 50.34 1.95 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.439 0.638 . . . . 0.0 110.145 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 m -89.1 137.56 32.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.779 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 p -88.68 34.75 0.77 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.201 0.524 . . . . 0.0 110.598 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.9 tp -153.28 132.16 12.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.772 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.497 ' SG ' HG13 ' A' ' 32' ' ' ILE . 2.5 m -83.3 159.85 61.03 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.516 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 6.3 Cg_exo -71.83 -161.68 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.288 1.992 . . . . 0.0 111.723 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.562 ' O ' HD23 ' A' ' 34' ' ' LEU . 74.4 m -79.01 137.86 37.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.887 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HD2' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -66.86 153.46 43.39 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.1 m -46.28 113.1 0.57 Allowed 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.571 0.545 . . . . 0.0 111.6 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.37 -32.58 4.64 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.262 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.538 ' HB3' ' HB3' ' A' ' 76' ' ' CYS . 3.6 mm? -89.72 143.12 27.07 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.2 m -110.5 128.14 55.49 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.599 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 20.8 t -72.96 119.2 16.87 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.9 m -131.22 144.33 51.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.991 0.424 . . . . 0.0 111.408 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.539 ' NZ ' ' HA ' ' A' ' 72' ' ' GLU . 53.2 tttm -67.3 109.11 2.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.379 0.609 . . . . 0.0 110.38 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.9 m -88.95 76.53 7.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.664 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.94 -69.67 3.2 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.539 ' HA ' ' NZ ' ' A' ' 69' ' ' LYS . 33.9 tp10 -130.57 -41.53 1.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.753 0.311 . . . . 0.0 110.489 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -86.56 -172.79 4.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.7 128.84 47.32 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -135.14 150.32 50.15 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.542 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 68.9 m -70.83 133.9 46.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.945 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.9 m . . . . . 0 C--O 1.254 1.294 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.192 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 121.654 0.74 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . -171.01 72.36 0.11 Allowed Glycine 0 C--O 1.226 -0.368 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.929 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -81.35 -23.6 37.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.464 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 18.6 p -151.13 154.92 37.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -92.03 -60.77 1.77 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.611 0.719 . . . . 0.0 110.236 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -101.35 139.32 37.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.798 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.59 ' OD2' ' HB2' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -46.68 -33.19 4.07 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.32 1.012 . . . . 0.0 111.797 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.8 t -49.55 -32.4 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.631 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -66.03 -30.19 70.69 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.592 ' HB3' ' HG1' ' A' ' 17' ' ' THR . 66.6 m -89.88 159.84 16.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.118 0.485 . . . . 0.0 111.378 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.99 166.49 54.9 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.48 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.442 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 56.9 m -63.79 67.13 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.71 0.804 . . . . 0.0 112.125 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.35 -26.44 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.404 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.592 ' HG1' ' HB3' ' A' ' 13' ' ' CYS . 26.5 p -124.39 142.73 51.07 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.59 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 0.7 OUTLIER -119.74 154.19 34.53 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 60.4 m -89.52 48.52 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 0.0 111.961 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -95.54 -170.09 2.09 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.11 141.34 28.78 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.421 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 88.2 p -63.46 142.98 58.19 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.108 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.659 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -55.93 -26.38 47.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -87.97 -32.23 18.96 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.444 ' C ' ' H ' ' A' ' 27' ' ' ASN . 68.1 m -151.67 135.87 16.7 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.914 -0.492 . . . . 0.0 111.538 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.464 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 59.7 mtm180 -78.46 20.55 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.128 0.489 . . . . 0.0 110.785 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.444 ' H ' ' C ' ' A' ' 25' ' ' SER . 74.2 m-20 -92.55 -31.32 15.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.605 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.664 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 1.8 mp -85.39 120.81 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 89.2 mtt180 -139.14 77.44 1.62 Allowed 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.914 0.759 . . . . 0.0 109.717 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.929 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.0 OUTLIER -150.83 -167.08 2.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.565 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 84.2 m -60.34 77.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.667 HG13 ' SG ' ' A' ' 59' ' ' CYS . 34.0 pt -97.99 146.37 31.37 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -57.01 151.39 50.21 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.267 2.644 . . . . 0.0 115.084 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.522 HD13 ' HB3' ' A' ' 59' ' ' CYS . 5.1 mp -87.11 168.79 12.96 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.769 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.74 147.07 37.9 Favored Glycine 0 C--O 1.239 0.436 0 CA-C-N 115.246 -0.888 . . . . 0.0 114.02 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 72.5 m-80 -100.85 -178.98 3.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.163 -0.518 . . . . 0.0 109.799 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.3 m -62.86 129.51 40.75 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.07 -6.76 76.32 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.179 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -88.2 154.56 20.34 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.897 0.379 . . . . 0.0 111.029 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -67.6 142.82 56.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.821 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.504 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 31.6 p -146.01 150.15 35.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.207 0.527 . . . . 0.0 110.688 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -95.4 126.94 43.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.56 -40.83 77.64 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.092 2.528 . . . . 0.0 112.907 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.46 -33.86 76.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.134 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.626 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 17.7 m -73.31 138.82 45.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.362 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -129.29 175.46 8.72 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 7.7 ptmt -59.69 150.88 26.43 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.445 0.466 . . . . 0.0 111.6 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.488 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 60.3 t -87.14 142.56 33.77 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.651 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 48' ' ' VAL . 33.5 Cg_exo -63.07 138.46 28.27 Favored 'Cis proline' 0 C--N 1.351 0.683 0 C-N-CA 124.392 -1.087 . . . . 0.0 113.73 1.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.489 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 34.5 t80 -146.57 141.79 27.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.703 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -74.13 79.46 1.75 Allowed 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.547 ' HA3' ' OD1' ' A' ' 10' ' ' ASP . . . -89.48 131.84 10.93 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.783 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.18 37.46 0.55 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.324 0.583 . . . . 0.0 109.432 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.404 HH12 ' CG ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -115.88 139.9 49.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.915 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.68 48.53 1.6 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.223 0.535 . . . . 0.0 110.463 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.7 m -103.04 143.38 32.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.39 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.659 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 72.7 m -88.86 47.92 1.56 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.57 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 53.9 tp -152.51 124.14 7.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.726 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.667 ' SG ' HG13 ' A' ' 32' ' ' ILE . 3.7 m -84.14 153.94 63.29 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.718 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.626 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 12.3 Cg_exo -69.44 -169.96 0.34 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.497 2.132 . . . . 0.0 111.642 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 82.5 m -77.75 139.37 39.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.67 0.271 . . . . 0.0 111.248 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.435 ' HG2' HD11 ' A' ' 65' ' ' LEU . 19.1 ptmt -62.13 154.12 28.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.22 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.442 ' OG ' ' HB3' ' A' ' 15' ' ' SER . 17.6 m -51.03 125.27 13.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.312 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.54 -29.67 9.7 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.415 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.435 HD11 ' HG2' ' A' ' 62' ' ' LYS . 22.6 mt -88.91 152.7 21.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.025 0.44 . . . . 0.0 111.936 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -113.26 128.13 56.38 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.998 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.544 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 53.8 t -84.69 119.67 25.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.1 t -150.97 158.97 44.81 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 23.8 ttpp -65.82 102.4 0.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.245 0.545 . . . . 0.0 109.824 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.533 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 12.1 m -101.6 43.46 1.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.182 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.4 -105.6 0.47 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.322 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.495 ' CD ' ' HG2' ' A' ' 73' ' ' LYS . 1.1 pm0 -86.08 -40.51 15.65 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 122.776 0.43 . . . . 0.0 110.406 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.495 ' HG2' ' CD ' ' A' ' 72' ' ' GLU . 25.0 pttt -133.23 -164.26 1.46 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.902 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 5.1 m-85 -90.09 134.4 34.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.148 0.499 . . . . 0.0 111.468 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 46.4 mttp -135.86 154.33 51.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.063 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 73.0 m -75.39 126.44 31.01 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.469 -178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.249 1.065 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.677 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.413 HG21 ' N ' ' A' ' 5' ' ' GLY . 14.5 t . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.413 ' N ' HG21 ' A' ' 4' ' ' THR . . . -161.67 108.39 0.35 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.043 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 1.003 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -91.17 -14.19 31.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 p -147.7 145.82 29.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.087 0.47 . . . . 0.0 111.904 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.552 ' O ' ' HB3' ' A' ' 53' ' ' LYS . 17.6 t70 -88.23 -44.79 10.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.42 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.53 ' HG3' ' OD2' ' A' ' 8' ' ' ASP . 61.6 mttp -121.49 144.88 48.46 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 108.962 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.674 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 37.8 t0 -55.31 -18.8 7.03 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.838 0.711 . . . . 0.0 111.005 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.45 HG11 ' N ' ' A' ' 12' ' ' GLN . 1.7 p -55.49 -25.33 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.802 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.45 ' N ' HG11 ' A' ' 11' ' ' VAL . 78.8 mt-30 -82.13 -16.76 48.76 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 68.8 m -89.8 -129.79 0.08 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.784 0.326 . . . . 0.0 110.678 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.86 169.88 35.92 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.507 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.4 m -51.96 105.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.125 0.488 . . . . 0.0 111.364 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.63 -35.22 1.89 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.462 HG21 ' HA ' ' A' ' 33' ' ' PRO . 23.6 p -139.75 143.58 37.04 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.745 0.418 . . . . 0.0 110.08 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.581 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -128.13 159.51 34.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.674 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 67.9 m -85.78 105.09 16.05 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.192 0.52 . . . . 0.0 109.689 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.64 ' HB3' ' HB2' ' A' ' 54' ' ' ARG . . . -159.58 173.36 16.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.07 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -82.27 138.07 34.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.298 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.657 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -66.03 137.37 57.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.865 0.364 . . . . 0.0 110.881 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.03 -24.73 66.4 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -86.78 -34.82 19.47 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.416 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.466 ' C ' ' H ' ' A' ' 27' ' ' ASN . 28.2 m -151.59 124.88 8.78 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.48 ' HD3' ' N ' ' A' ' 26' ' ' ARG . 1.6 mpp_? -76.29 30.0 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.019 0.438 . . . . 0.0 111.834 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.466 ' H ' ' C ' ' A' ' 25' ' ' SER . 5.6 m120 -90.03 -37.26 14.42 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.657 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.0 mp -89.58 125.76 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.198 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.51 ' HD3' ' C ' ' A' ' 28' ' ' ILE . 1.3 mpp_? -136.84 68.19 1.43 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 1.003 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.1 p90 -147.29 -161.09 1.26 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.495 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 82.9 m -60.87 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.966 0.791 . . . . 0.0 111.911 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.546 HG13 ' SG ' ' A' ' 59' ' ' CYS . 43.4 pt -100.84 150.54 37.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HA ' HG21 ' A' ' 17' ' ' THR . 10.0 Cg_endo -52.48 148.14 27.59 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 123.41 2.74 . . . . 0.0 114.67 -177.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.631 ' HB2' ' HG2' ' A' ' 62' ' ' LYS . 90.8 mt -85.53 163.84 18.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.979 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 62' ' ' LYS . . . -59.67 137.41 49.76 Favored Glycine 0 C--O 1.24 0.509 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.91 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -88.88 165.6 14.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.172 0.589 . . . . 0.0 110.289 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.6 t -62.52 133.77 55.44 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.493 ' O ' ' HD3' ' A' ' 75' ' ' LYS . . . 87.96 -12.08 65.07 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.548 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -88.59 159.79 17.72 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 117.107 0.453 . . . . 0.0 111.861 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.535 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 0.3 OUTLIER -65.65 147.73 52.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.091 -178.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.3 p -149.83 142.52 24.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.273 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -88.0 124.8 66.22 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -51.7 -38.98 67.38 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.47 2.78 . . . . 0.0 113.795 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.65 25.67 0.42 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.426 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . 49.5 m -90.64 122.36 33.36 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.915 -0.491 . . . . 0.0 110.372 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.532 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 19.3 m170 -77.46 149.24 35.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HZ2' ' HB3' ' A' ' 47' ' ' LYS . 1.7 ttpm? -55.39 149.65 12.85 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.631 0.582 . . . . 0.0 111.298 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 49' ' ' PRO . 84.9 t -85.87 138.3 35.3 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.891 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HA ' HG12 ' A' ' 48' ' ' VAL . 8.2 Cg_exo -73.58 135.18 38.83 Favored 'Cis proline' 0 C--N 1.344 0.296 0 C-N-CA 123.603 -1.415 . . . . 0.0 112.88 1.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.532 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 89.1 t80 -64.32 143.05 58.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.421 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.58 44.82 0.13 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.06 -139.75 6.9 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.801 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.552 ' HB3' ' O ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -121.49 134.27 55.06 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.64 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . 61.4 mtp85 -88.08 124.07 33.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.845 0.355 . . . . 0.0 111.209 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.474 ' N ' HD21 ' A' ' 55' ' ' LEU . 3.4 mm? -88.94 -5.87 57.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.299 0.571 . . . . 0.0 109.946 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m -87.85 146.43 25.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.459 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 13.3 m -87.41 42.82 1.06 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.983 0.42 . . . . 0.0 111.387 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.1 tp -153.62 121.99 6.22 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.379 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.546 ' SG ' HG13 ' A' ' 32' ' ' ILE . 3.4 m -81.0 148.19 63.62 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.43 ' HD3' ' CZ ' ' A' ' 54' ' ' ARG . 37.3 Cg_endo -67.41 173.39 8.8 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 121.849 1.7 . . . . 0.0 111.46 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.8 m -59.34 144.37 46.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.121 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.631 ' HG2' ' HB2' ' A' ' 34' ' ' LEU . 60.2 mttm -56.17 143.96 31.39 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -51.56 110.3 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.17 0.51 . . . . 0.0 110.543 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.75 -30.06 3.65 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.7 mt -88.83 147.19 24.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.698 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.3 m -109.91 126.78 54.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.017 0.437 . . . . 0.0 111.481 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.4 t -78.53 116.23 18.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.0 t -134.46 158.68 43.28 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.902 0.382 . . . . 0.0 110.416 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 41.5 ttmt -71.63 112.04 7.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.5 t -91.34 56.94 3.23 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.18 -92.43 1.77 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.226 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -91.02 -46.39 8.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.052 0.453 . . . . 0.0 111.257 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.564 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -107.22 167.06 10.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.711 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 13.4 m-85 -95.38 132.16 40.72 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.535 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 55.1 mttm -138.75 153.36 48.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.379 0.609 . . . . 0.0 111.013 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 70.7 m -66.33 132.51 48.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.364 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 C--O 1.253 1.266 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.129 179.701 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.59 0.71 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.56 129.72 4.06 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.674 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.95 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.4 -10.24 44.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.637 0.256 . . . . 0.0 111.571 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 18.8 p -150.76 150.67 31.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.973 0.416 . . . . 0.0 111.409 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -97.41 -46.22 6.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.117 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -114.33 145.08 42.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.439 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.764 ' HB2' ' H ' ' A' ' 50' ' ' TYR . 88.2 m-20 -57.35 -26.85 61.63 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.509 0.505 . . . . 0.0 111.417 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -57.39 -29.15 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.898 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -70.23 -26.05 63.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.491 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 58.0 m -90.69 -122.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.119 0.485 . . . . 0.0 110.784 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.33 157.08 28.14 Favored Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.666 ' HA ' HG13 ' A' ' 48' ' ' VAL . 15.8 m -55.67 101.0 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.297 0.57 . . . . 0.0 110.846 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.03 -28.08 1.13 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.6 p -135.27 139.49 44.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.15 -0.525 . . . . 0.0 109.833 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.591 ' SG ' ' HB1' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -123.83 159.64 29.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.0 m -88.06 51.22 2.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.89 0.376 . . . . 0.0 111.539 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.591 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . -79.62 160.79 26.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.043 0.449 . . . . 0.0 110.998 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.68 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -90.4 144.5 25.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.422 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.637 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -64.58 135.45 55.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.972 0.415 . . . . 0.0 110.395 179.179 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.498 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -64.87 -23.06 67.12 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.0 p90 -87.94 -37.68 16.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.4 m -151.74 152.63 32.98 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.19 -0.318 . . . . 0.0 110.162 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -81.75 41.4 0.64 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.775 0.322 . . . . 0.0 111.453 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -97.07 -39.43 9.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.951 0.405 . . . . 0.0 110.828 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.637 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 53.2 mt -88.86 125.63 41.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.918 0.39 . . . . 0.0 110.297 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.3 mmm-85 -150.95 41.03 0.74 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.865 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.95 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.4 p90 -121.64 -172.77 2.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.971 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.4 m -61.15 82.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 O-C-N 124.369 1.043 . . . . 0.0 112.609 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.514 HG13 ' SG ' ' A' ' 59' ' ' CYS . 30.4 pt -97.86 147.13 32.62 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.07 152.5 36.95 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.388 2.725 . . . . 0.0 114.663 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 59' ' ' CYS . 3.8 mp -87.38 164.73 16.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.317 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.597 ' O ' ' HG3' ' A' ' 62' ' ' LYS . . . -75.4 154.89 46.5 Favored Glycine 0 C--O 1.237 0.335 0 CA-C-N 115.116 -0.947 . . . . 0.0 114.291 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.526 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 1.3 p30 -109.18 169.56 8.61 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.131 0.491 . . . . 0.0 110.991 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.402 ' OG ' HD23 ' A' ' 65' ' ' LEU . 12.7 m -54.59 121.91 9.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.287 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.12 -24.38 16.42 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.04 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 10.7 pt-20 -100.53 153.02 19.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.365 0.582 . . . . 0.0 110.958 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.45 150.71 21.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.299 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.526 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 13.3 p -149.23 154.47 39.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.787 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -90.97 128.54 47.46 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.45 -60.07 0.8 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.5 2.8 . . . . 0.0 114.207 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.35 26.79 0.3 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.189 0.518 . . . . 0.0 110.551 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -81.98 2.63 29.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.761 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.538 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -178.18 36.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.621 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.571 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -68.33 136.14 52.95 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.603 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.666 HG13 ' HA ' ' A' ' 15' ' ' SER . 24.6 t -86.44 128.39 57.26 Favored Pre-proline 0 C--N 1.315 -0.906 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.94 -178.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -91.13 131.03 7.72 Favored 'Cis proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.797 -1.335 . . . . 0.0 112.855 0.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.764 ' H ' ' HB2' ' A' ' 10' ' ' ASP . 12.1 t80 -109.12 120.46 42.61 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.266 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -84.15 63.8 7.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.909 0.861 . . . . 0.0 108.838 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.15 142.62 7.32 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.881 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.49 52.2 0.83 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.292 0.568 . . . . 0.0 110.126 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.4 tpt85 -57.73 139.46 53.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.079 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 55' ' ' LEU . 3.3 mm? -84.46 61.68 6.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.797 0.808 . . . . 0.0 110.391 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.5 m -102.17 129.41 48.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.471 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 7.0 m -89.24 28.39 1.24 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.849 0.357 . . . . 0.0 111.496 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.1 tp -153.9 129.09 9.69 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.342 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.514 ' SG ' HG13 ' A' ' 32' ' ' ILE . 3.8 m -78.77 164.44 55.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.844 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.522 ' HG3' ' HA ' ' A' ' 47' ' ' LYS . 94.7 Cg_endo -78.5 -157.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.305 2.003 . . . . 0.0 111.508 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 90.4 m -87.14 145.5 26.4 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.399 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 29.5 mtpp -57.46 153.44 12.72 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.678 0.611 . . . . 0.0 110.236 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.8 m -49.39 121.73 5.35 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.229 0.331 . . . . 0.0 111.178 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.6 -24.34 28.91 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 65' ' ' LEU . 42.3 mt -88.27 152.13 22.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.845 0.355 . . . . 0.0 111.396 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.2 m -115.59 129.51 56.54 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.132 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.0 t -81.65 116.2 21.27 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 m -132.72 146.05 51.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.708 0.289 . . . . 0.0 110.663 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.665 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 34.8 ttpt -70.33 108.03 4.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.116 0.484 . . . . 0.0 110.887 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.863 ' HB3' ' HD3' ' A' ' 75' ' ' LYS . 19.6 t -94.38 76.85 3.9 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.54 -102.1 2.86 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.104 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.53 ' OE1' ' HG3' ' A' ' 73' ' ' LYS . 2.8 tt0 -89.01 -56.46 3.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.518 -0.341 . . . . 0.0 111.503 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.53 ' HG3' ' OE1' ' A' ' 72' ' ' GLU . 64.5 mttp -102.8 172.46 6.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.17 0.509 . . . . 0.0 111.953 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 10.1 m-85 -89.48 132.05 35.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.352 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.863 ' HD3' ' HB3' ' A' ' 70' ' ' SER . 1.6 mptp? -130.95 150.05 52.29 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 62.5 m -69.64 144.98 52.77 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.699 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--O 1.248 0.981 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.398 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.32 121.42 0.64 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.454 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 1.056 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -91.34 -14.84 30.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.2 p -150.66 167.47 27.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.923 0.392 . . . . 0.0 111.49 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.24 -44.0 2.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.186 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 46.3 mmtm -104.09 138.16 41.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.734 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.406 ' OD2' ' HG2' ' A' ' 54' ' ' ARG . 70.4 m-20 -57.96 -28.58 64.48 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.347 0.594 . . . . 0.0 109.847 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.4 t -56.74 -29.87 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 114.827 -1.078 . . . . 0.0 111.486 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -69.11 -22.77 63.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.636 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.8 m -89.48 -126.44 0.07 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.138 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.39 -177.8 43.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.127 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.5 m -67.63 66.18 0.08 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.435 0.636 . . . . 0.0 111.488 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 176.58 -24.2 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.341 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.1 p -139.55 147.89 41.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.023 0.129 . . . . 0.0 110.655 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.481 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -136.16 160.27 39.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.4 m -87.6 51.82 2.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.136 0.493 . . . . 0.0 111.762 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.75 164.19 16.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.805 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.66 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -86.06 144.59 27.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.102 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.636 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -64.76 134.07 53.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.932 0.396 . . . . 0.0 111.146 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.766 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -65.7 -21.23 66.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -87.57 -35.15 18.28 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 27' ' ' ASN . 40.7 m -151.84 144.06 23.98 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.079 -0.388 . . . . 0.0 110.524 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.94 33.79 0.18 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.955 0.407 . . . . 0.0 111.627 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 25' ' ' SER . 4.8 m120 -98.18 -40.83 8.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.755 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.636 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.8 mp -88.08 127.23 41.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.961 0.41 . . . . 0.0 110.918 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HD3' ' C ' ' A' ' 28' ' ' ILE . 1.1 mpp_? -143.34 68.49 1.29 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.863 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 1.056 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.5 p90 -145.76 -170.52 3.49 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.763 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.2 m -60.92 75.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.288 0.992 . . . . 0.0 112.946 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.547 HG13 ' SG ' ' A' ' 59' ' ' CYS . 43.9 pt -89.83 153.05 47.34 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.78 151.54 47.54 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.137 2.558 . . . . 0.0 114.691 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 60' ' ' PRO . 3.6 mp -87.09 170.82 11.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.936 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.54 133.28 25.47 Favored Glycine 0 C--O 1.243 0.696 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.483 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -89.75 167.83 12.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.191 -0.505 . . . . 0.0 110.36 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 m -59.97 128.1 35.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.767 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.8 -5.2 84.5 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.145 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.475 ' HA ' ' NZ ' ' A' ' 75' ' ' LYS . 5.9 mm-40 -99.21 162.44 13.05 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 117.411 0.606 . . . . 0.0 111.8 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.524 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 41.3 p-10 -63.59 151.82 40.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.251 1.024 . . . . 0.0 113.217 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 21.5 p -151.08 143.65 24.33 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.331 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -89.45 121.65 69.09 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -48.54 -40.25 37.28 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.775 2.984 . . . . 0.0 113.738 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.43 ' HB1' ' NH2' ' A' ' 54' ' ' ARG . . . -66.28 -28.39 68.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.121 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 53.9 m -73.82 137.07 43.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.889 0.376 . . . . 0.0 110.587 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -123.0 145.89 48.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.87 144.12 1.9 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.554 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 21.9 t -88.25 143.21 32.35 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.052 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.554 ' C ' ' HA ' ' A' ' 48' ' ' VAL . 19.1 Cg_endo -60.75 131.8 8.24 Favored 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.402 -1.082 . . . . 0.0 114.185 1.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -115.73 137.76 51.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.176 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -69.62 109.87 4.54 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.21 -133.78 11.5 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -152.5 152.42 31.91 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.43 ' NH2' ' HB1' ' A' ' 44' ' ' ALA . 23.1 mmm180 -85.41 107.19 17.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.143 0.497 . . . . 0.0 111.906 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.75 61.49 6.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 t -144.66 163.39 34.11 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.598 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.766 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 6.6 m -88.02 21.98 2.55 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.5 tp -154.08 127.82 8.76 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 121.168 -0.213 . . . . 0.0 111.299 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.547 ' SG ' HG13 ' A' ' 32' ' ' ILE . 13.3 m -74.76 154.29 87.18 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.066 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.513 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 57.0 Cg_endo -69.76 178.28 4.73 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.475 2.117 . . . . 0.0 111.973 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 71.4 m -70.27 143.1 52.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.449 ' HG2' HD13 ' A' ' 65' ' ' LEU . 9.8 ptmm? -60.66 146.91 43.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.1 m -45.52 128.88 8.47 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.078 0.466 . . . . 0.0 111.381 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.99 -28.97 10.86 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.585 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.449 HD13 ' HG2' ' A' ' 62' ' ' LYS . 22.2 mt -89.85 145.28 25.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.955 0.407 . . . . 0.0 111.735 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.9 m -108.59 126.44 52.94 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.955 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 48.1 t -81.01 126.58 31.58 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.6 p -149.46 149.15 30.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.752 0.31 . . . . 0.0 111.231 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.871 ' HE3' ' HA ' ' A' ' 72' ' ' GLU . 46.8 tttt -66.92 105.58 1.66 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.376 0.608 . . . . 0.0 110.984 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 6.8 m -89.83 82.7 6.2 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.833 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.91 -64.09 3.96 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.274 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.871 ' HA ' ' HE3' ' A' ' 69' ' ' LYS . 0.8 OUTLIER -141.02 -47.27 0.4 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.999 0.428 . . . . 0.0 110.028 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -94.77 158.47 15.49 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 15.2 m-85 -88.37 130.08 35.24 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.45 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.524 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 37.2 mttm -134.85 155.52 50.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.315 0.579 . . . . 0.0 110.141 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.3 m -73.86 137.16 43.57 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.373 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.244 0.805 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.413 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.2 p . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.041 0.448 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.19 122.7 0.28 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.435 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.986 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -82.56 -6.53 59.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.722 0.296 . . . . 0.0 111.614 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 p -149.89 146.25 26.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.954 0.406 . . . . 0.0 111.739 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.453 ' OD1' ' HG2' ' A' ' 9' ' ' LYS . 3.2 t70 -95.37 -57.01 2.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.453 ' HG2' ' OD1' ' A' ' 8' ' ' ASP . 23.6 mmtp -93.99 141.5 28.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.746 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.2 -31.03 66.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.538 0.685 . . . . 0.0 109.881 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.805 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 47.8 t -55.97 -27.16 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.943 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -67.08 -25.56 66.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.605 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 71.3 m -89.61 138.27 31.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.03 0.443 . . . . 0.0 111.331 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.17 151.2 49.74 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.631 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.409 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 18.4 m -51.48 113.02 0.85 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.187 0.517 . . . . 0.0 110.741 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.13 -27.86 3.1 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.4 p -128.87 144.87 51.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.965 -0.618 . . . . 0.0 109.535 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.411 ' HB3' HD12 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -128.96 166.51 19.03 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 72.3 m -88.02 52.77 2.55 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.797 0.332 . . . . 0.0 111.678 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.473 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -89.81 156.6 18.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.11 0.481 . . . . 0.0 111.336 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.26 145.88 24.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.463 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.585 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -66.0 128.0 34.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.086 0.469 . . . . 0.0 110.883 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.69 -20.13 65.91 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -86.81 -36.17 18.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.811 0.338 . . . . 0.0 111.441 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.8 m -152.0 138.79 18.89 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.452 ' HD3' ' N ' ' A' ' 26' ' ' ARG . 1.6 mpp_? -76.7 48.26 0.55 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.639 0.257 . . . . 0.0 111.547 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -103.95 -41.03 5.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.856 0.36 . . . . 0.0 110.379 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.585 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 69.5 mt -89.6 131.02 37.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.816 0.341 . . . . 0.0 110.335 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -151.73 52.63 0.82 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.986 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.9 p90 -140.45 -168.49 2.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.871 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 67.0 m -57.62 99.06 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 O-C-N 124.11 0.881 . . . . 0.0 112.378 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.514 HG13 ' SG ' ' A' ' 59' ' ' CYS . 46.1 pt -120.74 149.9 51.53 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.39 147.52 67.43 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.408 2.739 . . . . 0.0 115.125 -177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 61' ' ' CYS . 7.1 mp -88.34 164.5 15.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.359 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.77 149.29 26.79 Favored Glycine 0 C--O 1.238 0.348 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.252 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 49.6 m-80 -103.34 -168.12 1.47 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.999 0.428 . . . . 0.0 110.922 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 m -61.61 129.95 43.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.626 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.409 ' O ' ' HE3' ' A' ' 75' ' ' LYS . . . 93.11 -12.24 70.28 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.323 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 36' ' ' ASN . 49.1 mt-10 -90.86 144.8 25.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.29 0.566 . . . . 0.0 111.293 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.568 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 11.6 m-20 -62.38 145.63 53.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.301 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.414 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -135.52 179.91 6.04 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -116.76 122.12 31.99 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -57.77 -34.79 98.71 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.771 2.314 . . . . 0.0 112.492 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.52 -26.46 62.67 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.565 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.562 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 40.6 m -78.35 129.94 35.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.419 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -88.35 -152.25 0.22 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.607 ' HD2' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -88.2 146.57 25.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.437 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 70.8 t -88.65 136.72 30.8 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 123.436 0.46 . . . . 0.0 110.191 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.805 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 16.7 Cg_exo -68.82 128.25 11.3 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.863 -1.307 . . . . 0.0 113.115 0.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.48 ' CE2' ' HG2' ' A' ' 54' ' ' ARG . 80.5 t80 -65.26 145.86 55.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.111 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.93 49.9 0.25 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.23 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.61 -143.51 9.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.955 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -150.4 59.45 0.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.1 0.476 . . . . 0.0 111.37 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.48 ' HG2' ' CE2' ' A' ' 50' ' ' TYR . 22.0 mmt85 -59.39 140.55 56.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.29 57.76 4.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.416 0.627 . . . . 0.0 110.311 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.2 m -88.84 141.78 28.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.253 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 4.1 p -89.13 17.6 5.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.955 0.407 . . . . 0.0 111.698 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.9 tp -154.18 129.88 10.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.724 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.514 ' SG ' HG13 ' A' ' 32' ' ' ILE . 9.0 m -73.37 149.49 88.96 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 7.5 Cg_exo -72.11 -160.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.396 2.064 . . . . 0.0 111.762 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.856 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 44.1 m -75.72 139.31 41.82 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.992 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.423 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -60.79 150.11 33.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.835 179.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 15' ' ' SER . 13.8 m -49.67 125.29 11.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.625 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.86 -33.72 5.74 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.917 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.5 mt -89.95 163.59 14.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.922 0.391 . . . . 0.0 111.817 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -133.64 137.75 45.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.08 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.856 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 10.5 t -92.53 148.99 21.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.785 0.326 . . . . 0.0 111.039 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.6 t -147.94 156.6 42.85 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -73.79 111.99 9.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.381 0.61 . . . . 0.0 110.302 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.8 m -89.55 66.88 7.42 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.94 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.16 -60.4 1.94 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.169 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -142.17 -46.15 0.34 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -88.24 160.46 17.68 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.461 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 25.4 m-85 -99.28 122.38 42.36 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.477 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.568 ' HD2' ' HA ' ' A' ' 40' ' ' ASP . 19.6 mmmt -123.2 144.07 49.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 95.1 m -73.42 149.84 42.16 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.237 -0.887 . . . . 0.0 109.382 179.426 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 C--O 1.237 0.408 0 CA-C-O 121.739 0.781 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.5 ' CA ' ' HB2' ' A' ' 29' ' ' ARG . . . 107.25 132.17 6.87 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.465 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -76.97 -20.39 56.15 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.171 0.51 . . . . 0.0 110.542 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 p -137.08 158.85 43.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.876 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -83.17 -51.05 7.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.602 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.913 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 28.1 mttm -126.11 147.3 49.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.737 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . 40.8 m-20 -51.41 -28.72 13.56 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.01 0.819 . . . . 0.0 111.33 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 t -53.74 -32.67 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.049 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -69.18 -25.47 64.36 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.3 m -89.3 135.19 33.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.903 0.383 . . . . 0.0 110.409 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.04 156.05 50.19 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.4 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.4 m -52.71 104.12 0.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.288 0.566 . . . . 0.0 110.442 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.17 -19.66 1.92 Allowed Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.0 p -137.56 157.1 47.26 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.284 -0.458 . . . . 0.0 110.55 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.484 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -140.85 162.3 35.78 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.7 m -91.09 35.52 0.91 Allowed 'General case' 0 C--O 1.239 0.528 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.71 169.34 15.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.909 0.385 . . . . 0.0 110.639 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.709 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -78.96 135.92 37.08 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.8 p -66.47 146.24 54.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.39 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.41 -26.12 66.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.358 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 35.8 p90 -88.02 -29.6 20.59 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.731 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.626 ' HB2' HD12 ' A' ' 28' ' ' ILE . 69.3 m -150.99 122.7 8.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.244 0.545 . . . . 0.0 110.937 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.492 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . 99.2 mtt180 -72.32 3.04 5.09 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.633 ' OD1' HD13 ' A' ' 28' ' ' ILE . 20.6 p30 -89.27 -17.04 29.79 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.709 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.0 mp -87.48 121.11 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.5 ' HB2' ' CA ' ' A' ' 5' ' ' GLY . 12.7 mtm105 -141.88 39.85 1.66 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 6' ' ' ALA . 2.2 m-85 -89.57 -175.68 4.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 91.3 m -69.09 79.1 0.34 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.639 HG13 ' SG ' ' A' ' 59' ' ' CYS . 31.1 pt -89.25 146.01 35.3 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.12 144.79 45.55 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.832 3.021 . . . . 0.0 115.042 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 94.8 mt -87.33 160.48 18.37 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.986 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 62' ' ' LYS . . . -61.12 151.38 42.28 Favored Glycine 0 C--O 1.238 0.392 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.1 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.583 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 16.3 p30 -118.93 -167.72 1.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 m -62.85 117.59 6.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.873 0.368 . . . . 0.0 111.259 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.53 1.65 68.45 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.759 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -88.38 152.31 22.0 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.678 0.275 . . . . 0.0 111.228 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.489 ' CG ' ' HZ1' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -67.76 143.91 55.64 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.356 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.7 p -147.12 144.4 29.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.986 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.41 ' HB2' ' OG ' ' A' ' 45' ' ' SER . 50.3 m170 -89.46 129.42 47.31 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.82 -41.3 39.06 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.291 2.66 . . . . 0.0 114.236 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.4 12.78 3.38 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.649 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . 5.7 m -91.25 122.54 33.96 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.016 -0.428 . . . . 0.0 110.212 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.58 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 27.6 m170 -88.56 153.71 20.92 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.24 149.3 20.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.54 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.543 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 78.3 t -88.91 139.22 29.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.78 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 48' ' ' VAL . 29.9 Cg_endo -64.17 125.28 4.57 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 123.615 -1.411 . . . . 0.0 113.326 1.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.58 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 90.8 t80 -72.77 145.95 46.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.212 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.79 55.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.547 0.689 . . . . 0.0 111.315 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.67 -129.54 3.24 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.913 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 2.6 pptp? -150.72 129.75 12.61 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -77.3 128.45 34.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.277 0.56 . . . . 0.0 112.277 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.443 ' HA ' HD22 ' A' ' 55' ' ' LEU . 90.1 mt -101.44 15.72 27.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.766 0.793 . . . . 0.0 109.399 178.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.3 m -89.73 157.58 17.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.657 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 8.1 m -88.34 30.89 0.84 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.186 0.517 . . . . 0.0 110.511 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.3 tp -154.9 127.77 8.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.912 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.639 ' SG ' HG13 ' A' ' 32' ' ' ILE . 1.7 m -76.35 142.37 71.27 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.649 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 41.9 Cg_endo -68.17 -176.35 1.04 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.039 1.826 . . . . 0.0 112.096 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.0 m -67.15 139.09 57.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.331 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 6.2 ptpp? -67.49 151.5 47.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.8 m -48.34 109.25 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.599 0.562 . . . . 0.0 110.911 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.04 -34.3 2.76 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 76' ' ' CYS . 3.9 mm? -89.16 139.12 30.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.797 0.332 . . . . 0.0 110.809 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -106.12 129.54 54.18 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.957 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 41.9 t -78.34 126.04 30.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.7 t -145.66 156.12 43.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.874 0.368 . . . . 0.0 110.479 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -71.44 107.69 4.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.339 0.59 . . . . 0.0 110.846 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.975 ' HB3' ' HD3' ' A' ' 75' ' ' LYS . 47.7 t -98.4 70.91 2.01 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.871 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.15 -106.02 3.33 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.119 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.614 ' OE1' ' HG2' ' A' ' 73' ' ' LYS . 11.6 tm-20 -89.31 -51.21 5.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.624 0.212 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.614 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 43.7 mmtm -94.76 178.68 5.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.942 0.401 . . . . 0.0 111.141 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -103.88 131.87 50.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.433 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.975 ' HD3' ' HB3' ' A' ' 70' ' ' SER . 3.6 mptp? -130.13 154.63 47.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.029 0.442 . . . . 0.0 110.314 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 61.6 m -77.8 136.22 38.08 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.388 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.723 -1.132 . . . . 0.0 109.365 179.912 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 121.239 0.542 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.08 124.45 1.31 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.76 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 1.031 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -81.22 -12.14 59.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.9 p -141.74 157.04 45.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.09 0.471 . . . . 0.0 111.514 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.741 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 26.7 t70 -105.18 -44.35 4.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.033 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -111.98 139.43 47.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.854 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -53.63 -32.9 53.18 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.725 0.64 . . . . 0.0 111.474 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.3 t -52.7 -28.9 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.314 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -68.23 -29.38 68.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 71.3 m -90.41 140.21 29.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.137 0.494 . . . . 0.0 111.499 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.21 154.58 50.8 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.963 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.9 m -53.46 105.83 0.15 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.353 0.597 . . . . 0.0 110.784 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.39 -28.55 1.79 Allowed Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.6 p -127.62 142.79 51.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.801 -0.7 . . . . 0.0 109.229 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HB3' HD13 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -125.64 158.84 33.72 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.354 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 81.1 m -88.16 47.94 1.57 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.407 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . -92.0 162.49 14.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.815 0.341 . . . . 0.0 110.493 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.603 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -83.87 134.49 34.69 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.483 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 81.2 p -72.41 137.19 46.32 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.705 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.14 -24.46 67.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.567 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.6 p90 -88.32 -20.03 25.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.878 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.436 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 59.9 m -149.24 117.4 6.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.197 0.523 . . . . 0.0 110.955 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -69.07 -13.68 62.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.226 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.436 ' OD1' ' HB3' ' A' ' 25' ' ' SER . 16.1 p-10 -88.29 -15.81 34.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.694 0.283 . . . . 0.0 111.204 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 1.7 mp -88.13 118.78 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.741 ' NH2' ' HA ' ' A' ' 8' ' ' ASP . 28.4 ttp180 -150.43 50.77 0.89 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 1.031 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.1 p90 -117.44 -166.17 1.16 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.637 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.6 m -62.04 76.97 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.077 0.861 . . . . 0.0 112.606 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.688 HG13 ' SG ' ' A' ' 59' ' ' CYS . 39.0 pt -93.31 145.43 30.01 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.89 149.86 75.81 Favored 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 123.243 2.629 . . . . 0.0 114.774 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 HD13 ' HB3' ' A' ' 18' ' ' CYS . 7.4 mp -88.09 166.08 14.68 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.059 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.62 151.93 25.79 Favored Glycine 0 C--O 1.239 0.412 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.023 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 5.0 p30 -112.0 -176.38 2.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.8 m -55.18 126.85 26.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.191 0.519 . . . . 0.0 111.783 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.55 -20.62 48.86 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.368 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -89.56 149.25 22.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.709 0.29 . . . . 0.0 110.598 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.405 ' CG ' ' HZ1' ' A' ' 75' ' ' LYS . 29.4 m-20 -68.71 148.37 50.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.794 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.513 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 12.6 p -139.44 147.86 41.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.822 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 50.2 m170 -89.42 121.0 69.7 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 10.6 Cg_endo -54.99 -36.5 92.62 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.15 2.567 . . . . 0.0 112.66 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.61 -30.79 71.15 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.377 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.8 m -75.68 128.87 36.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.798 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -101.01 166.73 10.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.374 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -55.79 148.76 15.95 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.676 0.61 . . . . 0.0 112.13 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.2 t -87.17 140.89 32.56 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.345 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.03 128.53 16.81 Favored 'Cis proline' 0 C--N 1.346 0.445 0 C-N-CA 123.499 -1.459 . . . . 0.0 113.764 0.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -75.53 134.24 40.81 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.882 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.4 114.47 7.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.64 -133.47 11.74 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.996 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -150.37 141.11 22.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.838 0.351 . . . . 0.0 110.149 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -118.91 137.25 53.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.392 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.72 47.33 1.49 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.501 0.667 . . . . 0.0 109.794 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.7 t -89.66 140.2 29.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.952 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.603 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 5.6 m -89.12 13.42 13.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.217 0.532 . . . . 0.0 110.842 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.3 tp -153.93 132.22 11.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.731 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.688 ' SG ' HG13 ' A' ' 32' ' ' ILE . 7.4 m -71.24 150.94 94.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.23 -165.2 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.083 1.855 . . . . 0.0 111.675 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 68.4 m -76.76 141.98 40.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.706 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.43 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 19.8 ptmt -57.54 146.24 30.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.065 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.5 m -49.73 120.1 4.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 119.52 -33.18 4.75 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.743 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.3 mt -89.26 165.0 14.7 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.008 0.432 . . . . 0.0 111.964 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.7 m -120.44 132.51 55.26 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.872 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 53.2 t -89.14 125.77 35.18 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.5 t -150.36 155.97 40.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.723 0.297 . . . . 0.0 110.469 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 36.1 ttpt -69.05 106.03 2.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.293 0.568 . . . . 0.0 110.584 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.489 ' HB2' ' HD3' ' A' ' 75' ' ' LYS . 13.3 m -92.13 58.19 3.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.553 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.07 -100.7 1.33 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.299 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.552 ' CD ' ' HZ1' ' A' ' 73' ' ' LYS . 8.4 tt0 -89.75 -55.69 3.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.945 0.403 . . . . 0.0 110.912 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.552 ' HZ1' ' CD ' ' A' ' 72' ' ' GLU . 34.9 mttm -100.34 170.76 8.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.314 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.62 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 13.1 m-85 -88.68 128.26 35.6 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.489 ' HD3' ' HB2' ' A' ' 70' ' ' SER . 24.2 mtpp -132.7 152.18 51.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.145 0.498 . . . . 0.0 109.694 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 98.4 m -71.47 134.94 46.92 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.795 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.248 0.978 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.82 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 8.7 t . . . . . 0 CA--C 1.532 0.258 0 CA-C-O 120.632 0.253 . . . . 0.0 111.466 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 4' ' ' THR . . . -175.95 118.01 0.63 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.302 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 1.003 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -91.21 -8.19 49.22 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.1 p -148.6 145.24 27.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.204 0.526 . . . . 0.0 112.368 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.615 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 14.4 t70 -90.21 -32.23 16.69 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.732 0.777 . . . . 0.0 109.325 178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 52' ' ' GLY . 55.0 mttp -135.8 139.74 43.72 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.777 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.626 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 41.9 t0 -55.98 -25.49 44.23 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.77 0.669 . . . . 0.0 110.571 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 49' ' ' PRO . 21.3 t -55.03 -29.85 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.688 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -72.95 -19.6 61.21 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.683 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.451 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 59.1 m -89.53 -120.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.341 . . . . 0.0 110.702 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.28 156.11 15.28 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.736 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.4 m -51.3 104.29 0.08 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.222 0.534 . . . . 0.0 111.016 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.06 -32.96 1.39 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.5 p -138.53 135.7 35.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.824 -0.688 . . . . 0.0 109.173 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.609 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -120.31 162.85 18.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.626 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 62.5 m -87.02 110.55 20.14 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' A' ' 54' ' ' ARG . . . -164.09 172.52 13.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.929 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.667 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -74.49 138.13 42.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.054 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.531 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 81.4 p -75.61 141.8 42.78 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.178 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.29 -24.11 67.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.882 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -88.27 -25.54 22.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.513 ' HB2' HD13 ' A' ' 28' ' ' ILE . 71.4 m -150.93 130.48 13.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.276 0.56 . . . . 0.0 111.872 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -74.32 -0.06 15.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.689 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 4' ' ' THR . 30.8 m-20 -87.99 -26.76 22.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.883 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.3 mp -87.94 126.95 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 98.9 mtt180 -146.62 67.97 1.17 Allowed 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.687 0.617 . . . . 0.0 109.475 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 1.003 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.0 OUTLIER -142.39 -160.95 1.16 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.165 -179.584 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 24.3 m -61.54 85.22 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.845 0.716 . . . . 0.0 111.668 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.494 HG13 ' SG ' ' A' ' 59' ' ' CYS . 41.4 pt -104.84 149.29 37.36 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.6 148.5 20.8 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.844 3.03 . . . . 0.0 115.035 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.435 ' CD1' ' HA ' ' A' ' 62' ' ' LYS . 98.6 mt -87.5 159.63 18.56 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.52 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.15 137.64 38.33 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.829 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 68.0 m-80 -95.11 176.06 6.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.026 0.441 . . . . 0.0 110.713 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.53 ' HG ' HD21 ' A' ' 65' ' ' LEU . 10.9 m -61.24 127.93 33.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.91 -6.59 82.83 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.931 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.8 146.85 24.75 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 120.85 0.357 . . . . 0.0 110.405 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.426 ' O ' HD21 ' A' ' 58' ' ' LEU . 1.6 m-20 -61.29 139.4 58.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.926 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.466 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 25.0 p -135.07 142.4 46.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.19 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -88.39 125.38 63.78 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -47.37 -36.54 23.44 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.83 3.02 . . . . 0.0 113.304 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.27 37.27 0.2 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.297 0.57 . . . . 0.0 112.031 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.6 ' HB2' ' HB3' ' A' ' 60' ' ' PRO . 6.2 p -92.05 155.89 17.77 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.929 0.395 . . . . 0.0 110.198 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.431 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 58.5 m-70 -133.26 143.57 49.19 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -55.34 152.95 7.8 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.486 ' CG1' ' HA ' ' A' ' 49' ' ' PRO . 95.4 t -87.01 141.56 33.29 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.509 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HA ' ' CG1' ' A' ' 48' ' ' VAL . 71.8 Cg_endo -78.83 132.21 25.41 Favored 'Cis proline' 0 C--O 1.235 0.355 0 C-N-CA 123.454 -1.477 . . . . 0.0 113.818 1.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.549 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 54.6 t80 -77.72 134.44 38.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.069 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -82.35 119.13 23.76 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.572 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 9' ' ' LYS . . . 94.76 -149.82 19.5 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -178.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.615 ' HG3' ' O ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -144.32 133.24 22.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.119 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.775 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 40.6 mtp85 -70.3 136.47 49.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.367 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.28 -7.64 57.63 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 t -88.38 148.8 24.06 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.462 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 18.1 m -86.43 44.27 1.13 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.426 HD21 ' O ' ' A' ' 40' ' ' ASP . 24.3 tp -154.41 121.44 5.61 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.494 ' SG ' HG13 ' A' ' 32' ' ' ILE . 1.7 m -80.09 157.84 73.04 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.496 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.6 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 12.5 Cg_exo -68.28 177.46 4.51 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.066 1.844 . . . . 0.0 111.18 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 77.7 m -68.25 142.28 55.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.491 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.456 ' HG2' HD11 ' A' ' 65' ' ' LEU . 16.5 ptmt -61.71 151.57 33.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.349 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.5 m -45.94 125.84 6.71 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.56 0.538 . . . . 0.0 111.671 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.76 -32.71 6.86 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.83 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.53 HD21 ' HG ' ' A' ' 37' ' ' SER . 36.0 mt -89.15 155.67 19.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.951 0.405 . . . . 0.0 111.637 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.1 m -127.47 129.29 47.18 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.373 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 48.3 t -71.42 124.81 25.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.3 t -142.98 155.53 44.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.112 0.482 . . . . 0.0 110.753 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -72.43 105.7 4.24 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.418 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.969 ' HB2' ' HD3' ' A' ' 75' ' ' LYS . 13.4 m -98.19 81.08 2.74 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.03 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.69 -109.01 3.29 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.664 ' OE1' ' HG2' ' A' ' 73' ' ' LYS . 1.3 tm-20 -89.24 -49.16 6.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.661 0.231 . . . . 0.0 111.579 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.664 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 43.9 mmtm -92.81 -172.47 3.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.157 0.503 . . . . 0.0 111.396 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -112.21 130.4 55.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.969 ' HD3' ' HB2' ' A' ' 70' ' ' SER . 1.7 mptp? -132.79 152.19 51.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.074 0.464 . . . . 0.0 109.798 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 89.2 m -70.1 118.59 13.13 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.942 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.522 -0.752 . . . . 0.0 109.271 179.37 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.525 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 9.1 t . . . . . 0 CA--C 1.532 0.253 0 CA-C-O 121.026 0.441 . . . . 0.0 110.728 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 4' ' ' THR . . . 169.41 114.5 0.31 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.968 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.82 -12.99 34.68 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.0 p -141.36 145.22 35.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.548 0.69 . . . . 0.0 112.578 -178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.16 -38.61 9.25 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.231 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' HD2' ' OD1' ' A' ' 51' ' ' ASP . 14.0 mmtp -115.43 132.54 56.59 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.992 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.683 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 33.0 t70 -56.57 -25.32 52.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.991 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.827 HG22 ' HB2' ' A' ' 49' ' ' PRO . 22.0 t -58.04 -28.28 33.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.351 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -69.93 -20.28 63.35 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.002 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 70.0 m -89.18 129.59 35.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.126 0.489 . . . . 0.0 111.093 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.11 160.28 47.98 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.809 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.6 m -50.17 115.21 1.33 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.361 0.601 . . . . 0.0 110.868 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.74 -28.25 3.58 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.7 p -132.63 158.44 42.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.084 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.478 ' HB3' HD23 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -147.57 164.24 34.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.683 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 77.0 m -86.13 112.79 21.63 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HB3' HD13 ' A' ' 32' ' ' ILE . . . -161.34 166.74 27.03 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.146 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -85.83 149.48 25.21 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.46 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.577 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -67.67 137.37 55.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.835 0.35 . . . . 0.0 110.686 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.735 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -66.04 -24.0 66.65 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.4 p90 -86.98 -36.8 18.07 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.0 m -151.82 142.89 23.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -79.02 40.91 0.42 Allowed 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.06 -0.4 . . . . 0.0 111.511 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -96.28 -38.91 9.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.853 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 3.2 mp -89.72 131.94 35.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 4' ' ' THR . 1.6 mpt_? -143.07 65.2 1.34 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.968 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.1 p90 -150.46 -163.27 1.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.9 m -62.17 87.29 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 O-C-N 124.063 0.852 . . . . 0.0 112.187 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.541 HG13 ' SG ' ' A' ' 59' ' ' CYS . 45.0 pt -103.06 158.27 32.1 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 32' ' ' ILE . 11.8 Cg_endo -53.9 142.52 63.59 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.243 2.629 . . . . 0.0 114.502 -177.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.525 HD23 ' HB3' ' A' ' 59' ' ' CYS . 30.5 mt -86.87 158.85 19.24 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.674 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.81 150.13 37.37 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.047 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 3.7 p-10 -117.69 176.95 4.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.674 0.273 . . . . 0.0 110.82 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.3 m -52.38 131.14 32.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.833 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.0 -14.92 61.17 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.245 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.56 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 3.9 mm-40 -106.82 158.4 17.02 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.567 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 42.5 t0 -58.75 149.49 26.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.313 -1.767 . . . . 0.0 113.067 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.77 145.96 26.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -90.81 116.44 66.43 Favored Pre-proline 0 C--N 1.317 -0.821 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.705 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 74' ' ' PHE . 15.9 Cg_endo -58.46 -42.35 56.01 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.234 2.623 . . . . 0.0 112.927 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.6 -34.71 77.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.466 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.588 ' HB3' ' HD2' ' A' ' 54' ' ' ARG . 19.9 m -72.83 119.36 16.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.307 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.415 ' HB2' ' HD2' ' A' ' 50' ' ' TYR . 11.7 m170 -69.86 144.87 52.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -63.68 -172.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.561 0.696 . . . . 0.0 111.603 -179.173 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.5 t -85.79 138.18 35.53 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.744 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.827 ' HB2' HG22 ' A' ' 11' ' ' VAL . 72.4 Cg_endo -96.79 135.13 3.9 Favored 'Cis proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.72 -1.367 . . . . 0.0 113.79 1.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.458 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 51.1 t80 -91.67 139.32 30.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.406 178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.42 ' OD1' ' HD2' ' A' ' 9' ' ' LYS . 49.0 t0 -77.03 59.02 1.6 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.861 0.838 . . . . 0.0 110.408 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 153.3 -139.43 6.9 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.83 128.77 20.68 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.588 ' HD2' ' HB3' ' A' ' 45' ' ' SER . 31.9 mtm-85 -70.14 137.1 50.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.315 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.8 58.68 5.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.851 0.834 . . . . 0.0 109.485 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.9 m -143.95 144.2 31.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.348 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.735 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 62.1 m -88.24 41.0 0.98 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.942 0.401 . . . . 0.0 111.21 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.4 tp -153.69 127.11 8.6 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.655 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.541 ' SG ' HG13 ' A' ' 32' ' ' ILE . 1.6 m -81.05 141.03 50.03 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.462 ' O ' HD21 ' A' ' 34' ' ' LEU . 49.4 Cg_endo -69.36 -166.97 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.111 1.874 . . . . 0.0 111.821 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.752 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 34.6 m -69.34 137.35 52.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.705 0.288 . . . . 0.0 111.17 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.407 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . 11.8 ptpt -66.19 148.52 51.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.87 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.6 m -45.61 122.52 3.68 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 123.487 0.492 . . . . 0.0 111.909 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.22 -32.99 5.5 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.09 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.0 mt -89.19 154.71 19.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.934 0.397 . . . . 0.0 111.816 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.0 m -121.89 131.91 54.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.225 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.752 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 9.7 t -91.9 143.17 26.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.798 0.333 . . . . 0.0 110.885 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t -141.22 159.24 42.63 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -69.14 104.34 2.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.312 0.577 . . . . 0.0 110.941 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 10.5 t -89.67 75.96 7.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.478 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.85 -98.27 2.2 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.32 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.45 -56.86 3.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.029 0.443 . . . . 0.0 111.104 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 14.3 ptpt -98.17 -165.9 1.31 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.82 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.505 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 8.9 m-85 -109.7 133.98 52.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.148 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.567 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 21.8 mttt -132.42 146.8 52.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.535 0.683 . . . . 0.0 110.427 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 73.5 m -68.32 150.44 48.21 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.745 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 C--O 1.248 0.984 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.321 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 120.748 0.309 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.33 125.58 0.95 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.329 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 1.003 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -84.18 -8.81 58.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.713 0.292 . . . . 0.0 111.457 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.6 p -148.32 145.96 28.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.762 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.3 -48.38 5.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.242 0.544 . . . . 0.0 109.58 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -102.97 139.54 38.41 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.778 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -55.25 -25.7 35.22 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.76 0.662 . . . . 0.0 111.429 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 50' ' ' TYR . 22.0 t -54.16 -31.7 22.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.957 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -67.8 -28.02 67.24 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.3 m -89.58 138.92 31.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.074 0.464 . . . . 0.0 111.458 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.7 164.07 50.26 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.723 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.7 m -57.39 97.83 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.4 0.619 . . . . 0.0 110.763 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 153.64 -24.74 0.74 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.549 ' O ' HG11 ' A' ' 48' ' ' VAL . 25.7 p -137.39 155.24 49.6 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.17 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.722 ' SG ' ' HB1' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -139.09 167.24 22.5 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.1 m -89.3 49.49 1.77 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.965 0.412 . . . . 0.0 111.869 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.722 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . -83.98 150.62 25.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.211 0.529 . . . . 0.0 111.101 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -86.6 142.3 28.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.525 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.495 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -61.42 126.05 25.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.981 0.42 . . . . 0.0 110.613 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.45 -21.61 65.57 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -86.99 -32.82 19.85 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.896 -0.321 . . . . 0.0 111.309 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.1 m -151.65 130.69 12.61 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -76.21 56.96 1.08 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.282 0.563 . . . . 0.0 111.189 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -118.5 -43.34 2.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.501 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 3.0 mp -88.97 128.16 41.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.313 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -152.07 58.65 0.85 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.763 0.792 . . . . 0.0 109.816 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 1.003 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.2 p90 -126.96 -170.95 2.3 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.533 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.7 m -60.43 79.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.061 0.85 . . . . 0.0 112.947 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.501 HG13 ' SG ' ' A' ' 59' ' ' CYS . 40.9 pt -95.83 151.93 38.71 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.05 148.54 38.89 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.331 2.687 . . . . 0.0 114.507 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.668 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 92.5 mt -86.93 171.05 11.09 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.509 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.64 145.29 32.58 Favored Glycine 0 C--O 1.241 0.553 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.88 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -88.79 -177.27 5.48 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.189 0.596 . . . . 0.0 110.948 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.459 ' HA ' HD13 ' A' ' 65' ' ' LEU . 3.2 m -61.72 132.33 52.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.036 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.521 ' O ' ' HD3' ' A' ' 75' ' ' LYS . . . 81.94 -3.97 77.54 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.259 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.539 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -88.91 157.32 18.46 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 117.448 0.624 . . . . 0.0 112.039 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.52 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -60.89 144.43 52.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.733 -178.312 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.4 p -150.53 145.36 25.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.535 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.509 ' HB2' ' OG ' ' A' ' 45' ' ' SER . 56.7 m170 -89.51 128.92 49.04 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.02 -39.61 90.07 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.918 2.412 . . . . 0.0 112.962 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.83 97.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.464 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.693 ' HB2' ' HG3' ' A' ' 60' ' ' PRO . 10.8 p -76.98 132.6 39.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -109.13 -160.93 0.74 Allowed 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.301 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.51 146.19 42.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.032 0.444 . . . . 0.0 111.382 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.549 HG11 ' O ' ' A' ' 17' ' ' THR . 40.8 t -88.34 143.38 32.44 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.847 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.53 ' HA ' ' CG1' ' A' ' 48' ' ' VAL . 16.4 Cg_exo -69.04 124.51 7.32 Favored 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 124.128 -1.197 . . . . 0.0 113.717 0.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.44 ' O ' HG23 ' A' ' 11' ' ' VAL . 79.9 t80 -89.06 133.4 34.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.761 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.22 111.46 10.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.036 0.446 . . . . 0.0 109.84 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 122.83 -157.86 17.42 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.582 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -152.68 132.83 13.5 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -130.01 153.41 48.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.898 0.38 . . . . 0.0 111.03 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.51 45.02 0.98 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.217 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.0 m -89.52 138.42 31.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.978 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 20.4 m -89.98 30.3 1.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.32 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.9 tp -153.55 125.35 7.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.756 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.501 ' SG ' HG13 ' A' ' 32' ' ' ILE . 1.7 m -76.38 141.29 69.72 Favored Pre-proline 0 C--N 1.327 -0.377 0 O-C-N 123.26 0.35 . . . . 0.0 110.423 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.693 ' HG3' ' HB2' ' A' ' 45' ' ' SER . 6.5 Cg_exo -70.93 -167.22 0.26 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.515 2.143 . . . . 0.0 112.329 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 61.5 m -70.55 138.86 51.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.045 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.668 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 15.5 ptpt -76.4 -179.15 4.97 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.563 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.7 m -52.91 131.28 35.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.839 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.25 -31.03 6.61 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.913 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 61' ' ' CYS . 3.6 mm? -88.9 144.86 25.91 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.373 0.606 . . . . 0.0 112.302 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.3 m -121.97 132.59 54.61 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.295 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.9 t -76.56 130.61 38.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.209 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t -149.77 159.83 44.04 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.47 ' NZ ' ' HA ' ' A' ' 72' ' ' GLU . 47.0 tttm -71.8 104.01 3.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.298 0.571 . . . . 0.0 110.043 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 t -92.59 80.87 4.79 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.57 -101.88 2.5 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.496 ' OE1' ' HA ' ' A' ' 72' ' ' GLU . 36.5 tp10 -98.15 -50.88 4.2 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.531 -0.468 . . . . 0.0 112.006 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.53 -174.55 3.52 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.513 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -104.53 133.46 49.35 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.045 0.45 . . . . 0.0 110.897 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 38' ' ' GLY . 47.8 mttm -141.42 155.78 45.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.94 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 67.5 m -69.15 140.42 54.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.284 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 C--O 1.244 0.771 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.191 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 5' ' ' GLY . 8.8 t . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 120.591 0.234 . . . . 0.0 111.444 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.412 ' N ' HG22 ' A' ' 4' ' ' THR . . . 149.68 130.75 1.85 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.0 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 30' ' ' PHE . . . -90.48 -23.7 20.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.947 0.403 . . . . 0.0 110.658 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.57 -142.93 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.069 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -164.16 -45.14 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.2 0.524 . . . . 0.0 110.857 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -109.33 135.41 50.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.78 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.621 ' HB3' HG22 ' A' ' 48' ' ' VAL . 56.7 m-20 -46.28 -38.28 8.42 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.019 0.824 . . . . 0.0 112.09 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.7 t -48.15 -35.09 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.565 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -68.34 -33.2 73.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.427 ' HB3' ' OG1' ' A' ' 17' ' ' THR . 37.8 m -93.45 -31.91 14.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.201 0.524 . . . . 0.0 111.946 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.0 159.63 34.3 Favored Glycine 0 C--N 1.314 -0.641 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.409 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.509 ' HA ' HG21 ' A' ' 48' ' ' VAL . 15.1 m -61.1 80.5 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.496 0.665 . . . . 0.0 111.835 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 177.67 -33.55 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.427 ' OG1' ' HB3' ' A' ' 13' ' ' CYS . 7.5 p -137.21 147.33 45.77 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -130.59 159.11 38.15 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.08 -178.448 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.4 m -89.54 46.37 1.36 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.581 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.622 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . . . -87.42 159.38 18.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.913 0.387 . . . . 0.0 110.946 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.742 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -78.57 131.63 36.83 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.468 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 89.6 p -61.64 139.38 58.29 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.621 -178.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.1 -24.68 63.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.294 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -87.98 -27.25 22.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.684 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.657 ' HB3' HD11 ' A' ' 28' ' ' ILE . 8.6 t -151.24 126.62 10.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.148 0.499 . . . . 0.0 111.042 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -73.23 4.72 4.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.392 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -88.91 -19.55 25.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.029 0.443 . . . . 0.0 110.479 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.742 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.5 mp -87.98 120.13 36.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 45.0 mtp85 -141.59 42.52 1.73 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 123.761 0.663 . . . . 0.0 109.454 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.562 ' CD2' HG22 ' A' ' 28' ' ' ILE . 1.3 m-85 -97.67 -175.07 3.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 99.8 m -72.62 80.43 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.416 0.448 . . . . 0.0 110.237 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.593 HG13 ' SG ' ' A' ' 59' ' ' CYS . 39.3 pt -89.03 148.42 41.01 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.3 156.15 26.84 Favored 'Trans proline' 0 N--CA 1.473 0.29 0 C-N-CA 123.329 2.686 . . . . 0.0 114.3 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.488 ' HA ' ' HB3' ' A' ' 59' ' ' CYS . 4.1 mp -86.94 165.48 15.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.413 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.77 134.11 37.81 Favored Glycine 0 C--O 1.24 0.529 0 CA-C-N 115.143 -0.935 . . . . 0.0 113.028 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -95.06 -179.72 4.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.285 0.564 . . . . 0.0 111.304 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -61.39 122.72 15.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.904 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.06 4.13 90.07 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.238 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -88.56 148.42 24.11 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 117.29 0.545 . . . . 0.0 109.664 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.28 138.4 55.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.424 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.2 p -136.8 153.34 50.84 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.076 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -89.76 122.57 67.91 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -57.42 -40.2 83.24 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.897 2.398 . . . . 0.0 112.602 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.6 -36.76 81.45 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.23 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.9 m -66.27 113.13 4.36 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.221 0.534 . . . . 0.0 110.385 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -70.98 153.94 42.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.76 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -65.36 176.06 1.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.216 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.621 HG22 ' HB3' ' A' ' 10' ' ' ASP . 10.0 p -88.62 139.7 29.7 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.029 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HA ' HG23 ' A' ' 48' ' ' VAL . 89.5 Cg_endo -89.04 134.2 11.41 Favored 'Cis proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.768 -1.347 . . . . 0.0 113.055 0.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.596 ' HB2' ' NH2' ' A' ' 54' ' ' ARG . 66.1 t80 -75.29 130.82 39.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.124 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -87.65 130.01 34.94 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.66 -113.6 3.83 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.755 ' HD3' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -150.53 126.88 10.69 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.473 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.596 ' NH2' ' HB2' ' A' ' 50' ' ' TYR . 60.5 ttm-85 -85.84 102.24 13.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.157 0.504 . . . . 0.0 111.771 -177.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.755 HD22 ' HD3' ' A' ' 53' ' ' LYS . 1.3 mm? -105.33 27.04 8.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.423 0.63 . . . . 0.0 109.925 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.8 m -89.7 148.46 23.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.944 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 4.3 m -88.93 21.83 2.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.829 0.347 . . . . 0.0 111.493 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.37 136.13 14.45 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.593 ' SG ' HG13 ' A' ' 32' ' ' ILE . 1.8 m -75.54 153.04 85.59 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.485 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 64.6 Cg_endo -72.52 174.06 12.25 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.115 1.877 . . . . 0.0 110.995 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.3 m -68.66 139.29 55.45 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.557 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.4 154.1 14.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.827 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.5 m -44.59 129.17 6.82 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.611 0.569 . . . . 0.0 111.226 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.61 -38.28 3.28 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.954 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.1 mt -88.84 154.93 19.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.883 0.373 . . . . 0.0 111.618 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.0 m -135.8 139.48 43.52 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.866 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 23.2 t -72.26 128.73 36.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.763 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.7 t -150.04 156.94 42.58 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 31.9 ttpt -73.19 110.08 7.21 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.301 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.461 ' HB3' ' HD2' ' A' ' 75' ' ' LYS . 10.5 t -93.24 63.04 3.56 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.372 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.76 -93.56 1.49 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.052 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.487 ' OE2' ' HG3' ' A' ' 73' ' ' LYS . 2.0 tt0 -88.33 -54.49 4.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.477 -0.362 . . . . 0.0 111.042 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.487 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 34.7 mtmm -112.91 177.99 4.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.13 0.491 . . . . 0.0 111.58 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 8.5 m-85 -89.21 133.95 34.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.268 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.461 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 56.4 mttm -136.66 154.55 50.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.719 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 95.6 m -75.54 128.43 35.28 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.953 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.252 1.236 0 CA-C-O 117.531 -1.223 . . . . 0.0 109.152 179.934 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 5' ' ' GLY . 5.1 t . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 120.944 0.402 . . . . 0.0 110.545 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.404 ' N ' HG22 ' A' ' 4' ' ' THR . . . 150.91 123.96 1.15 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.07 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 1.049 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.25 -13.29 35.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.814 0.34 . . . . 0.0 111.107 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' A' ' 30' ' ' PHE . 17.3 p -151.19 -152.03 0.42 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.87 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -163.59 -43.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.441 0.639 . . . . 0.0 109.362 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -106.59 133.29 51.5 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.592 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -52.73 -31.16 36.49 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.557 0.536 . . . . 0.0 111.184 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.8 t -51.61 -32.05 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.407 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -70.68 -32.73 70.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.126 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.4 m -95.23 -46.32 6.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.209 0.528 . . . . 0.0 112.228 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.89 153.19 9.57 Favored Glycine 0 C--N 1.31 -0.886 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.714 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.629 ' HA ' HG11 ' A' ' 48' ' ' VAL . 16.2 m -57.13 98.23 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.546 0.689 . . . . 0.0 110.776 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.502 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . 161.08 -31.43 0.35 Allowed Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.8 p -135.14 139.0 44.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.824 -0.688 . . . . 0.0 109.334 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -111.34 156.66 21.22 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.0 m -97.23 45.83 1.04 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.399 . . . . 0.0 111.369 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -84.79 178.38 7.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.117 0.484 . . . . 0.0 111.469 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.82 142.21 28.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.378 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.66 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -60.69 139.65 57.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.148 0.499 . . . . 0.0 111.649 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.702 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -64.17 -26.17 68.4 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -86.25 -42.37 13.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.899 0.38 . . . . 0.0 111.609 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.1 m -151.96 136.79 17.15 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -74.86 51.7 0.5 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -101.89 -35.38 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.841 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.66 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 53.1 mt -88.8 131.11 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.279 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 6.2 mtp180 -150.16 49.19 0.91 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.912 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 1.049 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.4 p90 -128.51 -168.86 1.97 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.582 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 33.1 m -59.21 82.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.222 0.952 . . . . 0.0 112.44 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.609 HG13 ' SG ' ' A' ' 59' ' ' CYS . 23.8 pt -104.27 143.79 27.38 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.57 159.22 14.11 Favored 'Trans proline' 0 CA--C 1.529 0.225 0 C-N-CA 123.197 2.598 . . . . 0.0 114.112 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 95.1 mt -84.86 167.91 15.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.174 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.09 144.73 35.23 Favored Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.714 -0.676 . . . . 0.0 113.726 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 0.1 OUTLIER -118.07 -167.21 1.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.062 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 76' ' ' CYS . 6.1 m -59.21 125.26 22.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.789 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.59 0.14 82.26 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.28 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -88.0 148.38 24.57 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 117.068 0.434 . . . . 0.0 110.541 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.578 ' O ' HD11 ' A' ' 58' ' ' LEU . 12.3 t70 -68.05 145.61 54.29 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.984 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.4 p -150.14 143.83 25.31 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.623 ' CD2' HD23 ' A' ' 58' ' ' LEU . 90.0 m-70 -88.32 139.75 30.26 Favored Pre-proline 0 C--N 1.319 -0.747 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.862 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.73 38.03 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.196 2.597 . . . . 0.0 113.106 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.45 ' H ' ' C ' ' A' ' 42' ' ' HIS . . . -172.57 33.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.384 0.674 . . . . 0.0 109.266 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -80.71 133.23 35.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.433 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.49 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 19.8 m170 -80.66 146.85 30.92 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -67.57 166.34 15.11 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.629 HG11 ' HA ' ' A' ' 15' ' ' SER . 58.8 t -86.33 136.99 34.88 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 48' ' ' VAL . 15.7 Cg_exo -69.42 128.58 12.44 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 123.898 -1.293 . . . . 0.0 114.061 1.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.6 ' HH ' ' HB3' ' A' ' 54' ' ' ARG . 71.9 t80 -71.48 154.61 41.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.506 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.516 ' OD2' ' HG3' ' A' ' 53' ' ' LYS . 5.3 p-10 -56.33 -33.2 65.39 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.698 0.285 . . . . 0.0 111.528 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.38 34.09 67.45 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.248 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.516 ' HG3' ' OD2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -129.36 -22.76 3.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.6 ' HB3' ' HH ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -75.24 150.6 38.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.067 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 55' ' ' LEU . 3.7 mm? -85.46 56.66 4.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.2 0.524 . . . . 0.0 111.565 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 51.3 m -89.31 128.5 35.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.27 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.702 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 15.2 m -89.67 26.61 1.71 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.623 HD23 ' CD2' ' A' ' 42' ' ' HIS . 1.6 pp -153.97 172.16 17.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.073 0.463 . . . . 0.0 110.921 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.609 ' SG ' HG13 ' A' ' 32' ' ' ILE . 37.1 m -106.23 143.2 26.47 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.012 178.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.434 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 32.4 Cg_exo -57.14 159.52 15.08 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.539 2.159 . . . . 0.0 111.721 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 32.5 m -59.22 134.09 56.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.269 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.585 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 15.4 ptpt -70.38 163.31 26.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.251 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.0 m -47.62 124.69 7.41 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.397 0.435 . . . . 0.0 111.367 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.18 -30.07 10.56 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.11 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.499 ' HG ' ' HA ' ' A' ' 36' ' ' ASN . 4.0 mm? -88.48 136.55 32.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.792 0.33 . . . . 0.0 111.006 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.5 m -116.77 124.74 50.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.467 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.5 t -71.23 125.18 26.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.7 t -150.3 158.06 43.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.836 0.35 . . . . 0.0 110.125 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.597 ' HE2' ' O ' ' A' ' 71' ' ' GLY . 85.3 tttt -71.8 105.92 3.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.257 0.551 . . . . 0.0 110.739 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 15.1 m -89.75 64.49 6.5 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.796 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.597 ' O ' ' HE2' ' A' ' 69' ' ' LYS . . . 96.16 -97.58 2.08 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.825 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.404 ' O ' ' HE3' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -91.83 -55.73 3.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.361 0.6 . . . . 0.0 110.085 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.781 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -100.09 171.07 8.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.332 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.582 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 9.1 m-85 -94.92 133.69 38.4 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.852 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.582 ' HD2' ' O ' ' A' ' 74' ' ' PHE . 14.1 mptt -135.58 157.1 47.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.605 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 82.5 m -76.21 118.53 19.03 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.576 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 C--O 1.253 1.256 0 CA-C-O 117.701 -1.143 . . . . 0.0 109.381 179.855 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.223 -0.326 0 CA-C-O 120.5 0.19 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.46 116.24 0.64 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.491 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 1.054 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.96 -9.5 45.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.703 -0.248 . . . . 0.0 111.375 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 30' ' ' PHE . 12.6 p -150.69 146.37 26.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.227 0.537 . . . . 0.0 111.696 -178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.06 -42.86 12.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.992 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -121.62 145.42 48.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.218 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.412 ' OD2' ' HB2' ' A' ' 18' ' ' CYS . 1.6 m-20 -54.74 -27.37 40.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.223 0.535 . . . . 0.0 110.148 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.791 HG21 ' HB2' ' A' ' 49' ' ' PRO . 77.6 t -52.47 -35.01 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.057 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -72.46 -21.93 61.15 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 97.6 m -89.09 141.4 28.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.222 0.534 . . . . 0.0 111.585 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.32 157.49 52.1 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.073 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.492 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 19.9 m -54.29 112.28 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.17 0.509 . . . . 0.0 110.312 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.461 ' C ' ' HG ' ' A' ' 34' ' ' LEU . . . 136.46 -22.84 3.33 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 p -136.01 152.24 50.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.196 -0.502 . . . . 0.0 110.232 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -135.74 162.15 33.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 59.8 m -89.07 49.28 1.75 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.658 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . . . -82.07 163.26 22.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.98 0.419 . . . . 0.0 110.631 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -83.93 145.16 28.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.619 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.629 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -58.11 130.46 46.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.945 0.403 . . . . 0.0 110.703 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.79 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -58.4 -27.06 63.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -85.5 -38.77 18.2 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.861 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m -150.83 136.1 17.72 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.139 -0.351 . . . . 0.0 110.431 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.92 55.05 0.17 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.051 0.54 . . . . 0.0 111.823 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -114.91 -38.76 3.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.966 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.68 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 1.9 mp -88.09 133.58 30.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.81 0.338 . . . . 0.0 110.401 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.2 mmm-85 -144.63 57.18 1.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.985 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 1.054 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.0 p90 -136.1 -173.28 3.35 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.171 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.5 m -59.04 84.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 O-C-N 124.295 0.997 . . . . 0.0 113.111 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.551 HG13 ' SG ' ' A' ' 59' ' ' CYS . 38.9 pt -102.0 151.01 37.94 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.32 151.7 28.41 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.365 2.71 . . . . 0.0 114.77 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.461 ' HG ' ' C ' ' A' ' 16' ' ' GLY . 80.7 mt -87.52 165.35 15.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.361 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.9 145.97 39.13 Favored Glycine 0 C--O 1.241 0.541 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.594 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 1.5 t-20 -96.82 -175.92 3.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.413 0.625 . . . . 0.0 111.253 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.8 m -60.97 129.26 40.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.555 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.99 -4.64 82.4 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.865 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.17 149.12 23.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.99 0.395 . . . . 0.0 110.519 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.594 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 1.1 t70 -63.96 141.56 58.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.357 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 74' ' ' PHE . 25.0 p -141.81 139.38 32.72 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.067 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 33.2 m170 -89.12 128.41 51.8 Favored Pre-proline 0 C--N 1.318 -0.797 0 C-N-CA 120.086 -0.645 . . . . 0.0 109.653 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 0.9 OUTLIER -44.64 -49.47 9.29 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 124.17 3.246 . . . . 0.0 114.608 -177.318 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.42 31.56 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.89 0.376 . . . . 0.0 111.821 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.423 ' O ' ' HD3' ' A' ' 54' ' ' ARG . 14.5 m -90.72 -20.23 22.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.135 0.493 . . . . 0.0 110.469 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.746 ' HD2' ' HB2' ' A' ' 56' ' ' SER . 3.7 m-70 -169.36 125.89 0.9 Allowed 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.667 ' H ' ' HB2' ' A' ' 50' ' ' TYR . 9.2 mmmm -140.39 177.74 7.79 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 61.4 t -125.95 107.7 25.23 Favored Pre-proline 0 C--N 1.32 -0.7 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.224 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.791 ' HB2' HG21 ' A' ' 11' ' ' VAL . 59.0 Cg_endo -96.49 129.46 3.38 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.483 -1.049 . . . . 0.0 112.79 -0.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.667 ' HB2' ' H ' ' A' ' 47' ' ' LYS . 1.3 t80 -82.74 124.12 29.94 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -76.83 -38.4 53.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.67 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.53 -167.75 29.56 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.549 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -152.51 140.82 20.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.593 0.235 . . . . 0.0 110.569 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 45' ' ' SER . 6.9 ptm180 -167.24 159.53 12.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.1 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 55' ' ' LEU . 3.7 mm? -87.75 54.04 2.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.928 0.394 . . . . 0.0 111.912 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.746 ' HB2' ' HD2' ' A' ' 46' ' ' HIS . 50.9 m -88.31 127.19 35.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.79 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 20.8 m -88.81 44.44 1.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.4 tp -153.37 126.57 8.52 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.399 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.551 ' SG ' HG13 ' A' ' 32' ' ' ILE . 1.7 m -87.47 148.04 43.34 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.107 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 46' ' ' HIS . 42.1 Cg_endo -66.96 -177.99 1.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.488 2.125 . . . . 0.0 111.715 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 81.6 m -69.81 141.33 53.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.767 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . 9.6 ptmm? -62.35 148.64 44.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.775 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.492 ' OG ' ' HB3' ' A' ' 15' ' ' SER . 10.2 m -46.33 130.92 10.74 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 123.44 0.463 . . . . 0.0 111.274 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.41 -30.23 10.21 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.774 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.9 mt -91.4 147.56 22.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.747 0.308 . . . . 0.0 111.464 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -108.41 126.49 52.94 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.323 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.423 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 54.1 t -83.59 116.21 22.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.0 t -137.48 157.9 45.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.765 0.316 . . . . 0.0 110.185 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 84.1 tttt -69.25 105.44 2.52 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.358 0.599 . . . . 0.0 111.198 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -92.92 77.14 4.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.746 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.436 ' O ' ' HE2' ' A' ' 69' ' ' LYS . . . 87.42 -102.52 2.8 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.579 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.532 ' O ' ' HE3' ' A' ' 69' ' ' LYS . 5.2 tm-20 -91.28 -53.08 4.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.739 0.304 . . . . 0.0 110.634 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.414 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 45.2 mmtm -98.21 171.2 8.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.073 0.463 . . . . 0.0 111.241 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 6.3 m-85 -92.19 138.34 31.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.462 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.594 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 48.8 mttp -143.92 155.08 43.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.23 0.538 . . . . 0.0 110.439 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 59.8 m -70.96 135.67 48.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.942 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.3 m . . . . . 0 C--O 1.255 1.364 0 CA-C-O 117.557 -1.211 . . . . 0.0 108.888 179.548 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.99 133.58 30.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.749 0.309 . . . . 0.0 110.254 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.4 mm -94.67 115.12 32.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 t -140.18 26.51 2.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.803 0.811 . . . . 0.0 110.008 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.19 128.16 1.08 Allowed Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.878 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . . . -90.57 -33.73 15.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.279 0.562 . . . . 0.0 110.158 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 5.0 p -152.0 -165.0 2.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.152 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.453 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 27.4 t70 -141.72 -40.45 0.37 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.311 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -105.61 128.41 53.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.436 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.439 ' HB2' ' HB3' ' A' ' 49' ' ' PRO . 12.9 m-20 -54.84 -24.56 23.58 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.591 0.557 . . . . 0.0 111.069 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.53 -31.42 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.834 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -69.27 -29.59 67.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.287 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.451 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 59.7 m -93.49 -119.09 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.048 0.451 . . . . 0.0 110.545 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.96 157.8 30.39 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 m -53.39 117.29 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.068 0.461 . . . . 0.0 110.481 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.22 -23.98 5.41 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.9 p -128.34 142.13 51.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.601 -0.3 . . . . 0.0 110.211 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.416 ' HB3' HD12 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -123.05 154.48 38.47 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.2 m -91.51 38.58 0.98 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.932 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -88.69 -173.02 3.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.766 0.317 . . . . 0.0 110.558 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.33 140.56 29.58 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.462 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 93.6 p -67.75 144.46 55.4 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.467 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.07 65.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.354 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 41.7 p90 -87.65 -32.21 19.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.4 m -149.93 127.38 11.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.401 0.619 . . . . 0.0 112.287 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.85 5.34 1.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.725 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -88.58 -24.68 22.8 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.323 0.582 . . . . 0.0 109.895 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.4 mp -87.38 122.89 39.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.534 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 31.9 mtp180 -140.64 46.08 1.8 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.269 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.472 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 0.3 OUTLIER -98.53 -172.91 2.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 38.3 m -71.67 78.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.659 HG13 ' SG ' ' A' ' 59' ' ' CYS . 17.0 pt -88.75 142.7 30.9 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.739 0.304 . . . . 0.0 110.583 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.79 150.33 71.81 Favored 'Trans proline' 0 N--CA 1.475 0.409 0 C-N-CA 123.413 2.742 . . . . 0.0 114.834 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 59' ' ' CYS . 8.1 mp -87.11 167.3 14.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.164 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.98 141.2 32.52 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.882 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 68.9 m-80 -102.46 -168.13 1.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.856 0.36 . . . . 0.0 110.893 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 m -62.2 125.59 24.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.056 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.18 1.68 86.24 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.569 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 20.8 mm-40 -88.92 150.44 22.85 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.853 0.359 . . . . 0.0 110.748 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.486 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -73.64 139.39 45.42 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.371 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.9 p -138.4 148.44 44.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.275 0.56 . . . . 0.0 110.388 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -89.25 122.63 68.45 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.76 -31.56 95.28 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.825 2.35 . . . . 0.0 111.929 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.83 -22.3 62.34 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.641 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.461 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 46.7 m -79.9 125.79 30.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.907 0.384 . . . . 0.0 110.219 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.417 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 34.9 m170 -86.41 168.92 13.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.477 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 149.0 23.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.42 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 42.7 t -87.71 136.65 32.53 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.057 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 15.9 Cg_exo -69.31 136.98 40.51 Favored 'Cis proline' 0 C--N 1.35 0.623 0 C-N-CA 123.871 -1.304 . . . . 0.0 112.819 0.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.439 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 53.9 t80 -63.72 127.96 33.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.866 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.16 58.03 1.95 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.373 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 158.92 -143.05 8.85 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.026 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -136.19 136.72 40.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.439 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 1.7 tpt180 -157.85 126.62 5.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.0 mp -89.1 52.89 2.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.337 0.589 . . . . 0.0 110.764 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 54.7 m -88.82 138.64 31.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.399 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 13.4 m -89.92 32.35 0.91 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.457 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.6 tp -154.62 127.81 8.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.985 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.659 ' SG ' HG13 ' A' ' 32' ' ' ILE . 54.8 m -74.97 145.03 80.5 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.461 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 17.0 Cg_exo -67.59 -168.34 0.18 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.496 2.131 . . . . 0.0 111.704 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 81.5 m -72.17 140.46 48.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.651 0.262 . . . . 0.0 111.04 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.409 ' HA ' HD22 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -63.97 152.89 38.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.073 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.9 m -49.28 123.95 8.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.51 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.05 -32.4 6.73 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.261 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.402 HD12 ' HG3' ' A' ' 62' ' ' LYS . 28.3 mt -89.8 151.39 21.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.068 0.461 . . . . 0.0 112.147 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -111.63 134.45 53.2 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.388 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.503 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 46.2 t -88.45 120.07 29.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.6 t -150.44 155.86 40.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 32.8 ttpt -61.63 114.38 3.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.08 0.467 . . . . 0.0 110.015 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.533 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 14.7 m -123.74 50.15 1.65 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.296 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.1 -112.29 0.84 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.66 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.84 ' HG2' ' HG3' ' A' ' 73' ' ' LYS . 2.7 pm0 -86.68 -37.63 17.79 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.29 0.567 . . . . 0.0 109.912 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.84 ' HG3' ' HG2' ' A' ' 72' ' ' GLU . 9.8 mtmp? -131.31 -165.02 1.51 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.987 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 3.5 m-85 -89.67 139.45 30.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.672 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 51.0 mttp -137.9 154.92 49.39 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 63.2 m -78.94 134.41 36.85 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.72 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.0 m . . . . . 0 C--O 1.245 0.835 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.354 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.614 HG23 HG22 ' A' ' 4' ' ' THR . 12.0 p -150.63 141.33 16.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.3 mm -89.14 65.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.099 0.476 . . . . 0.0 111.293 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.614 HG22 HG23 ' A' ' 2' ' ' VAL . 12.8 t -150.7 31.76 0.64 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.744 0.783 . . . . 0.0 109.919 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.85 97.66 0.68 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.375 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.964 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -78.0 -12.31 59.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.836 0.35 . . . . 0.0 111.573 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 p -150.83 152.12 33.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.928 0.394 . . . . 0.0 111.524 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.446 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 7.6 t70 -106.23 -50.2 3.21 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -89.66 130.34 35.96 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.514 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 34.4 t70 -55.51 -28.46 54.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.619 0.724 . . . . 0.0 110.081 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.59 ' HA ' ' CB ' ' A' ' 49' ' ' PRO . 42.9 t -54.79 -29.35 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.24 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -65.59 -26.71 67.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.463 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 76.7 m -89.95 132.5 35.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.128 0.49 . . . . 0.0 111.175 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.37 158.78 53.42 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.911 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.1 m -52.95 107.92 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.307 0.575 . . . . 0.0 110.995 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.06 -30.88 2.0 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 35.5 p -132.35 149.25 52.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.291 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -136.03 162.81 31.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.861 0.3 . . . . 0.0 110.807 -178.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.514 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 65.3 m -87.82 85.99 7.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.043 0.449 . . . . 0.0 110.031 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.501 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . . . -130.97 157.45 42.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.562 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.667 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -85.81 144.34 27.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.295 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.702 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -65.58 140.89 58.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.035 0.445 . . . . 0.0 111.003 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.549 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -66.81 -24.67 66.2 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -87.06 -36.08 18.36 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.1 m -151.53 138.93 19.44 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -80.31 35.29 0.33 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.919 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -89.86 -38.47 13.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.266 0.555 . . . . 0.0 109.885 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.702 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.4 mp -88.33 126.77 41.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.446 ' NH2' ' HA ' ' A' ' 8' ' ' ASP . 0.8 OUTLIER -150.93 57.17 0.91 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.964 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.6 p90 -138.69 -169.32 2.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.234 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.8 m -58.47 98.16 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 O-C-N 124.028 0.83 . . . . 0.0 112.236 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.606 HG13 ' SG ' ' A' ' 59' ' ' CYS . 33.1 pt -116.68 149.48 43.98 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.74 144.63 53.19 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.629 2.886 . . . . 0.0 115.434 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 59' ' ' CYS . 7.4 mp -88.11 173.85 8.59 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.915 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.01 143.54 23.2 Favored Glycine 0 C--O 1.239 0.429 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.771 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.558 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 71.4 m-80 -99.65 -169.77 1.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.909 0.385 . . . . 0.0 111.057 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.7 m -61.0 128.06 34.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.101 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.26 8.77 85.65 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.834 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 2.2 mm-40 -88.89 161.64 16.57 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.807 0.337 . . . . 0.0 110.972 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.46 ' CG ' ' HZ1' ' A' ' 73' ' ' LYS . 2.0 t70 -71.3 137.36 48.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.909 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.83 142.56 28.96 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -89.95 124.23 64.09 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -56.36 -39.95 87.91 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.794 2.33 . . . . 0.0 112.147 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.56 -38.98 77.65 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.373 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.4 m -66.29 101.37 0.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.325 0.583 . . . . 0.0 109.954 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.483 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 66.0 m-70 -68.6 148.27 50.73 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.053 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' A' ' 63' ' ' SER . 52.0 tttm -54.15 163.72 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.493 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.501 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 44.5 t -85.01 143.08 39.35 Favored Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.629 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.59 ' CB ' ' HA ' ' A' ' 11' ' ' VAL . 18.9 Cg_endo -91.99 129.85 6.53 Favored 'Cis proline' 0 N--CA 1.461 -0.415 0 C-N-CA 124.013 -1.245 . . . . 0.0 114.495 1.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.5 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 20.4 t80 -87.15 128.57 35.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.838 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -82.69 61.56 5.85 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.463 -0.773 . . . . 0.0 110.789 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.13 176.62 44.48 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.81 126.05 35.54 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.403 HH12 ' CG ' ' A' ' 10' ' ' ASP . 22.6 ttm105 -75.19 120.24 20.42 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.3 -2.19 58.44 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.223 0.535 . . . . 0.0 110.594 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.4 m -87.31 142.73 27.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.579 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 30.2 m -88.0 34.76 0.73 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.901 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.7 tp -154.31 130.73 10.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.709 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.606 ' SG ' HG13 ' A' ' 32' ' ' ILE . 9.8 m -76.06 148.79 81.83 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -72.92 -166.15 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.425 2.083 . . . . 0.0 111.792 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 72.2 m -76.46 140.59 41.32 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.335 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.435 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 11.1 ptmm? -60.88 148.17 40.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.997 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.507 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 68.1 m -51.04 131.77 27.26 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.142 0.496 . . . . 0.0 110.551 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.95 -28.68 10.18 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 mt -102.51 150.58 23.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.359 -0.42 . . . . 0.0 110.871 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.9 m -118.92 131.64 56.05 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.23 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 52.5 t -78.14 125.67 29.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.889 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.8 t -150.52 155.99 40.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 80.7 tttt -65.79 123.17 19.04 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.989 0.423 . . . . 0.0 110.266 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 m -128.0 41.6 3.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.255 0.55 . . . . 0.0 110.24 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 144.97 -112.72 0.67 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.03 -45.65 10.0 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.104 0.478 . . . . 0.0 109.748 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.46 ' HZ1' ' CG ' ' A' ' 40' ' ' ASP . 46.4 mtmt -110.98 -158.64 0.65 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.162 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 5.4 m-85 -107.38 137.24 45.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.81 0.338 . . . . 0.0 110.949 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 5.5 mptp? -126.83 159.44 33.87 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 70.1 m -81.17 131.99 35.33 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.824 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.244 0.783 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.842 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.55 137.86 13.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.8 mm -89.18 103.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.968 0.413 . . . . 0.0 110.303 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.424 HG23 ' N ' ' A' ' 5' ' ' GLY . 9.0 t -151.93 -38.33 0.12 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.039 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.424 ' N ' HG23 ' A' ' 4' ' ' THR . . . 159.82 124.77 0.76 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.009 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.997 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.88 -13.22 34.06 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.0 p -150.97 -159.92 1.1 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.784 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -153.15 -53.31 0.11 Allowed 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 52' ' ' GLY . 29.9 mmtp -89.83 132.97 34.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 50' ' ' TYR . 45.1 m-20 -53.86 -30.66 46.67 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.551 0.532 . . . . 0.0 110.622 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.1 t -54.94 -31.47 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.794 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.403 ' NE2' ' H ' ' A' ' 9' ' ' LYS . 73.6 mt-30 -67.26 -27.78 67.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.407 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 75.4 m -89.67 138.51 31.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.019 0.437 . . . . 0.0 111.171 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.99 154.15 52.82 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.056 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 m -49.49 108.66 0.21 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.033 0.49 . . . . 0.0 110.755 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.22 -18.37 4.21 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.304 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.5 p -135.11 161.46 35.26 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.385 0.274 . . . . 0.0 110.934 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.636 ' SG ' ' HB1' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -145.87 167.63 22.77 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.1 m -88.91 58.63 4.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.02 0.438 . . . . 0.0 111.268 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.815 ' HA ' ' HB2' ' A' ' 54' ' ' ARG . . . -90.08 152.81 20.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.26 0.552 . . . . 0.0 111.871 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -82.91 147.69 28.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.833 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.518 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -63.22 137.76 58.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.028 0.442 . . . . 0.0 111.092 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.612 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -67.09 -22.99 65.8 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -87.38 -40.03 14.78 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.89 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.0 m -152.32 148.42 27.5 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -78.09 48.36 0.73 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.936 0.398 . . . . 0.0 111.522 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -98.27 -43.14 7.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.417 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.8 mp -88.18 131.87 34.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.818 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -148.6 55.67 1.02 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.997 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.4 p90 -138.43 -173.8 3.64 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.2 m -57.6 98.31 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.915 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.478 HG13 ' SG ' ' A' ' 59' ' ' CYS . 44.8 pt -119.13 155.59 53.22 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 32' ' ' ILE . 10.1 Cg_endo -52.0 143.59 39.88 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.409 2.739 . . . . 0.0 115.152 -177.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.512 ' CD2' ' HB3' ' A' ' 18' ' ' CYS . 70.0 mt -87.19 159.74 18.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.689 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -52.98 141.53 29.11 Favored Glycine 0 C--O 1.242 0.614 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.268 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.624 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 66.1 m-20 -95.65 176.37 6.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.322 -0.439 . . . . 0.0 110.997 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.5 m -64.38 128.11 34.38 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.17 5.52 90.02 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.357 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.522 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 3.2 mm-40 -92.56 152.81 19.42 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.833 0.349 . . . . 0.0 111.497 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -68.72 145.1 54.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.426 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.45 179.0 7.05 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -116.12 122.75 31.82 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -47.9 -44.12 28.03 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.425 2.75 . . . . 0.0 113.407 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.94 80.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.281 0.563 . . . . 0.0 110.984 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.498 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 19.6 m -78.17 83.15 4.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.172 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -61.59 146.47 48.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.957 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.8 143.21 10.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.796 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.498 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 99.7 t -87.93 144.3 34.56 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.938 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 48' ' ' VAL . 34.4 Cg_exo -62.53 142.45 40.82 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 124.634 -0.986 . . . . 0.0 114.144 1.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 87.8 t80 -166.36 137.59 3.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.621 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -84.66 113.82 21.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.687 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 9' ' ' LYS . . . 169.7 -174.2 43.95 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.225 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.568 ' HZ1' ' HB3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -132.86 142.58 49.01 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.242 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.815 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . 3.6 mmp_? -86.67 110.53 19.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.247 0.546 . . . . 0.0 112.076 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 55' ' ' LEU . 3.1 mm? -88.42 -21.94 23.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.6 m -88.7 153.82 20.79 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.27 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.612 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 43.6 m -87.69 46.04 1.34 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.044 0.45 . . . . 0.0 111.044 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.6 tp -153.08 127.0 8.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.078 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.568 ' SG ' ' HB1' ' A' ' 20' ' ' ALA . 1.6 m -77.86 141.58 64.02 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.262 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.498 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 20.4 Cg_exo -65.57 -178.31 0.9 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.677 2.251 . . . . 0.0 111.499 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 72.7 m -62.4 140.43 58.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.313 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -64.11 155.56 31.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.073 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.4 m -51.78 127.4 20.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.211 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.72 -30.48 9.06 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.695 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.611 HD11 ' HG2' ' A' ' 62' ' ' LYS . 26.3 mt -88.98 145.77 25.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.109 0.481 . . . . 0.0 112.081 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.2 m -119.85 125.02 47.5 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.791 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.616 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 4.4 t -81.82 135.55 35.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.858 0.361 . . . . 0.0 111.242 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.4 m -137.53 148.33 45.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.438 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' A' ' 72' ' ' GLU . 16.0 ttmt -64.54 114.26 4.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.471 0.653 . . . . 0.0 110.962 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.493 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 11.1 m -97.75 83.37 3.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.985 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.07 -62.47 4.17 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.46 ' OE1' ' HA ' ' A' ' 72' ' ' GLU . 35.6 tp10 -150.11 -43.67 0.13 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.928 0.394 . . . . 0.0 109.957 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.621 ' HB2' ' HZ2' ' A' ' 73' ' ' LYS . 9.0 mtmp? -87.79 153.68 21.15 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.565 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 11.8 m-85 -89.39 129.57 35.89 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.89 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.493 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 45.8 mttm -125.81 150.28 47.94 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.137 0.494 . . . . 0.0 110.027 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 59.2 m -75.03 141.33 43.9 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.125 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.253 1.241 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.214 179.6 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.525 HG21 HG22 ' A' ' 4' ' ' THR . 7.2 p -89.13 135.87 24.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.861 0.363 . . . . 0.0 110.217 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.9 mm -88.59 81.93 2.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.215 0.531 . . . . 0.0 110.467 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.525 HG22 HG21 ' A' ' 2' ' ' VAL . 12.2 t -150.08 29.26 0.73 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.673 0.749 . . . . 0.0 110.105 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . 167.91 69.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.142 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.792 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -71.3 -17.33 62.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.7 p -150.06 144.99 26.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.826 0.345 . . . . 0.0 111.192 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.561 ' O ' ' HD2' ' A' ' 53' ' ' LYS . 11.6 t70 -86.91 -47.7 8.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.672 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.527 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 36.7 mttm -117.88 146.41 43.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.573 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' A' ' 53' ' ' LYS . 1.8 m-20 -51.24 -28.17 10.98 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.873 0.733 . . . . 0.0 111.529 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.853 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 22.0 t -55.25 -31.17 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.763 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -69.94 -17.98 63.34 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.1 m -89.42 -139.61 0.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.7 -141.84 4.77 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 119.395 -1.383 . . . . 0.0 113.777 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m -50.68 115.71 1.61 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.913 -0.644 . . . . 0.0 112.646 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 33' ' ' PRO . . . 60.45 31.45 74.36 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 114.928 -1.033 . . . . 0.0 114.907 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.539 ' O ' HG13 ' A' ' 48' ' ' VAL . 6.0 p -148.57 143.06 26.36 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.149 0.974 . . . . 0.0 111.685 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.549 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 0.7 OUTLIER -142.43 167.67 21.55 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.016 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.2 m -89.67 45.19 1.26 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.523 ' HB3' ' SG ' ' A' ' 59' ' ' CYS . . . -79.81 159.87 26.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.405 0.621 . . . . 0.0 111.407 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -88.27 152.68 21.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.945 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.621 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -63.33 136.5 57.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.048 0.452 . . . . 0.0 110.694 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.677 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -66.91 -22.43 65.96 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -86.99 -37.36 17.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.895 0.379 . . . . 0.0 111.674 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.0 m -152.01 145.92 25.18 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -80.14 38.84 0.42 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.47 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -89.93 -41.66 11.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.511 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.621 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.0 mp -87.35 130.76 36.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.569 ' O ' ' HA2' ' A' ' 5' ' ' GLY . 88.4 mtm180 -148.44 65.63 1.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.86 0.725 . . . . 0.0 109.304 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.792 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.4 p90 -150.84 -170.6 3.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.816 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 94.6 m -58.76 102.8 0.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.804 0.69 . . . . 0.0 112.539 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.492 HG13 ' SG ' ' A' ' 59' ' ' CYS . 47.1 pt -123.85 157.62 62.57 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 14.4 Cg_endo -56.0 147.7 62.13 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.235 2.623 . . . . 0.0 115.061 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 59' ' ' CYS . 78.5 mt -87.15 160.43 18.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.501 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.74 144.76 45.85 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 114.156 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.449 ' H ' ' CD ' ' A' ' 39' ' ' GLU . 35.1 m-80 -99.69 159.89 14.71 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.34 0.656 . . . . 0.0 110.685 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.2 m -56.39 128.58 36.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.883 0.373 . . . . 0.0 110.437 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.5 -21.69 36.31 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.966 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 36' ' ' ASN . 7.2 pt-20 -96.44 155.34 16.81 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 117.561 0.68 . . . . 0.0 110.648 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.413 ' CG ' ' HZ1' ' A' ' 75' ' ' LYS . 1.5 m-20 -60.71 145.32 49.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.998 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.2 p -144.7 156.13 43.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.079 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.452 ' CD2' ' HB3' ' A' ' 58' ' ' LEU . 84.0 m-70 -90.61 126.9 54.54 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.93 -34.67 99.21 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.708 2.272 . . . . 0.0 112.387 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.93 98.95 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.543 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.643 ' HB2' ' HB3' ' A' ' 60' ' ' PRO . 3.4 p -74.31 133.39 42.58 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -112.88 -150.31 0.46 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.947 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.615 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -70.02 155.19 40.95 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -179.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.606 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 92.0 t -111.99 137.77 21.49 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.114 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.853 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 37.9 Cg_exo -59.13 126.26 2.5 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 124.193 -1.17 . . . . 0.0 113.383 1.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.561 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 57.2 t80 -75.16 146.65 41.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.732 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.473 ' CG ' ' HZ3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -74.51 56.31 0.67 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.266 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.15 -136.54 6.38 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.643 ' HE3' HD23 ' A' ' 55' ' ' LEU . 29.7 pttt -150.38 138.24 20.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.731 0.3 . . . . 0.0 110.256 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 29.9 mmt180 -114.87 115.3 26.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.059 0.457 . . . . 0.0 111.224 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.643 HD23 ' HE3' ' A' ' 53' ' ' LYS . 3.1 mm? -89.23 32.75 0.82 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.931 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 p -89.2 157.38 18.28 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.703 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.677 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 68.0 m -88.02 30.21 0.87 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.044 0.45 . . . . 0.0 111.595 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.452 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 60.9 tp -154.5 123.65 6.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.382 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 20' ' ' ALA . 1.7 m -73.94 146.75 85.51 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.643 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 57.0 Cg_endo -70.16 -173.31 0.75 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.843 1.695 . . . . 0.0 111.339 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . 80.0 m -67.69 142.35 56.37 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.995 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.472 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . 46.8 mtpt -55.24 145.41 21.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.182 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.8 m -47.16 117.39 1.71 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.427 0.454 . . . . 0.0 110.966 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.26 -27.53 8.93 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.496 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 61' ' ' CYS . 56.2 mt -88.3 156.64 19.07 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.781 0.324 . . . . 0.0 111.04 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.7 m -123.15 130.57 52.94 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.496 -0.482 . . . . 0.0 112.163 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.438 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 35.6 t -78.06 119.23 21.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.5 m -131.99 145.02 51.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.638 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 54.2 tttp -65.37 107.8 1.75 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.277 0.56 . . . . 0.0 110.332 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.44 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 14.4 m -95.02 83.73 3.99 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.855 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.51 -69.75 3.27 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.449 ' OE1' ' HA ' ' A' ' 72' ' ' GLU . 36.4 tp10 -135.58 -49.46 0.71 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -88.15 157.87 18.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.438 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 12.8 m-85 -89.83 130.83 36.02 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.677 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 34.5 mttp -131.39 150.62 52.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.247 0.546 . . . . 0.0 109.906 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 62.1 m -67.23 134.29 51.38 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.983 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.254 1.295 0 CA-C-O 117.747 -1.12 . . . . 0.0 108.54 179.092 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.65 137.35 12.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 110.118 -0.326 . . . . 0.0 110.118 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 mm -88.9 99.58 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.931 0.396 . . . . 0.0 110.04 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 15.4 t -151.24 -30.21 0.18 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.426 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.5 117.55 0.4 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 1.103 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.71 -7.93 51.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.709 0.29 . . . . 0.0 111.776 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.498 ' SG ' ' HA ' ' A' ' 30' ' ' PHE . 6.0 p -132.3 139.13 48.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.024 0.44 . . . . 0.0 111.801 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.525 ' HB3' ' NE2' ' A' ' 12' ' ' GLN . 0.2 OUTLIER -71.55 -46.01 60.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.697 178.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -139.87 153.99 47.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.996 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.469 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 6.6 t70 -50.09 -30.87 11.9 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.155 0.91 . . . . 0.0 111.688 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.567 ' HA ' ' CB ' ' A' ' 49' ' ' PRO . 46.3 t -53.94 -30.15 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.512 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.525 ' NE2' ' HB3' ' A' ' 8' ' ' ASP . 72.3 mt-30 -76.36 -15.17 60.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 92.0 m -89.32 132.14 35.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.128 0.49 . . . . 0.0 111.088 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.51 156.83 51.39 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.095 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.1 m -52.14 108.9 0.32 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.135 0.493 . . . . 0.0 110.632 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.31 -21.18 3.3 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.1 p -136.3 156.34 48.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.136 -0.532 . . . . 0.0 110.077 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.672 ' SG ' ' HB2' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -145.17 161.69 38.9 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.325 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 62.1 m -87.01 59.41 5.62 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.078 0.465 . . . . 0.0 111.26 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.672 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . . . -93.33 144.5 25.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.97 0.414 . . . . 0.0 110.821 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.591 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -78.6 143.12 36.72 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.65 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 66.0 m -65.46 133.66 51.76 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.883 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.62 -24.71 67.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.901 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -86.68 -37.08 18.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 110.623 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.627 ' O ' ' HB2' ' A' ' 22' ' ' SER . 23.1 t -152.06 128.1 10.39 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.483 ' HD3' ' N ' ' A' ' 26' ' ' ARG . 1.7 mpp_? -77.22 37.87 0.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 4' ' ' THR . 13.4 p-10 -89.23 -37.69 14.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.65 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 42.9 mt -89.02 124.33 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.6 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.422 ' HG2' ' HB2' ' A' ' 21' ' ' ALA . 89.0 mtm180 -145.99 53.74 1.15 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 1.103 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.6 p90 -131.51 -171.0 2.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.478 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.7 m -61.56 77.3 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.19 0.931 . . . . 0.0 113.266 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.434 HG13 ' SG ' ' A' ' 59' ' ' CYS . 44.7 pt -93.54 154.6 41.17 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -55.29 151.63 35.37 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.222 2.615 . . . . 0.0 114.442 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.496 ' HA ' ' HB3' ' A' ' 59' ' ' CYS . 75.7 mt -86.91 159.68 18.96 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.12 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.53 138.25 44.17 Favored Glycine 0 C--O 1.238 0.353 0 O-C-N 124.059 0.849 . . . . 0.0 114.145 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.49 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 44.7 m-80 -105.75 162.51 13.48 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.238 0.615 . . . . 0.0 110.161 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.539 ' HG ' HD22 ' A' ' 65' ' ' LEU . 5.4 m -55.95 121.02 8.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.729 0.3 . . . . 0.0 110.63 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.77 -25.84 13.94 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.422 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 13.6 pt-20 -93.71 152.89 18.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.873 0.836 . . . . 0.0 110.769 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -59.69 153.64 19.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.537 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 27.2 p -144.72 154.85 43.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.775 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 56.8 m170 -90.2 126.14 57.87 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.531 ' HG3' ' CG ' ' A' ' 74' ' ' PHE . 36.5 Cg_exo -59.52 -53.45 3.39 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 123.15 2.566 . . . . 0.0 113.721 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.41 30.62 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.626 ' HG ' ' HG3' ' A' ' 60' ' ' PRO . 23.1 t -90.54 120.86 31.98 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.561 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 83.8 m-70 -68.65 144.32 54.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.186 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.571 ' HE3' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -54.16 154.98 3.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.969 -178.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' A' ' 49' ' ' PRO . 95.8 t -88.71 135.46 32.22 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.567 ' CB ' ' HA ' ' A' ' 11' ' ' VAL . 60.7 Cg_endo -73.21 140.77 69.08 Favored 'Cis proline' 0 C--O 1.237 0.469 0 C-N-CA 123.881 -1.3 . . . . 0.0 113.08 0.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.561 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 68.7 t80 -62.25 133.75 55.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.112 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.04 60.22 1.39 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.725 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.72 -133.9 4.26 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.92 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -117.89 124.76 49.08 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -90.63 111.91 23.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.215 0.531 . . . . 0.0 112.181 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.408 ' N ' HD23 ' A' ' 55' ' ' LEU . 4.0 mm? -111.65 18.43 19.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.14 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -89.34 142.3 27.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.37 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 15.8 m -89.25 30.51 0.97 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.7 tp -154.46 130.22 10.05 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.263 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 34' ' ' LEU . 1.7 m -80.51 140.31 51.81 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.626 ' HG3' ' HG ' ' A' ' 45' ' ' SER . 16.8 Cg_exo -66.35 171.06 11.01 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.539 2.159 . . . . 0.0 111.139 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.3 m -60.35 139.91 57.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.772 0.32 . . . . 0.0 110.937 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.428 ' HG2' HD11 ' A' ' 65' ' ' LEU . 14.6 ptmt -62.37 153.14 32.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.482 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.6 m -47.81 124.68 7.63 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.417 0.448 . . . . 0.0 111.294 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.18 -32.04 6.98 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.539 HD22 ' HG ' ' A' ' 37' ' ' SER . 28.2 mt -89.29 156.9 18.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 0.0 111.565 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.1 m -124.87 133.28 53.14 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.332 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 48.1 t -79.16 122.49 26.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 m -151.0 151.98 32.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.658 0.266 . . . . 0.0 111.08 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 83.0 tttt -62.25 116.29 4.88 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.7 m -115.97 49.02 1.15 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.775 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.413 ' O ' ' HE2' ' A' ' 69' ' ' LYS . . . 131.26 -102.59 0.52 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.039 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.17 -49.61 7.17 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.062 0.458 . . . . 0.0 110.683 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -121.42 -167.29 1.49 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.673 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 5.5 m-85 -91.38 134.96 34.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.889 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -133.75 155.83 49.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.537 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 60.6 m -75.61 137.64 40.89 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.946 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.667 -0.683 . . . . 0.0 109.158 179.684 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.594 HG22 HG22 ' A' ' 4' ' ' THR . 12.6 p -150.89 144.86 16.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.8 mm -88.02 57.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.69 0.757 . . . . 0.0 110.823 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.594 HG22 HG22 ' A' ' 2' ' ' VAL . 3.1 t -151.73 15.54 0.67 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.827 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.788 ' HA2' ' HB2' ' A' ' 29' ' ' ARG . . . 132.03 126.55 2.75 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.463 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 30' ' ' PHE . . . -91.71 -35.67 14.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.224 0.535 . . . . 0.0 110.597 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -127.58 150.02 49.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.064 -177.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -77.1 -44.03 32.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.842 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 1.012 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 32.0 mttm -131.48 152.04 51.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.789 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . 41.8 m-20 -54.87 -22.68 15.47 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.723 0.639 . . . . 0.0 110.586 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.92 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 2.2 p -54.22 -28.4 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.956 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.444 ' N ' HG11 ' A' ' 11' ' ' VAL . 62.0 mt-30 -77.55 -24.13 49.93 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 73.4 m -89.55 136.94 32.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.941 0.4 . . . . 0.0 110.979 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.63 154.86 53.39 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.869 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -53.66 100.34 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.141 0.496 . . . . 0.0 110.966 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.33 -23.71 1.55 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.3 p -133.41 147.88 51.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.639 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.459 ' HB3' HD12 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -134.87 167.97 19.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.994 0.361 . . . . 0.0 110.186 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.7 m -89.83 31.83 0.93 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.424 ' O ' HD12 ' A' ' 32' ' ' ILE . . . -73.99 148.67 41.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.974 0.416 . . . . 0.0 110.936 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.726 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -76.7 132.19 39.21 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.506 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 78.3 p -60.04 138.95 57.75 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.927 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.53 -24.73 63.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.375 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.3 p90 -87.39 -27.32 22.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.45 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 27' ' ' ASN . 67.9 m -150.8 122.8 8.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.038 0.447 . . . . 0.0 110.904 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.487 ' HE ' ' HB3' ' A' ' 21' ' ' ALA . 46.1 mmm-85 -74.75 10.94 1.18 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.78 0.324 . . . . 0.0 110.92 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 25' ' ' SER . 78.9 m-20 -89.75 -26.37 20.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.694 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.726 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.2 mp -85.97 115.95 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.788 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 62.0 mtt180 -140.52 43.8 1.86 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.486 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 0.8 OUTLIER -101.83 -178.12 3.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.99 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 89.1 m -68.64 79.64 0.28 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.573 0.546 . . . . 0.0 110.918 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 20' ' ' ALA . 43.9 pt -89.18 150.54 45.2 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.06 151.72 40.88 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.54 2.827 . . . . 0.0 114.896 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' A' ' 59' ' ' CYS . 5.2 mp -87.99 166.5 14.44 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.958 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.93 142.41 47.41 Favored Glycine 0 C--O 1.245 0.838 0 CA-C-N 114.714 -1.13 . . . . 0.0 114.496 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.487 ' O ' ' HB3' ' A' ' 39' ' ' GLU . 57.1 m-80 -91.23 173.08 8.12 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.396 -0.902 . . . . 0.0 111.316 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.6 m -63.0 128.83 37.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.395 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.57 11.38 85.27 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.651 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 36' ' ' ASN . 15.4 tt0 -100.56 155.35 17.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.43 140.23 58.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.175 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.7 p -143.12 145.5 32.9 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 52.7 m170 -89.5 123.5 66.59 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 9.6 Cg_endo -54.14 -34.11 77.13 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.244 2.629 . . . . 0.0 112.513 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.95 85.72 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.861 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 m -72.11 136.62 46.61 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -119.58 -142.21 0.35 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.639 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -68.49 166.37 17.05 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.618 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 72.3 t -133.8 130.63 20.74 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.92 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 52.4 Cg_exo -57.03 131.24 4.63 Favored 'Cis proline' 0 C--N 1.348 0.529 0 C-N-CA 124.278 -1.134 . . . . 0.0 113.197 0.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.789 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 69.1 t80 -77.57 150.93 34.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.226 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -74.17 52.06 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.096 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.53 -135.13 5.63 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 1.012 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 3.6 pptp? -151.48 127.73 10.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.988 0.394 . . . . 0.0 110.132 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -86.4 125.67 33.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.951 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.455 HD21 ' HD2' ' A' ' 53' ' ' LYS . 3.0 mm? -94.72 24.09 4.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.592 0.711 . . . . 0.0 109.395 178.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 m -89.84 158.79 17.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.476 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.682 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 4.6 m -89.24 24.34 2.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.726 0.298 . . . . 0.0 111.303 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.1 tp -154.07 130.15 10.31 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.79 -0.186 . . . . 0.0 111.42 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.501 ' HB3' HD12 ' A' ' 34' ' ' LEU . 16.7 m -76.26 156.7 83.57 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.72 -166.75 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 121.728 1.619 . . . . 0.0 111.229 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.436 ' O ' HD23 ' A' ' 34' ' ' LEU . 73.2 m -74.16 140.02 44.89 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.604 0.24 . . . . 0.0 111.296 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -64.55 157.64 26.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.715 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.9 m -44.05 125.26 4.3 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.736 0.647 . . . . 0.0 112.08 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.26 -30.58 10.07 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.514 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.12 140.98 28.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.095 0.474 . . . . 0.0 112.13 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.0 m -107.25 131.73 53.86 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.818 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 45.2 t -85.06 117.74 24.21 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.2 t -150.57 154.01 36.77 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 15.7 ttpp -65.4 119.67 11.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.945 0.402 . . . . 0.0 110.801 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -137.12 45.39 2.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 122.08 0.943 . . . . 0.0 108.921 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.7 -121.17 1.02 Allowed Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.5 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.18 -44.04 12.52 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -120.06 -161.01 0.85 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.593 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.576 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 3.5 m-85 -89.75 141.6 28.47 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.885 0.374 . . . . 0.0 111.196 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -131.02 160.14 35.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.274 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 81.7 m -84.76 129.2 34.86 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.715 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 C--O 1.252 1.192 0 CA-C-O 117.626 -1.178 . . . . 0.0 109.367 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.868 0.366 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.74 135.88 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.9 mm -89.12 60.18 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.561 0.696 . . . . 0.0 110.365 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.2 t -89.67 -29.54 18.71 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.594 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.27 116.47 0.69 Allowed Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.779 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 1.005 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -89.89 -11.66 41.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.506 -0.347 . . . . 0.0 111.437 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.2 p -151.03 159.41 44.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.765 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -104.53 -54.69 2.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.309 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.59 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 21.9 ttmm -108.03 146.01 33.15 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.279 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 50' ' ' TYR . 76.7 m-20 -51.41 -22.43 2.99 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.947 0.779 . . . . 0.0 110.731 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.7 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -57.11 -27.2 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.501 179.273 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.49 ' N ' HG11 ' A' ' 11' ' ' VAL . 53.0 mt-30 -81.11 -19.62 43.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.811 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.4 m -89.95 -138.26 0.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.115 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.3 -138.24 3.62 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 119.676 -1.25 . . . . 0.0 113.3 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 m -49.86 112.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.991 -0.604 . . . . 0.0 112.582 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.452 ' HA2' HD21 ' A' ' 34' ' ' LEU . . . 57.52 34.32 68.9 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.017 -0.992 . . . . 0.0 114.83 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.3 p -145.44 140.56 27.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.914 0.857 . . . . 0.0 111.113 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.492 ' HB3' HD13 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -145.03 162.18 37.58 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.7 m -88.32 57.58 4.32 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.169 0.509 . . . . 0.0 111.73 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.795 ' HB3' HH12 ' A' ' 54' ' ' ARG . . . -93.19 168.95 10.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.006 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -85.16 152.04 23.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.938 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.506 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -59.44 134.35 56.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.524 0.202 . . . . 0.0 111.068 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.91 37.2 0.08 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -151.48 -36.68 0.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.008 0.433 . . . . 0.0 110.485 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.7 m -151.05 149.54 29.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -83.4 43.99 0.93 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.342 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -97.35 -45.05 6.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.067 0.46 . . . . 0.0 110.231 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.6 mp -89.39 135.44 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.772 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.67 54.58 0.89 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 1.005 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.4 p90 -130.74 -166.91 1.75 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.986 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.2 m -62.08 80.69 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.988 0.805 . . . . 0.0 112.959 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.497 HG13 ' SG ' ' A' ' 59' ' ' CYS . 48.8 pt -96.74 154.21 38.46 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.46 151.82 80.74 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 122.785 2.323 . . . . 0.0 114.528 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 61' ' ' CYS . 5.8 mp -87.23 164.34 16.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.874 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.9 140.01 26.09 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.111 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 58.2 m-80 -95.63 -164.64 1.18 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.181 0.515 . . . . 0.0 111.124 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.441 ' HA ' HD13 ' A' ' 65' ' ' LEU . 6.1 m -61.43 123.79 18.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.315 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.1 -6.56 82.58 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.465 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.78 150.96 22.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.376 0.588 . . . . 0.0 111.343 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.13 146.86 49.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.533 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.542 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 24.5 p -143.58 145.45 32.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.093 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 39.9 m170 -90.11 122.68 67.38 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 9.9 Cg_endo -54.15 -38.78 87.78 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.219 2.613 . . . . 0.0 112.904 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.53 65.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.86 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.516 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 17.2 m -81.33 121.01 25.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.915 0.388 . . . . 0.0 110.47 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -93.05 -172.31 2.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.196 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -72.69 165.65 24.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 49' ' ' PRO . 60.4 t -87.09 139.92 32.54 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.7 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 2.6 Cg_exo -77.12 133.11 29.61 Favored 'Cis proline' 0 C--N 1.346 0.415 0 C-N-CA 123.845 -1.314 . . . . 0.0 113.505 1.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.482 ' HB3' ' OD2' ' A' ' 10' ' ' ASP . 48.8 t80 -113.64 149.25 34.88 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.59 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 25.8 t70 -58.63 -23.67 59.52 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.394 0.616 . . . . 0.0 111.3 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.13 33.31 57.57 Favored Glycine 0 C--N 1.318 -0.426 0 N-CA-C 115.409 0.924 . . . . 0.0 115.409 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.2 pttm -88.3 56.74 3.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.035 0.917 . . . . 0.0 109.739 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.795 HH12 ' HB3' ' A' ' 20' ' ' ALA . 4.0 ppt_? -150.32 130.04 13.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.619 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 55' ' ' LEU . 94.8 mt -88.48 50.34 1.95 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.439 0.638 . . . . 0.0 110.145 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 m -89.1 137.56 32.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.779 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 p -88.68 34.75 0.77 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.201 0.524 . . . . 0.0 110.598 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.9 tp -153.28 132.16 12.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.772 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.497 ' SG ' HG13 ' A' ' 32' ' ' ILE . 2.5 m -83.3 159.85 61.03 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.516 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 6.3 Cg_exo -71.83 -161.68 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.288 1.992 . . . . 0.0 111.723 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.562 ' O ' HD23 ' A' ' 34' ' ' LEU . 74.4 m -79.01 137.86 37.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.887 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HD2' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -66.86 153.46 43.39 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.1 m -46.28 113.1 0.57 Allowed 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.571 0.545 . . . . 0.0 111.6 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.37 -32.58 4.64 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.262 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.538 ' HB3' ' HB3' ' A' ' 76' ' ' CYS . 3.6 mm? -89.72 143.12 27.07 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.2 m -110.5 128.14 55.49 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.599 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 20.8 t -72.96 119.2 16.87 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.9 m -131.22 144.33 51.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.991 0.424 . . . . 0.0 111.408 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.539 ' NZ ' ' HA ' ' A' ' 72' ' ' GLU . 53.2 tttm -67.3 109.11 2.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.379 0.609 . . . . 0.0 110.38 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.9 m -88.95 76.53 7.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.664 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.94 -69.67 3.2 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.539 ' HA ' ' NZ ' ' A' ' 69' ' ' LYS . 33.9 tp10 -130.57 -41.53 1.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.753 0.311 . . . . 0.0 110.489 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -86.56 -172.79 4.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.7 128.84 47.32 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -135.14 150.32 50.15 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.542 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 68.9 m -70.83 133.9 46.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.945 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.9 m . . . . . 0 C--O 1.254 1.294 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.192 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.03 132.18 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.949 0.405 . . . . 0.0 110.266 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 51.2 mm -93.24 119.16 40.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.138 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.6 t -150.4 18.11 0.83 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.654 0.74 . . . . 0.0 110.054 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . -171.01 72.36 0.11 Allowed Glycine 0 C--O 1.226 -0.368 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.929 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -81.35 -23.6 37.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.464 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 18.6 p -151.13 154.92 37.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -92.03 -60.77 1.77 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.611 0.719 . . . . 0.0 110.236 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -101.35 139.32 37.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.798 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.59 ' OD2' ' HB2' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -46.68 -33.19 4.07 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.32 1.012 . . . . 0.0 111.797 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.8 t -49.55 -32.4 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.631 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -66.03 -30.19 70.69 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.592 ' HB3' ' HG1' ' A' ' 17' ' ' THR . 66.6 m -89.88 159.84 16.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.118 0.485 . . . . 0.0 111.378 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.99 166.49 54.9 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.48 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.442 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 56.9 m -63.79 67.13 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.71 0.804 . . . . 0.0 112.125 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.35 -26.44 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.404 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.592 ' HG1' ' HB3' ' A' ' 13' ' ' CYS . 26.5 p -124.39 142.73 51.07 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.59 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . 0.7 OUTLIER -119.74 154.19 34.53 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 60.4 m -89.52 48.52 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 0.0 111.961 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -95.54 -170.09 2.09 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.11 141.34 28.78 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.421 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 88.2 p -63.46 142.98 58.19 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.108 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.659 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -55.93 -26.38 47.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -87.97 -32.23 18.96 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.444 ' C ' ' H ' ' A' ' 27' ' ' ASN . 68.1 m -151.67 135.87 16.7 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.914 -0.492 . . . . 0.0 111.538 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.464 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 59.7 mtm180 -78.46 20.55 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.128 0.489 . . . . 0.0 110.785 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.444 ' H ' ' C ' ' A' ' 25' ' ' SER . 74.2 m-20 -92.55 -31.32 15.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.605 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.664 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 1.8 mp -85.39 120.81 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 89.2 mtt180 -139.14 77.44 1.62 Allowed 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.914 0.759 . . . . 0.0 109.717 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.929 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.0 OUTLIER -150.83 -167.08 2.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.565 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 84.2 m -60.34 77.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.667 HG13 ' SG ' ' A' ' 59' ' ' CYS . 34.0 pt -97.99 146.37 31.37 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -57.01 151.39 50.21 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.267 2.644 . . . . 0.0 115.084 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.522 HD13 ' HB3' ' A' ' 59' ' ' CYS . 5.1 mp -87.11 168.79 12.96 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.769 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.74 147.07 37.9 Favored Glycine 0 C--O 1.239 0.436 0 CA-C-N 115.246 -0.888 . . . . 0.0 114.02 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 72.5 m-80 -100.85 -178.98 3.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.163 -0.518 . . . . 0.0 109.799 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.3 m -62.86 129.51 40.75 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.07 -6.76 76.32 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.179 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -88.2 154.56 20.34 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.897 0.379 . . . . 0.0 111.029 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -67.6 142.82 56.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.821 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.504 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 31.6 p -146.01 150.15 35.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.207 0.527 . . . . 0.0 110.688 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -95.4 126.94 43.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.56 -40.83 77.64 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.092 2.528 . . . . 0.0 112.907 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.46 -33.86 76.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.134 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.626 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 17.7 m -73.31 138.82 45.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.362 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -129.29 175.46 8.72 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 7.7 ptmt -59.69 150.88 26.43 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.445 0.466 . . . . 0.0 111.6 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.488 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 60.3 t -87.14 142.56 33.77 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.651 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 48' ' ' VAL . 33.5 Cg_exo -63.07 138.46 28.27 Favored 'Cis proline' 0 C--N 1.351 0.683 0 C-N-CA 124.392 -1.087 . . . . 0.0 113.73 1.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.489 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 34.5 t80 -146.57 141.79 27.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.703 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -74.13 79.46 1.75 Allowed 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.547 ' HA3' ' OD1' ' A' ' 10' ' ' ASP . . . -89.48 131.84 10.93 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.783 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.18 37.46 0.55 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.324 0.583 . . . . 0.0 109.432 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.404 HH12 ' CG ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -115.88 139.9 49.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.915 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.68 48.53 1.6 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.223 0.535 . . . . 0.0 110.463 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.7 m -103.04 143.38 32.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.39 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.659 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 72.7 m -88.86 47.92 1.56 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.57 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 53.9 tp -152.51 124.14 7.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.726 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.667 ' SG ' HG13 ' A' ' 32' ' ' ILE . 3.7 m -84.14 153.94 63.29 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.718 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.626 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 12.3 Cg_exo -69.44 -169.96 0.34 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.497 2.132 . . . . 0.0 111.642 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 82.5 m -77.75 139.37 39.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.67 0.271 . . . . 0.0 111.248 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.435 ' HG2' HD11 ' A' ' 65' ' ' LEU . 19.1 ptmt -62.13 154.12 28.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.22 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.442 ' OG ' ' HB3' ' A' ' 15' ' ' SER . 17.6 m -51.03 125.27 13.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.312 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.54 -29.67 9.7 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.415 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.435 HD11 ' HG2' ' A' ' 62' ' ' LYS . 22.6 mt -88.91 152.7 21.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.025 0.44 . . . . 0.0 111.936 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -113.26 128.13 56.38 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.998 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.544 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 53.8 t -84.69 119.67 25.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.1 t -150.97 158.97 44.81 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 23.8 ttpp -65.82 102.4 0.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.245 0.545 . . . . 0.0 109.824 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.533 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 12.1 m -101.6 43.46 1.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.182 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.4 -105.6 0.47 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.322 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.495 ' CD ' ' HG2' ' A' ' 73' ' ' LYS . 1.1 pm0 -86.08 -40.51 15.65 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 122.776 0.43 . . . . 0.0 110.406 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.495 ' HG2' ' CD ' ' A' ' 72' ' ' GLU . 25.0 pttt -133.23 -164.26 1.46 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.902 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 5.1 m-85 -90.09 134.4 34.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.148 0.499 . . . . 0.0 111.468 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 46.4 mttp -135.86 154.33 51.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.063 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 73.0 m -75.39 126.44 31.01 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.469 -178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.249 1.065 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.677 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.56 HG11 HG22 ' A' ' 4' ' ' THR . 7.3 p -150.82 138.53 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.8 mm -88.56 90.68 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.195 0.522 . . . . 0.0 110.064 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.56 HG22 HG11 ' A' ' 2' ' ' VAL . 14.5 t -150.41 -29.3 0.22 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.396 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.413 ' N ' HG21 ' A' ' 4' ' ' THR . . . -161.67 108.39 0.35 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.043 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 1.003 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -91.17 -14.19 31.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 p -147.7 145.82 29.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.087 0.47 . . . . 0.0 111.904 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.552 ' O ' ' HB3' ' A' ' 53' ' ' LYS . 17.6 t70 -88.23 -44.79 10.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.42 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.53 ' HG3' ' OD2' ' A' ' 8' ' ' ASP . 61.6 mttp -121.49 144.88 48.46 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 108.962 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.674 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 37.8 t0 -55.31 -18.8 7.03 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.838 0.711 . . . . 0.0 111.005 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.45 HG11 ' N ' ' A' ' 12' ' ' GLN . 1.7 p -55.49 -25.33 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.802 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.45 ' N ' HG11 ' A' ' 11' ' ' VAL . 78.8 mt-30 -82.13 -16.76 48.76 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 68.8 m -89.8 -129.79 0.08 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.784 0.326 . . . . 0.0 110.678 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.86 169.88 35.92 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.507 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.4 m -51.96 105.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.125 0.488 . . . . 0.0 111.364 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.63 -35.22 1.89 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.462 HG21 ' HA ' ' A' ' 33' ' ' PRO . 23.6 p -139.75 143.58 37.04 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.745 0.418 . . . . 0.0 110.08 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.581 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -128.13 159.51 34.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.674 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 67.9 m -85.78 105.09 16.05 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.192 0.52 . . . . 0.0 109.689 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.64 ' HB3' ' HB2' ' A' ' 54' ' ' ARG . . . -159.58 173.36 16.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.07 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -82.27 138.07 34.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.298 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.657 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -66.03 137.37 57.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.865 0.364 . . . . 0.0 110.881 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.03 -24.73 66.4 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -86.78 -34.82 19.47 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.416 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.466 ' C ' ' H ' ' A' ' 27' ' ' ASN . 28.2 m -151.59 124.88 8.78 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.48 ' HD3' ' N ' ' A' ' 26' ' ' ARG . 1.6 mpp_? -76.29 30.0 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.019 0.438 . . . . 0.0 111.834 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.466 ' H ' ' C ' ' A' ' 25' ' ' SER . 5.6 m120 -90.03 -37.26 14.42 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.657 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.0 mp -89.58 125.76 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.198 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.51 ' HD3' ' C ' ' A' ' 28' ' ' ILE . 1.3 mpp_? -136.84 68.19 1.43 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 1.003 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.1 p90 -147.29 -161.09 1.26 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.495 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 82.9 m -60.87 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.966 0.791 . . . . 0.0 111.911 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.546 HG13 ' SG ' ' A' ' 59' ' ' CYS . 43.4 pt -100.84 150.54 37.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HA ' HG21 ' A' ' 17' ' ' THR . 10.0 Cg_endo -52.48 148.14 27.59 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 123.41 2.74 . . . . 0.0 114.67 -177.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.631 ' HB2' ' HG2' ' A' ' 62' ' ' LYS . 90.8 mt -85.53 163.84 18.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.979 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 62' ' ' LYS . . . -59.67 137.41 49.76 Favored Glycine 0 C--O 1.24 0.509 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.91 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -88.88 165.6 14.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.172 0.589 . . . . 0.0 110.289 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.6 t -62.52 133.77 55.44 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.493 ' O ' ' HD3' ' A' ' 75' ' ' LYS . . . 87.96 -12.08 65.07 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.548 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -88.59 159.79 17.72 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 117.107 0.453 . . . . 0.0 111.861 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.535 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 0.3 OUTLIER -65.65 147.73 52.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.091 -178.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.3 p -149.83 142.52 24.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.273 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -88.0 124.8 66.22 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -51.7 -38.98 67.38 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.47 2.78 . . . . 0.0 113.795 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.65 25.67 0.42 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.426 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . 49.5 m -90.64 122.36 33.36 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.915 -0.491 . . . . 0.0 110.372 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.532 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 19.3 m170 -77.46 149.24 35.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HZ2' ' HB3' ' A' ' 47' ' ' LYS . 1.7 ttpm? -55.39 149.65 12.85 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.631 0.582 . . . . 0.0 111.298 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 49' ' ' PRO . 84.9 t -85.87 138.3 35.3 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.891 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HA ' HG12 ' A' ' 48' ' ' VAL . 8.2 Cg_exo -73.58 135.18 38.83 Favored 'Cis proline' 0 C--N 1.344 0.296 0 C-N-CA 123.603 -1.415 . . . . 0.0 112.88 1.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.532 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 89.1 t80 -64.32 143.05 58.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.421 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.58 44.82 0.13 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.06 -139.75 6.9 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.801 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.552 ' HB3' ' O ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -121.49 134.27 55.06 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.64 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . 61.4 mtp85 -88.08 124.07 33.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.845 0.355 . . . . 0.0 111.209 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.474 ' N ' HD21 ' A' ' 55' ' ' LEU . 3.4 mm? -88.94 -5.87 57.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.299 0.571 . . . . 0.0 109.946 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m -87.85 146.43 25.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.459 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 13.3 m -87.41 42.82 1.06 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.983 0.42 . . . . 0.0 111.387 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.1 tp -153.62 121.99 6.22 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.379 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.546 ' SG ' HG13 ' A' ' 32' ' ' ILE . 3.4 m -81.0 148.19 63.62 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.43 ' HD3' ' CZ ' ' A' ' 54' ' ' ARG . 37.3 Cg_endo -67.41 173.39 8.8 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 121.849 1.7 . . . . 0.0 111.46 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.8 m -59.34 144.37 46.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.121 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.631 ' HG2' ' HB2' ' A' ' 34' ' ' LEU . 60.2 mttm -56.17 143.96 31.39 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -51.56 110.3 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.17 0.51 . . . . 0.0 110.543 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.75 -30.06 3.65 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.7 mt -88.83 147.19 24.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.698 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.3 m -109.91 126.78 54.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.017 0.437 . . . . 0.0 111.481 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.4 t -78.53 116.23 18.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.0 t -134.46 158.68 43.28 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.902 0.382 . . . . 0.0 110.416 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 41.5 ttmt -71.63 112.04 7.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.5 t -91.34 56.94 3.23 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.18 -92.43 1.77 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.226 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -91.02 -46.39 8.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.052 0.453 . . . . 0.0 111.257 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.564 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -107.22 167.06 10.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.711 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 13.4 m-85 -95.38 132.16 40.72 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.535 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 55.1 mttm -138.75 153.36 48.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.379 0.609 . . . . 0.0 111.013 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 70.7 m -66.33 132.51 48.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.364 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 C--O 1.253 1.266 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.129 179.701 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -88.96 135.56 25.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 123.177 0.298 . . . . 0.0 110.237 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 51.4 mm -96.82 119.81 45.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.171 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 t -150.3 26.5 0.77 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.59 0.71 . . . . 0.0 110.171 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.56 129.72 4.06 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.674 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.95 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.4 -10.24 44.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.637 0.256 . . . . 0.0 111.571 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 18.8 p -150.76 150.67 31.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.973 0.416 . . . . 0.0 111.409 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -97.41 -46.22 6.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.117 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -114.33 145.08 42.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.439 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.764 ' HB2' ' H ' ' A' ' 50' ' ' TYR . 88.2 m-20 -57.35 -26.85 61.63 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.509 0.505 . . . . 0.0 111.417 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -57.39 -29.15 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.898 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -70.23 -26.05 63.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.491 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 58.0 m -90.69 -122.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.119 0.485 . . . . 0.0 110.784 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.33 157.08 28.14 Favored Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.666 ' HA ' HG13 ' A' ' 48' ' ' VAL . 15.8 m -55.67 101.0 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.297 0.57 . . . . 0.0 110.846 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.03 -28.08 1.13 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.6 p -135.27 139.49 44.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.15 -0.525 . . . . 0.0 109.833 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.591 ' SG ' ' HB1' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -123.83 159.64 29.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.0 m -88.06 51.22 2.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.89 0.376 . . . . 0.0 111.539 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.591 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . -79.62 160.79 26.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.043 0.449 . . . . 0.0 110.998 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.68 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -90.4 144.5 25.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.422 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.637 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -64.58 135.45 55.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.972 0.415 . . . . 0.0 110.395 179.179 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.498 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -64.87 -23.06 67.12 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.0 p90 -87.94 -37.68 16.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.4 m -151.74 152.63 32.98 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.19 -0.318 . . . . 0.0 110.162 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -81.75 41.4 0.64 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.775 0.322 . . . . 0.0 111.453 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -97.07 -39.43 9.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.951 0.405 . . . . 0.0 110.828 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.637 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 53.2 mt -88.86 125.63 41.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.918 0.39 . . . . 0.0 110.297 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.3 mmm-85 -150.95 41.03 0.74 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.865 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.95 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.4 p90 -121.64 -172.77 2.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.971 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.4 m -61.15 82.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 O-C-N 124.369 1.043 . . . . 0.0 112.609 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.514 HG13 ' SG ' ' A' ' 59' ' ' CYS . 30.4 pt -97.86 147.13 32.62 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.07 152.5 36.95 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.388 2.725 . . . . 0.0 114.663 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 59' ' ' CYS . 3.8 mp -87.38 164.73 16.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.317 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.597 ' O ' ' HG3' ' A' ' 62' ' ' LYS . . . -75.4 154.89 46.5 Favored Glycine 0 C--O 1.237 0.335 0 CA-C-N 115.116 -0.947 . . . . 0.0 114.291 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.526 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 1.3 p30 -109.18 169.56 8.61 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.131 0.491 . . . . 0.0 110.991 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.402 ' OG ' HD23 ' A' ' 65' ' ' LEU . 12.7 m -54.59 121.91 9.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.287 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.12 -24.38 16.42 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.04 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 10.7 pt-20 -100.53 153.02 19.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.365 0.582 . . . . 0.0 110.958 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.45 150.71 21.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.299 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.526 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 13.3 p -149.23 154.47 39.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.787 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -90.97 128.54 47.46 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.45 -60.07 0.8 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.5 2.8 . . . . 0.0 114.207 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.35 26.79 0.3 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.189 0.518 . . . . 0.0 110.551 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -81.98 2.63 29.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.761 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.538 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -178.18 36.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.621 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.571 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -68.33 136.14 52.95 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.603 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.666 HG13 ' HA ' ' A' ' 15' ' ' SER . 24.6 t -86.44 128.39 57.26 Favored Pre-proline 0 C--N 1.315 -0.906 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.94 -178.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -91.13 131.03 7.72 Favored 'Cis proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.797 -1.335 . . . . 0.0 112.855 0.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.764 ' H ' ' HB2' ' A' ' 10' ' ' ASP . 12.1 t80 -109.12 120.46 42.61 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.266 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -84.15 63.8 7.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.909 0.861 . . . . 0.0 108.838 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.15 142.62 7.32 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.881 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.49 52.2 0.83 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.292 0.568 . . . . 0.0 110.126 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.4 tpt85 -57.73 139.46 53.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.079 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 55' ' ' LEU . 3.3 mm? -84.46 61.68 6.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.797 0.808 . . . . 0.0 110.391 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.5 m -102.17 129.41 48.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.471 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 7.0 m -89.24 28.39 1.24 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.849 0.357 . . . . 0.0 111.496 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.1 tp -153.9 129.09 9.69 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.342 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.514 ' SG ' HG13 ' A' ' 32' ' ' ILE . 3.8 m -78.77 164.44 55.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.844 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.522 ' HG3' ' HA ' ' A' ' 47' ' ' LYS . 94.7 Cg_endo -78.5 -157.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.305 2.003 . . . . 0.0 111.508 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 90.4 m -87.14 145.5 26.4 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.399 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 29.5 mtpp -57.46 153.44 12.72 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.678 0.611 . . . . 0.0 110.236 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.8 m -49.39 121.73 5.35 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.229 0.331 . . . . 0.0 111.178 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.6 -24.34 28.91 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 65' ' ' LEU . 42.3 mt -88.27 152.13 22.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.845 0.355 . . . . 0.0 111.396 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.2 m -115.59 129.51 56.54 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.132 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.0 t -81.65 116.2 21.27 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 m -132.72 146.05 51.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.708 0.289 . . . . 0.0 110.663 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.665 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 34.8 ttpt -70.33 108.03 4.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.116 0.484 . . . . 0.0 110.887 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.863 ' HB3' ' HD3' ' A' ' 75' ' ' LYS . 19.6 t -94.38 76.85 3.9 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.54 -102.1 2.86 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.104 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.53 ' OE1' ' HG3' ' A' ' 73' ' ' LYS . 2.8 tt0 -89.01 -56.46 3.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.518 -0.341 . . . . 0.0 111.503 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.53 ' HG3' ' OE1' ' A' ' 72' ' ' GLU . 64.5 mttp -102.8 172.46 6.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.17 0.509 . . . . 0.0 111.953 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 10.1 m-85 -89.48 132.05 35.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.352 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.863 ' HD3' ' HB3' ' A' ' 70' ' ' SER . 1.6 mptp? -130.95 150.05 52.29 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 62.5 m -69.64 144.98 52.77 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.699 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--O 1.248 0.981 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.398 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.12 131.93 35.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.936 0.398 . . . . 0.0 110.436 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.6 mm -93.6 123.4 45.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.9 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 t -151.01 -42.53 0.12 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.564 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.32 121.42 0.64 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.454 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 1.056 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -91.34 -14.84 30.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.2 p -150.66 167.47 27.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.923 0.392 . . . . 0.0 111.49 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.24 -44.0 2.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.186 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 46.3 mmtm -104.09 138.16 41.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.734 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.406 ' OD2' ' HG2' ' A' ' 54' ' ' ARG . 70.4 m-20 -57.96 -28.58 64.48 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.347 0.594 . . . . 0.0 109.847 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.4 t -56.74 -29.87 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 114.827 -1.078 . . . . 0.0 111.486 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -69.11 -22.77 63.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.636 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.8 m -89.48 -126.44 0.07 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.138 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.39 -177.8 43.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.127 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.5 m -67.63 66.18 0.08 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.435 0.636 . . . . 0.0 111.488 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 176.58 -24.2 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.341 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.1 p -139.55 147.89 41.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.023 0.129 . . . . 0.0 110.655 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.481 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -136.16 160.27 39.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.4 m -87.6 51.82 2.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.136 0.493 . . . . 0.0 111.762 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.75 164.19 16.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.805 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.66 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -86.06 144.59 27.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.102 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.636 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -64.76 134.07 53.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.932 0.396 . . . . 0.0 111.146 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.766 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -65.7 -21.23 66.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -87.57 -35.15 18.28 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 27' ' ' ASN . 40.7 m -151.84 144.06 23.98 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.079 -0.388 . . . . 0.0 110.524 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.94 33.79 0.18 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.955 0.407 . . . . 0.0 111.627 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 25' ' ' SER . 4.8 m120 -98.18 -40.83 8.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.755 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.636 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.8 mp -88.08 127.23 41.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.961 0.41 . . . . 0.0 110.918 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HD3' ' C ' ' A' ' 28' ' ' ILE . 1.1 mpp_? -143.34 68.49 1.29 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.863 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 1.056 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.5 p90 -145.76 -170.52 3.49 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.763 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.2 m -60.92 75.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.288 0.992 . . . . 0.0 112.946 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.547 HG13 ' SG ' ' A' ' 59' ' ' CYS . 43.9 pt -89.83 153.05 47.34 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.78 151.54 47.54 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.137 2.558 . . . . 0.0 114.691 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 60' ' ' PRO . 3.6 mp -87.09 170.82 11.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.936 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.54 133.28 25.47 Favored Glycine 0 C--O 1.243 0.696 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.483 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -89.75 167.83 12.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.191 -0.505 . . . . 0.0 110.36 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 m -59.97 128.1 35.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.767 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.8 -5.2 84.5 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.145 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.475 ' HA ' ' NZ ' ' A' ' 75' ' ' LYS . 5.9 mm-40 -99.21 162.44 13.05 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 117.411 0.606 . . . . 0.0 111.8 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.524 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 41.3 p-10 -63.59 151.82 40.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.251 1.024 . . . . 0.0 113.217 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 21.5 p -151.08 143.65 24.33 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.331 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -89.45 121.65 69.09 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -48.54 -40.25 37.28 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.775 2.984 . . . . 0.0 113.738 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.43 ' HB1' ' NH2' ' A' ' 54' ' ' ARG . . . -66.28 -28.39 68.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.121 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 53.9 m -73.82 137.07 43.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.889 0.376 . . . . 0.0 110.587 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -123.0 145.89 48.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.87 144.12 1.9 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.554 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 21.9 t -88.25 143.21 32.35 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.052 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.554 ' C ' ' HA ' ' A' ' 48' ' ' VAL . 19.1 Cg_endo -60.75 131.8 8.24 Favored 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.402 -1.082 . . . . 0.0 114.185 1.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -115.73 137.76 51.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.176 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -69.62 109.87 4.54 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.21 -133.78 11.5 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -152.5 152.42 31.91 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.43 ' NH2' ' HB1' ' A' ' 44' ' ' ALA . 23.1 mmm180 -85.41 107.19 17.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.143 0.497 . . . . 0.0 111.906 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.75 61.49 6.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 t -144.66 163.39 34.11 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.598 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.766 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 6.6 m -88.02 21.98 2.55 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.5 tp -154.08 127.82 8.76 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 121.168 -0.213 . . . . 0.0 111.299 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.547 ' SG ' HG13 ' A' ' 32' ' ' ILE . 13.3 m -74.76 154.29 87.18 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.066 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.513 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 57.0 Cg_endo -69.76 178.28 4.73 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.475 2.117 . . . . 0.0 111.973 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 71.4 m -70.27 143.1 52.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.449 ' HG2' HD13 ' A' ' 65' ' ' LEU . 9.8 ptmm? -60.66 146.91 43.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.1 m -45.52 128.88 8.47 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.078 0.466 . . . . 0.0 111.381 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.99 -28.97 10.86 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.585 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.449 HD13 ' HG2' ' A' ' 62' ' ' LYS . 22.2 mt -89.85 145.28 25.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.955 0.407 . . . . 0.0 111.735 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.9 m -108.59 126.44 52.94 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.955 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 48.1 t -81.01 126.58 31.58 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.6 p -149.46 149.15 30.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.752 0.31 . . . . 0.0 111.231 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.871 ' HE3' ' HA ' ' A' ' 72' ' ' GLU . 46.8 tttt -66.92 105.58 1.66 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.376 0.608 . . . . 0.0 110.984 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 6.8 m -89.83 82.7 6.2 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.833 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.91 -64.09 3.96 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.274 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.871 ' HA ' ' HE3' ' A' ' 69' ' ' LYS . 0.8 OUTLIER -141.02 -47.27 0.4 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.999 0.428 . . . . 0.0 110.028 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -94.77 158.47 15.49 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 15.2 m-85 -88.37 130.08 35.24 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.45 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.524 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 37.2 mttm -134.85 155.52 50.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.315 0.579 . . . . 0.0 110.141 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.3 m -73.86 137.16 43.57 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.373 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.244 0.805 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.413 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.11 136.56 23.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.6 mm -96.94 119.79 45.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.29 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.2 p -120.96 30.5 6.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.041 0.448 . . . . 0.0 110.57 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.19 122.7 0.28 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.435 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.986 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -82.56 -6.53 59.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.722 0.296 . . . . 0.0 111.614 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 p -149.89 146.25 26.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.954 0.406 . . . . 0.0 111.739 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.453 ' OD1' ' HG2' ' A' ' 9' ' ' LYS . 3.2 t70 -95.37 -57.01 2.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.453 ' HG2' ' OD1' ' A' ' 8' ' ' ASP . 23.6 mmtp -93.99 141.5 28.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.746 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.2 -31.03 66.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.538 0.685 . . . . 0.0 109.881 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.805 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 47.8 t -55.97 -27.16 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.943 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -67.08 -25.56 66.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.605 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 71.3 m -89.61 138.27 31.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.03 0.443 . . . . 0.0 111.331 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.17 151.2 49.74 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.631 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.409 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 18.4 m -51.48 113.02 0.85 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.187 0.517 . . . . 0.0 110.741 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.13 -27.86 3.1 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.4 p -128.87 144.87 51.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.965 -0.618 . . . . 0.0 109.535 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.411 ' HB3' HD12 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -128.96 166.51 19.03 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 72.3 m -88.02 52.77 2.55 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.797 0.332 . . . . 0.0 111.678 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.473 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -89.81 156.6 18.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.11 0.481 . . . . 0.0 111.336 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.26 145.88 24.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.463 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.585 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -66.0 128.0 34.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.086 0.469 . . . . 0.0 110.883 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.69 -20.13 65.91 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -86.81 -36.17 18.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.811 0.338 . . . . 0.0 111.441 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.8 m -152.0 138.79 18.89 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.452 ' HD3' ' N ' ' A' ' 26' ' ' ARG . 1.6 mpp_? -76.7 48.26 0.55 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.639 0.257 . . . . 0.0 111.547 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -103.95 -41.03 5.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.856 0.36 . . . . 0.0 110.379 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.585 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 69.5 mt -89.6 131.02 37.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.816 0.341 . . . . 0.0 110.335 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -151.73 52.63 0.82 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.986 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.9 p90 -140.45 -168.49 2.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.871 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 67.0 m -57.62 99.06 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 O-C-N 124.11 0.881 . . . . 0.0 112.378 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.514 HG13 ' SG ' ' A' ' 59' ' ' CYS . 46.1 pt -120.74 149.9 51.53 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.39 147.52 67.43 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.408 2.739 . . . . 0.0 115.125 -177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 61' ' ' CYS . 7.1 mp -88.34 164.5 15.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.359 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.77 149.29 26.79 Favored Glycine 0 C--O 1.238 0.348 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.252 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 49.6 m-80 -103.34 -168.12 1.47 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.999 0.428 . . . . 0.0 110.922 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 m -61.61 129.95 43.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.626 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.409 ' O ' ' HE3' ' A' ' 75' ' ' LYS . . . 93.11 -12.24 70.28 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.323 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 36' ' ' ASN . 49.1 mt-10 -90.86 144.8 25.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.29 0.566 . . . . 0.0 111.293 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.568 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 11.6 m-20 -62.38 145.63 53.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.301 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.414 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -135.52 179.91 6.04 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -116.76 122.12 31.99 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -57.77 -34.79 98.71 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.771 2.314 . . . . 0.0 112.492 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.52 -26.46 62.67 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.565 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.562 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 40.6 m -78.35 129.94 35.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.419 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -88.35 -152.25 0.22 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.607 ' HD2' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -88.2 146.57 25.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.437 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 70.8 t -88.65 136.72 30.8 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 123.436 0.46 . . . . 0.0 110.191 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.805 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 16.7 Cg_exo -68.82 128.25 11.3 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.863 -1.307 . . . . 0.0 113.115 0.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.48 ' CE2' ' HG2' ' A' ' 54' ' ' ARG . 80.5 t80 -65.26 145.86 55.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.111 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.93 49.9 0.25 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.23 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.61 -143.51 9.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.955 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -150.4 59.45 0.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.1 0.476 . . . . 0.0 111.37 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.48 ' HG2' ' CE2' ' A' ' 50' ' ' TYR . 22.0 mmt85 -59.39 140.55 56.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.29 57.76 4.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.416 0.627 . . . . 0.0 110.311 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.2 m -88.84 141.78 28.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.253 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 4.1 p -89.13 17.6 5.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.955 0.407 . . . . 0.0 111.698 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.9 tp -154.18 129.88 10.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.724 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.514 ' SG ' HG13 ' A' ' 32' ' ' ILE . 9.0 m -73.37 149.49 88.96 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 7.5 Cg_exo -72.11 -160.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.396 2.064 . . . . 0.0 111.762 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.856 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 44.1 m -75.72 139.31 41.82 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.992 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.423 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -60.79 150.11 33.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.835 179.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 15' ' ' SER . 13.8 m -49.67 125.29 11.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.625 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.86 -33.72 5.74 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.917 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.5 mt -89.95 163.59 14.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.922 0.391 . . . . 0.0 111.817 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -133.64 137.75 45.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.08 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.856 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 10.5 t -92.53 148.99 21.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.785 0.326 . . . . 0.0 111.039 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.6 t -147.94 156.6 42.85 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -73.79 111.99 9.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.381 0.61 . . . . 0.0 110.302 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.8 m -89.55 66.88 7.42 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.94 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.16 -60.4 1.94 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.169 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -142.17 -46.15 0.34 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -88.24 160.46 17.68 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.461 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 25.4 m-85 -99.28 122.38 42.36 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.477 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.568 ' HD2' ' HA ' ' A' ' 40' ' ' ASP . 19.6 mmmt -123.2 144.07 49.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 95.1 m -73.42 149.84 42.16 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.237 -0.887 . . . . 0.0 109.382 179.426 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.15 135.44 25.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 123.262 0.351 . . . . 0.0 110.281 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.5 mm -88.98 95.18 5.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.993 0.425 . . . . 0.0 110.108 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 t -150.6 27.8 0.72 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.739 0.781 . . . . 0.0 110.155 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.5 ' CA ' ' HB2' ' A' ' 29' ' ' ARG . . . 107.25 132.17 6.87 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.465 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -76.97 -20.39 56.15 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.171 0.51 . . . . 0.0 110.542 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 p -137.08 158.85 43.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.876 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -83.17 -51.05 7.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.602 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.913 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 28.1 mttm -126.11 147.3 49.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.737 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . 40.8 m-20 -51.41 -28.72 13.56 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.01 0.819 . . . . 0.0 111.33 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 t -53.74 -32.67 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.049 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -69.18 -25.47 64.36 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.3 m -89.3 135.19 33.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.903 0.383 . . . . 0.0 110.409 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.04 156.05 50.19 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.4 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.4 m -52.71 104.12 0.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.288 0.566 . . . . 0.0 110.442 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.17 -19.66 1.92 Allowed Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.0 p -137.56 157.1 47.26 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.284 -0.458 . . . . 0.0 110.55 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.484 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -140.85 162.3 35.78 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.7 m -91.09 35.52 0.91 Allowed 'General case' 0 C--O 1.239 0.528 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.71 169.34 15.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.909 0.385 . . . . 0.0 110.639 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.709 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -78.96 135.92 37.08 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.8 p -66.47 146.24 54.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.39 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.41 -26.12 66.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.358 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 35.8 p90 -88.02 -29.6 20.59 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.731 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.626 ' HB2' HD12 ' A' ' 28' ' ' ILE . 69.3 m -150.99 122.7 8.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.244 0.545 . . . . 0.0 110.937 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.492 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . 99.2 mtt180 -72.32 3.04 5.09 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.633 ' OD1' HD13 ' A' ' 28' ' ' ILE . 20.6 p30 -89.27 -17.04 29.79 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.709 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.0 mp -87.48 121.11 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.5 ' HB2' ' CA ' ' A' ' 5' ' ' GLY . 12.7 mtm105 -141.88 39.85 1.66 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 6' ' ' ALA . 2.2 m-85 -89.57 -175.68 4.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 91.3 m -69.09 79.1 0.34 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.639 HG13 ' SG ' ' A' ' 59' ' ' CYS . 31.1 pt -89.25 146.01 35.3 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.12 144.79 45.55 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.832 3.021 . . . . 0.0 115.042 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 94.8 mt -87.33 160.48 18.37 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.986 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 62' ' ' LYS . . . -61.12 151.38 42.28 Favored Glycine 0 C--O 1.238 0.392 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.1 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.583 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 16.3 p30 -118.93 -167.72 1.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 m -62.85 117.59 6.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.873 0.368 . . . . 0.0 111.259 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.53 1.65 68.45 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.759 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -88.38 152.31 22.0 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.678 0.275 . . . . 0.0 111.228 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.489 ' CG ' ' HZ1' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -67.76 143.91 55.64 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.356 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.7 p -147.12 144.4 29.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.986 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.41 ' HB2' ' OG ' ' A' ' 45' ' ' SER . 50.3 m170 -89.46 129.42 47.31 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.82 -41.3 39.06 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.291 2.66 . . . . 0.0 114.236 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.4 12.78 3.38 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.649 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . 5.7 m -91.25 122.54 33.96 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.016 -0.428 . . . . 0.0 110.212 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.58 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 27.6 m170 -88.56 153.71 20.92 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.24 149.3 20.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.54 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.543 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 78.3 t -88.91 139.22 29.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.78 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 48' ' ' VAL . 29.9 Cg_endo -64.17 125.28 4.57 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 123.615 -1.411 . . . . 0.0 113.326 1.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.58 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 90.8 t80 -72.77 145.95 46.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.212 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.79 55.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.547 0.689 . . . . 0.0 111.315 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.67 -129.54 3.24 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.913 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 2.6 pptp? -150.72 129.75 12.61 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -77.3 128.45 34.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.277 0.56 . . . . 0.0 112.277 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.443 ' HA ' HD22 ' A' ' 55' ' ' LEU . 90.1 mt -101.44 15.72 27.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.766 0.793 . . . . 0.0 109.399 178.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.3 m -89.73 157.58 17.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.657 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 8.1 m -88.34 30.89 0.84 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.186 0.517 . . . . 0.0 110.511 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.3 tp -154.9 127.77 8.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.912 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.639 ' SG ' HG13 ' A' ' 32' ' ' ILE . 1.7 m -76.35 142.37 71.27 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.649 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 41.9 Cg_endo -68.17 -176.35 1.04 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.039 1.826 . . . . 0.0 112.096 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.0 m -67.15 139.09 57.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.331 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 6.2 ptpp? -67.49 151.5 47.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.8 m -48.34 109.25 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.599 0.562 . . . . 0.0 110.911 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.04 -34.3 2.76 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 76' ' ' CYS . 3.9 mm? -89.16 139.12 30.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.797 0.332 . . . . 0.0 110.809 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -106.12 129.54 54.18 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.957 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 41.9 t -78.34 126.04 30.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.7 t -145.66 156.12 43.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.874 0.368 . . . . 0.0 110.479 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -71.44 107.69 4.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.339 0.59 . . . . 0.0 110.846 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.975 ' HB3' ' HD3' ' A' ' 75' ' ' LYS . 47.7 t -98.4 70.91 2.01 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.871 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.15 -106.02 3.33 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.119 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.614 ' OE1' ' HG2' ' A' ' 73' ' ' LYS . 11.6 tm-20 -89.31 -51.21 5.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.624 0.212 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.614 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 43.7 mmtm -94.76 178.68 5.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.942 0.401 . . . . 0.0 111.141 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -103.88 131.87 50.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.433 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.975 ' HD3' ' HB3' ' A' ' 70' ' ' SER . 3.6 mptp? -130.13 154.63 47.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.029 0.442 . . . . 0.0 110.314 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 61.6 m -77.8 136.22 38.08 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.388 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.723 -1.132 . . . . 0.0 109.365 179.912 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.16 135.26 26.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 110.11 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.3 mm -90.35 118.88 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.367 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.2 p -130.29 35.76 4.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.239 0.542 . . . . 0.0 110.638 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.08 124.45 1.31 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.76 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 1.031 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -81.22 -12.14 59.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.9 p -141.74 157.04 45.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.09 0.471 . . . . 0.0 111.514 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.741 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 26.7 t70 -105.18 -44.35 4.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.033 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -111.98 139.43 47.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.854 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -53.63 -32.9 53.18 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.725 0.64 . . . . 0.0 111.474 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.3 t -52.7 -28.9 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.314 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -68.23 -29.38 68.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 71.3 m -90.41 140.21 29.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.137 0.494 . . . . 0.0 111.499 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.21 154.58 50.8 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.963 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.9 m -53.46 105.83 0.15 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.353 0.597 . . . . 0.0 110.784 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.39 -28.55 1.79 Allowed Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.6 p -127.62 142.79 51.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.801 -0.7 . . . . 0.0 109.229 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HB3' HD13 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -125.64 158.84 33.72 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.354 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 81.1 m -88.16 47.94 1.57 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.407 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . -92.0 162.49 14.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.815 0.341 . . . . 0.0 110.493 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.603 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -83.87 134.49 34.69 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.483 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 81.2 p -72.41 137.19 46.32 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.705 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.14 -24.46 67.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.567 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.6 p90 -88.32 -20.03 25.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.878 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.436 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 59.9 m -149.24 117.4 6.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.197 0.523 . . . . 0.0 110.955 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -69.07 -13.68 62.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.226 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.436 ' OD1' ' HB3' ' A' ' 25' ' ' SER . 16.1 p-10 -88.29 -15.81 34.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.694 0.283 . . . . 0.0 111.204 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 1.7 mp -88.13 118.78 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.741 ' NH2' ' HA ' ' A' ' 8' ' ' ASP . 28.4 ttp180 -150.43 50.77 0.89 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 1.031 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.1 p90 -117.44 -166.17 1.16 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.637 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.6 m -62.04 76.97 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.077 0.861 . . . . 0.0 112.606 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.688 HG13 ' SG ' ' A' ' 59' ' ' CYS . 39.0 pt -93.31 145.43 30.01 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.89 149.86 75.81 Favored 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 123.243 2.629 . . . . 0.0 114.774 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 HD13 ' HB3' ' A' ' 18' ' ' CYS . 7.4 mp -88.09 166.08 14.68 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.059 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.62 151.93 25.79 Favored Glycine 0 C--O 1.239 0.412 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.023 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 5.0 p30 -112.0 -176.38 2.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.8 m -55.18 126.85 26.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.191 0.519 . . . . 0.0 111.783 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.55 -20.62 48.86 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.368 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -89.56 149.25 22.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.709 0.29 . . . . 0.0 110.598 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.405 ' CG ' ' HZ1' ' A' ' 75' ' ' LYS . 29.4 m-20 -68.71 148.37 50.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.794 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.513 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 12.6 p -139.44 147.86 41.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.822 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 50.2 m170 -89.42 121.0 69.7 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 10.6 Cg_endo -54.99 -36.5 92.62 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.15 2.567 . . . . 0.0 112.66 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.61 -30.79 71.15 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.377 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.8 m -75.68 128.87 36.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.798 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -101.01 166.73 10.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.374 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -55.79 148.76 15.95 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.676 0.61 . . . . 0.0 112.13 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.2 t -87.17 140.89 32.56 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.345 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.03 128.53 16.81 Favored 'Cis proline' 0 C--N 1.346 0.445 0 C-N-CA 123.499 -1.459 . . . . 0.0 113.764 0.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -75.53 134.24 40.81 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.882 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.4 114.47 7.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.64 -133.47 11.74 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.996 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -150.37 141.11 22.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.838 0.351 . . . . 0.0 110.149 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -118.91 137.25 53.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.392 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.72 47.33 1.49 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.501 0.667 . . . . 0.0 109.794 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.7 t -89.66 140.2 29.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.952 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.603 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 5.6 m -89.12 13.42 13.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.217 0.532 . . . . 0.0 110.842 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.3 tp -153.93 132.22 11.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.731 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.688 ' SG ' HG13 ' A' ' 32' ' ' ILE . 7.4 m -71.24 150.94 94.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.23 -165.2 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.083 1.855 . . . . 0.0 111.675 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 68.4 m -76.76 141.98 40.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.706 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.43 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 19.8 ptmt -57.54 146.24 30.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.065 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.5 m -49.73 120.1 4.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 119.52 -33.18 4.75 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.743 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.3 mt -89.26 165.0 14.7 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.008 0.432 . . . . 0.0 111.964 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.7 m -120.44 132.51 55.26 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.872 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 53.2 t -89.14 125.77 35.18 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.5 t -150.36 155.97 40.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.723 0.297 . . . . 0.0 110.469 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 36.1 ttpt -69.05 106.03 2.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.293 0.568 . . . . 0.0 110.584 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.489 ' HB2' ' HD3' ' A' ' 75' ' ' LYS . 13.3 m -92.13 58.19 3.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.553 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.07 -100.7 1.33 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.299 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.552 ' CD ' ' HZ1' ' A' ' 73' ' ' LYS . 8.4 tt0 -89.75 -55.69 3.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.945 0.403 . . . . 0.0 110.912 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.552 ' HZ1' ' CD ' ' A' ' 72' ' ' GLU . 34.9 mttm -100.34 170.76 8.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.314 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.62 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 13.1 m-85 -88.68 128.26 35.6 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.489 ' HD3' ' HB2' ' A' ' 70' ' ' SER . 24.2 mtpp -132.7 152.18 51.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.145 0.498 . . . . 0.0 109.694 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 98.4 m -71.47 134.94 46.92 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.795 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.248 0.978 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.82 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.61 135.19 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 123.287 0.367 . . . . 0.0 110.037 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.4 mm -91.35 118.67 37.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.109 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 8.7 t -151.01 -38.81 0.13 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.466 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 4' ' ' THR . . . -175.95 118.01 0.63 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.302 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 1.003 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -91.21 -8.19 49.22 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.1 p -148.6 145.24 27.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.204 0.526 . . . . 0.0 112.368 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.615 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 14.4 t70 -90.21 -32.23 16.69 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.732 0.777 . . . . 0.0 109.325 178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 52' ' ' GLY . 55.0 mttp -135.8 139.74 43.72 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.777 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.626 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 41.9 t0 -55.98 -25.49 44.23 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.77 0.669 . . . . 0.0 110.571 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 49' ' ' PRO . 21.3 t -55.03 -29.85 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.688 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -72.95 -19.6 61.21 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.683 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.451 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 59.1 m -89.53 -120.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.341 . . . . 0.0 110.702 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.28 156.11 15.28 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.736 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.4 m -51.3 104.29 0.08 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.222 0.534 . . . . 0.0 111.016 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.06 -32.96 1.39 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.5 p -138.53 135.7 35.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.824 -0.688 . . . . 0.0 109.173 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.609 ' HA ' ' OD1' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -120.31 162.85 18.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.626 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 62.5 m -87.02 110.55 20.14 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' A' ' 54' ' ' ARG . . . -164.09 172.52 13.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.929 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.667 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -74.49 138.13 42.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.054 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.531 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 81.4 p -75.61 141.8 42.78 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.178 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.29 -24.11 67.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.882 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -88.27 -25.54 22.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.513 ' HB2' HD13 ' A' ' 28' ' ' ILE . 71.4 m -150.93 130.48 13.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.276 0.56 . . . . 0.0 111.872 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -74.32 -0.06 15.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.689 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 4' ' ' THR . 30.8 m-20 -87.99 -26.76 22.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.883 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.3 mp -87.94 126.95 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 98.9 mtt180 -146.62 67.97 1.17 Allowed 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.687 0.617 . . . . 0.0 109.475 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 1.003 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.0 OUTLIER -142.39 -160.95 1.16 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.165 -179.584 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 24.3 m -61.54 85.22 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.845 0.716 . . . . 0.0 111.668 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.494 HG13 ' SG ' ' A' ' 59' ' ' CYS . 41.4 pt -104.84 149.29 37.36 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.6 148.5 20.8 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.844 3.03 . . . . 0.0 115.035 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.435 ' CD1' ' HA ' ' A' ' 62' ' ' LYS . 98.6 mt -87.5 159.63 18.56 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.52 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.15 137.64 38.33 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.829 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 68.0 m-80 -95.11 176.06 6.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.026 0.441 . . . . 0.0 110.713 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.53 ' HG ' HD21 ' A' ' 65' ' ' LEU . 10.9 m -61.24 127.93 33.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.91 -6.59 82.83 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.931 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.8 146.85 24.75 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 120.85 0.357 . . . . 0.0 110.405 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.426 ' O ' HD21 ' A' ' 58' ' ' LEU . 1.6 m-20 -61.29 139.4 58.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.926 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.466 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 25.0 p -135.07 142.4 46.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.19 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -88.39 125.38 63.78 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -47.37 -36.54 23.44 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.83 3.02 . . . . 0.0 113.304 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.27 37.27 0.2 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.297 0.57 . . . . 0.0 112.031 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.6 ' HB2' ' HB3' ' A' ' 60' ' ' PRO . 6.2 p -92.05 155.89 17.77 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.929 0.395 . . . . 0.0 110.198 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.431 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 58.5 m-70 -133.26 143.57 49.19 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -55.34 152.95 7.8 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.486 ' CG1' ' HA ' ' A' ' 49' ' ' PRO . 95.4 t -87.01 141.56 33.29 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.509 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HA ' ' CG1' ' A' ' 48' ' ' VAL . 71.8 Cg_endo -78.83 132.21 25.41 Favored 'Cis proline' 0 C--O 1.235 0.355 0 C-N-CA 123.454 -1.477 . . . . 0.0 113.818 1.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.549 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 54.6 t80 -77.72 134.44 38.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.069 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -82.35 119.13 23.76 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.572 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 9' ' ' LYS . . . 94.76 -149.82 19.5 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -178.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.615 ' HG3' ' O ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -144.32 133.24 22.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.119 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.775 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 40.6 mtp85 -70.3 136.47 49.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.367 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.28 -7.64 57.63 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 t -88.38 148.8 24.06 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.462 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 18.1 m -86.43 44.27 1.13 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.426 HD21 ' O ' ' A' ' 40' ' ' ASP . 24.3 tp -154.41 121.44 5.61 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.494 ' SG ' HG13 ' A' ' 32' ' ' ILE . 1.7 m -80.09 157.84 73.04 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.496 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.6 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 12.5 Cg_exo -68.28 177.46 4.51 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.066 1.844 . . . . 0.0 111.18 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 77.7 m -68.25 142.28 55.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.491 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.456 ' HG2' HD11 ' A' ' 65' ' ' LEU . 16.5 ptmt -61.71 151.57 33.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.349 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.5 m -45.94 125.84 6.71 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.56 0.538 . . . . 0.0 111.671 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.76 -32.71 6.86 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.83 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.53 HD21 ' HG ' ' A' ' 37' ' ' SER . 36.0 mt -89.15 155.67 19.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.951 0.405 . . . . 0.0 111.637 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.1 m -127.47 129.29 47.18 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.373 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 48.3 t -71.42 124.81 25.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.3 t -142.98 155.53 44.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.112 0.482 . . . . 0.0 110.753 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -72.43 105.7 4.24 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.418 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.969 ' HB2' ' HD3' ' A' ' 75' ' ' LYS . 13.4 m -98.19 81.08 2.74 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.03 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.69 -109.01 3.29 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.664 ' OE1' ' HG2' ' A' ' 73' ' ' LYS . 1.3 tm-20 -89.24 -49.16 6.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.661 0.231 . . . . 0.0 111.579 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.664 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 43.9 mmtm -92.81 -172.47 3.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.157 0.503 . . . . 0.0 111.396 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -112.21 130.4 55.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.969 ' HD3' ' HB2' ' A' ' 70' ' ' SER . 1.7 mptp? -132.79 152.19 51.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.074 0.464 . . . . 0.0 109.798 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 89.2 m -70.1 118.59 13.13 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.942 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.522 -0.752 . . . . 0.0 109.271 179.37 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.19 133.7 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.81 0.338 . . . . 0.0 110.275 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.699 HG22 HG13 ' A' ' 28' ' ' ILE . 3.9 mp -89.76 116.94 32.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.294 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.525 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 9.1 t -152.08 -36.61 0.12 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.728 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 4' ' ' THR . . . 169.41 114.5 0.31 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.968 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.82 -12.99 34.68 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.0 p -141.36 145.22 35.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.548 0.69 . . . . 0.0 112.578 -178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.16 -38.61 9.25 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.231 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' HD2' ' OD1' ' A' ' 51' ' ' ASP . 14.0 mmtp -115.43 132.54 56.59 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.992 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.683 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 33.0 t70 -56.57 -25.32 52.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.991 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.827 HG22 ' HB2' ' A' ' 49' ' ' PRO . 22.0 t -58.04 -28.28 33.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.351 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -69.93 -20.28 63.35 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.002 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 70.0 m -89.18 129.59 35.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.126 0.489 . . . . 0.0 111.093 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.11 160.28 47.98 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.809 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.6 m -50.17 115.21 1.33 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.361 0.601 . . . . 0.0 110.868 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.74 -28.25 3.58 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.7 p -132.63 158.44 42.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.084 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.478 ' HB3' HD23 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -147.57 164.24 34.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.683 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 77.0 m -86.13 112.79 21.63 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HB3' HD13 ' A' ' 32' ' ' ILE . . . -161.34 166.74 27.03 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.146 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -85.83 149.48 25.21 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.46 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.577 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -67.67 137.37 55.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.835 0.35 . . . . 0.0 110.686 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.735 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -66.04 -24.0 66.65 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.4 p90 -86.98 -36.8 18.07 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.0 m -151.82 142.89 23.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -79.02 40.91 0.42 Allowed 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.06 -0.4 . . . . 0.0 111.511 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -96.28 -38.91 9.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.853 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.699 HG13 HG22 ' A' ' 3' ' ' ILE . 3.2 mp -89.72 131.94 35.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 4' ' ' THR . 1.6 mpt_? -143.07 65.2 1.34 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.968 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.1 p90 -150.46 -163.27 1.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.9 m -62.17 87.29 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 O-C-N 124.063 0.852 . . . . 0.0 112.187 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.541 HG13 ' SG ' ' A' ' 59' ' ' CYS . 45.0 pt -103.06 158.27 32.1 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 32' ' ' ILE . 11.8 Cg_endo -53.9 142.52 63.59 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.243 2.629 . . . . 0.0 114.502 -177.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.525 HD23 ' HB3' ' A' ' 59' ' ' CYS . 30.5 mt -86.87 158.85 19.24 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.674 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.81 150.13 37.37 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.047 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 3.7 p-10 -117.69 176.95 4.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.674 0.273 . . . . 0.0 110.82 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.3 m -52.38 131.14 32.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.833 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.0 -14.92 61.17 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.245 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.56 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 3.9 mm-40 -106.82 158.4 17.02 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.567 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 42.5 t0 -58.75 149.49 26.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.313 -1.767 . . . . 0.0 113.067 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.77 145.96 26.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -90.81 116.44 66.43 Favored Pre-proline 0 C--N 1.317 -0.821 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.705 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 74' ' ' PHE . 15.9 Cg_endo -58.46 -42.35 56.01 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.234 2.623 . . . . 0.0 112.927 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.6 -34.71 77.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.466 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.588 ' HB3' ' HD2' ' A' ' 54' ' ' ARG . 19.9 m -72.83 119.36 16.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.307 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.415 ' HB2' ' HD2' ' A' ' 50' ' ' TYR . 11.7 m170 -69.86 144.87 52.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -63.68 -172.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.561 0.696 . . . . 0.0 111.603 -179.173 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.5 t -85.79 138.18 35.53 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.744 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.827 ' HB2' HG22 ' A' ' 11' ' ' VAL . 72.4 Cg_endo -96.79 135.13 3.9 Favored 'Cis proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.72 -1.367 . . . . 0.0 113.79 1.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.458 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 51.1 t80 -91.67 139.32 30.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.406 178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.42 ' OD1' ' HD2' ' A' ' 9' ' ' LYS . 49.0 t0 -77.03 59.02 1.6 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.861 0.838 . . . . 0.0 110.408 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 153.3 -139.43 6.9 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.83 128.77 20.68 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.588 ' HD2' ' HB3' ' A' ' 45' ' ' SER . 31.9 mtm-85 -70.14 137.1 50.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.315 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.8 58.68 5.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.851 0.834 . . . . 0.0 109.485 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.9 m -143.95 144.2 31.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.348 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.735 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 62.1 m -88.24 41.0 0.98 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.942 0.401 . . . . 0.0 111.21 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.4 tp -153.69 127.11 8.6 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.655 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.541 ' SG ' HG13 ' A' ' 32' ' ' ILE . 1.6 m -81.05 141.03 50.03 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.462 ' O ' HD21 ' A' ' 34' ' ' LEU . 49.4 Cg_endo -69.36 -166.97 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.111 1.874 . . . . 0.0 111.821 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.752 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 34.6 m -69.34 137.35 52.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.705 0.288 . . . . 0.0 111.17 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.407 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . 11.8 ptpt -66.19 148.52 51.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.87 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.6 m -45.61 122.52 3.68 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 123.487 0.492 . . . . 0.0 111.909 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.22 -32.99 5.5 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.09 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.0 mt -89.19 154.71 19.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.934 0.397 . . . . 0.0 111.816 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.0 m -121.89 131.91 54.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.225 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.752 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 9.7 t -91.9 143.17 26.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.798 0.333 . . . . 0.0 110.885 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t -141.22 159.24 42.63 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -69.14 104.34 2.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.312 0.577 . . . . 0.0 110.941 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 10.5 t -89.67 75.96 7.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.478 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.85 -98.27 2.2 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.32 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.45 -56.86 3.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.029 0.443 . . . . 0.0 111.104 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 14.3 ptpt -98.17 -165.9 1.31 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.82 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.505 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 8.9 m-85 -109.7 133.98 52.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.148 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.567 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 21.8 mttt -132.42 146.8 52.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.535 0.683 . . . . 0.0 110.427 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 73.5 m -68.32 150.44 48.21 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.745 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 C--O 1.248 0.984 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.321 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.01 137.75 20.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.4 mm -88.99 115.66 29.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.838 0.351 . . . . 0.0 110.26 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 t -151.1 -36.14 0.14 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.857 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.33 125.58 0.95 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.329 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 1.003 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -84.18 -8.81 58.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.713 0.292 . . . . 0.0 111.457 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.6 p -148.32 145.96 28.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.762 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.3 -48.38 5.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.242 0.544 . . . . 0.0 109.58 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -102.97 139.54 38.41 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.778 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -55.25 -25.7 35.22 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.76 0.662 . . . . 0.0 111.429 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 50' ' ' TYR . 22.0 t -54.16 -31.7 22.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.957 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -67.8 -28.02 67.24 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.3 m -89.58 138.92 31.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.074 0.464 . . . . 0.0 111.458 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.7 164.07 50.26 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.723 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.7 m -57.39 97.83 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.4 0.619 . . . . 0.0 110.763 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 153.64 -24.74 0.74 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.549 ' O ' HG11 ' A' ' 48' ' ' VAL . 25.7 p -137.39 155.24 49.6 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.17 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.722 ' SG ' ' HB1' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -139.09 167.24 22.5 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.1 m -89.3 49.49 1.77 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.965 0.412 . . . . 0.0 111.869 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.722 ' HB1' ' SG ' ' A' ' 18' ' ' CYS . . . -83.98 150.62 25.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.211 0.529 . . . . 0.0 111.101 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -86.6 142.3 28.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.525 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.495 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -61.42 126.05 25.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.981 0.42 . . . . 0.0 110.613 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.45 -21.61 65.57 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -86.99 -32.82 19.85 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.896 -0.321 . . . . 0.0 111.309 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.1 m -151.65 130.69 12.61 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -76.21 56.96 1.08 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.282 0.563 . . . . 0.0 111.189 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -118.5 -43.34 2.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.501 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 3.0 mp -88.97 128.16 41.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.313 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -152.07 58.65 0.85 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.763 0.792 . . . . 0.0 109.816 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 1.003 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.2 p90 -126.96 -170.95 2.3 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.533 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.7 m -60.43 79.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.061 0.85 . . . . 0.0 112.947 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.501 HG13 ' SG ' ' A' ' 59' ' ' CYS . 40.9 pt -95.83 151.93 38.71 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.05 148.54 38.89 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.331 2.687 . . . . 0.0 114.507 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.668 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 92.5 mt -86.93 171.05 11.09 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.509 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.64 145.29 32.58 Favored Glycine 0 C--O 1.241 0.553 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.88 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -88.79 -177.27 5.48 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.189 0.596 . . . . 0.0 110.948 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.459 ' HA ' HD13 ' A' ' 65' ' ' LEU . 3.2 m -61.72 132.33 52.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.036 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.521 ' O ' ' HD3' ' A' ' 75' ' ' LYS . . . 81.94 -3.97 77.54 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.259 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.539 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -88.91 157.32 18.46 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 117.448 0.624 . . . . 0.0 112.039 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.52 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -60.89 144.43 52.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.733 -178.312 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.4 p -150.53 145.36 25.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.535 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.509 ' HB2' ' OG ' ' A' ' 45' ' ' SER . 56.7 m170 -89.51 128.92 49.04 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.02 -39.61 90.07 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.918 2.412 . . . . 0.0 112.962 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.83 97.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.464 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.693 ' HB2' ' HG3' ' A' ' 60' ' ' PRO . 10.8 p -76.98 132.6 39.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -109.13 -160.93 0.74 Allowed 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.301 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.51 146.19 42.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.032 0.444 . . . . 0.0 111.382 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.549 HG11 ' O ' ' A' ' 17' ' ' THR . 40.8 t -88.34 143.38 32.44 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.847 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.53 ' HA ' ' CG1' ' A' ' 48' ' ' VAL . 16.4 Cg_exo -69.04 124.51 7.32 Favored 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 124.128 -1.197 . . . . 0.0 113.717 0.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.44 ' O ' HG23 ' A' ' 11' ' ' VAL . 79.9 t80 -89.06 133.4 34.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.761 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.22 111.46 10.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.036 0.446 . . . . 0.0 109.84 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 122.83 -157.86 17.42 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.582 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -152.68 132.83 13.5 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -130.01 153.41 48.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.898 0.38 . . . . 0.0 111.03 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.51 45.02 0.98 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.217 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.0 m -89.52 138.42 31.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.978 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 20.4 m -89.98 30.3 1.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.32 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.9 tp -153.55 125.35 7.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.756 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.501 ' SG ' HG13 ' A' ' 32' ' ' ILE . 1.7 m -76.38 141.29 69.72 Favored Pre-proline 0 C--N 1.327 -0.377 0 O-C-N 123.26 0.35 . . . . 0.0 110.423 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.693 ' HG3' ' HB2' ' A' ' 45' ' ' SER . 6.5 Cg_exo -70.93 -167.22 0.26 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.515 2.143 . . . . 0.0 112.329 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 61.5 m -70.55 138.86 51.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.045 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.668 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 15.5 ptpt -76.4 -179.15 4.97 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.563 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.7 m -52.91 131.28 35.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.839 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.25 -31.03 6.61 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.913 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 61' ' ' CYS . 3.6 mm? -88.9 144.86 25.91 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.373 0.606 . . . . 0.0 112.302 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.3 m -121.97 132.59 54.61 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.295 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.9 t -76.56 130.61 38.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.209 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t -149.77 159.83 44.04 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.47 ' NZ ' ' HA ' ' A' ' 72' ' ' GLU . 47.0 tttm -71.8 104.01 3.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.298 0.571 . . . . 0.0 110.043 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 t -92.59 80.87 4.79 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.57 -101.88 2.5 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.496 ' OE1' ' HA ' ' A' ' 72' ' ' GLU . 36.5 tp10 -98.15 -50.88 4.2 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.531 -0.468 . . . . 0.0 112.006 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.53 -174.55 3.52 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.513 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -104.53 133.46 49.35 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.045 0.45 . . . . 0.0 110.897 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 38' ' ' GLY . 47.8 mttm -141.42 155.78 45.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.94 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 67.5 m -69.15 140.42 54.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.284 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 C--O 1.244 0.771 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.191 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.17 128.8 41.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.158 0.504 . . . . 0.0 110.484 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.8 mm -89.75 91.42 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.136 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 5' ' ' GLY . 8.8 t -151.21 -32.55 0.16 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.444 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.412 ' N ' HG22 ' A' ' 4' ' ' THR . . . 149.68 130.75 1.85 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.0 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 30' ' ' PHE . . . -90.48 -23.7 20.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.947 0.403 . . . . 0.0 110.658 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.57 -142.93 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.069 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -164.16 -45.14 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.2 0.524 . . . . 0.0 110.857 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -109.33 135.41 50.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.78 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.621 ' HB3' HG22 ' A' ' 48' ' ' VAL . 56.7 m-20 -46.28 -38.28 8.42 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.019 0.824 . . . . 0.0 112.09 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.7 t -48.15 -35.09 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.565 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -68.34 -33.2 73.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.427 ' HB3' ' OG1' ' A' ' 17' ' ' THR . 37.8 m -93.45 -31.91 14.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.201 0.524 . . . . 0.0 111.946 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.0 159.63 34.3 Favored Glycine 0 C--N 1.314 -0.641 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.409 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.509 ' HA ' HG21 ' A' ' 48' ' ' VAL . 15.1 m -61.1 80.5 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.496 0.665 . . . . 0.0 111.835 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 177.67 -33.55 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.427 ' OG1' ' HB3' ' A' ' 13' ' ' CYS . 7.5 p -137.21 147.33 45.77 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -130.59 159.11 38.15 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.08 -178.448 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.4 m -89.54 46.37 1.36 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.581 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.622 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . . . -87.42 159.38 18.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.913 0.387 . . . . 0.0 110.946 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.742 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -78.57 131.63 36.83 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.468 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 89.6 p -61.64 139.38 58.29 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.621 -178.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.1 -24.68 63.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.294 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -87.98 -27.25 22.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.684 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.657 ' HB3' HD11 ' A' ' 28' ' ' ILE . 8.6 t -151.24 126.62 10.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.148 0.499 . . . . 0.0 111.042 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -73.23 4.72 4.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.392 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -88.91 -19.55 25.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.029 0.443 . . . . 0.0 110.479 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.742 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.5 mp -87.98 120.13 36.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 45.0 mtp85 -141.59 42.52 1.73 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 123.761 0.663 . . . . 0.0 109.454 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.562 ' CD2' HG22 ' A' ' 28' ' ' ILE . 1.3 m-85 -97.67 -175.07 3.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 99.8 m -72.62 80.43 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.416 0.448 . . . . 0.0 110.237 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.593 HG13 ' SG ' ' A' ' 59' ' ' CYS . 39.3 pt -89.03 148.42 41.01 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.3 156.15 26.84 Favored 'Trans proline' 0 N--CA 1.473 0.29 0 C-N-CA 123.329 2.686 . . . . 0.0 114.3 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.488 ' HA ' ' HB3' ' A' ' 59' ' ' CYS . 4.1 mp -86.94 165.48 15.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.413 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.77 134.11 37.81 Favored Glycine 0 C--O 1.24 0.529 0 CA-C-N 115.143 -0.935 . . . . 0.0 113.028 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -95.06 -179.72 4.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.285 0.564 . . . . 0.0 111.304 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -61.39 122.72 15.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.904 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.06 4.13 90.07 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.238 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -88.56 148.42 24.11 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 117.29 0.545 . . . . 0.0 109.664 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.28 138.4 55.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.424 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.2 p -136.8 153.34 50.84 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.076 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -89.76 122.57 67.91 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -57.42 -40.2 83.24 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.897 2.398 . . . . 0.0 112.602 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.6 -36.76 81.45 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.23 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.9 m -66.27 113.13 4.36 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.221 0.534 . . . . 0.0 110.385 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -70.98 153.94 42.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.76 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -65.36 176.06 1.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.216 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.621 HG22 ' HB3' ' A' ' 10' ' ' ASP . 10.0 p -88.62 139.7 29.7 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.029 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HA ' HG23 ' A' ' 48' ' ' VAL . 89.5 Cg_endo -89.04 134.2 11.41 Favored 'Cis proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.768 -1.347 . . . . 0.0 113.055 0.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.596 ' HB2' ' NH2' ' A' ' 54' ' ' ARG . 66.1 t80 -75.29 130.82 39.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.124 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -87.65 130.01 34.94 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.66 -113.6 3.83 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.755 ' HD3' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -150.53 126.88 10.69 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.473 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.596 ' NH2' ' HB2' ' A' ' 50' ' ' TYR . 60.5 ttm-85 -85.84 102.24 13.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.157 0.504 . . . . 0.0 111.771 -177.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.755 HD22 ' HD3' ' A' ' 53' ' ' LYS . 1.3 mm? -105.33 27.04 8.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.423 0.63 . . . . 0.0 109.925 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.8 m -89.7 148.46 23.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.944 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 4.3 m -88.93 21.83 2.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.829 0.347 . . . . 0.0 111.493 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.37 136.13 14.45 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.593 ' SG ' HG13 ' A' ' 32' ' ' ILE . 1.8 m -75.54 153.04 85.59 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.485 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 64.6 Cg_endo -72.52 174.06 12.25 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.115 1.877 . . . . 0.0 110.995 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.3 m -68.66 139.29 55.45 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.557 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.4 154.1 14.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.827 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.5 m -44.59 129.17 6.82 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.611 0.569 . . . . 0.0 111.226 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.61 -38.28 3.28 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.954 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.1 mt -88.84 154.93 19.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.883 0.373 . . . . 0.0 111.618 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.0 m -135.8 139.48 43.52 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.866 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 23.2 t -72.26 128.73 36.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.763 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.7 t -150.04 156.94 42.58 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 31.9 ttpt -73.19 110.08 7.21 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.301 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.461 ' HB3' ' HD2' ' A' ' 75' ' ' LYS . 10.5 t -93.24 63.04 3.56 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.372 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.76 -93.56 1.49 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.052 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.487 ' OE2' ' HG3' ' A' ' 73' ' ' LYS . 2.0 tt0 -88.33 -54.49 4.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.477 -0.362 . . . . 0.0 111.042 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.487 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 34.7 mtmm -112.91 177.99 4.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.13 0.491 . . . . 0.0 111.58 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 8.5 m-85 -89.21 133.95 34.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.268 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.461 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 56.4 mttm -136.66 154.55 50.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.719 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 95.6 m -75.54 128.43 35.28 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.953 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.252 1.236 0 CA-C-O 117.531 -1.223 . . . . 0.0 109.152 179.934 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.884 0.373 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.4 p -150.91 140.2 15.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.414 HG22 HD12 ' A' ' 3' ' ' ILE . 50.9 mm -89.39 106.58 17.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.88 0.371 . . . . 0.0 110.41 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 5' ' ' GLY . 5.1 t -151.98 -38.99 0.11 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.545 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.404 ' N ' HG22 ' A' ' 4' ' ' THR . . . 150.91 123.96 1.15 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.07 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 1.049 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.25 -13.29 35.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.814 0.34 . . . . 0.0 111.107 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' A' ' 30' ' ' PHE . 17.3 p -151.19 -152.03 0.42 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.87 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -163.59 -43.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.441 0.639 . . . . 0.0 109.362 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -106.59 133.29 51.5 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.592 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -52.73 -31.16 36.49 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.557 0.536 . . . . 0.0 111.184 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.8 t -51.61 -32.05 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.407 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -70.68 -32.73 70.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.126 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.4 m -95.23 -46.32 6.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.209 0.528 . . . . 0.0 112.228 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.89 153.19 9.57 Favored Glycine 0 C--N 1.31 -0.886 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.714 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.629 ' HA ' HG11 ' A' ' 48' ' ' VAL . 16.2 m -57.13 98.23 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.546 0.689 . . . . 0.0 110.776 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.502 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . 161.08 -31.43 0.35 Allowed Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.8 p -135.14 139.0 44.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.824 -0.688 . . . . 0.0 109.334 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -111.34 156.66 21.22 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.0 m -97.23 45.83 1.04 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.399 . . . . 0.0 111.369 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -84.79 178.38 7.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.117 0.484 . . . . 0.0 111.469 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.82 142.21 28.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.378 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.66 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -60.69 139.65 57.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.148 0.499 . . . . 0.0 111.649 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.702 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -64.17 -26.17 68.4 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -86.25 -42.37 13.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.899 0.38 . . . . 0.0 111.609 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.1 m -151.96 136.79 17.15 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -74.86 51.7 0.5 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -101.89 -35.38 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.841 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.66 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 53.1 mt -88.8 131.11 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.279 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 6.2 mtp180 -150.16 49.19 0.91 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.912 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 1.049 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.4 p90 -128.51 -168.86 1.97 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.582 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 33.1 m -59.21 82.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.222 0.952 . . . . 0.0 112.44 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.609 HG13 ' SG ' ' A' ' 59' ' ' CYS . 23.8 pt -104.27 143.79 27.38 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.57 159.22 14.11 Favored 'Trans proline' 0 CA--C 1.529 0.225 0 C-N-CA 123.197 2.598 . . . . 0.0 114.112 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 95.1 mt -84.86 167.91 15.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.174 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.09 144.73 35.23 Favored Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.714 -0.676 . . . . 0.0 113.726 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 0.1 OUTLIER -118.07 -167.21 1.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.062 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 76' ' ' CYS . 6.1 m -59.21 125.26 22.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.789 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.59 0.14 82.26 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.28 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -88.0 148.38 24.57 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 117.068 0.434 . . . . 0.0 110.541 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.578 ' O ' HD11 ' A' ' 58' ' ' LEU . 12.3 t70 -68.05 145.61 54.29 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.984 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.4 p -150.14 143.83 25.31 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.623 ' CD2' HD23 ' A' ' 58' ' ' LEU . 90.0 m-70 -88.32 139.75 30.26 Favored Pre-proline 0 C--N 1.319 -0.747 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.862 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.73 38.03 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.196 2.597 . . . . 0.0 113.106 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.45 ' H ' ' C ' ' A' ' 42' ' ' HIS . . . -172.57 33.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.384 0.674 . . . . 0.0 109.266 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -80.71 133.23 35.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.433 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.49 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 19.8 m170 -80.66 146.85 30.92 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -67.57 166.34 15.11 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.629 HG11 ' HA ' ' A' ' 15' ' ' SER . 58.8 t -86.33 136.99 34.88 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 48' ' ' VAL . 15.7 Cg_exo -69.42 128.58 12.44 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 123.898 -1.293 . . . . 0.0 114.061 1.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.6 ' HH ' ' HB3' ' A' ' 54' ' ' ARG . 71.9 t80 -71.48 154.61 41.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.506 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.516 ' OD2' ' HG3' ' A' ' 53' ' ' LYS . 5.3 p-10 -56.33 -33.2 65.39 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.698 0.285 . . . . 0.0 111.528 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.38 34.09 67.45 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.248 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.516 ' HG3' ' OD2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -129.36 -22.76 3.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.6 ' HB3' ' HH ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -75.24 150.6 38.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.067 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 55' ' ' LEU . 3.7 mm? -85.46 56.66 4.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.2 0.524 . . . . 0.0 111.565 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 51.3 m -89.31 128.5 35.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.27 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.702 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 15.2 m -89.67 26.61 1.71 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.623 HD23 ' CD2' ' A' ' 42' ' ' HIS . 1.6 pp -153.97 172.16 17.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.073 0.463 . . . . 0.0 110.921 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.609 ' SG ' HG13 ' A' ' 32' ' ' ILE . 37.1 m -106.23 143.2 26.47 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.012 178.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.434 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 32.4 Cg_exo -57.14 159.52 15.08 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.539 2.159 . . . . 0.0 111.721 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 32.5 m -59.22 134.09 56.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.269 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.585 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 15.4 ptpt -70.38 163.31 26.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.251 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.0 m -47.62 124.69 7.41 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.397 0.435 . . . . 0.0 111.367 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.18 -30.07 10.56 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.11 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.499 ' HG ' ' HA ' ' A' ' 36' ' ' ASN . 4.0 mm? -88.48 136.55 32.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.792 0.33 . . . . 0.0 111.006 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.5 m -116.77 124.74 50.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.467 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.5 t -71.23 125.18 26.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.7 t -150.3 158.06 43.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.836 0.35 . . . . 0.0 110.125 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.597 ' HE2' ' O ' ' A' ' 71' ' ' GLY . 85.3 tttt -71.8 105.92 3.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.257 0.551 . . . . 0.0 110.739 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 15.1 m -89.75 64.49 6.5 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.796 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.597 ' O ' ' HE2' ' A' ' 69' ' ' LYS . . . 96.16 -97.58 2.08 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.825 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.404 ' O ' ' HE3' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -91.83 -55.73 3.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.361 0.6 . . . . 0.0 110.085 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.781 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -100.09 171.07 8.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.332 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.582 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 9.1 m-85 -94.92 133.69 38.4 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.852 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.582 ' HD2' ' O ' ' A' ' 74' ' ' PHE . 14.1 mptt -135.58 157.1 47.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.605 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 82.5 m -76.21 118.53 19.03 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.576 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 C--O 1.253 1.256 0 CA-C-O 117.701 -1.143 . . . . 0.0 109.381 179.855 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.09 134.39 28.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.876 0.37 . . . . 0.0 110.294 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 mm -88.93 97.51 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 t -150.82 -33.34 0.16 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.184 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.46 116.24 0.64 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.491 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 1.054 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.96 -9.5 45.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.703 -0.248 . . . . 0.0 111.375 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 30' ' ' PHE . 12.6 p -150.69 146.37 26.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.227 0.537 . . . . 0.0 111.696 -178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.06 -42.86 12.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.992 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -121.62 145.42 48.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.218 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.412 ' OD2' ' HB2' ' A' ' 18' ' ' CYS . 1.6 m-20 -54.74 -27.37 40.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.223 0.535 . . . . 0.0 110.148 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.791 HG21 ' HB2' ' A' ' 49' ' ' PRO . 77.6 t -52.47 -35.01 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.057 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -72.46 -21.93 61.15 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 97.6 m -89.09 141.4 28.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.222 0.534 . . . . 0.0 111.585 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.32 157.49 52.1 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.073 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.492 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 19.9 m -54.29 112.28 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.17 0.509 . . . . 0.0 110.312 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.461 ' C ' ' HG ' ' A' ' 34' ' ' LEU . . . 136.46 -22.84 3.33 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 p -136.01 152.24 50.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.196 -0.502 . . . . 0.0 110.232 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -135.74 162.15 33.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 59.8 m -89.07 49.28 1.75 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.658 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . . . -82.07 163.26 22.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.98 0.419 . . . . 0.0 110.631 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -83.93 145.16 28.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.619 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.629 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -58.11 130.46 46.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.945 0.403 . . . . 0.0 110.703 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.79 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -58.4 -27.06 63.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -85.5 -38.77 18.2 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.861 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m -150.83 136.1 17.72 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.139 -0.351 . . . . 0.0 110.431 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.92 55.05 0.17 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.051 0.54 . . . . 0.0 111.823 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -114.91 -38.76 3.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.966 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.68 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 1.9 mp -88.09 133.58 30.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.81 0.338 . . . . 0.0 110.401 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.2 mmm-85 -144.63 57.18 1.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.985 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 1.054 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.0 p90 -136.1 -173.28 3.35 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.171 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.5 m -59.04 84.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 O-C-N 124.295 0.997 . . . . 0.0 113.111 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.551 HG13 ' SG ' ' A' ' 59' ' ' CYS . 38.9 pt -102.0 151.01 37.94 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.32 151.7 28.41 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.365 2.71 . . . . 0.0 114.77 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.461 ' HG ' ' C ' ' A' ' 16' ' ' GLY . 80.7 mt -87.52 165.35 15.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.361 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.9 145.97 39.13 Favored Glycine 0 C--O 1.241 0.541 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.594 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 1.5 t-20 -96.82 -175.92 3.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.413 0.625 . . . . 0.0 111.253 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.8 m -60.97 129.26 40.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.555 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.99 -4.64 82.4 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.865 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.17 149.12 23.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.99 0.395 . . . . 0.0 110.519 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.594 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 1.1 t70 -63.96 141.56 58.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.357 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 74' ' ' PHE . 25.0 p -141.81 139.38 32.72 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.067 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 33.2 m170 -89.12 128.41 51.8 Favored Pre-proline 0 C--N 1.318 -0.797 0 C-N-CA 120.086 -0.645 . . . . 0.0 109.653 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 0.9 OUTLIER -44.64 -49.47 9.29 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 124.17 3.246 . . . . 0.0 114.608 -177.318 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.42 31.56 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.89 0.376 . . . . 0.0 111.821 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.423 ' O ' ' HD3' ' A' ' 54' ' ' ARG . 14.5 m -90.72 -20.23 22.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.135 0.493 . . . . 0.0 110.469 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.746 ' HD2' ' HB2' ' A' ' 56' ' ' SER . 3.7 m-70 -169.36 125.89 0.9 Allowed 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.667 ' H ' ' HB2' ' A' ' 50' ' ' TYR . 9.2 mmmm -140.39 177.74 7.79 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 61.4 t -125.95 107.7 25.23 Favored Pre-proline 0 C--N 1.32 -0.7 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.224 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.791 ' HB2' HG21 ' A' ' 11' ' ' VAL . 59.0 Cg_endo -96.49 129.46 3.38 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.483 -1.049 . . . . 0.0 112.79 -0.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.667 ' HB2' ' H ' ' A' ' 47' ' ' LYS . 1.3 t80 -82.74 124.12 29.94 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -76.83 -38.4 53.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.67 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.53 -167.75 29.56 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.549 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -152.51 140.82 20.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.593 0.235 . . . . 0.0 110.569 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 45' ' ' SER . 6.9 ptm180 -167.24 159.53 12.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.1 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 55' ' ' LEU . 3.7 mm? -87.75 54.04 2.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.928 0.394 . . . . 0.0 111.912 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.746 ' HB2' ' HD2' ' A' ' 46' ' ' HIS . 50.9 m -88.31 127.19 35.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.79 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 20.8 m -88.81 44.44 1.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.4 tp -153.37 126.57 8.52 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.399 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.551 ' SG ' HG13 ' A' ' 32' ' ' ILE . 1.7 m -87.47 148.04 43.34 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.107 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 46' ' ' HIS . 42.1 Cg_endo -66.96 -177.99 1.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.488 2.125 . . . . 0.0 111.715 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 81.6 m -69.81 141.33 53.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.767 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . 9.6 ptmm? -62.35 148.64 44.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.775 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.492 ' OG ' ' HB3' ' A' ' 15' ' ' SER . 10.2 m -46.33 130.92 10.74 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 123.44 0.463 . . . . 0.0 111.274 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.41 -30.23 10.21 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.774 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.9 mt -91.4 147.56 22.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.747 0.308 . . . . 0.0 111.464 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -108.41 126.49 52.94 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.323 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.423 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 54.1 t -83.59 116.21 22.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.0 t -137.48 157.9 45.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.765 0.316 . . . . 0.0 110.185 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 84.1 tttt -69.25 105.44 2.52 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.358 0.599 . . . . 0.0 111.198 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -92.92 77.14 4.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.746 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.436 ' O ' ' HE2' ' A' ' 69' ' ' LYS . . . 87.42 -102.52 2.8 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.579 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.532 ' O ' ' HE3' ' A' ' 69' ' ' LYS . 5.2 tm-20 -91.28 -53.08 4.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.739 0.304 . . . . 0.0 110.634 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.414 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 45.2 mmtm -98.21 171.2 8.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.073 0.463 . . . . 0.0 111.241 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 6.3 m-85 -92.19 138.34 31.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.462 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.594 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 48.8 mttp -143.92 155.08 43.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.23 0.538 . . . . 0.0 110.439 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 59.8 m -70.96 135.67 48.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.942 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.3 m . . . . . 0 C--O 1.255 1.364 0 CA-C-O 117.557 -1.211 . . . . 0.0 108.888 179.548 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 121.803 0.811 . . . . 0.0 110.008 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.19 128.16 1.08 Allowed Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.878 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.722 ' HB3' ' HA ' ' A' ' 30' ' ' PHE . . . -90.57 -33.73 15.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.279 0.562 . . . . 0.0 110.158 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 5.0 p -152.0 -165.0 2.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.152 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.461 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 27.4 t70 -141.72 -40.45 0.37 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.311 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -105.61 128.41 53.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.436 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' A' ' 49' ' ' PRO . 12.9 m-20 -54.84 -24.56 23.58 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.591 0.557 . . . . 0.0 111.069 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.53 -31.42 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.834 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -69.27 -29.59 67.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.287 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.451 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 59.7 m -93.49 -119.09 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.048 0.451 . . . . 0.0 110.545 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.96 157.8 30.39 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 m -53.39 117.29 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.068 0.461 . . . . 0.0 110.481 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.22 -23.98 5.41 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.9 p -128.34 142.13 51.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.601 -0.3 . . . . 0.0 110.211 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.69 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -123.05 154.48 38.47 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.2 m -91.51 38.58 0.98 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.932 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -88.69 -173.02 3.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.766 0.317 . . . . 0.0 110.558 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.639 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.33 140.56 29.58 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.466 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 93.6 p -67.75 144.46 55.4 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.467 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.07 65.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.354 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 41.7 p90 -87.65 -32.21 19.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.477 ' HB2' HD13 ' A' ' 28' ' ' ILE . 67.4 m -149.93 127.38 11.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.401 0.619 . . . . 0.0 112.287 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.457 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -69.85 5.34 1.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.725 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -88.58 -24.68 22.8 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.323 0.582 . . . . 0.0 109.895 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.639 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.4 mp -87.38 122.89 39.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.534 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 31.9 mtp180 -140.64 46.08 1.8 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.269 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.722 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 0.3 OUTLIER -98.53 -172.91 2.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 38.3 m -71.67 78.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.664 HG13 ' SG ' ' A' ' 59' ' ' CYS . 17.0 pt -88.75 142.7 30.9 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.739 0.304 . . . . 0.0 110.583 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.79 150.33 71.81 Favored 'Trans proline' 0 N--CA 1.475 0.409 0 C-N-CA 123.413 2.742 . . . . 0.0 114.834 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.69 HD11 ' HB3' ' A' ' 18' ' ' CYS . 8.1 mp -87.11 167.3 14.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.164 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.98 141.2 32.52 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.882 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 68.9 m-80 -102.46 -168.13 1.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.856 0.36 . . . . 0.0 110.893 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 m -62.2 125.59 24.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.056 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.18 1.68 86.24 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.569 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 20.8 mm-40 -88.92 150.44 22.85 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.853 0.359 . . . . 0.0 110.748 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.501 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -73.64 139.39 45.42 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.371 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.9 p -138.4 148.44 44.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.275 0.56 . . . . 0.0 110.388 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -89.25 122.63 68.45 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.76 -31.56 95.28 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.825 2.35 . . . . 0.0 111.929 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.447 ' HB1' HH22 ' A' ' 54' ' ' ARG . . . -70.83 -22.3 62.34 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.641 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.48 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 46.7 m -79.9 125.79 30.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.907 0.384 . . . . 0.0 110.219 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.412 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 34.9 m170 -86.41 168.92 13.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.477 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -57.83 149.0 23.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 49' ' ' PRO . 42.7 t -87.71 136.65 32.53 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.057 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HA ' HG13 ' A' ' 48' ' ' VAL . 15.9 Cg_exo -69.31 136.98 40.51 Favored 'Cis proline' 0 C--N 1.35 0.623 0 C-N-CA 123.871 -1.304 . . . . 0.0 112.819 0.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 53.9 t80 -63.72 127.96 33.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.866 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.16 58.03 1.95 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.373 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 158.92 -143.05 8.85 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.026 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -136.19 136.72 40.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.451 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 1.7 tpt180 -157.85 126.62 5.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.0 mp -89.1 52.89 2.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.337 0.589 . . . . 0.0 110.764 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.449 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 54.7 m -88.82 138.64 31.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.399 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 13.4 m -89.92 32.35 0.91 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.457 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.6 tp -154.62 127.81 8.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.985 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.664 ' SG ' HG13 ' A' ' 32' ' ' ILE . 54.8 m -74.97 145.03 80.5 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 17.0 Cg_exo -67.59 -168.34 0.18 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.496 2.131 . . . . 0.0 111.704 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 81.5 m -72.17 140.46 48.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.651 0.262 . . . . 0.0 111.04 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.452 ' HG3' HD12 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -63.97 152.89 38.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.073 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.9 m -49.28 123.95 8.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.51 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.05 -32.4 6.73 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.261 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.452 HD12 ' HG3' ' A' ' 62' ' ' LYS . 28.3 mt -89.8 151.39 21.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.068 0.461 . . . . 0.0 112.147 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -111.63 134.45 53.2 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.388 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.501 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 46.2 t -88.45 120.07 29.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.6 t -150.44 155.86 40.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 32.8 ttpt -61.63 114.38 3.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.08 0.467 . . . . 0.0 110.015 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 14.7 m -123.74 50.15 1.65 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.296 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.1 -112.29 0.84 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.66 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.859 ' HG2' ' HG3' ' A' ' 73' ' ' LYS . 2.7 pm0 -86.68 -37.63 17.79 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.29 0.567 . . . . 0.0 109.912 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.859 ' HG3' ' HG2' ' A' ' 72' ' ' GLU . 9.8 mtmp? -131.31 -165.02 1.51 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.987 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 3.5 m-85 -89.67 139.45 30.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.672 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.54 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 51.0 mttp -137.9 154.92 49.39 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 63.2 m -78.94 134.41 36.85 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.72 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.0 m . . . . . 0 C--O 1.245 0.835 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.354 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 121.744 0.783 . . . . 0.0 109.919 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.85 97.66 0.68 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.375 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.048 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -78.0 -12.31 59.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.836 0.35 . . . . 0.0 111.573 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 p -150.83 152.12 33.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.928 0.394 . . . . 0.0 111.524 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.451 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 7.6 t70 -106.23 -50.2 3.21 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -89.66 130.34 35.96 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.521 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 34.4 t70 -55.51 -28.46 54.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.619 0.724 . . . . 0.0 110.081 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.613 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 42.9 t -54.79 -29.35 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.24 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -65.59 -26.71 67.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.463 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 76.7 m -89.95 132.5 35.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.128 0.49 . . . . 0.0 111.175 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.37 158.78 53.42 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.911 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.1 m -52.95 107.92 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.307 0.575 . . . . 0.0 110.995 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.06 -30.88 2.0 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 35.5 p -132.35 149.25 52.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.291 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.859 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -136.03 162.81 31.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.861 0.3 . . . . 0.0 110.807 -178.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.521 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 65.3 m -87.82 85.99 7.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.043 0.449 . . . . 0.0 110.031 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.551 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -130.97 157.45 42.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.562 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -85.81 144.34 27.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.295 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.717 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -65.58 140.89 58.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.035 0.445 . . . . 0.0 111.003 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -66.81 -24.67 66.2 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -87.06 -36.08 18.36 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.1 m -151.53 138.93 19.44 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -80.31 35.29 0.33 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.919 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -89.86 -38.47 13.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.266 0.555 . . . . 0.0 109.885 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.717 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.4 mp -88.33 126.77 41.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.451 ' NH2' ' HA ' ' A' ' 8' ' ' ASP . 0.8 OUTLIER -150.93 57.17 0.91 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 1.048 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.6 p90 -138.69 -169.32 2.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.234 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.8 m -58.47 98.16 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 O-C-N 124.028 0.83 . . . . 0.0 112.236 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.616 HG13 ' SG ' ' A' ' 59' ' ' CYS . 33.1 pt -116.68 149.48 43.98 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.74 144.63 53.19 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.629 2.886 . . . . 0.0 115.434 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.859 HD11 ' HB3' ' A' ' 18' ' ' CYS . 7.4 mp -88.11 173.85 8.59 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.915 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.01 143.54 23.2 Favored Glycine 0 C--O 1.239 0.429 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.771 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.562 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 71.4 m-80 -99.65 -169.77 1.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.909 0.385 . . . . 0.0 111.057 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.7 m -61.0 128.06 34.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.101 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.26 8.77 85.65 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.834 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 2.2 mm-40 -88.89 161.64 16.57 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.807 0.337 . . . . 0.0 110.972 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -71.3 137.36 48.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.909 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.83 142.56 28.96 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -89.95 124.23 64.09 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -56.36 -39.95 87.91 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.794 2.33 . . . . 0.0 112.147 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.56 -38.98 77.65 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.373 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.4 m -66.29 101.37 0.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.325 0.583 . . . . 0.0 109.954 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 34.4 m80 -68.6 148.27 50.73 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.053 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 63' ' ' SER . 52.0 tttm -54.15 163.72 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.493 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.511 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 44.5 t -85.01 143.08 39.35 Favored Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.629 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.613 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 18.9 Cg_endo -91.99 129.85 6.53 Favored 'Cis proline' 0 N--CA 1.461 -0.415 0 C-N-CA 124.013 -1.245 . . . . 0.0 114.495 1.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.518 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 20.4 t80 -87.15 128.57 35.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.838 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -82.69 61.56 5.85 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.463 -0.773 . . . . 0.0 110.789 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.13 176.62 44.48 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.459 ' HD2' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -89.81 126.05 35.54 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.408 HH12 ' CG ' ' A' ' 10' ' ' ASP . 22.6 ttm105 -75.19 120.24 20.42 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.3 -2.19 58.44 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.223 0.535 . . . . 0.0 110.594 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.4 m -87.31 142.73 27.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.579 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 30.2 m -88.0 34.76 0.73 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.901 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.7 tp -154.31 130.73 10.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.709 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.616 ' SG ' HG13 ' A' ' 32' ' ' ILE . 9.8 m -76.06 148.79 81.83 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -72.92 -166.15 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.425 2.083 . . . . 0.0 111.792 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 72.2 m -76.46 140.59 41.32 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.335 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.587 ' HA ' HD23 ' A' ' 34' ' ' LEU . 11.1 ptmm? -60.88 148.17 40.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.997 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.527 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 68.1 m -51.04 131.77 27.26 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.142 0.496 . . . . 0.0 110.551 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.95 -28.68 10.18 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 mt -102.51 150.58 23.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.359 -0.42 . . . . 0.0 110.871 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.9 m -118.92 131.64 56.05 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.23 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 52.5 t -78.14 125.67 29.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.889 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.8 t -150.52 155.99 40.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 80.7 tttt -65.79 123.17 19.04 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.989 0.423 . . . . 0.0 110.266 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 15.6 m -128.0 41.6 3.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.255 0.55 . . . . 0.0 110.24 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 144.97 -112.72 0.67 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.03 -45.65 10.0 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.104 0.478 . . . . 0.0 109.748 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -110.98 -158.64 0.65 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.162 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 5.4 m-85 -107.38 137.24 45.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.81 0.338 . . . . 0.0 110.949 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 5.5 mptp? -126.83 159.44 33.87 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 70.1 m -81.17 131.99 35.33 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.824 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.244 0.783 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.842 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.714 0.292 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.82 124.77 0.76 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.009 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.094 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.88 -13.22 34.06 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.0 p -150.97 -159.92 1.1 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.784 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -153.15 -53.31 0.11 Allowed 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 52' ' ' GLY . 29.9 mmtp -89.83 132.97 34.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 50' ' ' TYR . 45.1 m-20 -53.86 -30.66 46.67 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.551 0.532 . . . . 0.0 110.622 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.1 t -54.94 -31.47 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.794 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -67.26 -27.78 67.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.407 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 75.4 m -89.67 138.51 31.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.019 0.437 . . . . 0.0 111.171 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.99 154.15 52.82 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.056 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 m -49.49 108.66 0.21 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.033 0.49 . . . . 0.0 110.755 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.22 -18.37 4.21 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.304 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.5 p -135.11 161.46 35.26 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.385 0.274 . . . . 0.0 110.934 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.802 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -145.87 167.63 22.77 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.031 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.1 m -88.91 58.63 4.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.02 0.438 . . . . 0.0 111.268 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.839 ' HA ' ' HB2' ' A' ' 54' ' ' ARG . . . -90.08 152.81 20.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.26 0.552 . . . . 0.0 111.871 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -82.91 147.69 28.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.833 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.541 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -63.22 137.76 58.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.028 0.442 . . . . 0.0 111.092 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.622 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -67.09 -22.99 65.8 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -87.38 -40.03 14.78 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.89 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.0 m -152.32 148.42 27.5 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -78.09 48.36 0.73 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.936 0.398 . . . . 0.0 111.522 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -98.27 -43.14 7.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.417 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.8 mp -88.18 131.87 34.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.818 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -148.6 55.67 1.02 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 1.094 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.4 p90 -138.43 -173.8 3.64 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.2 m -57.6 98.31 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.915 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.782 HD11 ' HB3' ' A' ' 20' ' ' ALA . 44.8 pt -119.13 155.59 53.22 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 32' ' ' ILE . 10.1 Cg_endo -52.0 143.59 39.88 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.409 2.739 . . . . 0.0 115.152 -177.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.844 HD23 ' HB3' ' A' ' 59' ' ' CYS . 70.0 mt -87.19 159.74 18.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.689 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -52.98 141.53 29.11 Favored Glycine 0 C--O 1.242 0.614 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.268 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.643 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 66.1 m-20 -95.65 176.37 6.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.322 -0.439 . . . . 0.0 110.997 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.5 m -64.38 128.11 34.38 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.17 5.52 90.02 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.357 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.528 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 3.2 mm-40 -92.56 152.81 19.42 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.833 0.349 . . . . 0.0 111.497 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -68.72 145.1 54.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.426 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.45 179.0 7.05 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 37.7 m170 -116.12 122.75 31.82 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 3.7 Cg_endo -47.9 -44.12 28.03 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.425 2.75 . . . . 0.0 113.407 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.94 80.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.281 0.563 . . . . 0.0 110.984 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.528 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 19.6 m -78.17 83.15 4.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.172 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.412 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 44.4 m80 -61.59 146.47 48.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.957 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.8 143.21 10.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.796 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' A' ' 49' ' ' PRO . 99.7 t -87.93 144.3 34.56 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.938 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.585 ' HA ' HG13 ' A' ' 48' ' ' VAL . 34.4 Cg_exo -62.53 142.45 40.82 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 124.634 -0.986 . . . . 0.0 114.144 1.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 87.8 t80 -166.36 137.59 3.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.621 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -84.66 113.82 21.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.687 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' LYS . . . 169.7 -174.2 43.95 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.225 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.86 142.58 49.01 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.839 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . 3.6 mmp_? -86.67 110.53 19.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.247 0.546 . . . . 0.0 112.076 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.42 -21.94 23.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.6 m -88.7 153.82 20.79 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.27 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.622 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 43.6 m -87.69 46.04 1.34 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.044 0.45 . . . . 0.0 111.044 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.6 tp -153.08 127.0 8.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.078 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.844 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.6 m -77.86 141.58 64.02 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.262 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.528 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 20.4 Cg_exo -65.57 -178.31 0.9 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.677 2.251 . . . . 0.0 111.499 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 72.7 m -62.4 140.43 58.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.313 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -64.11 155.56 31.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.073 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.4 m -51.78 127.4 20.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.211 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.72 -30.48 9.06 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.695 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.633 HD12 ' HG2' ' A' ' 62' ' ' LYS . 26.3 mt -88.98 145.77 25.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.109 0.481 . . . . 0.0 112.081 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.2 m -119.85 125.02 47.5 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.791 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 4.4 t -81.82 135.55 35.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.858 0.361 . . . . 0.0 111.242 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.4 m -137.53 148.33 45.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.438 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 72' ' ' GLU . 16.0 ttmt -64.54 114.26 4.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.471 0.653 . . . . 0.0 110.962 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.505 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 11.1 m -97.75 83.37 3.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.985 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.07 -62.47 4.17 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.486 ' HA ' ' OE1' ' A' ' 72' ' ' GLU . 35.6 tp10 -150.11 -43.67 0.13 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.928 0.394 . . . . 0.0 109.957 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -87.79 153.68 21.15 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.58 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 11.8 m-85 -89.39 129.57 35.89 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.89 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 45.8 mttm -125.81 150.28 47.94 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.137 0.494 . . . . 0.0 110.027 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 67' ' ' CYS . 59.2 m -75.03 141.33 43.9 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.125 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.253 1.241 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.214 179.6 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.2 t . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 121.673 0.749 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . 167.91 69.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.142 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.85 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -71.3 -17.33 62.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.7 p -150.06 144.99 26.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.826 0.345 . . . . 0.0 111.192 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.574 ' O ' ' HD2' ' A' ' 53' ' ' LYS . 11.6 t70 -86.91 -47.7 8.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.672 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 36.7 mttm -117.88 146.41 43.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.573 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.607 ' OD1' ' HA ' ' A' ' 53' ' ' LYS . 1.8 m-20 -51.24 -28.17 10.98 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.873 0.733 . . . . 0.0 111.529 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.854 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 22.0 t -55.25 -31.17 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.763 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.459 HE22 ' HB3' ' A' ' 8' ' ' ASP . 54.5 mt-30 -69.94 -17.98 63.34 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.1 m -89.42 -139.61 0.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.7 -141.84 4.77 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 119.395 -1.383 . . . . 0.0 113.777 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m -50.68 115.71 1.61 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.913 -0.644 . . . . 0.0 112.646 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 33' ' ' PRO . . . 60.45 31.45 74.36 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 114.928 -1.033 . . . . 0.0 114.907 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.565 ' O ' HG11 ' A' ' 48' ' ' VAL . 6.0 p -148.57 143.06 26.36 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.149 0.974 . . . . 0.0 111.685 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.743 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -142.43 167.67 21.55 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.016 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.2 m -89.67 45.19 1.26 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.61 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -79.81 159.87 26.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.405 0.621 . . . . 0.0 111.407 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -88.27 152.68 21.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.945 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.641 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -63.33 136.5 57.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.048 0.452 . . . . 0.0 110.694 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.704 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -66.91 -22.43 65.96 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -86.99 -37.36 17.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.895 0.379 . . . . 0.0 111.674 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.0 m -152.01 145.92 25.18 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -80.14 38.84 0.42 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.47 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -89.93 -41.66 11.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.511 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.641 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.0 mp -87.35 130.76 36.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.572 ' O ' ' HA2' ' A' ' 5' ' ' GLY . 88.4 mtm180 -148.44 65.63 1.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.86 0.725 . . . . 0.0 109.304 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.85 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.4 p90 -150.84 -170.6 3.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.816 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 94.6 m -58.76 102.8 0.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.804 0.69 . . . . 0.0 112.539 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.61 HD11 ' HB3' ' A' ' 20' ' ' ALA . 47.1 pt -123.85 157.62 62.57 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 14.4 Cg_endo -56.0 147.7 62.13 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.235 2.623 . . . . 0.0 115.061 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.808 HD23 ' HB3' ' A' ' 59' ' ' CYS . 78.5 mt -87.15 160.43 18.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.501 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.74 144.76 45.85 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 114.156 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.455 ' H ' ' CD ' ' A' ' 39' ' ' GLU . 35.1 m-80 -99.69 159.89 14.71 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.34 0.656 . . . . 0.0 110.685 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.2 m -56.39 128.58 36.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.883 0.373 . . . . 0.0 110.437 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.5 -21.69 36.31 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.966 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 36' ' ' ASN . 7.2 pt-20 -96.44 155.34 16.81 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 117.561 0.68 . . . . 0.0 110.648 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.71 145.32 49.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.998 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.2 p -144.7 156.13 43.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.079 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -90.61 126.9 54.54 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.93 -34.67 99.21 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.708 2.272 . . . . 0.0 112.387 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.93 98.95 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.543 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.637 ' HB2' ' HB3' ' A' ' 60' ' ' PRO . 3.4 p -74.31 133.39 42.58 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -112.88 -150.31 0.46 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.947 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.623 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -70.02 155.19 40.95 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -179.318 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.595 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 92.0 t -111.99 137.77 21.49 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.114 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.854 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 37.9 Cg_exo -59.13 126.26 2.5 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 124.193 -1.17 . . . . 0.0 113.383 1.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.588 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 57.2 t80 -75.16 146.65 41.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.732 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.51 56.31 0.67 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.266 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.15 -136.54 6.38 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.667 ' HE3' HD21 ' A' ' 55' ' ' LEU . 29.7 pttt -150.38 138.24 20.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.731 0.3 . . . . 0.0 110.256 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.437 ' HA ' ' HD3' ' A' ' 54' ' ' ARG . 29.9 mmt180 -114.87 115.3 26.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.059 0.457 . . . . 0.0 111.224 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.667 HD21 ' HE3' ' A' ' 53' ' ' LYS . 3.1 mm? -89.23 32.75 0.82 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.931 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 p -89.2 157.38 18.28 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.703 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.704 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 68.0 m -88.02 30.21 0.87 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.044 0.45 . . . . 0.0 111.595 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.9 tp -154.5 123.65 6.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.382 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.808 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -73.94 146.75 85.51 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.637 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 57.0 Cg_endo -70.16 -173.31 0.75 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.843 1.695 . . . . 0.0 111.339 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . 80.0 m -67.69 142.35 56.37 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.995 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . 46.8 mtpt -55.24 145.41 21.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.182 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.8 m -47.16 117.39 1.71 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.427 0.454 . . . . 0.0 110.966 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.26 -27.53 8.93 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.496 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 61' ' ' CYS . 56.2 mt -88.3 156.64 19.07 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.781 0.324 . . . . 0.0 111.04 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.7 m -123.15 130.57 52.94 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.496 -0.482 . . . . 0.0 112.163 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 35.6 t -78.06 119.23 21.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.5 m -131.99 145.02 51.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.638 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 54.2 tttp -65.37 107.8 1.75 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.277 0.56 . . . . 0.0 110.332 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 14.4 m -95.02 83.73 3.99 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.855 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.51 -69.75 3.27 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.473 ' HA ' ' OE1' ' A' ' 72' ' ' GLU . 36.4 tp10 -135.58 -49.46 0.71 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -88.15 157.87 18.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.445 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 12.8 m-85 -89.83 130.83 36.02 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.677 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.457 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 34.5 mttp -131.39 150.62 52.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.247 0.546 . . . . 0.0 109.906 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 62.1 m -67.23 134.29 51.38 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.983 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.254 1.295 0 CA-C-O 117.747 -1.12 . . . . 0.0 108.54 179.092 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 15.4 t . . . . . 0 CA--C 1.532 0.284 0 CA-C-O 120.638 0.256 . . . . 0.0 111.426 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.5 117.55 0.4 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.046 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.71 -7.93 51.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.709 0.29 . . . . 0.0 111.776 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.514 ' SG ' ' HA ' ' A' ' 30' ' ' PHE . 6.0 p -132.3 139.13 48.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.024 0.44 . . . . 0.0 111.801 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -46.01 60.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.697 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -139.87 153.99 47.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.996 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.481 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 6.6 t70 -50.09 -30.87 11.9 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.155 0.91 . . . . 0.0 111.688 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.584 ' HA ' ' CB ' ' A' ' 49' ' ' PRO . 46.3 t -53.94 -30.15 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.512 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -76.36 -15.17 60.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 92.0 m -89.32 132.14 35.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.128 0.49 . . . . 0.0 111.088 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.51 156.83 51.39 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.095 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.1 m -52.14 108.9 0.32 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.135 0.493 . . . . 0.0 110.632 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.31 -21.18 3.3 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.1 p -136.3 156.34 48.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.136 -0.532 . . . . 0.0 110.077 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.703 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -145.17 161.69 38.9 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.325 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 62.1 m -87.01 59.41 5.62 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.078 0.465 . . . . 0.0 111.26 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.554 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -93.33 144.5 25.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.97 0.414 . . . . 0.0 110.821 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -78.6 143.12 36.72 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.651 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 66.0 m -65.46 133.66 51.76 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.883 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.62 -24.71 67.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.901 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -86.68 -37.08 18.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 110.623 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.64 ' O ' ' HB2' ' A' ' 22' ' ' SER . 23.1 t -152.06 128.1 10.39 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.476 ' N ' ' HD3' ' A' ' 26' ' ' ARG . 1.7 mpp_? -77.22 37.87 0.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 4' ' ' THR . 13.4 p-10 -89.23 -37.69 14.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.651 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 42.9 mt -89.02 124.33 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.6 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -145.99 53.74 1.15 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 1.046 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.6 p90 -131.51 -171.0 2.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.478 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.7 m -61.56 77.3 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.19 0.931 . . . . 0.0 113.266 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' A' ' 20' ' ' ALA . 44.7 pt -93.54 154.6 41.17 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -55.29 151.63 35.37 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.222 2.615 . . . . 0.0 114.442 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 18' ' ' CYS . 75.7 mt -86.91 159.68 18.96 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.12 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.53 138.25 44.17 Favored Glycine 0 C--O 1.238 0.353 0 O-C-N 124.059 0.849 . . . . 0.0 114.145 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.501 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 44.7 m-80 -105.75 162.51 13.48 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.238 0.615 . . . . 0.0 110.161 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.4 m -55.95 121.02 8.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.729 0.3 . . . . 0.0 110.63 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.77 -25.84 13.94 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.422 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 13.6 pt-20 -93.71 152.89 18.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.873 0.836 . . . . 0.0 110.769 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 67.6 m-20 -59.69 153.64 19.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.551 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 27.2 p -144.72 154.85 43.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.775 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 56.8 m170 -90.2 126.14 57.87 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.536 ' HG3' ' CG ' ' A' ' 74' ' ' PHE . 36.5 Cg_exo -59.52 -53.45 3.39 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 123.15 2.566 . . . . 0.0 113.721 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.41 30.62 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.1 t -90.54 120.86 31.98 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.57 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 37.8 m80 -68.65 144.32 54.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.186 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.57 ' N ' ' HE3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -54.16 154.98 3.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.969 -178.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.462 HG22 HH12 ' A' ' 54' ' ' ARG . 95.8 t -88.71 135.46 32.22 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.584 ' CB ' ' HA ' ' A' ' 11' ' ' VAL . 60.7 Cg_endo -73.21 140.77 69.08 Favored 'Cis proline' 0 C--O 1.237 0.469 0 C-N-CA 123.881 -1.3 . . . . 0.0 113.08 0.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.57 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 68.7 t80 -62.25 133.75 55.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.112 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.04 60.22 1.39 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.725 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.72 -133.9 4.26 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.92 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -117.89 124.76 49.08 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.462 HH12 HG22 ' A' ' 48' ' ' VAL . 25.4 ttm180 -90.63 111.91 23.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.215 0.531 . . . . 0.0 112.181 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 55' ' ' LEU . 4.0 mm? -111.65 18.43 19.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.14 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -89.34 142.3 27.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.37 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 15.8 m -89.25 30.51 0.97 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.7 tp -154.46 130.22 10.05 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.263 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.628 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -80.51 140.31 51.81 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.35 171.06 11.01 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.539 2.159 . . . . 0.0 111.139 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.3 m -60.35 139.91 57.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.772 0.32 . . . . 0.0 110.937 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.506 ' HG2' HD12 ' A' ' 65' ' ' LEU . 14.6 ptmt -62.37 153.14 32.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.482 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.6 m -47.81 124.68 7.63 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.417 0.448 . . . . 0.0 111.294 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.18 -32.04 6.98 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.506 HD12 ' HG2' ' A' ' 62' ' ' LYS . 28.2 mt -89.29 156.9 18.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 0.0 111.565 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.1 m -124.87 133.28 53.14 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.332 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 48.1 t -79.16 122.49 26.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 m -151.0 151.98 32.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.658 0.266 . . . . 0.0 111.08 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 83.0 tttt -62.25 116.29 4.88 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.7 m -115.97 49.02 1.15 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.775 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.429 ' O ' ' HE2' ' A' ' 69' ' ' LYS . . . 131.26 -102.59 0.52 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.039 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.17 -49.61 7.17 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.062 0.458 . . . . 0.0 110.683 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -121.42 -167.29 1.49 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.673 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.619 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 5.5 m-85 -91.38 134.96 34.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.889 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 40' ' ' ASP . 51.0 mttm -133.75 155.83 49.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 60.6 m -75.61 137.64 40.89 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.946 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.667 -0.683 . . . . 0.0 109.158 179.684 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.473 ' O ' ' HD2' ' A' ' 29' ' ' ARG . 3.1 t . . . . . 0 CA--C 1.534 0.333 0 CA-C-O 121.577 0.704 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.811 ' HA2' ' HB2' ' A' ' 29' ' ' ARG . . . 132.03 126.55 2.75 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.463 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.616 ' HB3' ' HA ' ' A' ' 30' ' ' PHE . . . -91.71 -35.67 14.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.224 0.535 . . . . 0.0 110.597 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -127.58 150.02 49.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.064 -177.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -77.1 -44.03 32.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.842 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 1.006 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 32.0 mttm -131.48 152.04 51.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.816 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . 41.8 m-20 -54.87 -22.68 15.47 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.723 0.639 . . . . 0.0 110.586 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.967 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 2.2 p -54.22 -28.4 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.956 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -77.55 -24.13 49.93 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 73.4 m -89.55 136.94 32.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.941 0.4 . . . . 0.0 110.979 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.63 154.86 53.39 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.869 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -53.66 100.34 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.141 0.496 . . . . 0.0 110.966 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.33 -23.71 1.55 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.3 p -133.41 147.88 51.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.639 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.655 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -134.87 167.97 19.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.994 0.361 . . . . 0.0 110.186 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 20.7 m -89.83 31.83 0.93 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.99 148.67 41.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.974 0.416 . . . . 0.0 110.936 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.74 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -76.7 132.19 39.21 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.509 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 78.3 p -60.04 138.95 57.75 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.927 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.53 -24.73 63.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.375 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.3 p90 -87.39 -27.32 22.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.45 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.433 ' HB2' HD13 ' A' ' 28' ' ' ILE . 67.9 m -150.8 122.8 8.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.038 0.447 . . . . 0.0 110.904 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.409 ' HE ' ' HB3' ' A' ' 21' ' ' ALA . 46.1 mmm-85 -74.75 10.94 1.18 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.78 0.324 . . . . 0.0 110.92 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -89.75 -26.37 20.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.694 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.74 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.2 mp -85.97 115.95 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.811 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 62.0 mtt180 -140.52 43.8 1.86 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.616 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 0.8 OUTLIER -101.83 -178.12 3.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.99 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 89.1 m -68.64 79.64 0.28 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.573 0.546 . . . . 0.0 110.918 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.433 HG13 ' SG ' ' A' ' 59' ' ' CYS . 43.9 pt -89.18 150.54 45.2 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.06 151.72 40.88 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.54 2.827 . . . . 0.0 114.896 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.655 HD11 ' HB3' ' A' ' 18' ' ' CYS . 5.2 mp -87.99 166.5 14.44 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.958 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.93 142.41 47.41 Favored Glycine 0 C--O 1.245 0.838 0 CA-C-N 114.714 -1.13 . . . . 0.0 114.496 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.501 ' O ' ' HB3' ' A' ' 39' ' ' GLU . 57.1 m-80 -91.23 173.08 8.12 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.396 -0.902 . . . . 0.0 111.316 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.6 m -63.0 128.83 37.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.395 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.57 11.38 85.27 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.651 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 36' ' ' ASN . 15.4 tt0 -100.56 155.35 17.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.4 ' O ' HD21 ' A' ' 58' ' ' LEU . 8.3 t70 -63.43 140.23 58.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.175 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.7 p -143.12 145.5 32.9 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 52.7 m170 -89.5 123.5 66.59 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 9.6 Cg_endo -54.14 -34.11 77.13 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.244 2.629 . . . . 0.0 112.513 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.95 85.72 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.861 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 m -72.11 136.62 46.61 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -119.58 -142.21 0.35 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.639 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -68.49 166.37 17.05 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.604 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 72.3 t -133.8 130.63 20.74 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.967 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 52.4 Cg_exo -57.03 131.24 4.63 Favored 'Cis proline' 0 C--N 1.348 0.529 0 C-N-CA 124.278 -1.134 . . . . 0.0 113.197 0.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.816 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 69.1 t80 -77.57 150.93 34.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.226 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -74.17 52.06 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.096 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.53 -135.13 5.63 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 1.006 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 3.6 pptp? -151.48 127.73 10.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.988 0.394 . . . . 0.0 110.132 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -86.4 125.67 33.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.951 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.72 24.09 4.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.592 0.711 . . . . 0.0 109.395 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 m -89.84 158.79 17.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.476 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.693 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 4.6 m -89.24 24.34 2.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.726 0.298 . . . . 0.0 111.303 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.4 HD21 ' O ' ' A' ' 40' ' ' ASP . 56.1 tp -154.07 130.15 10.31 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.79 -0.186 . . . . 0.0 111.42 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.477 ' HB3' HD12 ' A' ' 34' ' ' LEU . 16.7 m -76.26 156.7 83.57 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.72 -166.75 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 121.728 1.619 . . . . 0.0 111.229 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.416 ' O ' HD23 ' A' ' 34' ' ' LEU . 73.2 m -74.16 140.02 44.89 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.604 0.24 . . . . 0.0 111.296 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.599 ' HG2' HD12 ' A' ' 65' ' ' LEU . 17.6 ptpt -64.55 157.64 26.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.715 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.9 m -44.05 125.26 4.3 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.736 0.647 . . . . 0.0 112.08 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.26 -30.58 10.07 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.514 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.599 HD12 ' HG2' ' A' ' 62' ' ' LYS . 24.6 mt -89.12 140.98 28.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.095 0.474 . . . . 0.0 112.13 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.0 m -107.25 131.73 53.86 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.818 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 45.2 t -85.06 117.74 24.21 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.2 t -150.57 154.01 36.77 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 15.7 ttpp -65.4 119.67 11.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.945 0.402 . . . . 0.0 110.801 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -137.12 45.39 2.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 122.08 0.943 . . . . 0.0 108.921 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.7 -121.17 1.02 Allowed Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.5 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.18 -44.04 12.52 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -120.06 -161.01 0.85 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.593 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 3.5 m-85 -89.75 141.6 28.47 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.885 0.374 . . . . 0.0 111.196 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 74' ' ' PHE . 14.5 mptt -131.02 160.14 35.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.274 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.464 ' HB3' HD13 ' A' ' 65' ' ' LEU . 81.7 m -84.76 129.2 34.86 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.715 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 C--O 1.252 1.192 0 CA-C-O 117.626 -1.178 . . . . 0.0 109.367 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.971 0.415 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.27 116.47 0.69 Allowed Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.779 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.08 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -89.89 -11.66 41.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.506 -0.347 . . . . 0.0 111.437 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.2 p -151.03 159.41 44.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.765 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -104.53 -54.69 2.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.309 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.596 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 21.9 ttmm -108.03 146.01 33.15 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.279 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.488 ' OD2' ' HB3' ' A' ' 50' ' ' TYR . 76.7 m-20 -51.41 -22.43 2.99 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.947 0.779 . . . . 0.0 110.731 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.706 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -57.11 -27.2 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.501 179.273 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -81.11 -19.62 43.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.811 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.4 m -89.95 -138.26 0.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.115 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.3 -138.24 3.62 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 119.676 -1.25 . . . . 0.0 113.3 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 m -49.86 112.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.991 -0.604 . . . . 0.0 112.582 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 33' ' ' PRO . . . 57.52 34.32 68.9 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.017 -0.992 . . . . 0.0 114.83 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.479 ' N ' HD13 ' A' ' 34' ' ' LEU . 4.3 p -145.44 140.56 27.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.914 0.857 . . . . 0.0 111.113 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.726 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -145.03 162.18 37.58 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.7 m -88.32 57.58 4.32 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.169 0.509 . . . . 0.0 111.73 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.74 ' HB2' HH12 ' A' ' 54' ' ' ARG . . . -93.19 168.95 10.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.006 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -85.16 152.04 23.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.938 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.524 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -59.44 134.35 56.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.524 0.202 . . . . 0.0 111.068 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.91 37.2 0.08 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -151.48 -36.68 0.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.008 0.433 . . . . 0.0 110.485 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.7 m -151.05 149.54 29.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -83.4 43.99 0.93 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.342 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -97.35 -45.05 6.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.067 0.46 . . . . 0.0 110.231 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.613 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.6 mp -89.39 135.44 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.772 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.67 54.58 0.89 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 1.08 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.4 p90 -130.74 -166.91 1.75 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.986 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.2 m -62.08 80.69 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.988 0.805 . . . . 0.0 112.959 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 20' ' ' ALA . 48.8 pt -96.74 154.21 38.46 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 25.3 Cg_endo -62.46 151.82 80.74 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 122.785 2.323 . . . . 0.0 114.528 -177.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 18' ' ' CYS . 5.8 mp -87.23 164.34 16.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.874 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.9 140.01 26.09 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.111 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 58.2 m-80 -95.63 -164.64 1.18 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.181 0.515 . . . . 0.0 111.124 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 m -61.43 123.79 18.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.315 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.1 -6.56 82.58 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.465 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.78 150.96 22.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.376 0.588 . . . . 0.0 111.343 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.13 146.86 49.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.533 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.547 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 24.5 p -143.58 145.45 32.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.093 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 39.9 m170 -90.11 122.68 67.38 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 9.9 Cg_endo -54.15 -38.78 87.78 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.219 2.613 . . . . 0.0 112.904 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.53 65.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.86 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.546 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 17.2 m -81.33 121.01 25.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.915 0.388 . . . . 0.0 110.47 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -93.05 -172.31 2.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.196 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -72.69 165.65 24.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.512 HG13 ' HA ' ' A' ' 49' ' ' PRO . 60.4 t -87.09 139.92 32.54 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.706 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 2.6 Cg_exo -77.12 133.11 29.61 Favored 'Cis proline' 0 C--N 1.346 0.415 0 C-N-CA 123.845 -1.314 . . . . 0.0 113.505 1.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.488 ' HB3' ' OD2' ' A' ' 10' ' ' ASP . 48.8 t80 -113.64 149.25 34.88 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.596 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 25.8 t70 -58.63 -23.67 59.52 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.394 0.616 . . . . 0.0 111.3 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.13 33.31 57.57 Favored Glycine 0 C--N 1.318 -0.426 0 N-CA-C 115.409 0.924 . . . . 0.0 115.409 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.2 pttm -88.3 56.74 3.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.035 0.917 . . . . 0.0 109.739 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.74 HH12 ' HB2' ' A' ' 20' ' ' ALA . 4.0 ppt_? -150.32 130.04 13.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.619 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.8 mt -88.48 50.34 1.95 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.439 0.638 . . . . 0.0 110.145 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 m -89.1 137.56 32.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.779 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 p -88.68 34.75 0.77 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.201 0.524 . . . . 0.0 110.598 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.9 tp -153.28 132.16 12.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.772 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.624 ' HB3' HD12 ' A' ' 34' ' ' LEU . 2.5 m -83.3 159.85 61.03 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.546 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 6.3 Cg_exo -71.83 -161.68 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.288 1.992 . . . . 0.0 111.723 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.571 ' O ' HD23 ' A' ' 34' ' ' LEU . 74.4 m -79.01 137.86 37.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.887 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HD2' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -66.86 153.46 43.39 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.412 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.1 m -46.28 113.1 0.57 Allowed 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.571 0.545 . . . . 0.0 111.6 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.37 -32.58 4.64 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.262 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 76' ' ' CYS . 3.6 mm? -89.72 143.12 27.07 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.2 m -110.5 128.14 55.49 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.599 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 20.8 t -72.96 119.2 16.87 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.9 m -131.22 144.33 51.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.991 0.424 . . . . 0.0 111.408 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.544 ' NZ ' ' HA ' ' A' ' 72' ' ' GLU . 53.2 tttm -67.3 109.11 2.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.379 0.609 . . . . 0.0 110.38 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.9 m -88.95 76.53 7.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.664 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.94 -69.67 3.2 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.544 ' HA ' ' NZ ' ' A' ' 69' ' ' LYS . 33.9 tp10 -130.57 -41.53 1.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.753 0.311 . . . . 0.0 110.489 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -86.56 -172.79 4.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.7 128.84 47.32 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -135.14 150.32 50.15 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.556 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 68.9 m -70.83 133.9 46.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.945 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.9 m . . . . . 0 C--O 1.254 1.294 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.192 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 121.654 0.74 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . -171.01 72.36 0.11 Allowed Glycine 0 C--O 1.226 -0.368 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.027 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -81.35 -23.6 37.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.464 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 18.6 p -151.13 154.92 37.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -92.03 -60.77 1.77 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.611 0.719 . . . . 0.0 110.236 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -101.35 139.32 37.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.798 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.592 ' OD2' ' HB2' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -46.68 -33.19 4.07 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.32 1.012 . . . . 0.0 111.797 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.8 t -49.55 -32.4 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.631 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -66.03 -30.19 70.69 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.464 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 66.6 m -89.88 159.84 16.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.118 0.485 . . . . 0.0 111.378 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.99 166.49 54.9 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.48 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.456 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 56.9 m -63.79 67.13 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.71 0.804 . . . . 0.0 112.125 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.35 -26.44 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.404 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 13' ' ' CYS . 26.5 p -124.39 142.73 51.07 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.691 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -119.74 154.19 34.53 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 60.4 m -89.52 48.52 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 0.0 111.961 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -95.54 -170.09 2.09 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.821 ' HB1' ' HA ' ' A' ' 26' ' ' ARG . . . -90.11 141.34 28.78 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.425 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 88.2 p -63.46 142.98 58.19 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.108 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.705 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -55.93 -26.38 47.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -87.97 -32.23 18.96 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.419 ' C ' ' H ' ' A' ' 27' ' ' ASN . 68.1 m -151.67 135.87 16.7 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.914 -0.492 . . . . 0.0 111.538 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.821 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 59.7 mtm180 -78.46 20.55 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.128 0.489 . . . . 0.0 110.785 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 25' ' ' SER . 74.2 m-20 -92.55 -31.32 15.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.605 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 1.8 mp -85.39 120.81 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 89.2 mtt180 -139.14 77.44 1.62 Allowed 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.914 0.759 . . . . 0.0 109.717 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 1.027 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.0 OUTLIER -150.83 -167.08 2.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.565 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 84.2 m -60.34 77.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.672 HG13 ' SG ' ' A' ' 59' ' ' CYS . 34.0 pt -97.99 146.37 31.37 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -57.01 151.39 50.21 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.267 2.644 . . . . 0.0 115.084 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.691 HD11 ' HB3' ' A' ' 18' ' ' CYS . 5.1 mp -87.11 168.79 12.96 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.769 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.74 147.07 37.9 Favored Glycine 0 C--O 1.239 0.436 0 CA-C-N 115.246 -0.888 . . . . 0.0 114.02 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 72.5 m-80 -100.85 -178.98 3.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.163 -0.518 . . . . 0.0 109.799 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.3 m -62.86 129.51 40.75 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.07 -6.76 76.32 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.179 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -88.2 154.56 20.34 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.897 0.379 . . . . 0.0 111.029 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -67.6 142.82 56.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.821 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.511 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 31.6 p -146.01 150.15 35.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.207 0.527 . . . . 0.0 110.688 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -95.4 126.94 43.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.56 -40.83 77.64 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.092 2.528 . . . . 0.0 112.907 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.46 -33.86 76.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.134 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.632 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 17.7 m -73.31 138.82 45.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.362 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -129.29 175.46 8.72 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 7.7 ptmt -59.69 150.88 26.43 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.445 0.466 . . . . 0.0 111.6 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 49' ' ' PRO . 60.3 t -87.14 142.56 33.77 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.651 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HA ' HG13 ' A' ' 48' ' ' VAL . 33.5 Cg_exo -63.07 138.46 28.27 Favored 'Cis proline' 0 C--N 1.351 0.683 0 C-N-CA 124.392 -1.087 . . . . 0.0 113.73 1.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.491 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 34.5 t80 -146.57 141.79 27.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.703 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -74.13 79.46 1.75 Allowed 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.546 ' HA3' ' OD1' ' A' ' 10' ' ' ASP . . . -89.48 131.84 10.93 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.783 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.18 37.46 0.55 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.324 0.583 . . . . 0.0 109.432 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.44 ' H ' ' NE ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -115.88 139.9 49.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.915 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.68 48.53 1.6 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.223 0.535 . . . . 0.0 110.463 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.7 m -103.04 143.38 32.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.39 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.705 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 72.7 m -88.86 47.92 1.56 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.57 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 53.9 tp -152.51 124.14 7.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.726 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.672 ' SG ' HG13 ' A' ' 32' ' ' ILE . 3.7 m -84.14 153.94 63.29 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.718 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.632 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 12.3 Cg_exo -69.44 -169.96 0.34 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.497 2.132 . . . . 0.0 111.642 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 82.5 m -77.75 139.37 39.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.67 0.271 . . . . 0.0 111.248 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.474 ' HA ' HD23 ' A' ' 34' ' ' LEU . 19.1 ptmt -62.13 154.12 28.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.22 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 15' ' ' SER . 17.6 m -51.03 125.27 13.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.312 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.54 -29.67 9.7 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.415 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.46 HD12 ' HG2' ' A' ' 62' ' ' LYS . 22.6 mt -88.91 152.7 21.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.025 0.44 . . . . 0.0 111.936 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -113.26 128.13 56.38 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.998 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.545 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 53.8 t -84.69 119.67 25.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.1 t -150.97 158.97 44.81 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 23.8 ttpp -65.82 102.4 0.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.245 0.545 . . . . 0.0 109.824 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.536 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 12.1 m -101.6 43.46 1.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.182 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.4 -105.6 0.47 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.322 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.507 ' CD ' ' HG2' ' A' ' 73' ' ' LYS . 1.1 pm0 -86.08 -40.51 15.65 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 122.776 0.43 . . . . 0.0 110.406 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.507 ' HG2' ' CD ' ' A' ' 72' ' ' GLU . 25.0 pttt -133.23 -164.26 1.46 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.902 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 5.1 m-85 -90.09 134.4 34.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.148 0.499 . . . . 0.0 111.468 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 46.4 mttp -135.86 154.33 51.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.063 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.511 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 73.0 m -75.39 126.44 31.01 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.469 -178.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.249 1.065 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.677 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.67 108.39 0.35 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.043 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.027 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -91.17 -14.19 31.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 p -147.7 145.82 29.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.087 0.47 . . . . 0.0 111.904 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 53' ' ' LYS . 17.6 t70 -88.23 -44.79 10.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.42 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.546 ' HG3' ' OD2' ' A' ' 8' ' ' ASP . 61.6 mttp -121.49 144.88 48.46 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 108.962 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.679 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 37.8 t0 -55.31 -18.8 7.03 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.838 0.711 . . . . 0.0 111.005 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.7 p -55.49 -25.33 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.802 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -82.13 -16.76 48.76 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 68.8 m -89.8 -129.79 0.08 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.784 0.326 . . . . 0.0 110.678 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.86 169.88 35.92 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.507 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.4 m -51.96 105.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.125 0.488 . . . . 0.0 111.364 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.63 -35.22 1.89 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.6 p -139.75 143.58 37.04 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.745 0.418 . . . . 0.0 110.08 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.653 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -128.13 159.51 34.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.679 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 67.9 m -85.78 105.09 16.05 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.192 0.52 . . . . 0.0 109.689 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' A' ' 54' ' ' ARG . . . -159.58 173.36 16.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.07 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -82.27 138.07 34.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.298 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.662 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -66.03 137.37 57.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.865 0.364 . . . . 0.0 110.881 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.03 -24.73 66.4 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -86.78 -34.82 19.47 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.416 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 27' ' ' ASN . 28.2 m -151.59 124.88 8.78 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.471 ' N ' ' HD3' ' A' ' 26' ' ' ARG . 1.6 mpp_? -76.29 30.0 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.019 0.438 . . . . 0.0 111.834 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' A' ' 25' ' ' SER . 5.6 m120 -90.03 -37.26 14.42 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.662 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.0 mp -89.58 125.76 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.198 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.505 ' HD3' ' C ' ' A' ' 28' ' ' ILE . 1.3 mpp_? -136.84 68.19 1.43 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 1.027 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.1 p90 -147.29 -161.09 1.26 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.495 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 82.9 m -60.87 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.966 0.791 . . . . 0.0 111.911 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.556 HG13 ' SG ' ' A' ' 59' ' ' CYS . 43.4 pt -100.84 150.54 37.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.48 148.14 27.59 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 123.41 2.74 . . . . 0.0 114.67 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.74 HD23 ' HB3' ' A' ' 59' ' ' CYS . 90.8 mt -85.53 163.84 18.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.979 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.516 ' O ' ' HG3' ' A' ' 62' ' ' LYS . . . -59.67 137.41 49.76 Favored Glycine 0 C--O 1.24 0.509 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.91 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -88.88 165.6 14.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.172 0.589 . . . . 0.0 110.289 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.6 t -62.52 133.77 55.44 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.498 ' O ' ' HD3' ' A' ' 75' ' ' LYS . . . 87.96 -12.08 65.07 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.548 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -88.59 159.79 17.72 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 117.107 0.453 . . . . 0.0 111.861 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.551 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 0.3 OUTLIER -65.65 147.73 52.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.091 -178.766 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.3 p -149.83 142.52 24.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.273 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 41.1 m170 -88.0 124.8 66.22 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 8.2 Cg_endo -51.7 -38.98 67.38 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.47 2.78 . . . . 0.0 113.795 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.65 25.67 0.42 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . 49.5 m -90.64 122.36 33.36 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.915 -0.491 . . . . 0.0 110.372 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.533 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 19.3 m170 -77.46 149.24 35.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -55.39 149.65 12.85 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.631 0.582 . . . . 0.0 111.298 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 49' ' ' PRO . 84.9 t -85.87 138.3 35.3 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.891 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.531 ' HA ' HG13 ' A' ' 48' ' ' VAL . 8.2 Cg_exo -73.58 135.18 38.83 Favored 'Cis proline' 0 C--N 1.344 0.296 0 C-N-CA 123.603 -1.415 . . . . 0.0 112.88 1.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.533 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 89.1 t80 -64.32 143.05 58.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.421 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.58 44.82 0.13 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.06 -139.75 6.9 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.801 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -121.49 134.27 55.06 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.126 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.515 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 61.4 mtp85 -88.08 124.07 33.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.845 0.355 . . . . 0.0 111.209 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -88.94 -5.87 57.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.299 0.571 . . . . 0.0 109.946 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m -87.85 146.43 25.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.459 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 13.3 m -87.41 42.82 1.06 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.983 0.42 . . . . 0.0 111.387 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.1 tp -153.62 121.99 6.22 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.379 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.74 ' HB3' HD23 ' A' ' 34' ' ' LEU . 3.4 m -81.0 148.19 63.62 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 37.3 Cg_endo -67.41 173.39 8.8 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 121.849 1.7 . . . . 0.0 111.46 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.8 m -59.34 144.37 46.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.121 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.659 ' HG2' ' HB2' ' A' ' 34' ' ' LEU . 60.2 mttm -56.17 143.96 31.39 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -51.56 110.3 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.17 0.51 . . . . 0.0 110.543 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.75 -30.06 3.65 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 65' ' ' LEU . 24.7 mt -88.83 147.19 24.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.698 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.3 m -109.91 126.78 54.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.017 0.437 . . . . 0.0 111.481 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.4 t -78.53 116.23 18.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.0 t -134.46 158.68 43.28 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.902 0.382 . . . . 0.0 110.416 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 41.5 ttmt -71.63 112.04 7.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.5 t -91.34 56.94 3.23 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.18 -92.43 1.77 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.226 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -91.02 -46.39 8.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.052 0.453 . . . . 0.0 111.257 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.56 ' HE3' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -107.22 167.06 10.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.711 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 13.4 m-85 -95.38 132.16 40.72 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 55.1 mttm -138.75 153.36 48.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.379 0.609 . . . . 0.0 111.013 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 70.7 m -66.33 132.51 48.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.364 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 C--O 1.253 1.266 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.129 179.701 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.59 0.71 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.56 129.72 4.06 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.674 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.008 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.4 -10.24 44.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.637 0.256 . . . . 0.0 111.571 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 18.8 p -150.76 150.67 31.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.973 0.416 . . . . 0.0 111.409 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.429 ' HB3' HE22 ' A' ' 12' ' ' GLN . 11.9 t70 -97.41 -46.22 6.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.117 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.427 ' H ' ' NE2' ' A' ' 12' ' ' GLN . 95.0 mttt -114.33 145.08 42.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.439 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.835 ' HB2' ' H ' ' A' ' 50' ' ' TYR . 88.2 m-20 -57.35 -26.85 61.63 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.509 0.505 . . . . 0.0 111.417 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -57.39 -29.15 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.898 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.429 HE22 ' HB3' ' A' ' 8' ' ' ASP . 45.2 mt-30 -70.23 -26.05 63.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.491 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 58.0 m -90.69 -122.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.119 0.485 . . . . 0.0 110.784 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.33 157.08 28.14 Favored Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.8 m -55.67 101.0 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.297 0.57 . . . . 0.0 110.846 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.03 -28.08 1.13 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.6 p -135.27 139.49 44.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.15 -0.525 . . . . 0.0 109.833 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.507 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -123.83 159.64 29.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.0 m -88.06 51.22 2.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.89 0.376 . . . . 0.0 111.539 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.758 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -79.62 160.79 26.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.043 0.449 . . . . 0.0 110.998 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.694 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -90.4 144.5 25.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.422 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.646 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -64.58 135.45 55.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.972 0.415 . . . . 0.0 110.395 179.179 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -64.87 -23.06 67.12 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.0 p90 -87.94 -37.68 16.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.4 m -151.74 152.63 32.98 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.19 -0.318 . . . . 0.0 110.162 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -81.75 41.4 0.64 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.775 0.322 . . . . 0.0 111.453 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -97.07 -39.43 9.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.951 0.405 . . . . 0.0 110.828 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.646 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 53.2 mt -88.86 125.63 41.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.918 0.39 . . . . 0.0 110.297 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.3 mmm-85 -150.95 41.03 0.74 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.865 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 1.008 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.4 p90 -121.64 -172.77 2.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.971 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.4 m -61.15 82.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 O-C-N 124.369 1.043 . . . . 0.0 112.609 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 20' ' ' ALA . 30.4 pt -97.86 147.13 32.62 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.07 152.5 36.95 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.388 2.725 . . . . 0.0 114.663 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.549 HD23 ' O ' ' A' ' 61' ' ' CYS . 3.8 mp -87.38 164.73 16.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.317 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.596 ' O ' ' HG3' ' A' ' 62' ' ' LYS . . . -75.4 154.89 46.5 Favored Glycine 0 C--O 1.237 0.335 0 CA-C-N 115.116 -0.947 . . . . 0.0 114.291 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 1.3 p30 -109.18 169.56 8.61 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.131 0.491 . . . . 0.0 110.991 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.7 m -54.59 121.91 9.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.287 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.12 -24.38 16.42 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.04 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 10.7 pt-20 -100.53 153.02 19.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.365 0.582 . . . . 0.0 110.958 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 1.2 m-20 -58.45 150.71 21.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.299 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 13.3 p -149.23 154.47 39.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.787 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -90.97 128.54 47.46 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.45 -60.07 0.8 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.5 2.8 . . . . 0.0 114.207 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.35 26.79 0.3 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.189 0.518 . . . . 0.0 110.551 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -81.98 2.63 29.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.761 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.548 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -178.18 36.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.621 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.564 ' O ' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -68.33 136.14 52.95 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.603 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.6 t -86.44 128.39 57.26 Favored Pre-proline 0 C--N 1.315 -0.906 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.94 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -91.13 131.03 7.72 Favored 'Cis proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.797 -1.335 . . . . 0.0 112.855 0.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.835 ' H ' ' HB2' ' A' ' 10' ' ' ASP . 12.1 t80 -109.12 120.46 42.61 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.266 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -84.15 63.8 7.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.909 0.861 . . . . 0.0 108.838 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.15 142.62 7.32 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.881 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.449 ' H ' ' HD3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -101.49 52.2 0.83 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.292 0.568 . . . . 0.0 110.126 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.4 tpt85 -57.73 139.46 53.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.079 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.46 61.68 6.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.797 0.808 . . . . 0.0 110.391 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.5 m -102.17 129.41 48.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.471 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.694 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 7.0 m -89.24 28.39 1.24 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.849 0.357 . . . . 0.0 111.496 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.1 tp -153.9 129.09 9.69 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.342 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.527 ' SG ' HG13 ' A' ' 32' ' ' ILE . 3.8 m -78.77 164.44 55.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.844 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.508 ' HG3' ' HA ' ' A' ' 47' ' ' LYS . 94.7 Cg_endo -78.5 -157.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.305 2.003 . . . . 0.0 111.508 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.549 ' O ' HD23 ' A' ' 34' ' ' LEU . 90.4 m -87.14 145.5 26.4 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.399 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 29.5 mtpp -57.46 153.44 12.72 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.678 0.611 . . . . 0.0 110.236 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.8 m -49.39 121.73 5.35 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.229 0.331 . . . . 0.0 111.178 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.6 -24.34 28.91 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 65' ' ' LEU . 42.3 mt -88.27 152.13 22.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.845 0.355 . . . . 0.0 111.396 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.2 m -115.59 129.51 56.54 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.132 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.0 t -81.65 116.2 21.27 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 m -132.72 146.05 51.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.708 0.289 . . . . 0.0 110.663 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 34.8 ttpt -70.33 108.03 4.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.116 0.484 . . . . 0.0 110.887 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.886 ' HB3' ' HD3' ' A' ' 75' ' ' LYS . 19.6 t -94.38 76.85 3.9 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.54 -102.1 2.86 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.104 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.532 ' OE1' ' HG3' ' A' ' 73' ' ' LYS . 2.8 tt0 -89.01 -56.46 3.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.518 -0.341 . . . . 0.0 111.503 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HG3' ' OE1' ' A' ' 72' ' ' GLU . 64.5 mttp -102.8 172.46 6.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.17 0.509 . . . . 0.0 111.953 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.696 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 10.1 m-85 -89.48 132.05 35.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.352 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.886 ' HD3' ' HB3' ' A' ' 70' ' ' SER . 1.6 mptp? -130.95 150.05 52.29 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 62.5 m -69.64 144.98 52.77 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.699 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--O 1.248 0.981 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.398 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.32 121.42 0.64 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.454 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.109 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -91.34 -14.84 30.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.2 p -150.66 167.47 27.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.923 0.392 . . . . 0.0 111.49 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.24 -44.0 2.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.186 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 46.3 mmtm -104.09 138.16 41.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.734 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.416 ' OD2' ' HG2' ' A' ' 54' ' ' ARG . 70.4 m-20 -57.96 -28.58 64.48 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.347 0.594 . . . . 0.0 109.847 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.4 t -56.74 -29.87 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 114.827 -1.078 . . . . 0.0 111.486 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -69.11 -22.77 63.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.636 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.8 m -89.48 -126.44 0.07 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.138 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.39 -177.8 43.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.127 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.5 m -67.63 66.18 0.08 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.435 0.636 . . . . 0.0 111.488 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 176.58 -24.2 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.341 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.1 p -139.55 147.89 41.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.023 0.129 . . . . 0.0 110.655 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.503 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -136.16 160.27 39.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.528 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.4 m -87.6 51.82 2.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.136 0.493 . . . . 0.0 111.762 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.597 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -86.75 164.19 16.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.805 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.683 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -86.06 144.59 27.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.102 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.657 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -64.76 134.07 53.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.932 0.396 . . . . 0.0 111.146 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.784 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -65.7 -21.23 66.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -87.57 -35.15 18.28 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 m -151.84 144.06 23.98 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.079 -0.388 . . . . 0.0 110.524 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.94 33.79 0.18 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.955 0.407 . . . . 0.0 111.627 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -98.18 -40.83 8.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.755 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.657 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.8 mp -88.08 127.23 41.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.961 0.41 . . . . 0.0 110.918 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HD3' ' C ' ' A' ' 28' ' ' ILE . 1.1 mpp_? -143.34 68.49 1.29 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.863 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 1.109 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.5 p90 -145.76 -170.52 3.49 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.763 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.2 m -60.92 75.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.288 0.992 . . . . 0.0 112.946 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 20' ' ' ALA . 43.9 pt -89.83 153.05 47.34 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.78 151.54 47.54 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.137 2.558 . . . . 0.0 114.691 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.732 HD23 ' HA ' ' A' ' 62' ' ' LYS . 3.6 mp -87.09 170.82 11.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.936 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.54 133.28 25.47 Favored Glycine 0 C--O 1.243 0.696 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.483 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -89.75 167.83 12.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.191 -0.505 . . . . 0.0 110.36 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 m -59.97 128.1 35.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.767 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.8 -5.2 84.5 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.145 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.555 ' HA ' ' HZ2' ' A' ' 75' ' ' LYS . 5.9 mm-40 -99.21 162.44 13.05 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 117.411 0.606 . . . . 0.0 111.8 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.559 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 41.3 p-10 -63.59 151.82 40.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.251 1.024 . . . . 0.0 113.217 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 21.5 p -151.08 143.65 24.33 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.331 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.486 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 43.4 m170 -89.45 121.65 69.09 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 4.5 Cg_endo -48.54 -40.25 37.28 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.775 2.984 . . . . 0.0 113.738 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.28 -28.39 68.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.121 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 53.9 m -73.82 137.07 43.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.889 0.376 . . . . 0.0 110.587 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -123.0 145.89 48.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.87 144.12 1.9 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.556 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 21.9 t -88.25 143.21 32.35 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.052 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.556 ' C ' ' HA ' ' A' ' 48' ' ' VAL . 19.1 Cg_endo -60.75 131.8 8.24 Favored 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.402 -1.082 . . . . 0.0 114.185 1.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -115.73 137.76 51.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.176 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -69.62 109.87 4.54 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.21 -133.78 11.5 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -152.5 152.42 31.91 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.497 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 23.1 mmm180 -85.41 107.19 17.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.143 0.497 . . . . 0.0 111.906 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.75 61.49 6.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 t -144.66 163.39 34.11 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.598 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.784 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 6.6 m -88.02 21.98 2.55 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.5 tp -154.08 127.82 8.76 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 121.168 -0.213 . . . . 0.0 111.299 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.559 ' SG ' HG13 ' A' ' 32' ' ' ILE . 13.3 m -74.76 154.29 87.18 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.066 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.53 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 57.0 Cg_endo -69.76 178.28 4.73 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.475 2.117 . . . . 0.0 111.973 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 71.4 m -70.27 143.1 52.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.732 ' HA ' HD23 ' A' ' 34' ' ' LEU . 9.8 ptmm? -60.66 146.91 43.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.1 m -45.52 128.88 8.47 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.078 0.466 . . . . 0.0 111.381 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.99 -28.97 10.86 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.585 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.531 HD12 ' HG2' ' A' ' 62' ' ' LYS . 22.2 mt -89.85 145.28 25.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.955 0.407 . . . . 0.0 111.735 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.9 m -108.59 126.44 52.94 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.955 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 48.1 t -81.01 126.58 31.58 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.6 p -149.46 149.15 30.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.752 0.31 . . . . 0.0 111.231 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.884 ' HE3' ' HA ' ' A' ' 72' ' ' GLU . 46.8 tttt -66.92 105.58 1.66 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.376 0.608 . . . . 0.0 110.984 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 6.8 m -89.83 82.7 6.2 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.833 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.91 -64.09 3.96 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.274 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.884 ' HA ' ' HE3' ' A' ' 69' ' ' LYS . 0.8 OUTLIER -141.02 -47.27 0.4 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.999 0.428 . . . . 0.0 110.028 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -94.77 158.47 15.49 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 15.2 m-85 -88.37 130.08 35.24 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.45 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 37.2 mttm -134.85 155.52 50.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.315 0.579 . . . . 0.0 110.141 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.456 ' HB3' HD13 ' A' ' 65' ' ' LEU . 64.3 m -73.86 137.16 43.57 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.373 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.244 0.805 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.413 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.2 p . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.041 0.448 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.19 122.7 0.28 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.435 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.069 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -82.56 -6.53 59.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.722 0.296 . . . . 0.0 111.614 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 p -149.89 146.25 26.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.954 0.406 . . . . 0.0 111.739 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.455 ' OD1' ' HG2' ' A' ' 9' ' ' LYS . 3.2 t70 -95.37 -57.01 2.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.455 ' HG2' ' OD1' ' A' ' 8' ' ' ASP . 23.6 mmtp -93.99 141.5 28.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.746 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.2 -31.03 66.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.538 0.685 . . . . 0.0 109.881 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.865 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 47.8 t -55.97 -27.16 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.943 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.43 ' NE2' ' H ' ' A' ' 9' ' ' LYS . 55.3 mt-30 -67.08 -25.56 66.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.605 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 71.3 m -89.61 138.27 31.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.03 0.443 . . . . 0.0 111.331 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.17 151.2 49.74 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.631 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.412 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 18.4 m -51.48 113.02 0.85 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.187 0.517 . . . . 0.0 110.741 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.13 -27.86 3.1 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.4 p -128.87 144.87 51.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.965 -0.618 . . . . 0.0 109.535 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.77 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -128.96 166.51 19.03 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 72.3 m -88.02 52.77 2.55 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.797 0.332 . . . . 0.0 111.678 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.597 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -89.81 156.6 18.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.11 0.481 . . . . 0.0 111.336 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.26 145.88 24.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.463 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.597 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -66.0 128.0 34.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.086 0.469 . . . . 0.0 110.883 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.69 -20.13 65.91 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -86.81 -36.17 18.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.811 0.338 . . . . 0.0 111.441 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.8 m -152.0 138.79 18.89 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.442 ' N ' ' HD3' ' A' ' 26' ' ' ARG . 1.6 mpp_? -76.7 48.26 0.55 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.639 0.257 . . . . 0.0 111.547 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -103.95 -41.03 5.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.856 0.36 . . . . 0.0 110.379 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.597 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 69.5 mt -89.6 131.02 37.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.816 0.341 . . . . 0.0 110.335 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -151.73 52.63 0.82 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 1.069 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.9 p90 -140.45 -168.49 2.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.871 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 67.0 m -57.62 99.06 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 O-C-N 124.11 0.881 . . . . 0.0 112.378 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 20' ' ' ALA . 46.1 pt -120.74 149.9 51.53 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.39 147.52 67.43 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.408 2.739 . . . . 0.0 115.125 -177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.77 HD11 ' HB3' ' A' ' 18' ' ' CYS . 7.1 mp -88.34 164.5 15.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.359 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.77 149.29 26.79 Favored Glycine 0 C--O 1.238 0.348 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.252 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 49.6 m-80 -103.34 -168.12 1.47 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.999 0.428 . . . . 0.0 110.922 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 m -61.61 129.95 43.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.626 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.421 ' O ' ' HE3' ' A' ' 75' ' ' LYS . . . 93.11 -12.24 70.28 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.323 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 36' ' ' ASN . 49.1 mt-10 -90.86 144.8 25.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.29 0.566 . . . . 0.0 111.293 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.58 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 11.6 m-20 -62.38 145.63 53.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.301 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -135.52 179.91 6.04 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.78 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -116.76 122.12 31.99 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -57.77 -34.79 98.71 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.771 2.314 . . . . 0.0 112.492 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.52 -26.46 62.67 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.565 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.59 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 40.6 m -78.35 129.94 35.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.419 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -88.35 -152.25 0.22 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.698 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -88.2 146.57 25.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.857 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.501 HG13 ' HA ' ' A' ' 49' ' ' PRO . 70.8 t -88.65 136.72 30.8 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 123.436 0.46 . . . . 0.0 110.191 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.865 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 16.7 Cg_exo -68.82 128.25 11.3 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.863 -1.307 . . . . 0.0 113.115 0.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.5 ' CE2' ' HG2' ' A' ' 54' ' ' ARG . 80.5 t80 -65.26 145.86 55.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.111 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.93 49.9 0.25 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.23 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.61 -143.51 9.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.955 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -150.4 59.45 0.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.1 0.476 . . . . 0.0 111.37 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.5 ' HG2' ' CE2' ' A' ' 50' ' ' TYR . 22.0 mmt85 -59.39 140.55 56.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.29 57.76 4.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.416 0.627 . . . . 0.0 110.311 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.2 m -88.84 141.78 28.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.253 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 4.1 p -89.13 17.6 5.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.955 0.407 . . . . 0.0 111.698 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.9 tp -154.18 129.88 10.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.724 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.526 ' SG ' HG13 ' A' ' 32' ' ' ILE . 9.0 m -73.37 149.49 88.96 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.59 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 7.5 Cg_exo -72.11 -160.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.396 2.064 . . . . 0.0 111.762 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.857 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 44.1 m -75.72 139.31 41.82 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.992 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.418 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -60.79 150.11 33.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.835 179.191 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.412 ' OG ' ' HB3' ' A' ' 15' ' ' SER . 13.8 m -49.67 125.29 11.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.625 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.86 -33.72 5.74 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.917 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 65' ' ' LEU . 39.5 mt -89.95 163.59 14.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.922 0.391 . . . . 0.0 111.817 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -133.64 137.75 45.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.08 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.857 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 10.5 t -92.53 148.99 21.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.785 0.326 . . . . 0.0 111.039 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.6 t -147.94 156.6 42.85 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -73.79 111.99 9.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.381 0.61 . . . . 0.0 110.302 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.8 m -89.55 66.88 7.42 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.94 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.16 -60.4 1.94 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.169 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -142.17 -46.15 0.34 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -88.24 160.46 17.68 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.475 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 25.4 m-85 -99.28 122.38 42.36 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.477 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.58 ' HD2' ' HA ' ' A' ' 40' ' ' ASP . 19.6 mmmt -123.2 144.07 49.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 95.1 m -73.42 149.84 42.16 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.237 -0.887 . . . . 0.0 109.382 179.426 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 C--O 1.237 0.408 0 CA-C-O 121.739 0.781 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.518 ' CA ' ' HB2' ' A' ' 29' ' ' ARG . . . 107.25 132.17 6.87 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.465 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 30' ' ' PHE . . . -76.97 -20.39 56.15 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.171 0.51 . . . . 0.0 110.542 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 p -137.08 158.85 43.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.876 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -83.17 -51.05 7.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.602 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.941 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 28.1 mttm -126.11 147.3 49.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.737 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . 40.8 m-20 -51.41 -28.72 13.56 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.01 0.819 . . . . 0.0 111.33 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 t -53.74 -32.67 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.049 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -69.18 -25.47 64.36 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.3 m -89.3 135.19 33.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.903 0.383 . . . . 0.0 110.409 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.04 156.05 50.19 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.4 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.4 m -52.71 104.12 0.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.288 0.566 . . . . 0.0 110.442 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.17 -19.66 1.92 Allowed Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.0 p -137.56 157.1 47.26 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.284 -0.458 . . . . 0.0 110.55 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.796 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -140.85 162.3 35.78 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.7 m -91.09 35.52 0.91 Allowed 'General case' 0 C--O 1.239 0.528 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.71 169.34 15.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.909 0.385 . . . . 0.0 110.639 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.739 ' HB1' ' HA ' ' A' ' 26' ' ' ARG . . . -78.96 135.92 37.08 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.8 p -66.47 146.24 54.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.39 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.41 -26.12 66.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.358 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 35.8 p90 -88.02 -29.6 20.59 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.731 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.498 ' HB2' HD13 ' A' ' 28' ' ' ILE . 69.3 m -150.99 122.7 8.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.244 0.545 . . . . 0.0 110.937 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.739 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 99.2 mtt180 -72.32 3.04 5.09 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.495 ' OD1' HD12 ' A' ' 28' ' ' ILE . 20.6 p30 -89.27 -17.04 29.79 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.0 mp -87.48 121.11 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.518 ' HB2' ' CA ' ' A' ' 5' ' ' GLY . 12.7 mtm105 -141.88 39.85 1.66 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.552 ' CD2' HG23 ' A' ' 28' ' ' ILE . 2.2 m-85 -89.57 -175.68 4.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 91.3 m -69.09 79.1 0.34 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.644 HG13 ' SG ' ' A' ' 59' ' ' CYS . 31.1 pt -89.25 146.01 35.3 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.12 144.79 45.55 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.832 3.021 . . . . 0.0 115.042 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.845 HD23 ' HB3' ' A' ' 59' ' ' CYS . 94.8 mt -87.33 160.48 18.37 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.986 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 62' ' ' LYS . . . -61.12 151.38 42.28 Favored Glycine 0 C--O 1.238 0.392 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.1 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 16.3 p30 -118.93 -167.72 1.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 m -62.85 117.59 6.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.873 0.368 . . . . 0.0 111.259 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.53 1.65 68.45 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.759 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 36' ' ' ASN . 18.3 mm-40 -88.38 152.31 22.0 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.678 0.275 . . . . 0.0 111.228 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.468 ' CG ' ' HZ3' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -67.76 143.91 55.64 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.356 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.7 p -147.12 144.4 29.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.986 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.43 ' HB2' ' OG ' ' A' ' 45' ' ' SER . 50.3 m170 -89.46 129.42 47.31 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.82 -41.3 39.06 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.291 2.66 . . . . 0.0 114.236 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.4 12.78 3.38 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.683 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . 5.7 m -91.25 122.54 33.96 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.016 -0.428 . . . . 0.0 110.212 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.586 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 27.6 m170 -88.56 153.71 20.92 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.24 149.3 20.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.54 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.584 HG13 ' HA ' ' A' ' 49' ' ' PRO . 78.3 t -88.91 139.22 29.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.78 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.584 ' HA ' HG13 ' A' ' 48' ' ' VAL . 29.9 Cg_endo -64.17 125.28 4.57 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 123.615 -1.411 . . . . 0.0 113.326 1.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 90.8 t80 -72.77 145.95 46.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.212 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.79 55.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.547 0.689 . . . . 0.0 111.315 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.67 -129.54 3.24 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.941 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 2.6 pptp? -150.72 129.75 12.61 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -77.3 128.45 34.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.277 0.56 . . . . 0.0 112.277 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.1 mt -101.44 15.72 27.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.766 0.793 . . . . 0.0 109.399 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.3 m -89.73 157.58 17.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.657 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 8.1 m -88.34 30.89 0.84 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.186 0.517 . . . . 0.0 110.511 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.3 tp -154.9 127.77 8.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.912 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.845 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -76.35 142.37 71.27 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.683 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 41.9 Cg_endo -68.17 -176.35 1.04 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.039 1.826 . . . . 0.0 112.096 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.0 m -67.15 139.09 57.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.331 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.606 ' HA ' HD13 ' A' ' 34' ' ' LEU . 6.2 ptpp? -67.49 151.5 47.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.8 m -48.34 109.25 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.599 0.562 . . . . 0.0 110.911 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.04 -34.3 2.76 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 76' ' ' CYS . 3.9 mm? -89.16 139.12 30.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.797 0.332 . . . . 0.0 110.809 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -106.12 129.54 54.18 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.957 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 41.9 t -78.34 126.04 30.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.7 t -145.66 156.12 43.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.874 0.368 . . . . 0.0 110.479 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -71.44 107.69 4.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.339 0.59 . . . . 0.0 110.846 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.985 ' HB3' ' HD3' ' A' ' 75' ' ' LYS . 47.7 t -98.4 70.91 2.01 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.871 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.15 -106.02 3.33 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.119 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.617 ' OE1' ' HG2' ' A' ' 73' ' ' LYS . 11.6 tm-20 -89.31 -51.21 5.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.624 0.212 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.617 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 43.7 mmtm -94.76 178.68 5.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.942 0.401 . . . . 0.0 111.141 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -103.88 131.87 50.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.433 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.985 ' HD3' ' HB3' ' A' ' 70' ' ' SER . 3.6 mptp? -130.13 154.63 47.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.029 0.442 . . . . 0.0 110.314 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 61.6 m -77.8 136.22 38.08 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.388 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.723 -1.132 . . . . 0.0 109.365 179.912 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 121.239 0.542 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.08 124.45 1.31 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.76 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.06 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -81.22 -12.14 59.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.9 p -141.74 157.04 45.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.09 0.471 . . . . 0.0 111.514 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.752 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 26.7 t70 -105.18 -44.35 4.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.033 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -111.98 139.43 47.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.854 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -53.63 -32.9 53.18 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.725 0.64 . . . . 0.0 111.474 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.3 t -52.7 -28.9 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.314 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -68.23 -29.38 68.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 71.3 m -90.41 140.21 29.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.137 0.494 . . . . 0.0 111.499 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.21 154.58 50.8 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.963 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.9 m -53.46 105.83 0.15 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.353 0.597 . . . . 0.0 110.784 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.39 -28.55 1.79 Allowed Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.6 p -127.62 142.79 51.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.801 -0.7 . . . . 0.0 109.229 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.768 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -125.64 158.84 33.72 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.354 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 81.1 m -88.16 47.94 1.57 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 56' ' ' SER . . . -92.0 162.49 14.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.815 0.341 . . . . 0.0 110.493 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -83.87 134.49 34.69 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.476 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 81.2 p -72.41 137.19 46.32 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.705 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.14 -24.46 67.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.567 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.6 p90 -88.32 -20.03 25.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.878 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.479 ' HB2' HD13 ' A' ' 28' ' ' ILE . 59.9 m -149.24 117.4 6.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.197 0.523 . . . . 0.0 110.955 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -69.07 -13.68 62.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.226 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.446 ' OD1' ' HB3' ' A' ' 25' ' ' SER . 16.1 p-10 -88.29 -15.81 34.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.694 0.283 . . . . 0.0 111.204 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 1.7 mp -88.13 118.78 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.752 ' NH2' ' HA ' ' A' ' 8' ' ' ASP . 28.4 ttp180 -150.43 50.77 0.89 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 1.06 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.1 p90 -117.44 -166.17 1.16 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.637 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.6 m -62.04 76.97 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.077 0.861 . . . . 0.0 112.606 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.694 HG13 ' SG ' ' A' ' 59' ' ' CYS . 39.0 pt -93.31 145.43 30.01 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.89 149.86 75.81 Favored 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 123.243 2.629 . . . . 0.0 114.774 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.768 HD11 ' HB3' ' A' ' 18' ' ' CYS . 7.4 mp -88.09 166.08 14.68 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.059 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.62 151.93 25.79 Favored Glycine 0 C--O 1.239 0.412 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.023 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 5.0 p30 -112.0 -176.38 2.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.8 m -55.18 126.85 26.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.191 0.519 . . . . 0.0 111.783 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.55 -20.62 48.86 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.368 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -89.56 149.25 22.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.709 0.29 . . . . 0.0 110.598 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -68.71 148.37 50.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.794 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.514 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 12.6 p -139.44 147.86 41.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.822 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.442 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 50.2 m170 -89.42 121.0 69.7 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 10.6 Cg_endo -54.99 -36.5 92.62 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.15 2.567 . . . . 0.0 112.66 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.61 -30.79 71.15 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.377 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.8 m -75.68 128.87 36.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.798 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -101.01 166.73 10.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.374 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -55.79 148.76 15.95 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.676 0.61 . . . . 0.0 112.13 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.59 HG13 ' HA ' ' A' ' 49' ' ' PRO . 74.2 t -87.17 140.89 32.56 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.345 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.59 ' HA ' HG13 ' A' ' 48' ' ' VAL . 72.7 Cg_endo -78.03 128.53 16.81 Favored 'Cis proline' 0 C--N 1.346 0.445 0 C-N-CA 123.499 -1.459 . . . . 0.0 113.764 0.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -75.53 134.24 40.81 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.882 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.4 114.47 7.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.64 -133.47 11.74 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.996 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -150.37 141.11 22.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.838 0.351 . . . . 0.0 110.149 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -118.91 137.25 53.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.392 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.72 47.33 1.49 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.501 0.667 . . . . 0.0 109.794 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.409 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 45.7 t -89.66 140.2 29.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.952 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 5.6 m -89.12 13.42 13.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.217 0.532 . . . . 0.0 110.842 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.3 tp -153.93 132.22 11.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.731 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.694 ' SG ' HG13 ' A' ' 32' ' ' ILE . 7.4 m -71.24 150.94 94.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.23 -165.2 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.083 1.855 . . . . 0.0 111.675 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 68.4 m -76.76 141.98 40.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.706 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.559 ' HA ' HD23 ' A' ' 34' ' ' LEU . 19.8 ptmt -57.54 146.24 30.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.065 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.5 m -49.73 120.1 4.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 119.52 -33.18 4.75 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.743 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.3 mt -89.26 165.0 14.7 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.008 0.432 . . . . 0.0 111.964 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.7 m -120.44 132.51 55.26 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.872 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 53.2 t -89.14 125.77 35.18 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.5 t -150.36 155.97 40.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.723 0.297 . . . . 0.0 110.469 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.632 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 36.1 ttpt -69.05 106.03 2.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.293 0.568 . . . . 0.0 110.584 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.514 ' HB2' ' HD3' ' A' ' 75' ' ' LYS . 13.3 m -92.13 58.19 3.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.553 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.07 -100.7 1.33 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.299 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -89.75 -55.69 3.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.945 0.403 . . . . 0.0 110.912 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -100.34 170.76 8.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.314 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 13.1 m-85 -88.68 128.26 35.6 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.514 ' HD3' ' HB2' ' A' ' 70' ' ' SER . 24.2 mtpp -132.7 152.18 51.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.145 0.498 . . . . 0.0 109.694 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.514 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 98.4 m -71.47 134.94 46.92 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.795 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.248 0.978 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.82 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 8.7 t . . . . . 0 CA--C 1.532 0.258 0 CA-C-O 120.632 0.253 . . . . 0.0 111.466 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.95 118.01 0.63 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.302 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.064 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -91.21 -8.19 49.22 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.1 p -148.6 145.24 27.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.204 0.526 . . . . 0.0 112.368 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.629 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 14.4 t70 -90.21 -32.23 16.69 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.732 0.777 . . . . 0.0 109.325 178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.536 ' HG2' ' H ' ' A' ' 52' ' ' GLY . 55.0 mttp -135.8 139.74 43.72 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.777 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.62 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 41.9 t0 -55.98 -25.49 44.23 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.77 0.669 . . . . 0.0 110.571 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 t -55.03 -29.85 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.688 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.416 HE22 ' HB3' ' A' ' 8' ' ' ASP . 29.5 mt-30 -72.95 -19.6 61.21 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.683 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.451 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 59.1 m -89.53 -120.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.341 . . . . 0.0 110.702 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.28 156.11 15.28 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.736 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.4 m -51.3 104.29 0.08 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.222 0.534 . . . . 0.0 111.016 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.06 -32.96 1.39 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.5 p -138.53 135.7 35.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.824 -0.688 . . . . 0.0 109.173 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.667 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -120.31 162.85 18.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.62 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 62.5 m -87.02 110.55 20.14 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -164.09 172.52 13.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.929 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -74.49 138.13 42.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.054 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.534 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 81.4 p -75.61 141.8 42.78 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.178 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -62.29 -24.11 67.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.882 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -88.27 -25.54 22.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.556 ' HB2' HD13 ' A' ' 28' ' ' ILE . 71.4 m -150.93 130.48 13.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.276 0.56 . . . . 0.0 111.872 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -74.32 -0.06 15.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.689 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 4' ' ' THR . 30.8 m-20 -87.99 -26.76 22.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.883 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.3 mp -87.94 126.95 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 98.9 mtt180 -146.62 67.97 1.17 Allowed 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.687 0.617 . . . . 0.0 109.475 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 1.064 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.0 OUTLIER -142.39 -160.95 1.16 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.165 -179.584 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 24.3 m -61.54 85.22 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.845 0.716 . . . . 0.0 111.668 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.502 HG13 ' SG ' ' A' ' 59' ' ' CYS . 41.4 pt -104.84 149.29 37.36 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.6 148.5 20.8 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.844 3.03 . . . . 0.0 115.035 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.689 HD23 ' HB3' ' A' ' 59' ' ' CYS . 98.6 mt -87.5 159.63 18.56 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.52 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.15 137.64 38.33 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.829 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 68.0 m-80 -95.11 176.06 6.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.026 0.441 . . . . 0.0 110.713 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.9 m -61.24 127.93 33.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.91 -6.59 82.83 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.931 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.8 146.85 24.75 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 120.85 0.357 . . . . 0.0 110.405 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.431 ' O ' HD21 ' A' ' 58' ' ' LEU . 1.6 m-20 -61.29 139.4 58.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.926 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.472 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 25.0 p -135.07 142.4 46.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.19 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 44.2 m170 -88.39 125.38 63.78 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 2.5 Cg_endo -47.37 -36.54 23.44 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.83 3.02 . . . . 0.0 113.304 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.27 37.27 0.2 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.297 0.57 . . . . 0.0 112.031 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.598 ' HB2' ' HB3' ' A' ' 60' ' ' PRO . 6.2 p -92.05 155.89 17.77 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.929 0.395 . . . . 0.0 110.198 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.443 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 33.5 m170 -133.26 143.57 49.19 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -55.34 152.95 7.8 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.566 HG13 ' HA ' ' A' ' 49' ' ' PRO . 95.4 t -87.01 141.56 33.29 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.509 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' HG13 ' A' ' 48' ' ' VAL . 71.8 Cg_endo -78.83 132.21 25.41 Favored 'Cis proline' 0 C--O 1.235 0.355 0 C-N-CA 123.454 -1.477 . . . . 0.0 113.818 1.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.565 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 54.6 t80 -77.72 134.44 38.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.069 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -82.35 119.13 23.76 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.572 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.536 ' H ' ' HG2' ' A' ' 9' ' ' LYS . . . 94.76 -149.82 19.5 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -178.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.629 ' HG3' ' O ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -144.32 133.24 22.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.119 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.469 ' HB2' ' CB ' ' A' ' 20' ' ' ALA . 40.6 mtp85 -70.3 136.47 49.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.367 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.28 -7.64 57.63 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 t -88.38 148.8 24.06 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.462 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.671 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 18.1 m -86.43 44.27 1.13 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.431 HD21 ' O ' ' A' ' 40' ' ' ASP . 24.3 tp -154.41 121.44 5.61 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.689 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -80.09 157.84 73.04 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.496 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.598 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 12.5 Cg_exo -68.28 177.46 4.51 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.066 1.844 . . . . 0.0 111.18 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 77.7 m -68.25 142.28 55.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.491 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.576 ' HG2' HD12 ' A' ' 65' ' ' LEU . 16.5 ptmt -61.71 151.57 33.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.349 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.5 m -45.94 125.84 6.71 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.56 0.538 . . . . 0.0 111.671 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.76 -32.71 6.86 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.83 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.576 HD12 ' HG2' ' A' ' 62' ' ' LYS . 36.0 mt -89.15 155.67 19.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.951 0.405 . . . . 0.0 111.637 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.1 m -127.47 129.29 47.18 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.373 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 48.3 t -71.42 124.81 25.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.3 t -142.98 155.53 44.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.112 0.482 . . . . 0.0 110.753 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -72.43 105.7 4.24 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.418 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.993 ' HB2' ' HD3' ' A' ' 75' ' ' LYS . 13.4 m -98.19 81.08 2.74 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.03 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.69 -109.01 3.29 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.665 ' OE1' ' HG2' ' A' ' 73' ' ' LYS . 1.3 tm-20 -89.24 -49.16 6.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.661 0.231 . . . . 0.0 111.579 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.665 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 43.9 mmtm -92.81 -172.47 3.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.157 0.503 . . . . 0.0 111.396 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -112.21 130.4 55.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.993 ' HD3' ' HB2' ' A' ' 70' ' ' SER . 1.7 mptp? -132.79 152.19 51.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.074 0.464 . . . . 0.0 109.798 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 89.2 m -70.1 118.59 13.13 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.942 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.522 -0.752 . . . . 0.0 109.271 179.37 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.539 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 9.1 t . . . . . 0 CA--C 1.532 0.253 0 CA-C-O 121.026 0.441 . . . . 0.0 110.728 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.41 114.5 0.31 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.046 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.82 -12.99 34.68 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.0 p -141.36 145.22 35.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.548 0.69 . . . . 0.0 112.578 -178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.16 -38.61 9.25 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.231 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HD2' ' OD1' ' A' ' 51' ' ' ASP . 14.0 mmtp -115.43 132.54 56.59 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.992 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.673 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 33.0 t70 -56.57 -25.32 52.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.991 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.8 HG22 ' HB2' ' A' ' 49' ' ' PRO . 22.0 t -58.04 -28.28 33.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.351 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -69.93 -20.28 63.35 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.002 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 70.0 m -89.18 129.59 35.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.126 0.489 . . . . 0.0 111.093 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.11 160.28 47.98 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.809 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.6 m -50.17 115.21 1.33 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.361 0.601 . . . . 0.0 110.868 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.625 ' H ' HD12 ' A' ' 34' ' ' LEU . . . 131.74 -28.25 3.58 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.7 p -132.63 158.44 42.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.084 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.659 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -147.57 164.24 34.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.673 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 77.0 m -86.13 112.79 21.63 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -161.34 166.74 27.03 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.146 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.647 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -85.83 149.48 25.21 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.46 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.597 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -67.67 137.37 55.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.835 0.35 . . . . 0.0 110.686 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.757 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -66.04 -24.0 66.65 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.4 p90 -86.98 -36.8 18.07 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.0 m -151.82 142.89 23.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -79.02 40.91 0.42 Allowed 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.06 -0.4 . . . . 0.0 111.511 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -96.28 -38.91 9.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.853 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 3.2 mp -89.72 131.94 35.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.539 ' HD3' ' O ' ' A' ' 4' ' ' THR . 1.6 mpt_? -143.07 65.2 1.34 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 1.046 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.1 p90 -150.46 -163.27 1.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.9 m -62.17 87.29 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 O-C-N 124.063 0.852 . . . . 0.0 112.187 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.555 HG13 ' SG ' ' A' ' 59' ' ' CYS . 45.0 pt -103.06 158.27 32.1 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 32' ' ' ILE . 11.8 Cg_endo -53.9 142.52 63.59 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.243 2.629 . . . . 0.0 114.502 -177.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.893 HD13 ' HA ' ' A' ' 62' ' ' LYS . 30.5 mt -86.87 158.85 19.24 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.674 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.81 150.13 37.37 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.047 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 3.7 p-10 -117.69 176.95 4.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.674 0.273 . . . . 0.0 110.82 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.3 m -52.38 131.14 32.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.833 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.0 -14.92 61.17 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.245 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.539 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 3.9 mm-40 -106.82 158.4 17.02 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.563 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 42.5 t0 -58.75 149.49 26.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.313 -1.767 . . . . 0.0 113.067 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.77 145.96 26.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -90.81 116.44 66.43 Favored Pre-proline 0 C--N 1.317 -0.821 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.705 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HD3' ' HB2' ' A' ' 74' ' ' PHE . 15.9 Cg_endo -58.46 -42.35 56.01 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.234 2.623 . . . . 0.0 112.927 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.6 -34.71 77.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.466 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.619 ' HB3' ' HD2' ' A' ' 54' ' ' ARG . 19.9 m -72.83 119.36 16.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.307 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.438 ' HB2' ' HD2' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -69.86 144.87 52.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.48 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -63.68 -172.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.561 0.696 . . . . 0.0 111.603 -179.173 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.5 t -85.79 138.18 35.53 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.744 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.8 ' HB2' HG22 ' A' ' 11' ' ' VAL . 72.4 Cg_endo -96.79 135.13 3.9 Favored 'Cis proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.72 -1.367 . . . . 0.0 113.79 1.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.509 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 51.1 t80 -91.67 139.32 30.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.406 178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.433 ' OD1' ' HD2' ' A' ' 9' ' ' LYS . 49.0 t0 -77.03 59.02 1.6 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.861 0.838 . . . . 0.0 110.408 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 153.3 -139.43 6.9 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.83 128.77 20.68 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.619 ' HD2' ' HB3' ' A' ' 45' ' ' SER . 31.9 mtm-85 -70.14 137.1 50.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.315 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.8 58.68 5.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.851 0.834 . . . . 0.0 109.485 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.9 m -143.95 144.2 31.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.348 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.757 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 62.1 m -88.24 41.0 0.98 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.942 0.401 . . . . 0.0 111.21 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.4 tp -153.69 127.11 8.6 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.655 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.841 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.6 m -81.05 141.03 50.03 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.424 ' HD2' ' SG ' ' A' ' 18' ' ' CYS . 49.4 Cg_endo -69.36 -166.97 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.111 1.874 . . . . 0.0 111.821 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.749 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 34.6 m -69.34 137.35 52.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.705 0.288 . . . . 0.0 111.17 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.893 ' HA ' HD13 ' A' ' 34' ' ' LEU . 11.8 ptpt -66.19 148.52 51.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.87 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.6 m -45.61 122.52 3.68 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 123.487 0.492 . . . . 0.0 111.909 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.22 -32.99 5.5 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.09 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.0 mt -89.19 154.71 19.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.934 0.397 . . . . 0.0 111.816 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.0 m -121.89 131.91 54.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.225 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.749 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 9.7 t -91.9 143.17 26.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.798 0.333 . . . . 0.0 110.885 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t -141.22 159.24 42.63 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 27.5 ttpp -69.14 104.34 2.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.312 0.577 . . . . 0.0 110.941 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 10.5 t -89.67 75.96 7.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.478 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.85 -98.27 2.2 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.32 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.45 -56.86 3.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.029 0.443 . . . . 0.0 111.104 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.445 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 14.3 ptpt -98.17 -165.9 1.31 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.82 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.499 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 8.9 m-85 -109.7 133.98 52.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.148 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.563 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 21.8 mttt -132.42 146.8 52.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.535 0.683 . . . . 0.0 110.427 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 67' ' ' CYS . 73.5 m -68.32 150.44 48.21 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.745 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 C--O 1.248 0.984 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.321 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 120.748 0.309 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.33 125.58 0.95 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.329 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.076 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -84.18 -8.81 58.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.713 0.292 . . . . 0.0 111.457 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.6 p -148.32 145.96 28.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.762 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.3 -48.38 5.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.242 0.544 . . . . 0.0 109.58 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -102.97 139.54 38.41 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.778 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -55.25 -25.7 35.22 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.76 0.662 . . . . 0.0 111.429 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.427 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 22.0 t -54.16 -31.7 22.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.957 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -67.8 -28.02 67.24 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.3 m -89.58 138.92 31.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.074 0.464 . . . . 0.0 111.458 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.7 164.07 50.26 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.723 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.7 m -57.39 97.83 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.4 0.619 . . . . 0.0 110.763 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 153.64 -24.74 0.74 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.553 ' O ' HG11 ' A' ' 48' ' ' VAL . 25.7 p -137.39 155.24 49.6 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.17 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.786 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -139.09 167.24 22.5 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.1 m -89.3 49.49 1.77 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.965 0.412 . . . . 0.0 111.869 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.621 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -83.98 150.62 25.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.211 0.529 . . . . 0.0 111.101 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -86.6 142.3 28.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.525 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.517 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -61.42 126.05 25.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.981 0.42 . . . . 0.0 110.613 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.45 -21.61 65.57 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -86.99 -32.82 19.85 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.896 -0.321 . . . . 0.0 111.309 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.1 m -151.65 130.69 12.61 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -76.21 56.96 1.08 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.282 0.563 . . . . 0.0 111.189 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -118.5 -43.34 2.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.501 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 3.0 mp -88.97 128.16 41.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.313 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -152.07 58.65 0.85 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.763 0.792 . . . . 0.0 109.816 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 1.076 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.2 p90 -126.96 -170.95 2.3 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.533 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.7 m -60.43 79.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.061 0.85 . . . . 0.0 112.947 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.621 HD11 ' HB3' ' A' ' 20' ' ' ALA . 40.9 pt -95.83 151.93 38.71 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.05 148.54 38.89 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.331 2.687 . . . . 0.0 114.507 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.786 HD21 ' HB3' ' A' ' 18' ' ' CYS . 92.5 mt -86.93 171.05 11.09 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.509 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.64 145.29 32.58 Favored Glycine 0 C--O 1.241 0.553 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.88 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -88.79 -177.27 5.48 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.189 0.596 . . . . 0.0 110.948 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -61.72 132.33 52.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.036 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.519 ' O ' ' HD3' ' A' ' 75' ' ' LYS . . . 81.94 -3.97 77.54 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.259 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.543 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -88.91 157.32 18.46 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 117.448 0.624 . . . . 0.0 112.039 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.634 ' HB3' HD21 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -60.89 144.43 52.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.733 -178.312 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.4 p -150.53 145.36 25.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.535 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.527 ' HB2' ' OG ' ' A' ' 45' ' ' SER . 56.7 m170 -89.51 128.92 49.04 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.02 -39.61 90.07 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.918 2.412 . . . . 0.0 112.962 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.83 97.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.464 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.713 ' HB2' ' HG3' ' A' ' 60' ' ' PRO . 10.8 p -76.98 132.6 39.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -109.13 -160.93 0.74 Allowed 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.301 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.51 146.19 42.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.032 0.444 . . . . 0.0 111.382 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.553 HG11 ' O ' ' A' ' 17' ' ' THR . 40.8 t -88.34 143.38 32.44 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.847 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.551 ' HA ' ' CG1' ' A' ' 48' ' ' VAL . 16.4 Cg_exo -69.04 124.51 7.32 Favored 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 124.128 -1.197 . . . . 0.0 113.717 0.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.434 ' N ' ' HA ' ' A' ' 48' ' ' VAL . 79.9 t80 -89.06 133.4 34.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.761 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.22 111.46 10.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.036 0.446 . . . . 0.0 109.84 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 122.83 -157.86 17.42 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.582 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -152.68 132.83 13.5 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -130.01 153.41 48.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.898 0.38 . . . . 0.0 111.03 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.51 45.02 0.98 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.217 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.0 m -89.52 138.42 31.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.978 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 20.4 m -89.98 30.3 1.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.32 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.634 HD21 ' HB3' ' A' ' 40' ' ' ASP . 60.9 tp -153.55 125.35 7.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.756 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.764 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -76.38 141.29 69.72 Favored Pre-proline 0 C--N 1.327 -0.377 0 O-C-N 123.26 0.35 . . . . 0.0 110.423 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.713 ' HG3' ' HB2' ' A' ' 45' ' ' SER . 6.5 Cg_exo -70.93 -167.22 0.26 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.515 2.143 . . . . 0.0 112.329 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 61.5 m -70.55 138.86 51.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.045 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 15.5 ptpt -76.4 -179.15 4.97 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.563 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.7 m -52.91 131.28 35.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.839 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.25 -31.03 6.61 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.913 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 61' ' ' CYS . 3.6 mm? -88.9 144.86 25.91 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.373 0.606 . . . . 0.0 112.302 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.3 m -121.97 132.59 54.61 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.295 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.9 t -76.56 130.61 38.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.209 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t -149.77 159.83 44.04 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.478 ' NZ ' ' HA ' ' A' ' 72' ' ' GLU . 47.0 tttm -71.8 104.01 3.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.298 0.571 . . . . 0.0 110.043 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 t -92.59 80.87 4.79 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.57 -101.88 2.5 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.505 ' HA ' ' OE1' ' A' ' 72' ' ' GLU . 36.5 tp10 -98.15 -50.88 4.2 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.531 -0.468 . . . . 0.0 112.006 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.53 -174.55 3.52 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.513 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -104.53 133.46 49.35 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.045 0.45 . . . . 0.0 110.897 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 47.8 mttm -141.42 155.78 45.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.94 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 67.5 m -69.15 140.42 54.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.284 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 C--O 1.244 0.771 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.191 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 120.591 0.234 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.68 130.75 1.85 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.0 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.511 ' HB3' ' HA ' ' A' ' 30' ' ' PHE . . . -90.48 -23.7 20.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.947 0.403 . . . . 0.0 110.658 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.57 -142.93 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.069 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -164.16 -45.14 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.2 0.524 . . . . 0.0 110.857 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -109.33 135.41 50.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.78 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.598 ' HB3' HG23 ' A' ' 48' ' ' VAL . 56.7 m-20 -46.28 -38.28 8.42 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.019 0.824 . . . . 0.0 112.09 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.7 t -48.15 -35.09 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.565 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -68.34 -33.2 73.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.444 ' HB3' ' OG1' ' A' ' 17' ' ' THR . 37.8 m -93.45 -31.91 14.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.201 0.524 . . . . 0.0 111.946 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.0 159.63 34.3 Favored Glycine 0 C--N 1.314 -0.641 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.409 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -61.1 80.5 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.496 0.665 . . . . 0.0 111.835 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 177.67 -33.55 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 13' ' ' CYS . 7.5 p -137.21 147.33 45.77 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.531 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -130.59 159.11 38.15 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.08 -178.448 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.4 m -89.54 46.37 1.36 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.581 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.42 159.38 18.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.913 0.387 . . . . 0.0 110.946 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.754 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -78.57 131.63 36.83 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.477 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 89.6 p -61.64 139.38 58.29 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.621 -178.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.1 -24.68 63.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.294 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -87.98 -27.25 22.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.684 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.601 ' HB3' HD13 ' A' ' 28' ' ' ILE . 8.6 t -151.24 126.62 10.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.148 0.499 . . . . 0.0 111.042 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -73.23 4.72 4.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.392 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -88.91 -19.55 25.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.029 0.443 . . . . 0.0 110.479 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.754 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.5 mp -87.98 120.13 36.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 45.0 mtp85 -141.59 42.52 1.73 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 123.761 0.663 . . . . 0.0 109.454 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.691 ' CD2' HG23 ' A' ' 28' ' ' ILE . 1.3 m-85 -97.67 -175.07 3.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 99.8 m -72.62 80.43 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.416 0.448 . . . . 0.0 110.237 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.601 HG13 ' SG ' ' A' ' 59' ' ' CYS . 39.3 pt -89.03 148.42 41.01 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.3 156.15 26.84 Favored 'Trans proline' 0 N--CA 1.473 0.29 0 C-N-CA 123.329 2.686 . . . . 0.0 114.3 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.679 HD23 ' HA ' ' A' ' 62' ' ' LYS . 4.1 mp -86.94 165.48 15.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.413 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.77 134.11 37.81 Favored Glycine 0 C--O 1.24 0.529 0 CA-C-N 115.143 -0.935 . . . . 0.0 113.028 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 2.7 p30 -95.06 -179.72 4.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.285 0.564 . . . . 0.0 111.304 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -61.39 122.72 15.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.904 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.06 4.13 90.07 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.238 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -88.56 148.42 24.11 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 117.29 0.545 . . . . 0.0 109.664 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.28 138.4 55.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.424 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.2 p -136.8 153.34 50.84 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.076 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -89.76 122.57 67.91 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -57.42 -40.2 83.24 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.897 2.398 . . . . 0.0 112.602 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.6 -36.76 81.45 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.23 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.9 m -66.27 113.13 4.36 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.221 0.534 . . . . 0.0 110.385 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -70.98 153.94 42.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.76 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 60' ' ' PRO . 57.5 mtpt -65.36 176.06 1.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.216 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.598 HG23 ' HB3' ' A' ' 10' ' ' ASP . 10.0 p -88.62 139.7 29.7 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.029 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HA ' HG23 ' A' ' 48' ' ' VAL . 89.5 Cg_endo -89.04 134.2 11.41 Favored 'Cis proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.768 -1.347 . . . . 0.0 113.055 0.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.612 ' HB2' ' NH2' ' A' ' 54' ' ' ARG . 66.1 t80 -75.29 130.82 39.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.124 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -87.65 130.01 34.94 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.66 -113.6 3.83 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.863 ' HD3' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -150.53 126.88 10.69 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.473 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.612 ' NH2' ' HB2' ' A' ' 50' ' ' TYR . 60.5 ttm-85 -85.84 102.24 13.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.157 0.504 . . . . 0.0 111.771 -177.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.863 HD23 ' HD3' ' A' ' 53' ' ' LYS . 1.3 mm? -105.33 27.04 8.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.423 0.63 . . . . 0.0 109.925 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.8 m -89.7 148.46 23.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.944 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 4.3 m -88.93 21.83 2.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.829 0.347 . . . . 0.0 111.493 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.37 136.13 14.45 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.601 ' SG ' HG13 ' A' ' 32' ' ' ILE . 1.8 m -75.54 153.04 85.59 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.499 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 64.6 Cg_endo -72.52 174.06 12.25 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.115 1.877 . . . . 0.0 110.995 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.3 m -68.66 139.29 55.45 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.557 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.679 ' HA ' HD23 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -58.4 154.1 14.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.827 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.5 m -44.59 129.17 6.82 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.611 0.569 . . . . 0.0 111.226 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.61 -38.28 3.28 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.954 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.1 mt -88.84 154.93 19.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.883 0.373 . . . . 0.0 111.618 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.0 m -135.8 139.48 43.52 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.866 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 23.2 t -72.26 128.73 36.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.763 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.7 t -150.04 156.94 42.58 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 31.9 ttpt -73.19 110.08 7.21 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.301 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.466 ' HB3' ' HD2' ' A' ' 75' ' ' LYS . 10.5 t -93.24 63.04 3.56 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.372 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.76 -93.56 1.49 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.052 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.499 ' OE2' ' HG3' ' A' ' 73' ' ' LYS . 2.0 tt0 -88.33 -54.49 4.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.477 -0.362 . . . . 0.0 111.042 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 34.7 mtmm -112.91 177.99 4.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.13 0.491 . . . . 0.0 111.58 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 8.5 m-85 -89.21 133.95 34.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.268 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.466 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 56.4 mttm -136.66 154.55 50.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.719 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 95.6 m -75.54 128.43 35.28 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.953 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.252 1.236 0 CA-C-O 117.531 -1.223 . . . . 0.0 109.152 179.934 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 120.944 0.402 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.91 123.96 1.15 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.07 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.087 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.25 -13.29 35.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.814 0.34 . . . . 0.0 111.107 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 30' ' ' PHE . 17.3 p -151.19 -152.03 0.42 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.87 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -163.59 -43.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.441 0.639 . . . . 0.0 109.362 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -106.59 133.29 51.5 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.592 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -52.73 -31.16 36.49 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.557 0.536 . . . . 0.0 111.184 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.8 t -51.61 -32.05 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.407 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -70.68 -32.73 70.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.126 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.4 m -95.23 -46.32 6.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.209 0.528 . . . . 0.0 112.228 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.89 153.19 9.57 Favored Glycine 0 C--N 1.31 -0.886 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.714 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.453 ' HA ' HG11 ' A' ' 48' ' ' VAL . 16.2 m -57.13 98.23 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.546 0.689 . . . . 0.0 110.776 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.509 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . 161.08 -31.43 0.35 Allowed Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.428 HG22 ' HA ' ' A' ' 33' ' ' PRO . 22.8 p -135.14 139.0 44.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.824 -0.688 . . . . 0.0 109.334 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -111.34 156.66 21.22 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.0 m -97.23 45.83 1.04 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.399 . . . . 0.0 111.369 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -84.79 178.38 7.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.117 0.484 . . . . 0.0 111.469 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.82 142.21 28.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.378 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.675 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -60.69 139.65 57.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.148 0.499 . . . . 0.0 111.649 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.751 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -64.17 -26.17 68.4 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -86.25 -42.37 13.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.899 0.38 . . . . 0.0 111.609 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.1 m -151.96 136.79 17.15 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.408 ' NH2' ' HB3' ' A' ' 55' ' ' LEU . 99.3 mtt180 -74.86 51.7 0.5 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -101.89 -35.38 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.841 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.675 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 53.1 mt -88.8 131.11 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.279 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 6.2 mtp180 -150.16 49.19 0.91 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.912 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 1.087 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.4 p90 -128.51 -168.86 1.97 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.582 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 33.1 m -59.21 82.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.222 0.952 . . . . 0.0 112.44 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.613 HG13 ' SG ' ' A' ' 59' ' ' CYS . 23.8 pt -104.27 143.79 27.38 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.428 ' HA ' HG22 ' A' ' 17' ' ' THR . 13.6 Cg_endo -56.57 159.22 14.11 Favored 'Trans proline' 0 CA--C 1.529 0.225 0 C-N-CA 123.197 2.598 . . . . 0.0 114.112 -177.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 95.1 mt -84.86 167.91 15.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.174 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.09 144.73 35.23 Favored Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.714 -0.676 . . . . 0.0 113.726 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.566 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 0.1 OUTLIER -118.07 -167.21 1.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.062 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.448 ' OG ' HD11 ' A' ' 65' ' ' LEU . 6.1 m -59.21 125.26 22.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.789 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.59 0.14 82.26 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.28 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -88.0 148.38 24.57 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 117.068 0.434 . . . . 0.0 110.541 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.534 ' O ' HD13 ' A' ' 58' ' ' LEU . 12.3 t70 -68.05 145.61 54.29 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.984 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.4 p -150.14 143.83 25.31 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' A' ' 44' ' ' ALA . 48.0 m80 -88.32 139.75 30.26 Favored Pre-proline 0 C--N 1.319 -0.747 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.862 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.73 38.03 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.196 2.597 . . . . 0.0 113.106 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 42' ' ' HIS . . . -172.57 33.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.384 0.674 . . . . 0.0 109.266 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -80.71 133.23 35.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.433 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.493 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 19.8 m170 -80.66 146.85 30.92 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -67.57 166.34 15.11 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.453 HG11 ' HA ' ' A' ' 15' ' ' SER . 58.8 t -86.33 136.99 34.88 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.435 ' HA ' HG13 ' A' ' 48' ' ' VAL . 15.7 Cg_exo -69.42 128.58 12.44 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 123.898 -1.293 . . . . 0.0 114.061 1.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 71.9 t80 -71.48 154.61 41.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.506 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.521 ' OD2' ' HG3' ' A' ' 53' ' ' LYS . 5.3 p-10 -56.33 -33.2 65.39 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.698 0.285 . . . . 0.0 111.528 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.38 34.09 67.45 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.248 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.521 ' HG3' ' OD2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -129.36 -22.76 3.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -75.24 150.6 38.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.067 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.446 ' N ' ' HD3' ' A' ' 54' ' ' ARG . 3.7 mm? -85.46 56.66 4.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.2 0.524 . . . . 0.0 111.565 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 51.3 m -89.31 128.5 35.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.27 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.751 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 15.2 m -89.67 26.61 1.71 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 40' ' ' ASP . 1.6 pp -153.97 172.16 17.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.073 0.463 . . . . 0.0 110.921 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.613 ' SG ' HG13 ' A' ' 32' ' ' ILE . 37.1 m -106.23 143.2 26.47 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.012 178.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.437 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 32.4 Cg_exo -57.14 159.52 15.08 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.539 2.159 . . . . 0.0 111.721 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 32.5 m -59.22 134.09 56.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.269 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.615 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 15.4 ptpt -70.38 163.31 26.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.251 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.0 m -47.62 124.69 7.41 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.397 0.435 . . . . 0.0 111.367 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.18 -30.07 10.56 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.11 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 36' ' ' ASN . 4.0 mm? -88.48 136.55 32.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.792 0.33 . . . . 0.0 111.006 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.5 m -116.77 124.74 50.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.467 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.5 t -71.23 125.18 26.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.7 t -150.3 158.06 43.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.836 0.35 . . . . 0.0 110.125 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.611 ' HE2' ' O ' ' A' ' 71' ' ' GLY . 85.3 tttt -71.8 105.92 3.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.257 0.551 . . . . 0.0 110.739 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 15.1 m -89.75 64.49 6.5 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.796 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.611 ' O ' ' HE2' ' A' ' 69' ' ' LYS . . . 96.16 -97.58 2.08 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.825 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.424 ' O ' ' HE3' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -91.83 -55.73 3.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.361 0.6 . . . . 0.0 110.085 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.788 ' HE3' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -100.09 171.07 8.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.332 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.589 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 9.1 m-85 -94.92 133.69 38.4 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.852 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.589 ' HD2' ' O ' ' A' ' 74' ' ' PHE . 14.1 mptt -135.58 157.1 47.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.605 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 82.5 m -76.21 118.53 19.03 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.576 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 C--O 1.253 1.256 0 CA-C-O 117.701 -1.143 . . . . 0.0 109.381 179.855 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.223 -0.326 0 CA-C-O 120.5 0.19 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.46 116.24 0.64 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.491 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.052 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.96 -9.5 45.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.703 -0.248 . . . . 0.0 111.375 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 30' ' ' PHE . 12.6 p -150.69 146.37 26.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.227 0.537 . . . . 0.0 111.696 -178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.06 -42.86 12.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.992 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -121.62 145.42 48.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.218 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 50' ' ' TYR . 1.6 m-20 -54.74 -27.37 40.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.223 0.535 . . . . 0.0 110.148 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.822 HG22 ' HB2' ' A' ' 49' ' ' PRO . 77.6 t -52.47 -35.01 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.057 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -72.46 -21.93 61.15 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 97.6 m -89.09 141.4 28.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.222 0.534 . . . . 0.0 111.585 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.32 157.49 52.1 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.073 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.506 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 19.9 m -54.29 112.28 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.17 0.509 . . . . 0.0 110.312 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.467 ' C ' ' HG ' ' A' ' 34' ' ' LEU . . . 136.46 -22.84 3.33 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 p -136.01 152.24 50.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.196 -0.502 . . . . 0.0 110.232 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.6 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -135.74 162.15 33.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 59.8 m -89.07 49.28 1.75 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.641 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -82.07 163.26 22.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.98 0.419 . . . . 0.0 110.631 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.694 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -83.93 145.16 28.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.619 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.651 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -58.11 130.46 46.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.945 0.403 . . . . 0.0 110.703 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.822 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -58.4 -27.06 63.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -85.5 -38.77 18.2 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.861 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m -150.83 136.1 17.72 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.139 -0.351 . . . . 0.0 110.431 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.92 55.05 0.17 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.051 0.54 . . . . 0.0 111.823 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -114.91 -38.76 3.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.966 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.694 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 1.9 mp -88.09 133.58 30.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.81 0.338 . . . . 0.0 110.401 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.2 mmm-85 -144.63 57.18 1.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.985 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 1.052 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.0 p90 -136.1 -173.28 3.35 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.171 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.5 m -59.04 84.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 O-C-N 124.295 0.997 . . . . 0.0 113.111 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.641 HD11 ' HB3' ' A' ' 20' ' ' ALA . 38.9 pt -102.0 151.01 37.94 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.32 151.7 28.41 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.365 2.71 . . . . 0.0 114.77 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.6 HD21 ' HB3' ' A' ' 18' ' ' CYS . 80.7 mt -87.52 165.35 15.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.361 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.9 145.97 39.13 Favored Glycine 0 C--O 1.241 0.541 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.594 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 1.5 t-20 -96.82 -175.92 3.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.413 0.625 . . . . 0.0 111.253 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.8 m -60.97 129.26 40.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.555 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.99 -4.64 82.4 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.865 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.17 149.12 23.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.99 0.395 . . . . 0.0 110.519 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.631 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 1.1 t70 -63.96 141.56 58.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.357 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 74' ' ' PHE . 25.0 p -141.81 139.38 32.72 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.067 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 33.2 m170 -89.12 128.41 51.8 Favored Pre-proline 0 C--N 1.318 -0.797 0 C-N-CA 120.086 -0.645 . . . . 0.0 109.653 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 0.9 OUTLIER -44.64 -49.47 9.29 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 124.17 3.246 . . . . 0.0 114.608 -177.318 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.42 31.56 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.89 0.376 . . . . 0.0 111.821 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.423 ' O ' ' HD3' ' A' ' 54' ' ' ARG . 14.5 m -90.72 -20.23 22.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.135 0.493 . . . . 0.0 110.469 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.763 ' HD2' ' HB2' ' A' ' 56' ' ' SER . 3.7 m-70 -169.36 125.89 0.9 Allowed 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.739 ' H ' ' HB2' ' A' ' 50' ' ' TYR . 9.2 mmmm -140.39 177.74 7.79 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 61.4 t -125.95 107.7 25.23 Favored Pre-proline 0 C--N 1.32 -0.7 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.224 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.822 ' HB2' HG22 ' A' ' 11' ' ' VAL . 59.0 Cg_endo -96.49 129.46 3.38 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.483 -1.049 . . . . 0.0 112.79 -0.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.739 ' HB2' ' H ' ' A' ' 47' ' ' LYS . 1.3 t80 -82.74 124.12 29.94 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -76.83 -38.4 53.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.67 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.53 -167.75 29.56 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.549 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -152.51 140.82 20.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.593 0.235 . . . . 0.0 110.569 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 45' ' ' SER . 6.9 ptm180 -167.24 159.53 12.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.1 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.75 54.04 2.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.928 0.394 . . . . 0.0 111.912 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.763 ' HB2' ' HD2' ' A' ' 46' ' ' HIS . 50.9 m -88.31 127.19 35.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.822 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 20.8 m -88.81 44.44 1.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.4 tp -153.37 126.57 8.52 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.399 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.563 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -87.47 148.04 43.34 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.107 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 46' ' ' HIS . 42.1 Cg_endo -66.96 -177.99 1.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.488 2.125 . . . . 0.0 111.715 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 81.6 m -69.81 141.33 53.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.767 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.511 ' HA ' HD12 ' A' ' 34' ' ' LEU . 9.6 ptmm? -62.35 148.64 44.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.775 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.506 ' OG ' ' HB3' ' A' ' 15' ' ' SER . 10.2 m -46.33 130.92 10.74 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 123.44 0.463 . . . . 0.0 111.274 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.41 -30.23 10.21 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.774 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.9 mt -91.4 147.56 22.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.747 0.308 . . . . 0.0 111.464 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -108.41 126.49 52.94 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.323 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.422 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 54.1 t -83.59 116.21 22.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.0 t -137.48 157.9 45.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.765 0.316 . . . . 0.0 110.185 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 84.1 tttt -69.25 105.44 2.52 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.358 0.599 . . . . 0.0 111.198 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -92.92 77.14 4.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.746 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.452 ' O ' ' HE2' ' A' ' 69' ' ' LYS . . . 87.42 -102.52 2.8 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.579 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.548 ' O ' ' HE3' ' A' ' 69' ' ' LYS . 5.2 tm-20 -91.28 -53.08 4.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.739 0.304 . . . . 0.0 110.634 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.428 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 45.2 mmtm -98.21 171.2 8.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.073 0.463 . . . . 0.0 111.241 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 6.3 m-85 -92.19 138.34 31.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.462 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.631 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 48.8 mttp -143.92 155.08 43.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.23 0.538 . . . . 0.0 110.439 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 59.8 m -70.96 135.67 48.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.942 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.3 m . . . . . 0 C--O 1.255 1.364 0 CA-C-O 117.557 -1.211 . . . . 0.0 108.888 179.548 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.99 133.58 30.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.749 0.309 . . . . 0.0 110.254 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.417 HG22 ' CE1' ' A' ' 30' ' ' PHE . 45.4 mm -94.67 115.12 32.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 t -140.18 26.51 2.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.803 0.811 . . . . 0.0 110.008 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.19 128.16 1.08 Allowed Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.878 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.722 ' HB3' ' HA ' ' A' ' 30' ' ' PHE . . . -90.57 -33.73 15.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.279 0.562 . . . . 0.0 110.158 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 5.0 p -152.0 -165.0 2.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.152 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.461 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 27.4 t70 -141.72 -40.45 0.37 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.311 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -105.61 128.41 53.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.436 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' A' ' 49' ' ' PRO . 12.9 m-20 -54.84 -24.56 23.58 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.591 0.557 . . . . 0.0 111.069 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.53 -31.42 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.834 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -69.27 -29.59 67.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.287 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.451 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 59.7 m -93.49 -119.09 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.048 0.451 . . . . 0.0 110.545 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.96 157.8 30.39 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 m -53.39 117.29 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.068 0.461 . . . . 0.0 110.481 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.22 -23.98 5.41 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.9 p -128.34 142.13 51.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.601 -0.3 . . . . 0.0 110.211 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.69 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -123.05 154.48 38.47 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.2 m -91.51 38.58 0.98 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.932 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -88.69 -173.02 3.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.766 0.317 . . . . 0.0 110.558 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.639 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.33 140.56 29.58 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.466 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 93.6 p -67.75 144.46 55.4 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.467 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.07 65.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.354 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 41.7 p90 -87.65 -32.21 19.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.477 ' HB2' HD13 ' A' ' 28' ' ' ILE . 67.4 m -149.93 127.38 11.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.401 0.619 . . . . 0.0 112.287 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.457 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -69.85 5.34 1.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.725 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -88.58 -24.68 22.8 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.323 0.582 . . . . 0.0 109.895 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.639 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.4 mp -87.38 122.89 39.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.534 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 31.9 mtp180 -140.64 46.08 1.8 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.269 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.722 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 0.3 OUTLIER -98.53 -172.91 2.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 38.3 m -71.67 78.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.664 HG13 ' SG ' ' A' ' 59' ' ' CYS . 17.0 pt -88.75 142.7 30.9 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.739 0.304 . . . . 0.0 110.583 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.79 150.33 71.81 Favored 'Trans proline' 0 N--CA 1.475 0.409 0 C-N-CA 123.413 2.742 . . . . 0.0 114.834 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.69 HD11 ' HB3' ' A' ' 18' ' ' CYS . 8.1 mp -87.11 167.3 14.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.164 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.98 141.2 32.52 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.882 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 68.9 m-80 -102.46 -168.13 1.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.856 0.36 . . . . 0.0 110.893 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 m -62.2 125.59 24.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.056 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.18 1.68 86.24 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.569 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 20.8 mm-40 -88.92 150.44 22.85 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.853 0.359 . . . . 0.0 110.748 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.501 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -73.64 139.39 45.42 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.371 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.9 p -138.4 148.44 44.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.275 0.56 . . . . 0.0 110.388 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -89.25 122.63 68.45 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.76 -31.56 95.28 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.825 2.35 . . . . 0.0 111.929 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.447 ' HB1' HH22 ' A' ' 54' ' ' ARG . . . -70.83 -22.3 62.34 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.641 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.48 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 46.7 m -79.9 125.79 30.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.907 0.384 . . . . 0.0 110.219 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.412 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 34.9 m170 -86.41 168.92 13.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.477 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -57.83 149.0 23.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 49' ' ' PRO . 42.7 t -87.71 136.65 32.53 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.057 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HA ' HG13 ' A' ' 48' ' ' VAL . 15.9 Cg_exo -69.31 136.98 40.51 Favored 'Cis proline' 0 C--N 1.35 0.623 0 C-N-CA 123.871 -1.304 . . . . 0.0 112.819 0.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 53.9 t80 -63.72 127.96 33.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.866 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.16 58.03 1.95 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.373 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 158.92 -143.05 8.85 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.026 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -136.19 136.72 40.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.451 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 1.7 tpt180 -157.85 126.62 5.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.0 mp -89.1 52.89 2.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.337 0.589 . . . . 0.0 110.764 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.449 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 54.7 m -88.82 138.64 31.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.399 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 13.4 m -89.92 32.35 0.91 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.457 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.6 tp -154.62 127.81 8.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.985 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.664 ' SG ' HG13 ' A' ' 32' ' ' ILE . 54.8 m -74.97 145.03 80.5 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 17.0 Cg_exo -67.59 -168.34 0.18 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.496 2.131 . . . . 0.0 111.704 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 81.5 m -72.17 140.46 48.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.651 0.262 . . . . 0.0 111.04 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.452 ' HG3' HD12 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -63.97 152.89 38.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.073 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.9 m -49.28 123.95 8.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.51 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.05 -32.4 6.73 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.261 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.452 HD12 ' HG3' ' A' ' 62' ' ' LYS . 28.3 mt -89.8 151.39 21.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.068 0.461 . . . . 0.0 112.147 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -111.63 134.45 53.2 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.388 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.501 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 46.2 t -88.45 120.07 29.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.6 t -150.44 155.86 40.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 32.8 ttpt -61.63 114.38 3.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.08 0.467 . . . . 0.0 110.015 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 14.7 m -123.74 50.15 1.65 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.296 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.1 -112.29 0.84 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.66 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.859 ' HG2' ' HG3' ' A' ' 73' ' ' LYS . 2.7 pm0 -86.68 -37.63 17.79 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.29 0.567 . . . . 0.0 109.912 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.859 ' HG3' ' HG2' ' A' ' 72' ' ' GLU . 9.8 mtmp? -131.31 -165.02 1.51 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.987 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 3.5 m-85 -89.67 139.45 30.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.672 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.54 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 51.0 mttp -137.9 154.92 49.39 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 63.2 m -78.94 134.41 36.85 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.72 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.0 m . . . . . 0 C--O 1.245 0.835 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.354 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p -150.63 141.33 16.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.3 mm -89.14 65.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.099 0.476 . . . . 0.0 111.293 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.8 t -150.7 31.76 0.64 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.744 0.783 . . . . 0.0 109.919 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.85 97.66 0.68 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.375 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.048 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -78.0 -12.31 59.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.836 0.35 . . . . 0.0 111.573 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 p -150.83 152.12 33.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.928 0.394 . . . . 0.0 111.524 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.451 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 7.6 t70 -106.23 -50.2 3.21 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -89.66 130.34 35.96 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.521 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 34.4 t70 -55.51 -28.46 54.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.619 0.724 . . . . 0.0 110.081 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.613 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 42.9 t -54.79 -29.35 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.24 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -65.59 -26.71 67.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.463 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 76.7 m -89.95 132.5 35.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.128 0.49 . . . . 0.0 111.175 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.37 158.78 53.42 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.911 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.1 m -52.95 107.92 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.307 0.575 . . . . 0.0 110.995 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.06 -30.88 2.0 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 35.5 p -132.35 149.25 52.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.291 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.859 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -136.03 162.81 31.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.861 0.3 . . . . 0.0 110.807 -178.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.521 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 65.3 m -87.82 85.99 7.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.043 0.449 . . . . 0.0 110.031 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.551 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -130.97 157.45 42.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.562 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -85.81 144.34 27.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.295 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.717 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -65.58 140.89 58.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.035 0.445 . . . . 0.0 111.003 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -66.81 -24.67 66.2 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -87.06 -36.08 18.36 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.1 m -151.53 138.93 19.44 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -80.31 35.29 0.33 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.919 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -89.86 -38.47 13.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.266 0.555 . . . . 0.0 109.885 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.717 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.4 mp -88.33 126.77 41.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.451 ' NH2' ' HA ' ' A' ' 8' ' ' ASP . 0.8 OUTLIER -150.93 57.17 0.91 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 1.048 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.6 p90 -138.69 -169.32 2.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.234 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.8 m -58.47 98.16 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 O-C-N 124.028 0.83 . . . . 0.0 112.236 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.616 HG13 ' SG ' ' A' ' 59' ' ' CYS . 33.1 pt -116.68 149.48 43.98 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.74 144.63 53.19 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.629 2.886 . . . . 0.0 115.434 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.859 HD11 ' HB3' ' A' ' 18' ' ' CYS . 7.4 mp -88.11 173.85 8.59 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.915 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.01 143.54 23.2 Favored Glycine 0 C--O 1.239 0.429 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.771 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.562 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 71.4 m-80 -99.65 -169.77 1.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.909 0.385 . . . . 0.0 111.057 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.7 m -61.0 128.06 34.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.101 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.26 8.77 85.65 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.834 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 2.2 mm-40 -88.89 161.64 16.57 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.807 0.337 . . . . 0.0 110.972 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -71.3 137.36 48.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.909 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.83 142.56 28.96 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -89.95 124.23 64.09 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -56.36 -39.95 87.91 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.794 2.33 . . . . 0.0 112.147 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.56 -38.98 77.65 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.373 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.4 m -66.29 101.37 0.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.325 0.583 . . . . 0.0 109.954 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 34.4 m80 -68.6 148.27 50.73 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.053 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 63' ' ' SER . 52.0 tttm -54.15 163.72 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.493 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.511 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 44.5 t -85.01 143.08 39.35 Favored Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.629 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.613 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 18.9 Cg_endo -91.99 129.85 6.53 Favored 'Cis proline' 0 N--CA 1.461 -0.415 0 C-N-CA 124.013 -1.245 . . . . 0.0 114.495 1.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.518 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 20.4 t80 -87.15 128.57 35.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.838 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -82.69 61.56 5.85 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.463 -0.773 . . . . 0.0 110.789 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.13 176.62 44.48 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.459 ' HD2' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -89.81 126.05 35.54 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.408 HH12 ' CG ' ' A' ' 10' ' ' ASP . 22.6 ttm105 -75.19 120.24 20.42 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.3 -2.19 58.44 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.223 0.535 . . . . 0.0 110.594 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.4 m -87.31 142.73 27.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.579 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 30.2 m -88.0 34.76 0.73 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.901 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.7 tp -154.31 130.73 10.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.709 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.616 ' SG ' HG13 ' A' ' 32' ' ' ILE . 9.8 m -76.06 148.79 81.83 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -72.92 -166.15 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.425 2.083 . . . . 0.0 111.792 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 72.2 m -76.46 140.59 41.32 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.335 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.587 ' HA ' HD23 ' A' ' 34' ' ' LEU . 11.1 ptmm? -60.88 148.17 40.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.997 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.527 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 68.1 m -51.04 131.77 27.26 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.142 0.496 . . . . 0.0 110.551 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.95 -28.68 10.18 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 mt -102.51 150.58 23.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.359 -0.42 . . . . 0.0 110.871 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.9 m -118.92 131.64 56.05 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.23 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 52.5 t -78.14 125.67 29.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.889 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.8 t -150.52 155.99 40.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 80.7 tttt -65.79 123.17 19.04 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.989 0.423 . . . . 0.0 110.266 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 15.6 m -128.0 41.6 3.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.255 0.55 . . . . 0.0 110.24 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 144.97 -112.72 0.67 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.03 -45.65 10.0 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.104 0.478 . . . . 0.0 109.748 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -110.98 -158.64 0.65 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.162 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 5.4 m-85 -107.38 137.24 45.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.81 0.338 . . . . 0.0 110.949 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 5.5 mptp? -126.83 159.44 33.87 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 70.1 m -81.17 131.99 35.33 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.824 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.244 0.783 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.842 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.55 137.86 13.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.8 mm -89.18 103.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.968 0.413 . . . . 0.0 110.303 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.0 t -151.93 -38.33 0.12 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.039 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.82 124.77 0.76 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.009 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.094 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.88 -13.22 34.06 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.0 p -150.97 -159.92 1.1 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.784 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -153.15 -53.31 0.11 Allowed 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 52' ' ' GLY . 29.9 mmtp -89.83 132.97 34.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 50' ' ' TYR . 45.1 m-20 -53.86 -30.66 46.67 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.551 0.532 . . . . 0.0 110.622 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.1 t -54.94 -31.47 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.794 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -67.26 -27.78 67.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.407 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 75.4 m -89.67 138.51 31.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.019 0.437 . . . . 0.0 111.171 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.99 154.15 52.82 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.056 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 m -49.49 108.66 0.21 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.033 0.49 . . . . 0.0 110.755 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.22 -18.37 4.21 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.304 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.5 p -135.11 161.46 35.26 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.385 0.274 . . . . 0.0 110.934 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.802 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -145.87 167.63 22.77 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.031 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.1 m -88.91 58.63 4.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.02 0.438 . . . . 0.0 111.268 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.839 ' HA ' ' HB2' ' A' ' 54' ' ' ARG . . . -90.08 152.81 20.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.26 0.552 . . . . 0.0 111.871 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -82.91 147.69 28.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.833 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.541 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -63.22 137.76 58.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.028 0.442 . . . . 0.0 111.092 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.622 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -67.09 -22.99 65.8 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -87.38 -40.03 14.78 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.89 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.0 m -152.32 148.42 27.5 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -78.09 48.36 0.73 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.936 0.398 . . . . 0.0 111.522 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -98.27 -43.14 7.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.417 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.8 mp -88.18 131.87 34.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.818 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -148.6 55.67 1.02 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 1.094 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.4 p90 -138.43 -173.8 3.64 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.2 m -57.6 98.31 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.915 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.782 HD11 ' HB3' ' A' ' 20' ' ' ALA . 44.8 pt -119.13 155.59 53.22 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 32' ' ' ILE . 10.1 Cg_endo -52.0 143.59 39.88 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.409 2.739 . . . . 0.0 115.152 -177.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.844 HD23 ' HB3' ' A' ' 59' ' ' CYS . 70.0 mt -87.19 159.74 18.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.689 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -52.98 141.53 29.11 Favored Glycine 0 C--O 1.242 0.614 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.268 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.643 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 66.1 m-20 -95.65 176.37 6.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.322 -0.439 . . . . 0.0 110.997 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.5 m -64.38 128.11 34.38 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.17 5.52 90.02 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.357 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.528 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 3.2 mm-40 -92.56 152.81 19.42 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.833 0.349 . . . . 0.0 111.497 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -68.72 145.1 54.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.426 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.45 179.0 7.05 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 37.7 m170 -116.12 122.75 31.82 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 3.7 Cg_endo -47.9 -44.12 28.03 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.425 2.75 . . . . 0.0 113.407 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.94 80.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.281 0.563 . . . . 0.0 110.984 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.528 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 19.6 m -78.17 83.15 4.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.172 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.412 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 44.4 m80 -61.59 146.47 48.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.957 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.8 143.21 10.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.796 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' A' ' 49' ' ' PRO . 99.7 t -87.93 144.3 34.56 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.938 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.585 ' HA ' HG13 ' A' ' 48' ' ' VAL . 34.4 Cg_exo -62.53 142.45 40.82 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 124.634 -0.986 . . . . 0.0 114.144 1.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 87.8 t80 -166.36 137.59 3.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.621 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -84.66 113.82 21.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.687 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' LYS . . . 169.7 -174.2 43.95 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.225 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.86 142.58 49.01 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.839 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . 3.6 mmp_? -86.67 110.53 19.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.247 0.546 . . . . 0.0 112.076 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.42 -21.94 23.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.6 m -88.7 153.82 20.79 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.27 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.622 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 43.6 m -87.69 46.04 1.34 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.044 0.45 . . . . 0.0 111.044 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.6 tp -153.08 127.0 8.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.078 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.844 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.6 m -77.86 141.58 64.02 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.262 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.528 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 20.4 Cg_exo -65.57 -178.31 0.9 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.677 2.251 . . . . 0.0 111.499 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 72.7 m -62.4 140.43 58.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.313 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -64.11 155.56 31.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.073 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.4 m -51.78 127.4 20.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.211 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.72 -30.48 9.06 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.695 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.633 HD12 ' HG2' ' A' ' 62' ' ' LYS . 26.3 mt -88.98 145.77 25.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.109 0.481 . . . . 0.0 112.081 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.2 m -119.85 125.02 47.5 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.791 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 4.4 t -81.82 135.55 35.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.858 0.361 . . . . 0.0 111.242 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.4 m -137.53 148.33 45.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.438 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 72' ' ' GLU . 16.0 ttmt -64.54 114.26 4.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.471 0.653 . . . . 0.0 110.962 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.505 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 11.1 m -97.75 83.37 3.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.985 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.07 -62.47 4.17 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.486 ' HA ' ' OE1' ' A' ' 72' ' ' GLU . 35.6 tp10 -150.11 -43.67 0.13 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.928 0.394 . . . . 0.0 109.957 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -87.79 153.68 21.15 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.58 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 11.8 m-85 -89.39 129.57 35.89 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.89 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 45.8 mttm -125.81 150.28 47.94 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.137 0.494 . . . . 0.0 110.027 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 67' ' ' CYS . 59.2 m -75.03 141.33 43.9 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.125 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.253 1.241 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.214 179.6 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.13 135.87 24.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.861 0.363 . . . . 0.0 110.217 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.9 mm -88.59 81.93 2.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.215 0.531 . . . . 0.0 110.467 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.2 t -150.08 29.26 0.73 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.673 0.749 . . . . 0.0 110.105 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . 167.91 69.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.142 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.85 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -71.3 -17.33 62.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.7 p -150.06 144.99 26.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.826 0.345 . . . . 0.0 111.192 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.574 ' O ' ' HD2' ' A' ' 53' ' ' LYS . 11.6 t70 -86.91 -47.7 8.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.672 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 36.7 mttm -117.88 146.41 43.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.573 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.607 ' OD1' ' HA ' ' A' ' 53' ' ' LYS . 1.8 m-20 -51.24 -28.17 10.98 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.873 0.733 . . . . 0.0 111.529 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.854 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 22.0 t -55.25 -31.17 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.763 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.459 HE22 ' HB3' ' A' ' 8' ' ' ASP . 54.5 mt-30 -69.94 -17.98 63.34 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.1 m -89.42 -139.61 0.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.7 -141.84 4.77 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 119.395 -1.383 . . . . 0.0 113.777 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m -50.68 115.71 1.61 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.913 -0.644 . . . . 0.0 112.646 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 33' ' ' PRO . . . 60.45 31.45 74.36 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 114.928 -1.033 . . . . 0.0 114.907 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.565 ' O ' HG11 ' A' ' 48' ' ' VAL . 6.0 p -148.57 143.06 26.36 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.149 0.974 . . . . 0.0 111.685 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.743 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -142.43 167.67 21.55 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.016 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.2 m -89.67 45.19 1.26 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.61 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -79.81 159.87 26.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.405 0.621 . . . . 0.0 111.407 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -88.27 152.68 21.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.945 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.641 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -63.33 136.5 57.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.048 0.452 . . . . 0.0 110.694 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.704 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -66.91 -22.43 65.96 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -86.99 -37.36 17.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.895 0.379 . . . . 0.0 111.674 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.0 m -152.01 145.92 25.18 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -80.14 38.84 0.42 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.47 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -89.93 -41.66 11.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.511 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.641 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.0 mp -87.35 130.76 36.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.572 ' O ' ' HA2' ' A' ' 5' ' ' GLY . 88.4 mtm180 -148.44 65.63 1.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.86 0.725 . . . . 0.0 109.304 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.85 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.4 p90 -150.84 -170.6 3.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.816 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 94.6 m -58.76 102.8 0.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.804 0.69 . . . . 0.0 112.539 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.61 HD11 ' HB3' ' A' ' 20' ' ' ALA . 47.1 pt -123.85 157.62 62.57 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 14.4 Cg_endo -56.0 147.7 62.13 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.235 2.623 . . . . 0.0 115.061 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.808 HD23 ' HB3' ' A' ' 59' ' ' CYS . 78.5 mt -87.15 160.43 18.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.501 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.74 144.76 45.85 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 114.156 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.455 ' H ' ' CD ' ' A' ' 39' ' ' GLU . 35.1 m-80 -99.69 159.89 14.71 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.34 0.656 . . . . 0.0 110.685 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.2 m -56.39 128.58 36.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.883 0.373 . . . . 0.0 110.437 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.5 -21.69 36.31 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.966 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 36' ' ' ASN . 7.2 pt-20 -96.44 155.34 16.81 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 117.561 0.68 . . . . 0.0 110.648 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.71 145.32 49.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.998 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.2 p -144.7 156.13 43.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.079 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -90.61 126.9 54.54 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.93 -34.67 99.21 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.708 2.272 . . . . 0.0 112.387 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.93 98.95 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.543 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.637 ' HB2' ' HB3' ' A' ' 60' ' ' PRO . 3.4 p -74.31 133.39 42.58 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -112.88 -150.31 0.46 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.947 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.623 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -70.02 155.19 40.95 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -179.318 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.595 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 92.0 t -111.99 137.77 21.49 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.114 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.854 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 37.9 Cg_exo -59.13 126.26 2.5 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 124.193 -1.17 . . . . 0.0 113.383 1.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.588 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 57.2 t80 -75.16 146.65 41.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.732 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.51 56.31 0.67 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.266 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.15 -136.54 6.38 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.667 ' HE3' HD21 ' A' ' 55' ' ' LEU . 29.7 pttt -150.38 138.24 20.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.731 0.3 . . . . 0.0 110.256 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.437 ' HA ' ' HD3' ' A' ' 54' ' ' ARG . 29.9 mmt180 -114.87 115.3 26.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.059 0.457 . . . . 0.0 111.224 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.667 HD21 ' HE3' ' A' ' 53' ' ' LYS . 3.1 mm? -89.23 32.75 0.82 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.931 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 p -89.2 157.38 18.28 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.703 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.704 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 68.0 m -88.02 30.21 0.87 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.044 0.45 . . . . 0.0 111.595 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.9 tp -154.5 123.65 6.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.382 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.808 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -73.94 146.75 85.51 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.637 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 57.0 Cg_endo -70.16 -173.31 0.75 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.843 1.695 . . . . 0.0 111.339 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . 80.0 m -67.69 142.35 56.37 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.995 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . 46.8 mtpt -55.24 145.41 21.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.182 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.8 m -47.16 117.39 1.71 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.427 0.454 . . . . 0.0 110.966 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.26 -27.53 8.93 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.496 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 61' ' ' CYS . 56.2 mt -88.3 156.64 19.07 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.781 0.324 . . . . 0.0 111.04 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.7 m -123.15 130.57 52.94 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.496 -0.482 . . . . 0.0 112.163 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 35.6 t -78.06 119.23 21.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.5 m -131.99 145.02 51.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.638 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 54.2 tttp -65.37 107.8 1.75 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.277 0.56 . . . . 0.0 110.332 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 14.4 m -95.02 83.73 3.99 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.855 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.51 -69.75 3.27 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.473 ' HA ' ' OE1' ' A' ' 72' ' ' GLU . 36.4 tp10 -135.58 -49.46 0.71 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -88.15 157.87 18.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.445 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 12.8 m-85 -89.83 130.83 36.02 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.677 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.457 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 34.5 mttp -131.39 150.62 52.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.247 0.546 . . . . 0.0 109.906 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 62.1 m -67.23 134.29 51.38 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.983 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.254 1.295 0 CA-C-O 117.747 -1.12 . . . . 0.0 108.54 179.092 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.65 137.35 12.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 110.118 -0.326 . . . . 0.0 110.118 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 mm -88.9 99.58 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.931 0.396 . . . . 0.0 110.04 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 15.4 t -151.24 -30.21 0.18 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.426 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.5 117.55 0.4 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.046 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.71 -7.93 51.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.709 0.29 . . . . 0.0 111.776 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.514 ' SG ' ' HA ' ' A' ' 30' ' ' PHE . 6.0 p -132.3 139.13 48.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.024 0.44 . . . . 0.0 111.801 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -46.01 60.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.697 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -139.87 153.99 47.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.996 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.481 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 6.6 t70 -50.09 -30.87 11.9 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.155 0.91 . . . . 0.0 111.688 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.584 ' HA ' ' CB ' ' A' ' 49' ' ' PRO . 46.3 t -53.94 -30.15 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.512 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -76.36 -15.17 60.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 92.0 m -89.32 132.14 35.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.128 0.49 . . . . 0.0 111.088 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.51 156.83 51.39 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.095 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.1 m -52.14 108.9 0.32 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.135 0.493 . . . . 0.0 110.632 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.31 -21.18 3.3 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.1 p -136.3 156.34 48.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.136 -0.532 . . . . 0.0 110.077 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.703 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -145.17 161.69 38.9 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.325 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 62.1 m -87.01 59.41 5.62 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.078 0.465 . . . . 0.0 111.26 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.554 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -93.33 144.5 25.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.97 0.414 . . . . 0.0 110.821 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -78.6 143.12 36.72 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.651 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 66.0 m -65.46 133.66 51.76 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.883 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.62 -24.71 67.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.901 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -86.68 -37.08 18.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 110.623 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.64 ' O ' ' HB2' ' A' ' 22' ' ' SER . 23.1 t -152.06 128.1 10.39 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.476 ' N ' ' HD3' ' A' ' 26' ' ' ARG . 1.7 mpp_? -77.22 37.87 0.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 4' ' ' THR . 13.4 p-10 -89.23 -37.69 14.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.651 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 42.9 mt -89.02 124.33 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.6 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -145.99 53.74 1.15 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 1.046 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.6 p90 -131.51 -171.0 2.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.478 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.7 m -61.56 77.3 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.19 0.931 . . . . 0.0 113.266 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' A' ' 20' ' ' ALA . 44.7 pt -93.54 154.6 41.17 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -55.29 151.63 35.37 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.222 2.615 . . . . 0.0 114.442 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 18' ' ' CYS . 75.7 mt -86.91 159.68 18.96 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.12 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.53 138.25 44.17 Favored Glycine 0 C--O 1.238 0.353 0 O-C-N 124.059 0.849 . . . . 0.0 114.145 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.501 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 44.7 m-80 -105.75 162.51 13.48 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.238 0.615 . . . . 0.0 110.161 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.4 m -55.95 121.02 8.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.729 0.3 . . . . 0.0 110.63 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.77 -25.84 13.94 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.422 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 13.6 pt-20 -93.71 152.89 18.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.873 0.836 . . . . 0.0 110.769 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 67.6 m-20 -59.69 153.64 19.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.551 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 27.2 p -144.72 154.85 43.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.775 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 56.8 m170 -90.2 126.14 57.87 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.536 ' HG3' ' CG ' ' A' ' 74' ' ' PHE . 36.5 Cg_exo -59.52 -53.45 3.39 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 123.15 2.566 . . . . 0.0 113.721 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.41 30.62 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.1 t -90.54 120.86 31.98 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.57 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 37.8 m80 -68.65 144.32 54.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.186 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.57 ' N ' ' HE3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -54.16 154.98 3.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.969 -178.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.462 HG22 HH12 ' A' ' 54' ' ' ARG . 95.8 t -88.71 135.46 32.22 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.584 ' CB ' ' HA ' ' A' ' 11' ' ' VAL . 60.7 Cg_endo -73.21 140.77 69.08 Favored 'Cis proline' 0 C--O 1.237 0.469 0 C-N-CA 123.881 -1.3 . . . . 0.0 113.08 0.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.57 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 68.7 t80 -62.25 133.75 55.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.112 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.04 60.22 1.39 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.725 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.72 -133.9 4.26 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.92 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -117.89 124.76 49.08 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.462 HH12 HG22 ' A' ' 48' ' ' VAL . 25.4 ttm180 -90.63 111.91 23.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.215 0.531 . . . . 0.0 112.181 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 55' ' ' LEU . 4.0 mm? -111.65 18.43 19.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.14 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -89.34 142.3 27.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.37 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 15.8 m -89.25 30.51 0.97 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.7 tp -154.46 130.22 10.05 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.263 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.628 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -80.51 140.31 51.81 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.35 171.06 11.01 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.539 2.159 . . . . 0.0 111.139 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.3 m -60.35 139.91 57.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.772 0.32 . . . . 0.0 110.937 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.506 ' HG2' HD12 ' A' ' 65' ' ' LEU . 14.6 ptmt -62.37 153.14 32.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.482 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.6 m -47.81 124.68 7.63 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.417 0.448 . . . . 0.0 111.294 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.18 -32.04 6.98 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.506 HD12 ' HG2' ' A' ' 62' ' ' LYS . 28.2 mt -89.29 156.9 18.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 0.0 111.565 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.1 m -124.87 133.28 53.14 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.332 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 48.1 t -79.16 122.49 26.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 m -151.0 151.98 32.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.658 0.266 . . . . 0.0 111.08 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 83.0 tttt -62.25 116.29 4.88 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.7 m -115.97 49.02 1.15 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.775 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.429 ' O ' ' HE2' ' A' ' 69' ' ' LYS . . . 131.26 -102.59 0.52 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.039 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.17 -49.61 7.17 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.062 0.458 . . . . 0.0 110.683 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -121.42 -167.29 1.49 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.673 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.619 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 5.5 m-85 -91.38 134.96 34.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.889 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 40' ' ' ASP . 51.0 mttm -133.75 155.83 49.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 60.6 m -75.61 137.64 40.89 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.946 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.667 -0.683 . . . . 0.0 109.158 179.684 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p -150.89 144.86 16.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.8 mm -88.02 57.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.69 0.757 . . . . 0.0 110.823 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.473 ' O ' ' HD2' ' A' ' 29' ' ' ARG . 3.1 t -151.73 15.54 0.67 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.827 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.811 ' HA2' ' HB2' ' A' ' 29' ' ' ARG . . . 132.03 126.55 2.75 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.463 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.616 ' HB3' ' HA ' ' A' ' 30' ' ' PHE . . . -91.71 -35.67 14.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.224 0.535 . . . . 0.0 110.597 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -127.58 150.02 49.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.064 -177.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -77.1 -44.03 32.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.842 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 1.006 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 32.0 mttm -131.48 152.04 51.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.816 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . 41.8 m-20 -54.87 -22.68 15.47 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.723 0.639 . . . . 0.0 110.586 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.967 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 2.2 p -54.22 -28.4 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.956 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -77.55 -24.13 49.93 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 73.4 m -89.55 136.94 32.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.941 0.4 . . . . 0.0 110.979 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.63 154.86 53.39 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.869 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -53.66 100.34 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.141 0.496 . . . . 0.0 110.966 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.33 -23.71 1.55 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.3 p -133.41 147.88 51.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.639 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.655 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -134.87 167.97 19.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.994 0.361 . . . . 0.0 110.186 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 20.7 m -89.83 31.83 0.93 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.99 148.67 41.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.974 0.416 . . . . 0.0 110.936 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.74 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -76.7 132.19 39.21 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.509 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 78.3 p -60.04 138.95 57.75 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.927 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.53 -24.73 63.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.375 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.3 p90 -87.39 -27.32 22.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.45 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.433 ' HB2' HD13 ' A' ' 28' ' ' ILE . 67.9 m -150.8 122.8 8.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.038 0.447 . . . . 0.0 110.904 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.409 ' HE ' ' HB3' ' A' ' 21' ' ' ALA . 46.1 mmm-85 -74.75 10.94 1.18 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.78 0.324 . . . . 0.0 110.92 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -89.75 -26.37 20.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.694 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.74 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.2 mp -85.97 115.95 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.811 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 62.0 mtt180 -140.52 43.8 1.86 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.616 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 0.8 OUTLIER -101.83 -178.12 3.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.99 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 89.1 m -68.64 79.64 0.28 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.573 0.546 . . . . 0.0 110.918 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.433 HG13 ' SG ' ' A' ' 59' ' ' CYS . 43.9 pt -89.18 150.54 45.2 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.06 151.72 40.88 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.54 2.827 . . . . 0.0 114.896 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.655 HD11 ' HB3' ' A' ' 18' ' ' CYS . 5.2 mp -87.99 166.5 14.44 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.958 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.93 142.41 47.41 Favored Glycine 0 C--O 1.245 0.838 0 CA-C-N 114.714 -1.13 . . . . 0.0 114.496 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.501 ' O ' ' HB3' ' A' ' 39' ' ' GLU . 57.1 m-80 -91.23 173.08 8.12 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.396 -0.902 . . . . 0.0 111.316 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.6 m -63.0 128.83 37.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.395 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.57 11.38 85.27 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.651 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 36' ' ' ASN . 15.4 tt0 -100.56 155.35 17.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.4 ' O ' HD21 ' A' ' 58' ' ' LEU . 8.3 t70 -63.43 140.23 58.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.175 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.7 p -143.12 145.5 32.9 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 52.7 m170 -89.5 123.5 66.59 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 9.6 Cg_endo -54.14 -34.11 77.13 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.244 2.629 . . . . 0.0 112.513 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.95 85.72 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.861 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 m -72.11 136.62 46.61 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -119.58 -142.21 0.35 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.639 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -68.49 166.37 17.05 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.604 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 72.3 t -133.8 130.63 20.74 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.967 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 52.4 Cg_exo -57.03 131.24 4.63 Favored 'Cis proline' 0 C--N 1.348 0.529 0 C-N-CA 124.278 -1.134 . . . . 0.0 113.197 0.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.816 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 69.1 t80 -77.57 150.93 34.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.226 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -74.17 52.06 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.096 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.53 -135.13 5.63 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 1.006 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 3.6 pptp? -151.48 127.73 10.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.988 0.394 . . . . 0.0 110.132 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -86.4 125.67 33.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.951 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.72 24.09 4.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.592 0.711 . . . . 0.0 109.395 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 m -89.84 158.79 17.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.476 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.693 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 4.6 m -89.24 24.34 2.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.726 0.298 . . . . 0.0 111.303 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.4 HD21 ' O ' ' A' ' 40' ' ' ASP . 56.1 tp -154.07 130.15 10.31 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.79 -0.186 . . . . 0.0 111.42 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.477 ' HB3' HD12 ' A' ' 34' ' ' LEU . 16.7 m -76.26 156.7 83.57 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.72 -166.75 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 121.728 1.619 . . . . 0.0 111.229 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.416 ' O ' HD23 ' A' ' 34' ' ' LEU . 73.2 m -74.16 140.02 44.89 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.604 0.24 . . . . 0.0 111.296 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.599 ' HG2' HD12 ' A' ' 65' ' ' LEU . 17.6 ptpt -64.55 157.64 26.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.715 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.9 m -44.05 125.26 4.3 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.736 0.647 . . . . 0.0 112.08 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.26 -30.58 10.07 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.514 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.599 HD12 ' HG2' ' A' ' 62' ' ' LYS . 24.6 mt -89.12 140.98 28.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.095 0.474 . . . . 0.0 112.13 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.0 m -107.25 131.73 53.86 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.818 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 45.2 t -85.06 117.74 24.21 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.2 t -150.57 154.01 36.77 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 15.7 ttpp -65.4 119.67 11.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.945 0.402 . . . . 0.0 110.801 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -137.12 45.39 2.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 122.08 0.943 . . . . 0.0 108.921 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.7 -121.17 1.02 Allowed Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.5 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.18 -44.04 12.52 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -120.06 -161.01 0.85 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.593 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 3.5 m-85 -89.75 141.6 28.47 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.885 0.374 . . . . 0.0 111.196 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 74' ' ' PHE . 14.5 mptt -131.02 160.14 35.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.274 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.464 ' HB3' HD13 ' A' ' 65' ' ' LEU . 81.7 m -84.76 129.2 34.86 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.715 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 C--O 1.252 1.192 0 CA-C-O 117.626 -1.178 . . . . 0.0 109.367 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.868 0.366 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.74 135.88 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.9 mm -89.12 60.18 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.561 0.696 . . . . 0.0 110.365 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.2 t -89.67 -29.54 18.71 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.594 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.27 116.47 0.69 Allowed Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.779 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.08 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -89.89 -11.66 41.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.506 -0.347 . . . . 0.0 111.437 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.2 p -151.03 159.41 44.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.765 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -104.53 -54.69 2.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.309 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.596 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 21.9 ttmm -108.03 146.01 33.15 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.279 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.488 ' OD2' ' HB3' ' A' ' 50' ' ' TYR . 76.7 m-20 -51.41 -22.43 2.99 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.947 0.779 . . . . 0.0 110.731 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.706 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -57.11 -27.2 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.501 179.273 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -81.11 -19.62 43.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.811 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.4 m -89.95 -138.26 0.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.115 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.3 -138.24 3.62 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 119.676 -1.25 . . . . 0.0 113.3 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 m -49.86 112.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.991 -0.604 . . . . 0.0 112.582 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 33' ' ' PRO . . . 57.52 34.32 68.9 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.017 -0.992 . . . . 0.0 114.83 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.479 ' N ' HD13 ' A' ' 34' ' ' LEU . 4.3 p -145.44 140.56 27.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.914 0.857 . . . . 0.0 111.113 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.726 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -145.03 162.18 37.58 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.7 m -88.32 57.58 4.32 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.169 0.509 . . . . 0.0 111.73 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.74 ' HB2' HH12 ' A' ' 54' ' ' ARG . . . -93.19 168.95 10.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.006 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -85.16 152.04 23.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.938 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.524 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -59.44 134.35 56.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.524 0.202 . . . . 0.0 111.068 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.91 37.2 0.08 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -151.48 -36.68 0.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.008 0.433 . . . . 0.0 110.485 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.7 m -151.05 149.54 29.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -83.4 43.99 0.93 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.342 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -97.35 -45.05 6.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.067 0.46 . . . . 0.0 110.231 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.613 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.6 mp -89.39 135.44 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.772 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.67 54.58 0.89 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 1.08 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.4 p90 -130.74 -166.91 1.75 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.986 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.2 m -62.08 80.69 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.988 0.805 . . . . 0.0 112.959 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 20' ' ' ALA . 48.8 pt -96.74 154.21 38.46 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 25.3 Cg_endo -62.46 151.82 80.74 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 122.785 2.323 . . . . 0.0 114.528 -177.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 18' ' ' CYS . 5.8 mp -87.23 164.34 16.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.874 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.9 140.01 26.09 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.111 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 58.2 m-80 -95.63 -164.64 1.18 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.181 0.515 . . . . 0.0 111.124 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 m -61.43 123.79 18.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.315 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.1 -6.56 82.58 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.465 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.78 150.96 22.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.376 0.588 . . . . 0.0 111.343 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.13 146.86 49.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.533 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.547 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 24.5 p -143.58 145.45 32.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.093 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 39.9 m170 -90.11 122.68 67.38 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 9.9 Cg_endo -54.15 -38.78 87.78 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.219 2.613 . . . . 0.0 112.904 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.53 65.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.86 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.546 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 17.2 m -81.33 121.01 25.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.915 0.388 . . . . 0.0 110.47 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -93.05 -172.31 2.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.196 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -72.69 165.65 24.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.512 HG13 ' HA ' ' A' ' 49' ' ' PRO . 60.4 t -87.09 139.92 32.54 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.706 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 2.6 Cg_exo -77.12 133.11 29.61 Favored 'Cis proline' 0 C--N 1.346 0.415 0 C-N-CA 123.845 -1.314 . . . . 0.0 113.505 1.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.488 ' HB3' ' OD2' ' A' ' 10' ' ' ASP . 48.8 t80 -113.64 149.25 34.88 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.596 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 25.8 t70 -58.63 -23.67 59.52 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.394 0.616 . . . . 0.0 111.3 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.13 33.31 57.57 Favored Glycine 0 C--N 1.318 -0.426 0 N-CA-C 115.409 0.924 . . . . 0.0 115.409 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.2 pttm -88.3 56.74 3.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.035 0.917 . . . . 0.0 109.739 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.74 HH12 ' HB2' ' A' ' 20' ' ' ALA . 4.0 ppt_? -150.32 130.04 13.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.619 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.8 mt -88.48 50.34 1.95 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.439 0.638 . . . . 0.0 110.145 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 m -89.1 137.56 32.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.779 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 p -88.68 34.75 0.77 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.201 0.524 . . . . 0.0 110.598 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.9 tp -153.28 132.16 12.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.772 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.624 ' HB3' HD12 ' A' ' 34' ' ' LEU . 2.5 m -83.3 159.85 61.03 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.546 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 6.3 Cg_exo -71.83 -161.68 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.288 1.992 . . . . 0.0 111.723 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.571 ' O ' HD23 ' A' ' 34' ' ' LEU . 74.4 m -79.01 137.86 37.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.887 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HD2' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -66.86 153.46 43.39 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.412 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.1 m -46.28 113.1 0.57 Allowed 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.571 0.545 . . . . 0.0 111.6 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.37 -32.58 4.64 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.262 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 76' ' ' CYS . 3.6 mm? -89.72 143.12 27.07 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.2 m -110.5 128.14 55.49 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.599 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 20.8 t -72.96 119.2 16.87 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.9 m -131.22 144.33 51.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.991 0.424 . . . . 0.0 111.408 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.544 ' NZ ' ' HA ' ' A' ' 72' ' ' GLU . 53.2 tttm -67.3 109.11 2.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.379 0.609 . . . . 0.0 110.38 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.9 m -88.95 76.53 7.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.664 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.94 -69.67 3.2 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.544 ' HA ' ' NZ ' ' A' ' 69' ' ' LYS . 33.9 tp10 -130.57 -41.53 1.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.753 0.311 . . . . 0.0 110.489 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -86.56 -172.79 4.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.7 128.84 47.32 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -135.14 150.32 50.15 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.556 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 68.9 m -70.83 133.9 46.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.945 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.9 m . . . . . 0 C--O 1.254 1.294 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.192 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.03 132.18 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.949 0.405 . . . . 0.0 110.266 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 51.2 mm -93.24 119.16 40.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.138 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.6 t -150.4 18.11 0.83 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.654 0.74 . . . . 0.0 110.054 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . -171.01 72.36 0.11 Allowed Glycine 0 C--O 1.226 -0.368 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.027 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -81.35 -23.6 37.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.464 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 18.6 p -151.13 154.92 37.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -92.03 -60.77 1.77 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.611 0.719 . . . . 0.0 110.236 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -101.35 139.32 37.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.798 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.592 ' OD2' ' HB2' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -46.68 -33.19 4.07 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.32 1.012 . . . . 0.0 111.797 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.8 t -49.55 -32.4 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.631 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -66.03 -30.19 70.69 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.464 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 66.6 m -89.88 159.84 16.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.118 0.485 . . . . 0.0 111.378 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.99 166.49 54.9 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.48 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.456 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 56.9 m -63.79 67.13 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.71 0.804 . . . . 0.0 112.125 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.35 -26.44 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.404 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 13' ' ' CYS . 26.5 p -124.39 142.73 51.07 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.691 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -119.74 154.19 34.53 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 60.4 m -89.52 48.52 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 0.0 111.961 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -95.54 -170.09 2.09 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.821 ' HB1' ' HA ' ' A' ' 26' ' ' ARG . . . -90.11 141.34 28.78 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.425 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 88.2 p -63.46 142.98 58.19 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.108 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.705 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -55.93 -26.38 47.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -87.97 -32.23 18.96 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.419 ' C ' ' H ' ' A' ' 27' ' ' ASN . 68.1 m -151.67 135.87 16.7 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.914 -0.492 . . . . 0.0 111.538 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.821 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 59.7 mtm180 -78.46 20.55 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.128 0.489 . . . . 0.0 110.785 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 25' ' ' SER . 74.2 m-20 -92.55 -31.32 15.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.605 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 1.8 mp -85.39 120.81 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 89.2 mtt180 -139.14 77.44 1.62 Allowed 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.914 0.759 . . . . 0.0 109.717 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 1.027 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.0 OUTLIER -150.83 -167.08 2.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.565 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 84.2 m -60.34 77.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.672 HG13 ' SG ' ' A' ' 59' ' ' CYS . 34.0 pt -97.99 146.37 31.37 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -57.01 151.39 50.21 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.267 2.644 . . . . 0.0 115.084 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.691 HD11 ' HB3' ' A' ' 18' ' ' CYS . 5.1 mp -87.11 168.79 12.96 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.769 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.74 147.07 37.9 Favored Glycine 0 C--O 1.239 0.436 0 CA-C-N 115.246 -0.888 . . . . 0.0 114.02 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 72.5 m-80 -100.85 -178.98 3.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.163 -0.518 . . . . 0.0 109.799 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.3 m -62.86 129.51 40.75 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.07 -6.76 76.32 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.179 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -88.2 154.56 20.34 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.897 0.379 . . . . 0.0 111.029 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -67.6 142.82 56.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.821 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.511 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 31.6 p -146.01 150.15 35.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.207 0.527 . . . . 0.0 110.688 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -95.4 126.94 43.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.56 -40.83 77.64 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.092 2.528 . . . . 0.0 112.907 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.46 -33.86 76.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.134 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.632 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 17.7 m -73.31 138.82 45.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.362 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -129.29 175.46 8.72 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 7.7 ptmt -59.69 150.88 26.43 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.445 0.466 . . . . 0.0 111.6 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 49' ' ' PRO . 60.3 t -87.14 142.56 33.77 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.651 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HA ' HG13 ' A' ' 48' ' ' VAL . 33.5 Cg_exo -63.07 138.46 28.27 Favored 'Cis proline' 0 C--N 1.351 0.683 0 C-N-CA 124.392 -1.087 . . . . 0.0 113.73 1.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.491 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 34.5 t80 -146.57 141.79 27.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.703 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -74.13 79.46 1.75 Allowed 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.546 ' HA3' ' OD1' ' A' ' 10' ' ' ASP . . . -89.48 131.84 10.93 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.783 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.18 37.46 0.55 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.324 0.583 . . . . 0.0 109.432 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.44 ' H ' ' NE ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -115.88 139.9 49.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.915 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.68 48.53 1.6 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.223 0.535 . . . . 0.0 110.463 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.7 m -103.04 143.38 32.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.39 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.705 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 72.7 m -88.86 47.92 1.56 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.57 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 53.9 tp -152.51 124.14 7.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.726 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.672 ' SG ' HG13 ' A' ' 32' ' ' ILE . 3.7 m -84.14 153.94 63.29 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.718 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.632 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 12.3 Cg_exo -69.44 -169.96 0.34 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.497 2.132 . . . . 0.0 111.642 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 82.5 m -77.75 139.37 39.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.67 0.271 . . . . 0.0 111.248 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.474 ' HA ' HD23 ' A' ' 34' ' ' LEU . 19.1 ptmt -62.13 154.12 28.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.22 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 15' ' ' SER . 17.6 m -51.03 125.27 13.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.312 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.54 -29.67 9.7 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.415 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.46 HD12 ' HG2' ' A' ' 62' ' ' LYS . 22.6 mt -88.91 152.7 21.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.025 0.44 . . . . 0.0 111.936 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -113.26 128.13 56.38 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.998 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.545 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 53.8 t -84.69 119.67 25.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.1 t -150.97 158.97 44.81 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 23.8 ttpp -65.82 102.4 0.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.245 0.545 . . . . 0.0 109.824 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.536 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 12.1 m -101.6 43.46 1.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.182 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.4 -105.6 0.47 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.322 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.507 ' CD ' ' HG2' ' A' ' 73' ' ' LYS . 1.1 pm0 -86.08 -40.51 15.65 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 122.776 0.43 . . . . 0.0 110.406 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.507 ' HG2' ' CD ' ' A' ' 72' ' ' GLU . 25.0 pttt -133.23 -164.26 1.46 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.902 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 5.1 m-85 -90.09 134.4 34.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.148 0.499 . . . . 0.0 111.468 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 46.4 mttp -135.86 154.33 51.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.063 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.511 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 73.0 m -75.39 126.44 31.01 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.469 -178.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.249 1.065 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.677 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.82 138.53 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.8 mm -88.56 90.68 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.195 0.522 . . . . 0.0 110.064 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.5 t -150.41 -29.3 0.22 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.396 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.67 108.39 0.35 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.043 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.027 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -91.17 -14.19 31.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 p -147.7 145.82 29.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.087 0.47 . . . . 0.0 111.904 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 53' ' ' LYS . 17.6 t70 -88.23 -44.79 10.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.42 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.546 ' HG3' ' OD2' ' A' ' 8' ' ' ASP . 61.6 mttp -121.49 144.88 48.46 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 108.962 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.679 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 37.8 t0 -55.31 -18.8 7.03 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.838 0.711 . . . . 0.0 111.005 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.7 p -55.49 -25.33 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.802 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -82.13 -16.76 48.76 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 68.8 m -89.8 -129.79 0.08 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.784 0.326 . . . . 0.0 110.678 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.86 169.88 35.92 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.507 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.4 m -51.96 105.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.125 0.488 . . . . 0.0 111.364 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.63 -35.22 1.89 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.6 p -139.75 143.58 37.04 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.745 0.418 . . . . 0.0 110.08 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.653 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -128.13 159.51 34.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.679 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 67.9 m -85.78 105.09 16.05 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.192 0.52 . . . . 0.0 109.689 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' A' ' 54' ' ' ARG . . . -159.58 173.36 16.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.07 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -82.27 138.07 34.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.298 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.662 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -66.03 137.37 57.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.865 0.364 . . . . 0.0 110.881 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.03 -24.73 66.4 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -86.78 -34.82 19.47 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.416 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 27' ' ' ASN . 28.2 m -151.59 124.88 8.78 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.471 ' N ' ' HD3' ' A' ' 26' ' ' ARG . 1.6 mpp_? -76.29 30.0 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.019 0.438 . . . . 0.0 111.834 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' A' ' 25' ' ' SER . 5.6 m120 -90.03 -37.26 14.42 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.662 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.0 mp -89.58 125.76 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.198 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.505 ' HD3' ' C ' ' A' ' 28' ' ' ILE . 1.3 mpp_? -136.84 68.19 1.43 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 1.027 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.1 p90 -147.29 -161.09 1.26 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.495 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 82.9 m -60.87 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.966 0.791 . . . . 0.0 111.911 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.556 HG13 ' SG ' ' A' ' 59' ' ' CYS . 43.4 pt -100.84 150.54 37.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.48 148.14 27.59 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 123.41 2.74 . . . . 0.0 114.67 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.74 HD23 ' HB3' ' A' ' 59' ' ' CYS . 90.8 mt -85.53 163.84 18.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.979 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.516 ' O ' ' HG3' ' A' ' 62' ' ' LYS . . . -59.67 137.41 49.76 Favored Glycine 0 C--O 1.24 0.509 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.91 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -88.88 165.6 14.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.172 0.589 . . . . 0.0 110.289 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.6 t -62.52 133.77 55.44 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.498 ' O ' ' HD3' ' A' ' 75' ' ' LYS . . . 87.96 -12.08 65.07 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.548 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -88.59 159.79 17.72 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 117.107 0.453 . . . . 0.0 111.861 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.551 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 0.3 OUTLIER -65.65 147.73 52.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.091 -178.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.3 p -149.83 142.52 24.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.273 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 41.1 m170 -88.0 124.8 66.22 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 8.2 Cg_endo -51.7 -38.98 67.38 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.47 2.78 . . . . 0.0 113.795 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.65 25.67 0.42 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . 49.5 m -90.64 122.36 33.36 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.915 -0.491 . . . . 0.0 110.372 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.533 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 19.3 m170 -77.46 149.24 35.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -55.39 149.65 12.85 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.631 0.582 . . . . 0.0 111.298 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 49' ' ' PRO . 84.9 t -85.87 138.3 35.3 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.891 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.531 ' HA ' HG13 ' A' ' 48' ' ' VAL . 8.2 Cg_exo -73.58 135.18 38.83 Favored 'Cis proline' 0 C--N 1.344 0.296 0 C-N-CA 123.603 -1.415 . . . . 0.0 112.88 1.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.533 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 89.1 t80 -64.32 143.05 58.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.421 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.58 44.82 0.13 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.06 -139.75 6.9 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.801 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -121.49 134.27 55.06 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.126 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.515 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 61.4 mtp85 -88.08 124.07 33.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.845 0.355 . . . . 0.0 111.209 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -88.94 -5.87 57.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.299 0.571 . . . . 0.0 109.946 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m -87.85 146.43 25.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.459 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 13.3 m -87.41 42.82 1.06 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.983 0.42 . . . . 0.0 111.387 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.1 tp -153.62 121.99 6.22 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.379 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.74 ' HB3' HD23 ' A' ' 34' ' ' LEU . 3.4 m -81.0 148.19 63.62 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 37.3 Cg_endo -67.41 173.39 8.8 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 121.849 1.7 . . . . 0.0 111.46 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.8 m -59.34 144.37 46.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.121 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.659 ' HG2' ' HB2' ' A' ' 34' ' ' LEU . 60.2 mttm -56.17 143.96 31.39 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -51.56 110.3 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.17 0.51 . . . . 0.0 110.543 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.75 -30.06 3.65 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 65' ' ' LEU . 24.7 mt -88.83 147.19 24.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.698 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.3 m -109.91 126.78 54.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.017 0.437 . . . . 0.0 111.481 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.4 t -78.53 116.23 18.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.0 t -134.46 158.68 43.28 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.902 0.382 . . . . 0.0 110.416 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 41.5 ttmt -71.63 112.04 7.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.5 t -91.34 56.94 3.23 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.18 -92.43 1.77 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.226 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -91.02 -46.39 8.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.052 0.453 . . . . 0.0 111.257 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.56 ' HE3' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -107.22 167.06 10.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.711 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 13.4 m-85 -95.38 132.16 40.72 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 55.1 mttm -138.75 153.36 48.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.379 0.609 . . . . 0.0 111.013 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 70.7 m -66.33 132.51 48.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.364 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 C--O 1.253 1.266 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.129 179.701 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -88.96 135.56 25.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 123.177 0.298 . . . . 0.0 110.237 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 51.4 mm -96.82 119.81 45.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.171 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 t -150.3 26.5 0.77 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.59 0.71 . . . . 0.0 110.171 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.56 129.72 4.06 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.674 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.008 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.4 -10.24 44.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.637 0.256 . . . . 0.0 111.571 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 18.8 p -150.76 150.67 31.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.973 0.416 . . . . 0.0 111.409 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.429 ' HB3' HE22 ' A' ' 12' ' ' GLN . 11.9 t70 -97.41 -46.22 6.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.117 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.427 ' H ' ' NE2' ' A' ' 12' ' ' GLN . 95.0 mttt -114.33 145.08 42.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.439 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.835 ' HB2' ' H ' ' A' ' 50' ' ' TYR . 88.2 m-20 -57.35 -26.85 61.63 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.509 0.505 . . . . 0.0 111.417 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -57.39 -29.15 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.898 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.429 HE22 ' HB3' ' A' ' 8' ' ' ASP . 45.2 mt-30 -70.23 -26.05 63.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.491 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 58.0 m -90.69 -122.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.119 0.485 . . . . 0.0 110.784 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.33 157.08 28.14 Favored Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.8 m -55.67 101.0 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.297 0.57 . . . . 0.0 110.846 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.03 -28.08 1.13 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.6 p -135.27 139.49 44.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.15 -0.525 . . . . 0.0 109.833 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.507 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -123.83 159.64 29.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.0 m -88.06 51.22 2.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.89 0.376 . . . . 0.0 111.539 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.758 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -79.62 160.79 26.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.043 0.449 . . . . 0.0 110.998 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.694 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -90.4 144.5 25.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.422 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.646 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -64.58 135.45 55.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.972 0.415 . . . . 0.0 110.395 179.179 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -64.87 -23.06 67.12 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.0 p90 -87.94 -37.68 16.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.4 m -151.74 152.63 32.98 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.19 -0.318 . . . . 0.0 110.162 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -81.75 41.4 0.64 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.775 0.322 . . . . 0.0 111.453 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -97.07 -39.43 9.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.951 0.405 . . . . 0.0 110.828 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.646 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 53.2 mt -88.86 125.63 41.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.918 0.39 . . . . 0.0 110.297 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.3 mmm-85 -150.95 41.03 0.74 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.865 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 1.008 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.4 p90 -121.64 -172.77 2.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.971 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.4 m -61.15 82.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 O-C-N 124.369 1.043 . . . . 0.0 112.609 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 20' ' ' ALA . 30.4 pt -97.86 147.13 32.62 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.07 152.5 36.95 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.388 2.725 . . . . 0.0 114.663 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.549 HD23 ' O ' ' A' ' 61' ' ' CYS . 3.8 mp -87.38 164.73 16.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.317 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.596 ' O ' ' HG3' ' A' ' 62' ' ' LYS . . . -75.4 154.89 46.5 Favored Glycine 0 C--O 1.237 0.335 0 CA-C-N 115.116 -0.947 . . . . 0.0 114.291 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 1.3 p30 -109.18 169.56 8.61 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.131 0.491 . . . . 0.0 110.991 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.7 m -54.59 121.91 9.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.287 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.12 -24.38 16.42 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.04 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 10.7 pt-20 -100.53 153.02 19.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.365 0.582 . . . . 0.0 110.958 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 1.2 m-20 -58.45 150.71 21.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.299 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 13.3 p -149.23 154.47 39.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.787 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -90.97 128.54 47.46 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.45 -60.07 0.8 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.5 2.8 . . . . 0.0 114.207 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.35 26.79 0.3 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.189 0.518 . . . . 0.0 110.551 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -81.98 2.63 29.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.761 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.548 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -178.18 36.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.621 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.564 ' O ' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -68.33 136.14 52.95 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.603 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.6 t -86.44 128.39 57.26 Favored Pre-proline 0 C--N 1.315 -0.906 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.94 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -91.13 131.03 7.72 Favored 'Cis proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.797 -1.335 . . . . 0.0 112.855 0.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.835 ' H ' ' HB2' ' A' ' 10' ' ' ASP . 12.1 t80 -109.12 120.46 42.61 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.266 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -84.15 63.8 7.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.909 0.861 . . . . 0.0 108.838 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.15 142.62 7.32 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.881 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.449 ' H ' ' HD3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -101.49 52.2 0.83 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.292 0.568 . . . . 0.0 110.126 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.4 tpt85 -57.73 139.46 53.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.079 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.46 61.68 6.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.797 0.808 . . . . 0.0 110.391 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.5 m -102.17 129.41 48.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.471 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.694 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 7.0 m -89.24 28.39 1.24 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.849 0.357 . . . . 0.0 111.496 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.1 tp -153.9 129.09 9.69 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.342 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.527 ' SG ' HG13 ' A' ' 32' ' ' ILE . 3.8 m -78.77 164.44 55.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.844 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.508 ' HG3' ' HA ' ' A' ' 47' ' ' LYS . 94.7 Cg_endo -78.5 -157.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.305 2.003 . . . . 0.0 111.508 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.549 ' O ' HD23 ' A' ' 34' ' ' LEU . 90.4 m -87.14 145.5 26.4 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.399 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 29.5 mtpp -57.46 153.44 12.72 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.678 0.611 . . . . 0.0 110.236 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.8 m -49.39 121.73 5.35 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.229 0.331 . . . . 0.0 111.178 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.6 -24.34 28.91 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 65' ' ' LEU . 42.3 mt -88.27 152.13 22.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.845 0.355 . . . . 0.0 111.396 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.2 m -115.59 129.51 56.54 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.132 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.0 t -81.65 116.2 21.27 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 m -132.72 146.05 51.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.708 0.289 . . . . 0.0 110.663 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 34.8 ttpt -70.33 108.03 4.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.116 0.484 . . . . 0.0 110.887 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.886 ' HB3' ' HD3' ' A' ' 75' ' ' LYS . 19.6 t -94.38 76.85 3.9 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.54 -102.1 2.86 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.104 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.532 ' OE1' ' HG3' ' A' ' 73' ' ' LYS . 2.8 tt0 -89.01 -56.46 3.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.518 -0.341 . . . . 0.0 111.503 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HG3' ' OE1' ' A' ' 72' ' ' GLU . 64.5 mttp -102.8 172.46 6.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.17 0.509 . . . . 0.0 111.953 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.696 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 10.1 m-85 -89.48 132.05 35.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.352 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.886 ' HD3' ' HB3' ' A' ' 70' ' ' SER . 1.6 mptp? -130.95 150.05 52.29 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 62.5 m -69.64 144.98 52.77 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.699 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--O 1.248 0.981 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.398 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.12 131.93 35.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.936 0.398 . . . . 0.0 110.436 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.6 mm -93.6 123.4 45.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.9 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 t -151.01 -42.53 0.12 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.564 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.32 121.42 0.64 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.454 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.109 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -91.34 -14.84 30.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.2 p -150.66 167.47 27.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.923 0.392 . . . . 0.0 111.49 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.24 -44.0 2.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.186 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 46.3 mmtm -104.09 138.16 41.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.734 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.416 ' OD2' ' HG2' ' A' ' 54' ' ' ARG . 70.4 m-20 -57.96 -28.58 64.48 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.347 0.594 . . . . 0.0 109.847 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.4 t -56.74 -29.87 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 114.827 -1.078 . . . . 0.0 111.486 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -69.11 -22.77 63.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.636 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.8 m -89.48 -126.44 0.07 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.138 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.39 -177.8 43.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.127 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.5 m -67.63 66.18 0.08 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.435 0.636 . . . . 0.0 111.488 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 176.58 -24.2 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.341 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.1 p -139.55 147.89 41.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.023 0.129 . . . . 0.0 110.655 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.503 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -136.16 160.27 39.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.528 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.4 m -87.6 51.82 2.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.136 0.493 . . . . 0.0 111.762 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.597 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -86.75 164.19 16.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.805 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.683 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -86.06 144.59 27.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.102 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.657 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -64.76 134.07 53.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.932 0.396 . . . . 0.0 111.146 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.784 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -65.7 -21.23 66.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -87.57 -35.15 18.28 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 m -151.84 144.06 23.98 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.079 -0.388 . . . . 0.0 110.524 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.94 33.79 0.18 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.955 0.407 . . . . 0.0 111.627 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -98.18 -40.83 8.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.755 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.657 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.8 mp -88.08 127.23 41.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.961 0.41 . . . . 0.0 110.918 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HD3' ' C ' ' A' ' 28' ' ' ILE . 1.1 mpp_? -143.34 68.49 1.29 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.863 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 1.109 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.5 p90 -145.76 -170.52 3.49 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.763 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.2 m -60.92 75.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.288 0.992 . . . . 0.0 112.946 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 20' ' ' ALA . 43.9 pt -89.83 153.05 47.34 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.78 151.54 47.54 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.137 2.558 . . . . 0.0 114.691 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.732 HD23 ' HA ' ' A' ' 62' ' ' LYS . 3.6 mp -87.09 170.82 11.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.936 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.54 133.28 25.47 Favored Glycine 0 C--O 1.243 0.696 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.483 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -89.75 167.83 12.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.191 -0.505 . . . . 0.0 110.36 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 m -59.97 128.1 35.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.767 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.8 -5.2 84.5 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.145 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.555 ' HA ' ' HZ2' ' A' ' 75' ' ' LYS . 5.9 mm-40 -99.21 162.44 13.05 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 117.411 0.606 . . . . 0.0 111.8 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.559 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 41.3 p-10 -63.59 151.82 40.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.251 1.024 . . . . 0.0 113.217 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 21.5 p -151.08 143.65 24.33 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.331 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.486 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 43.4 m170 -89.45 121.65 69.09 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 4.5 Cg_endo -48.54 -40.25 37.28 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.775 2.984 . . . . 0.0 113.738 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.28 -28.39 68.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.121 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 53.9 m -73.82 137.07 43.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.889 0.376 . . . . 0.0 110.587 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -123.0 145.89 48.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.87 144.12 1.9 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.556 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 21.9 t -88.25 143.21 32.35 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.052 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.556 ' C ' ' HA ' ' A' ' 48' ' ' VAL . 19.1 Cg_endo -60.75 131.8 8.24 Favored 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.402 -1.082 . . . . 0.0 114.185 1.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -115.73 137.76 51.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.176 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -69.62 109.87 4.54 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.21 -133.78 11.5 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -152.5 152.42 31.91 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.497 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 23.1 mmm180 -85.41 107.19 17.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.143 0.497 . . . . 0.0 111.906 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.75 61.49 6.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 t -144.66 163.39 34.11 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.598 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.784 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 6.6 m -88.02 21.98 2.55 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.5 tp -154.08 127.82 8.76 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 121.168 -0.213 . . . . 0.0 111.299 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.559 ' SG ' HG13 ' A' ' 32' ' ' ILE . 13.3 m -74.76 154.29 87.18 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.066 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.53 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 57.0 Cg_endo -69.76 178.28 4.73 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.475 2.117 . . . . 0.0 111.973 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 71.4 m -70.27 143.1 52.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.732 ' HA ' HD23 ' A' ' 34' ' ' LEU . 9.8 ptmm? -60.66 146.91 43.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.1 m -45.52 128.88 8.47 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.078 0.466 . . . . 0.0 111.381 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.99 -28.97 10.86 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.585 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.531 HD12 ' HG2' ' A' ' 62' ' ' LYS . 22.2 mt -89.85 145.28 25.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.955 0.407 . . . . 0.0 111.735 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.9 m -108.59 126.44 52.94 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.955 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 48.1 t -81.01 126.58 31.58 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.6 p -149.46 149.15 30.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.752 0.31 . . . . 0.0 111.231 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.884 ' HE3' ' HA ' ' A' ' 72' ' ' GLU . 46.8 tttt -66.92 105.58 1.66 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.376 0.608 . . . . 0.0 110.984 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 6.8 m -89.83 82.7 6.2 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.833 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.91 -64.09 3.96 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.274 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.884 ' HA ' ' HE3' ' A' ' 69' ' ' LYS . 0.8 OUTLIER -141.02 -47.27 0.4 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.999 0.428 . . . . 0.0 110.028 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -94.77 158.47 15.49 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 15.2 m-85 -88.37 130.08 35.24 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.45 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 37.2 mttm -134.85 155.52 50.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.315 0.579 . . . . 0.0 110.141 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.456 ' HB3' HD13 ' A' ' 65' ' ' LEU . 64.3 m -73.86 137.16 43.57 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.373 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.244 0.805 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.413 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.11 136.56 23.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.6 mm -96.94 119.79 45.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.29 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.2 p -120.96 30.5 6.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.041 0.448 . . . . 0.0 110.57 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.19 122.7 0.28 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.435 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.069 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -82.56 -6.53 59.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.722 0.296 . . . . 0.0 111.614 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 p -149.89 146.25 26.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.954 0.406 . . . . 0.0 111.739 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.455 ' OD1' ' HG2' ' A' ' 9' ' ' LYS . 3.2 t70 -95.37 -57.01 2.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.455 ' HG2' ' OD1' ' A' ' 8' ' ' ASP . 23.6 mmtp -93.99 141.5 28.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.746 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.2 -31.03 66.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.538 0.685 . . . . 0.0 109.881 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.865 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 47.8 t -55.97 -27.16 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.943 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.43 ' NE2' ' H ' ' A' ' 9' ' ' LYS . 55.3 mt-30 -67.08 -25.56 66.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.605 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 71.3 m -89.61 138.27 31.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.03 0.443 . . . . 0.0 111.331 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.17 151.2 49.74 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.631 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.412 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 18.4 m -51.48 113.02 0.85 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.187 0.517 . . . . 0.0 110.741 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.13 -27.86 3.1 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.4 p -128.87 144.87 51.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.965 -0.618 . . . . 0.0 109.535 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.77 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -128.96 166.51 19.03 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 72.3 m -88.02 52.77 2.55 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.797 0.332 . . . . 0.0 111.678 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.597 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -89.81 156.6 18.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.11 0.481 . . . . 0.0 111.336 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.26 145.88 24.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.463 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.597 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -66.0 128.0 34.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.086 0.469 . . . . 0.0 110.883 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.69 -20.13 65.91 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -86.81 -36.17 18.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.811 0.338 . . . . 0.0 111.441 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.8 m -152.0 138.79 18.89 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.442 ' N ' ' HD3' ' A' ' 26' ' ' ARG . 1.6 mpp_? -76.7 48.26 0.55 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.639 0.257 . . . . 0.0 111.547 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -103.95 -41.03 5.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.856 0.36 . . . . 0.0 110.379 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.597 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 69.5 mt -89.6 131.02 37.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.816 0.341 . . . . 0.0 110.335 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -151.73 52.63 0.82 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 1.069 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.9 p90 -140.45 -168.49 2.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.871 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 67.0 m -57.62 99.06 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 O-C-N 124.11 0.881 . . . . 0.0 112.378 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 20' ' ' ALA . 46.1 pt -120.74 149.9 51.53 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.39 147.52 67.43 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.408 2.739 . . . . 0.0 115.125 -177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.77 HD11 ' HB3' ' A' ' 18' ' ' CYS . 7.1 mp -88.34 164.5 15.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.359 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.77 149.29 26.79 Favored Glycine 0 C--O 1.238 0.348 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.252 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 49.6 m-80 -103.34 -168.12 1.47 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.999 0.428 . . . . 0.0 110.922 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 m -61.61 129.95 43.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.626 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.421 ' O ' ' HE3' ' A' ' 75' ' ' LYS . . . 93.11 -12.24 70.28 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.323 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 36' ' ' ASN . 49.1 mt-10 -90.86 144.8 25.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.29 0.566 . . . . 0.0 111.293 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.58 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 11.6 m-20 -62.38 145.63 53.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.301 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -135.52 179.91 6.04 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -116.76 122.12 31.99 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -57.77 -34.79 98.71 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.771 2.314 . . . . 0.0 112.492 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.52 -26.46 62.67 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.565 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.59 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 40.6 m -78.35 129.94 35.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.419 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -88.35 -152.25 0.22 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.698 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -88.2 146.57 25.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.501 HG13 ' HA ' ' A' ' 49' ' ' PRO . 70.8 t -88.65 136.72 30.8 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 123.436 0.46 . . . . 0.0 110.191 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.865 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 16.7 Cg_exo -68.82 128.25 11.3 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.863 -1.307 . . . . 0.0 113.115 0.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.5 ' CE2' ' HG2' ' A' ' 54' ' ' ARG . 80.5 t80 -65.26 145.86 55.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.111 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.93 49.9 0.25 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.23 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.61 -143.51 9.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.955 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -150.4 59.45 0.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.1 0.476 . . . . 0.0 111.37 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.5 ' HG2' ' CE2' ' A' ' 50' ' ' TYR . 22.0 mmt85 -59.39 140.55 56.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.29 57.76 4.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.416 0.627 . . . . 0.0 110.311 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.2 m -88.84 141.78 28.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.253 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 4.1 p -89.13 17.6 5.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.955 0.407 . . . . 0.0 111.698 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.9 tp -154.18 129.88 10.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.724 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.526 ' SG ' HG13 ' A' ' 32' ' ' ILE . 9.0 m -73.37 149.49 88.96 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.59 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 7.5 Cg_exo -72.11 -160.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.396 2.064 . . . . 0.0 111.762 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.857 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 44.1 m -75.72 139.31 41.82 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.992 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.418 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -60.79 150.11 33.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.835 179.191 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.412 ' OG ' ' HB3' ' A' ' 15' ' ' SER . 13.8 m -49.67 125.29 11.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.625 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.86 -33.72 5.74 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.917 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 65' ' ' LEU . 39.5 mt -89.95 163.59 14.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.922 0.391 . . . . 0.0 111.817 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -133.64 137.75 45.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.08 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.857 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 10.5 t -92.53 148.99 21.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.785 0.326 . . . . 0.0 111.039 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.6 t -147.94 156.6 42.85 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -73.79 111.99 9.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.381 0.61 . . . . 0.0 110.302 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.8 m -89.55 66.88 7.42 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.94 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.16 -60.4 1.94 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.169 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -142.17 -46.15 0.34 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -88.24 160.46 17.68 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.475 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 25.4 m-85 -99.28 122.38 42.36 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.477 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.58 ' HD2' ' HA ' ' A' ' 40' ' ' ASP . 19.6 mmmt -123.2 144.07 49.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 95.1 m -73.42 149.84 42.16 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.237 -0.887 . . . . 0.0 109.382 179.426 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.15 135.44 25.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 123.262 0.351 . . . . 0.0 110.281 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.5 mm -88.98 95.18 5.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.993 0.425 . . . . 0.0 110.108 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 t -150.6 27.8 0.72 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.739 0.781 . . . . 0.0 110.155 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.518 ' CA ' ' HB2' ' A' ' 29' ' ' ARG . . . 107.25 132.17 6.87 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.465 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 30' ' ' PHE . . . -76.97 -20.39 56.15 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.171 0.51 . . . . 0.0 110.542 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 p -137.08 158.85 43.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.876 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -83.17 -51.05 7.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.602 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.941 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 28.1 mttm -126.11 147.3 49.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.737 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . 40.8 m-20 -51.41 -28.72 13.56 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.01 0.819 . . . . 0.0 111.33 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 t -53.74 -32.67 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.049 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -69.18 -25.47 64.36 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.3 m -89.3 135.19 33.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.903 0.383 . . . . 0.0 110.409 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.04 156.05 50.19 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.4 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.4 m -52.71 104.12 0.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.288 0.566 . . . . 0.0 110.442 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.17 -19.66 1.92 Allowed Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.0 p -137.56 157.1 47.26 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.284 -0.458 . . . . 0.0 110.55 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.796 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -140.85 162.3 35.78 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.7 m -91.09 35.52 0.91 Allowed 'General case' 0 C--O 1.239 0.528 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.71 169.34 15.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.909 0.385 . . . . 0.0 110.639 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.739 ' HB1' ' HA ' ' A' ' 26' ' ' ARG . . . -78.96 135.92 37.08 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.8 p -66.47 146.24 54.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.39 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.41 -26.12 66.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.358 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 35.8 p90 -88.02 -29.6 20.59 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.731 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.498 ' HB2' HD13 ' A' ' 28' ' ' ILE . 69.3 m -150.99 122.7 8.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.244 0.545 . . . . 0.0 110.937 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.739 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 99.2 mtt180 -72.32 3.04 5.09 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.495 ' OD1' HD12 ' A' ' 28' ' ' ILE . 20.6 p30 -89.27 -17.04 29.79 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.0 mp -87.48 121.11 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.518 ' HB2' ' CA ' ' A' ' 5' ' ' GLY . 12.7 mtm105 -141.88 39.85 1.66 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.552 ' CD2' HG23 ' A' ' 28' ' ' ILE . 2.2 m-85 -89.57 -175.68 4.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 91.3 m -69.09 79.1 0.34 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.644 HG13 ' SG ' ' A' ' 59' ' ' CYS . 31.1 pt -89.25 146.01 35.3 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.12 144.79 45.55 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.832 3.021 . . . . 0.0 115.042 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.845 HD23 ' HB3' ' A' ' 59' ' ' CYS . 94.8 mt -87.33 160.48 18.37 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.986 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 62' ' ' LYS . . . -61.12 151.38 42.28 Favored Glycine 0 C--O 1.238 0.392 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.1 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 16.3 p30 -118.93 -167.72 1.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 m -62.85 117.59 6.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.873 0.368 . . . . 0.0 111.259 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.53 1.65 68.45 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.759 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 36' ' ' ASN . 18.3 mm-40 -88.38 152.31 22.0 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.678 0.275 . . . . 0.0 111.228 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.468 ' CG ' ' HZ3' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -67.76 143.91 55.64 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.356 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.7 p -147.12 144.4 29.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.986 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.43 ' HB2' ' OG ' ' A' ' 45' ' ' SER . 50.3 m170 -89.46 129.42 47.31 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.82 -41.3 39.06 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.291 2.66 . . . . 0.0 114.236 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.4 12.78 3.38 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.683 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . 5.7 m -91.25 122.54 33.96 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.016 -0.428 . . . . 0.0 110.212 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.586 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 27.6 m170 -88.56 153.71 20.92 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.24 149.3 20.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.54 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.584 HG13 ' HA ' ' A' ' 49' ' ' PRO . 78.3 t -88.91 139.22 29.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.78 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.584 ' HA ' HG13 ' A' ' 48' ' ' VAL . 29.9 Cg_endo -64.17 125.28 4.57 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 123.615 -1.411 . . . . 0.0 113.326 1.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 90.8 t80 -72.77 145.95 46.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.212 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.79 55.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.547 0.689 . . . . 0.0 111.315 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.67 -129.54 3.24 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.941 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 2.6 pptp? -150.72 129.75 12.61 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -77.3 128.45 34.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.277 0.56 . . . . 0.0 112.277 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.1 mt -101.44 15.72 27.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.766 0.793 . . . . 0.0 109.399 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.3 m -89.73 157.58 17.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.657 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 8.1 m -88.34 30.89 0.84 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.186 0.517 . . . . 0.0 110.511 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.3 tp -154.9 127.77 8.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.912 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.845 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -76.35 142.37 71.27 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.683 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 41.9 Cg_endo -68.17 -176.35 1.04 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.039 1.826 . . . . 0.0 112.096 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.0 m -67.15 139.09 57.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.331 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.606 ' HA ' HD13 ' A' ' 34' ' ' LEU . 6.2 ptpp? -67.49 151.5 47.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.8 m -48.34 109.25 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.599 0.562 . . . . 0.0 110.911 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.04 -34.3 2.76 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 76' ' ' CYS . 3.9 mm? -89.16 139.12 30.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.797 0.332 . . . . 0.0 110.809 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -106.12 129.54 54.18 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.957 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 41.9 t -78.34 126.04 30.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.7 t -145.66 156.12 43.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.874 0.368 . . . . 0.0 110.479 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -71.44 107.69 4.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.339 0.59 . . . . 0.0 110.846 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.985 ' HB3' ' HD3' ' A' ' 75' ' ' LYS . 47.7 t -98.4 70.91 2.01 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.871 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.15 -106.02 3.33 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.119 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.617 ' OE1' ' HG2' ' A' ' 73' ' ' LYS . 11.6 tm-20 -89.31 -51.21 5.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.624 0.212 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.617 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 43.7 mmtm -94.76 178.68 5.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.942 0.401 . . . . 0.0 111.141 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -103.88 131.87 50.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.433 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.985 ' HD3' ' HB3' ' A' ' 70' ' ' SER . 3.6 mptp? -130.13 154.63 47.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.029 0.442 . . . . 0.0 110.314 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 61.6 m -77.8 136.22 38.08 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.388 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.723 -1.132 . . . . 0.0 109.365 179.912 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.16 135.26 26.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 110.11 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.3 mm -90.35 118.88 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.367 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.2 p -130.29 35.76 4.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.239 0.542 . . . . 0.0 110.638 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.08 124.45 1.31 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.76 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.06 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -81.22 -12.14 59.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.9 p -141.74 157.04 45.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.09 0.471 . . . . 0.0 111.514 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.752 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 26.7 t70 -105.18 -44.35 4.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.033 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -111.98 139.43 47.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.854 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -53.63 -32.9 53.18 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.725 0.64 . . . . 0.0 111.474 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.3 t -52.7 -28.9 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.314 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -68.23 -29.38 68.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 71.3 m -90.41 140.21 29.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.137 0.494 . . . . 0.0 111.499 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.21 154.58 50.8 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.963 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.9 m -53.46 105.83 0.15 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.353 0.597 . . . . 0.0 110.784 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.39 -28.55 1.79 Allowed Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.6 p -127.62 142.79 51.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.801 -0.7 . . . . 0.0 109.229 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.768 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -125.64 158.84 33.72 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.354 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 81.1 m -88.16 47.94 1.57 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 56' ' ' SER . . . -92.0 162.49 14.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.815 0.341 . . . . 0.0 110.493 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -83.87 134.49 34.69 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.476 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 81.2 p -72.41 137.19 46.32 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.705 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.14 -24.46 67.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.567 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.6 p90 -88.32 -20.03 25.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.878 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.479 ' HB2' HD13 ' A' ' 28' ' ' ILE . 59.9 m -149.24 117.4 6.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.197 0.523 . . . . 0.0 110.955 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -69.07 -13.68 62.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.226 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.446 ' OD1' ' HB3' ' A' ' 25' ' ' SER . 16.1 p-10 -88.29 -15.81 34.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.694 0.283 . . . . 0.0 111.204 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 1.7 mp -88.13 118.78 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.752 ' NH2' ' HA ' ' A' ' 8' ' ' ASP . 28.4 ttp180 -150.43 50.77 0.89 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 1.06 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.1 p90 -117.44 -166.17 1.16 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.637 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.6 m -62.04 76.97 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.077 0.861 . . . . 0.0 112.606 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.694 HG13 ' SG ' ' A' ' 59' ' ' CYS . 39.0 pt -93.31 145.43 30.01 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.89 149.86 75.81 Favored 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 123.243 2.629 . . . . 0.0 114.774 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.768 HD11 ' HB3' ' A' ' 18' ' ' CYS . 7.4 mp -88.09 166.08 14.68 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.059 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.62 151.93 25.79 Favored Glycine 0 C--O 1.239 0.412 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.023 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 5.0 p30 -112.0 -176.38 2.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.8 m -55.18 126.85 26.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.191 0.519 . . . . 0.0 111.783 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.55 -20.62 48.86 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.368 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -89.56 149.25 22.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.709 0.29 . . . . 0.0 110.598 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -68.71 148.37 50.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.794 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.514 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 12.6 p -139.44 147.86 41.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.822 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.442 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 50.2 m170 -89.42 121.0 69.7 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 10.6 Cg_endo -54.99 -36.5 92.62 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.15 2.567 . . . . 0.0 112.66 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.61 -30.79 71.15 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.377 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.8 m -75.68 128.87 36.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.798 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -101.01 166.73 10.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.374 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -55.79 148.76 15.95 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.676 0.61 . . . . 0.0 112.13 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.59 HG13 ' HA ' ' A' ' 49' ' ' PRO . 74.2 t -87.17 140.89 32.56 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.345 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.59 ' HA ' HG13 ' A' ' 48' ' ' VAL . 72.7 Cg_endo -78.03 128.53 16.81 Favored 'Cis proline' 0 C--N 1.346 0.445 0 C-N-CA 123.499 -1.459 . . . . 0.0 113.764 0.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -75.53 134.24 40.81 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.882 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.4 114.47 7.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.64 -133.47 11.74 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.996 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -150.37 141.11 22.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.838 0.351 . . . . 0.0 110.149 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -118.91 137.25 53.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.392 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.72 47.33 1.49 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.501 0.667 . . . . 0.0 109.794 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.409 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 45.7 t -89.66 140.2 29.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.952 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 5.6 m -89.12 13.42 13.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.217 0.532 . . . . 0.0 110.842 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.3 tp -153.93 132.22 11.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.731 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.694 ' SG ' HG13 ' A' ' 32' ' ' ILE . 7.4 m -71.24 150.94 94.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.23 -165.2 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.083 1.855 . . . . 0.0 111.675 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 68.4 m -76.76 141.98 40.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.706 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.559 ' HA ' HD23 ' A' ' 34' ' ' LEU . 19.8 ptmt -57.54 146.24 30.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.065 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.5 m -49.73 120.1 4.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 119.52 -33.18 4.75 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.743 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.3 mt -89.26 165.0 14.7 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.008 0.432 . . . . 0.0 111.964 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.7 m -120.44 132.51 55.26 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.872 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 53.2 t -89.14 125.77 35.18 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.5 t -150.36 155.97 40.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.723 0.297 . . . . 0.0 110.469 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.632 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 36.1 ttpt -69.05 106.03 2.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.293 0.568 . . . . 0.0 110.584 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.514 ' HB2' ' HD3' ' A' ' 75' ' ' LYS . 13.3 m -92.13 58.19 3.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.553 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.07 -100.7 1.33 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.299 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -89.75 -55.69 3.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.945 0.403 . . . . 0.0 110.912 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -100.34 170.76 8.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.314 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 13.1 m-85 -88.68 128.26 35.6 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.514 ' HD3' ' HB2' ' A' ' 70' ' ' SER . 24.2 mtpp -132.7 152.18 51.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.145 0.498 . . . . 0.0 109.694 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.514 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 98.4 m -71.47 134.94 46.92 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.795 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.248 0.978 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.82 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.61 135.19 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 123.287 0.367 . . . . 0.0 110.037 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.4 mm -91.35 118.67 37.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.109 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 8.7 t -151.01 -38.81 0.13 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.466 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.95 118.01 0.63 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.302 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.064 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -91.21 -8.19 49.22 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.1 p -148.6 145.24 27.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.204 0.526 . . . . 0.0 112.368 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.629 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 14.4 t70 -90.21 -32.23 16.69 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.732 0.777 . . . . 0.0 109.325 178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.536 ' HG2' ' H ' ' A' ' 52' ' ' GLY . 55.0 mttp -135.8 139.74 43.72 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.777 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.62 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 41.9 t0 -55.98 -25.49 44.23 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.77 0.669 . . . . 0.0 110.571 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 t -55.03 -29.85 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.688 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.416 HE22 ' HB3' ' A' ' 8' ' ' ASP . 29.5 mt-30 -72.95 -19.6 61.21 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.683 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.451 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 59.1 m -89.53 -120.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.341 . . . . 0.0 110.702 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.28 156.11 15.28 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.736 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.4 m -51.3 104.29 0.08 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.222 0.534 . . . . 0.0 111.016 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.06 -32.96 1.39 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.5 p -138.53 135.7 35.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.824 -0.688 . . . . 0.0 109.173 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.667 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -120.31 162.85 18.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.62 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 62.5 m -87.02 110.55 20.14 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -164.09 172.52 13.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.929 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -74.49 138.13 42.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.054 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.534 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 81.4 p -75.61 141.8 42.78 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.178 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -62.29 -24.11 67.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.882 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -88.27 -25.54 22.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.556 ' HB2' HD13 ' A' ' 28' ' ' ILE . 71.4 m -150.93 130.48 13.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.276 0.56 . . . . 0.0 111.872 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -74.32 -0.06 15.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.689 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 4' ' ' THR . 30.8 m-20 -87.99 -26.76 22.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.883 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.3 mp -87.94 126.95 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 98.9 mtt180 -146.62 67.97 1.17 Allowed 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.687 0.617 . . . . 0.0 109.475 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 1.064 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.0 OUTLIER -142.39 -160.95 1.16 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.165 -179.584 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 24.3 m -61.54 85.22 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.845 0.716 . . . . 0.0 111.668 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.502 HG13 ' SG ' ' A' ' 59' ' ' CYS . 41.4 pt -104.84 149.29 37.36 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.6 148.5 20.8 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.844 3.03 . . . . 0.0 115.035 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.689 HD23 ' HB3' ' A' ' 59' ' ' CYS . 98.6 mt -87.5 159.63 18.56 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.52 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.15 137.64 38.33 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.829 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 68.0 m-80 -95.11 176.06 6.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.026 0.441 . . . . 0.0 110.713 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.9 m -61.24 127.93 33.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.91 -6.59 82.83 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.931 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.8 146.85 24.75 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 120.85 0.357 . . . . 0.0 110.405 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.431 ' O ' HD21 ' A' ' 58' ' ' LEU . 1.6 m-20 -61.29 139.4 58.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.926 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.472 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 25.0 p -135.07 142.4 46.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.19 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 44.2 m170 -88.39 125.38 63.78 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 2.5 Cg_endo -47.37 -36.54 23.44 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.83 3.02 . . . . 0.0 113.304 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.27 37.27 0.2 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.297 0.57 . . . . 0.0 112.031 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.598 ' HB2' ' HB3' ' A' ' 60' ' ' PRO . 6.2 p -92.05 155.89 17.77 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.929 0.395 . . . . 0.0 110.198 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.443 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 33.5 m170 -133.26 143.57 49.19 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -55.34 152.95 7.8 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.566 HG13 ' HA ' ' A' ' 49' ' ' PRO . 95.4 t -87.01 141.56 33.29 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.509 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' HG13 ' A' ' 48' ' ' VAL . 71.8 Cg_endo -78.83 132.21 25.41 Favored 'Cis proline' 0 C--O 1.235 0.355 0 C-N-CA 123.454 -1.477 . . . . 0.0 113.818 1.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.565 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 54.6 t80 -77.72 134.44 38.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.069 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -82.35 119.13 23.76 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.572 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.536 ' H ' ' HG2' ' A' ' 9' ' ' LYS . . . 94.76 -149.82 19.5 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -178.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.629 ' HG3' ' O ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -144.32 133.24 22.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.119 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.469 ' HB2' ' CB ' ' A' ' 20' ' ' ALA . 40.6 mtp85 -70.3 136.47 49.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.367 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.28 -7.64 57.63 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 t -88.38 148.8 24.06 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.462 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.671 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 18.1 m -86.43 44.27 1.13 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.431 HD21 ' O ' ' A' ' 40' ' ' ASP . 24.3 tp -154.41 121.44 5.61 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.689 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -80.09 157.84 73.04 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.496 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.598 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 12.5 Cg_exo -68.28 177.46 4.51 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.066 1.844 . . . . 0.0 111.18 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 77.7 m -68.25 142.28 55.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.491 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.576 ' HG2' HD12 ' A' ' 65' ' ' LEU . 16.5 ptmt -61.71 151.57 33.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.349 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.5 m -45.94 125.84 6.71 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.56 0.538 . . . . 0.0 111.671 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.76 -32.71 6.86 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.83 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.576 HD12 ' HG2' ' A' ' 62' ' ' LYS . 36.0 mt -89.15 155.67 19.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.951 0.405 . . . . 0.0 111.637 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.1 m -127.47 129.29 47.18 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.373 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 48.3 t -71.42 124.81 25.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.3 t -142.98 155.53 44.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.112 0.482 . . . . 0.0 110.753 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -72.43 105.7 4.24 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.418 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.993 ' HB2' ' HD3' ' A' ' 75' ' ' LYS . 13.4 m -98.19 81.08 2.74 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.03 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.69 -109.01 3.29 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.665 ' OE1' ' HG2' ' A' ' 73' ' ' LYS . 1.3 tm-20 -89.24 -49.16 6.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.661 0.231 . . . . 0.0 111.579 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.665 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 43.9 mmtm -92.81 -172.47 3.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.157 0.503 . . . . 0.0 111.396 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -112.21 130.4 55.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.993 ' HD3' ' HB2' ' A' ' 70' ' ' SER . 1.7 mptp? -132.79 152.19 51.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.074 0.464 . . . . 0.0 109.798 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 89.2 m -70.1 118.59 13.13 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.942 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.522 -0.752 . . . . 0.0 109.271 179.37 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.19 133.7 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.81 0.338 . . . . 0.0 110.275 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.684 HG21 HG13 ' A' ' 28' ' ' ILE . 3.9 mp -89.76 116.94 32.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.294 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.539 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 9.1 t -152.08 -36.61 0.12 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.728 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.41 114.5 0.31 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.046 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.82 -12.99 34.68 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.0 p -141.36 145.22 35.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.548 0.69 . . . . 0.0 112.578 -178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.16 -38.61 9.25 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.231 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HD2' ' OD1' ' A' ' 51' ' ' ASP . 14.0 mmtp -115.43 132.54 56.59 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.992 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.673 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 33.0 t70 -56.57 -25.32 52.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.991 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.8 HG22 ' HB2' ' A' ' 49' ' ' PRO . 22.0 t -58.04 -28.28 33.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.351 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -69.93 -20.28 63.35 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.002 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 70.0 m -89.18 129.59 35.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.126 0.489 . . . . 0.0 111.093 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.11 160.28 47.98 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.809 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.6 m -50.17 115.21 1.33 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.361 0.601 . . . . 0.0 110.868 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.625 ' H ' HD12 ' A' ' 34' ' ' LEU . . . 131.74 -28.25 3.58 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.7 p -132.63 158.44 42.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.084 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.659 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -147.57 164.24 34.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.673 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 77.0 m -86.13 112.79 21.63 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -161.34 166.74 27.03 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.146 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.647 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -85.83 149.48 25.21 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.46 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.597 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -67.67 137.37 55.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.835 0.35 . . . . 0.0 110.686 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.757 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -66.04 -24.0 66.65 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.4 p90 -86.98 -36.8 18.07 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.0 m -151.82 142.89 23.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -79.02 40.91 0.42 Allowed 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.06 -0.4 . . . . 0.0 111.511 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -96.28 -38.91 9.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.853 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.684 HG13 HG21 ' A' ' 3' ' ' ILE . 3.2 mp -89.72 131.94 35.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.539 ' HD3' ' O ' ' A' ' 4' ' ' THR . 1.6 mpt_? -143.07 65.2 1.34 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 1.046 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.1 p90 -150.46 -163.27 1.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.9 m -62.17 87.29 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 O-C-N 124.063 0.852 . . . . 0.0 112.187 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.555 HG13 ' SG ' ' A' ' 59' ' ' CYS . 45.0 pt -103.06 158.27 32.1 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 32' ' ' ILE . 11.8 Cg_endo -53.9 142.52 63.59 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.243 2.629 . . . . 0.0 114.502 -177.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.893 HD13 ' HA ' ' A' ' 62' ' ' LYS . 30.5 mt -86.87 158.85 19.24 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.674 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.81 150.13 37.37 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.047 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 3.7 p-10 -117.69 176.95 4.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.674 0.273 . . . . 0.0 110.82 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.3 m -52.38 131.14 32.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.833 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.0 -14.92 61.17 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.245 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.539 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 3.9 mm-40 -106.82 158.4 17.02 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.563 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 42.5 t0 -58.75 149.49 26.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.313 -1.767 . . . . 0.0 113.067 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.77 145.96 26.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -90.81 116.44 66.43 Favored Pre-proline 0 C--N 1.317 -0.821 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.705 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HD3' ' HB2' ' A' ' 74' ' ' PHE . 15.9 Cg_endo -58.46 -42.35 56.01 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.234 2.623 . . . . 0.0 112.927 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.6 -34.71 77.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.466 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.619 ' HB3' ' HD2' ' A' ' 54' ' ' ARG . 19.9 m -72.83 119.36 16.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.307 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.438 ' HB2' ' HD2' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -69.86 144.87 52.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.48 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -63.68 -172.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.561 0.696 . . . . 0.0 111.603 -179.173 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.5 t -85.79 138.18 35.53 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.744 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.8 ' HB2' HG22 ' A' ' 11' ' ' VAL . 72.4 Cg_endo -96.79 135.13 3.9 Favored 'Cis proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.72 -1.367 . . . . 0.0 113.79 1.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.509 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 51.1 t80 -91.67 139.32 30.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.406 178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.433 ' OD1' ' HD2' ' A' ' 9' ' ' LYS . 49.0 t0 -77.03 59.02 1.6 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.861 0.838 . . . . 0.0 110.408 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 153.3 -139.43 6.9 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.83 128.77 20.68 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.619 ' HD2' ' HB3' ' A' ' 45' ' ' SER . 31.9 mtm-85 -70.14 137.1 50.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.315 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.8 58.68 5.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.851 0.834 . . . . 0.0 109.485 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.9 m -143.95 144.2 31.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.348 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.757 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 62.1 m -88.24 41.0 0.98 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.942 0.401 . . . . 0.0 111.21 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.4 tp -153.69 127.11 8.6 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.655 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.841 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.6 m -81.05 141.03 50.03 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.424 ' HD2' ' SG ' ' A' ' 18' ' ' CYS . 49.4 Cg_endo -69.36 -166.97 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.111 1.874 . . . . 0.0 111.821 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.749 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 34.6 m -69.34 137.35 52.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.705 0.288 . . . . 0.0 111.17 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.893 ' HA ' HD13 ' A' ' 34' ' ' LEU . 11.8 ptpt -66.19 148.52 51.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.87 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.6 m -45.61 122.52 3.68 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 123.487 0.492 . . . . 0.0 111.909 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.22 -32.99 5.5 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.09 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.0 mt -89.19 154.71 19.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.934 0.397 . . . . 0.0 111.816 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.0 m -121.89 131.91 54.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.225 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.749 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 9.7 t -91.9 143.17 26.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.798 0.333 . . . . 0.0 110.885 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t -141.22 159.24 42.63 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 27.5 ttpp -69.14 104.34 2.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.312 0.577 . . . . 0.0 110.941 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 10.5 t -89.67 75.96 7.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.478 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.85 -98.27 2.2 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.32 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.45 -56.86 3.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.029 0.443 . . . . 0.0 111.104 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.445 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 14.3 ptpt -98.17 -165.9 1.31 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.82 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.499 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 8.9 m-85 -109.7 133.98 52.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.148 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.563 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 21.8 mttt -132.42 146.8 52.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.535 0.683 . . . . 0.0 110.427 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 67' ' ' CYS . 73.5 m -68.32 150.44 48.21 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.745 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 C--O 1.248 0.984 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.321 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.01 137.75 20.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.4 mm -88.99 115.66 29.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.838 0.351 . . . . 0.0 110.26 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 t -151.1 -36.14 0.14 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.857 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.33 125.58 0.95 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.329 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.076 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -84.18 -8.81 58.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.713 0.292 . . . . 0.0 111.457 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.6 p -148.32 145.96 28.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.762 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.3 -48.38 5.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.242 0.544 . . . . 0.0 109.58 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -102.97 139.54 38.41 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.778 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -55.25 -25.7 35.22 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.76 0.662 . . . . 0.0 111.429 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.427 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 22.0 t -54.16 -31.7 22.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.957 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -67.8 -28.02 67.24 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.3 m -89.58 138.92 31.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.074 0.464 . . . . 0.0 111.458 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.7 164.07 50.26 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.723 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.7 m -57.39 97.83 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.4 0.619 . . . . 0.0 110.763 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 153.64 -24.74 0.74 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.553 ' O ' HG11 ' A' ' 48' ' ' VAL . 25.7 p -137.39 155.24 49.6 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.17 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.786 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -139.09 167.24 22.5 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.1 m -89.3 49.49 1.77 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.965 0.412 . . . . 0.0 111.869 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.621 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -83.98 150.62 25.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.211 0.529 . . . . 0.0 111.101 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -86.6 142.3 28.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.525 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.517 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -61.42 126.05 25.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.981 0.42 . . . . 0.0 110.613 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.45 -21.61 65.57 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -86.99 -32.82 19.85 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.896 -0.321 . . . . 0.0 111.309 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.1 m -151.65 130.69 12.61 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -76.21 56.96 1.08 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.282 0.563 . . . . 0.0 111.189 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -118.5 -43.34 2.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.501 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 3.0 mp -88.97 128.16 41.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.313 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -152.07 58.65 0.85 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.763 0.792 . . . . 0.0 109.816 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 1.076 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.2 p90 -126.96 -170.95 2.3 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.533 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.7 m -60.43 79.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.061 0.85 . . . . 0.0 112.947 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.621 HD11 ' HB3' ' A' ' 20' ' ' ALA . 40.9 pt -95.83 151.93 38.71 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.05 148.54 38.89 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.331 2.687 . . . . 0.0 114.507 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.786 HD21 ' HB3' ' A' ' 18' ' ' CYS . 92.5 mt -86.93 171.05 11.09 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.509 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.64 145.29 32.58 Favored Glycine 0 C--O 1.241 0.553 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.88 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -88.79 -177.27 5.48 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.189 0.596 . . . . 0.0 110.948 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -61.72 132.33 52.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.036 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.519 ' O ' ' HD3' ' A' ' 75' ' ' LYS . . . 81.94 -3.97 77.54 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.259 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.543 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -88.91 157.32 18.46 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 117.448 0.624 . . . . 0.0 112.039 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.634 ' HB3' HD21 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -60.89 144.43 52.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.733 -178.312 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.4 p -150.53 145.36 25.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.535 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.527 ' HB2' ' OG ' ' A' ' 45' ' ' SER . 56.7 m170 -89.51 128.92 49.04 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.02 -39.61 90.07 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.918 2.412 . . . . 0.0 112.962 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.83 97.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.464 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.713 ' HB2' ' HG3' ' A' ' 60' ' ' PRO . 10.8 p -76.98 132.6 39.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -109.13 -160.93 0.74 Allowed 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.301 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.51 146.19 42.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.032 0.444 . . . . 0.0 111.382 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.553 HG11 ' O ' ' A' ' 17' ' ' THR . 40.8 t -88.34 143.38 32.44 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.847 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.551 ' HA ' ' CG1' ' A' ' 48' ' ' VAL . 16.4 Cg_exo -69.04 124.51 7.32 Favored 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 124.128 -1.197 . . . . 0.0 113.717 0.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.434 ' N ' ' HA ' ' A' ' 48' ' ' VAL . 79.9 t80 -89.06 133.4 34.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.761 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.22 111.46 10.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.036 0.446 . . . . 0.0 109.84 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 122.83 -157.86 17.42 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.582 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -152.68 132.83 13.5 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -130.01 153.41 48.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.898 0.38 . . . . 0.0 111.03 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.51 45.02 0.98 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.217 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.0 m -89.52 138.42 31.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.978 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 20.4 m -89.98 30.3 1.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.32 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.634 HD21 ' HB3' ' A' ' 40' ' ' ASP . 60.9 tp -153.55 125.35 7.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.756 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.764 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -76.38 141.29 69.72 Favored Pre-proline 0 C--N 1.327 -0.377 0 O-C-N 123.26 0.35 . . . . 0.0 110.423 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.713 ' HG3' ' HB2' ' A' ' 45' ' ' SER . 6.5 Cg_exo -70.93 -167.22 0.26 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.515 2.143 . . . . 0.0 112.329 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 61.5 m -70.55 138.86 51.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.045 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 15.5 ptpt -76.4 -179.15 4.97 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.563 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.7 m -52.91 131.28 35.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.839 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.25 -31.03 6.61 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.913 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 61' ' ' CYS . 3.6 mm? -88.9 144.86 25.91 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.373 0.606 . . . . 0.0 112.302 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.3 m -121.97 132.59 54.61 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.295 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.9 t -76.56 130.61 38.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.209 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t -149.77 159.83 44.04 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' NZ ' ' HA ' ' A' ' 72' ' ' GLU . 47.0 tttm -71.8 104.01 3.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.298 0.571 . . . . 0.0 110.043 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 t -92.59 80.87 4.79 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.57 -101.88 2.5 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.505 ' HA ' ' OE1' ' A' ' 72' ' ' GLU . 36.5 tp10 -98.15 -50.88 4.2 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.531 -0.468 . . . . 0.0 112.006 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.53 -174.55 3.52 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.513 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -104.53 133.46 49.35 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.045 0.45 . . . . 0.0 110.897 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 47.8 mttm -141.42 155.78 45.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.94 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 67.5 m -69.15 140.42 54.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.284 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 C--O 1.244 0.771 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.191 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.17 128.8 41.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.158 0.504 . . . . 0.0 110.484 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.8 mm -89.75 91.42 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.136 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -151.21 -32.55 0.16 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.444 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.68 130.75 1.85 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.0 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.511 ' HB3' ' HA ' ' A' ' 30' ' ' PHE . . . -90.48 -23.7 20.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.947 0.403 . . . . 0.0 110.658 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.57 -142.93 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.069 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -164.16 -45.14 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.2 0.524 . . . . 0.0 110.857 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -109.33 135.41 50.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.78 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.598 ' HB3' HG23 ' A' ' 48' ' ' VAL . 56.7 m-20 -46.28 -38.28 8.42 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.019 0.824 . . . . 0.0 112.09 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.7 t -48.15 -35.09 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.565 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -68.34 -33.2 73.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.444 ' HB3' ' OG1' ' A' ' 17' ' ' THR . 37.8 m -93.45 -31.91 14.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.201 0.524 . . . . 0.0 111.946 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.0 159.63 34.3 Favored Glycine 0 C--N 1.314 -0.641 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.409 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -61.1 80.5 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.496 0.665 . . . . 0.0 111.835 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 177.67 -33.55 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 13' ' ' CYS . 7.5 p -137.21 147.33 45.77 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.531 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -130.59 159.11 38.15 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.08 -178.448 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.4 m -89.54 46.37 1.36 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.581 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.42 159.38 18.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.913 0.387 . . . . 0.0 110.946 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.754 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -78.57 131.63 36.83 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.477 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 89.6 p -61.64 139.38 58.29 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.621 -178.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.1 -24.68 63.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.294 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -87.98 -27.25 22.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.684 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.601 ' HB3' HD13 ' A' ' 28' ' ' ILE . 8.6 t -151.24 126.62 10.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.148 0.499 . . . . 0.0 111.042 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -73.23 4.72 4.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.392 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -88.91 -19.55 25.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.029 0.443 . . . . 0.0 110.479 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.754 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.5 mp -87.98 120.13 36.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 45.0 mtp85 -141.59 42.52 1.73 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 123.761 0.663 . . . . 0.0 109.454 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.691 ' CD2' HG23 ' A' ' 28' ' ' ILE . 1.3 m-85 -97.67 -175.07 3.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 99.8 m -72.62 80.43 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.416 0.448 . . . . 0.0 110.237 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.601 HG13 ' SG ' ' A' ' 59' ' ' CYS . 39.3 pt -89.03 148.42 41.01 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.3 156.15 26.84 Favored 'Trans proline' 0 N--CA 1.473 0.29 0 C-N-CA 123.329 2.686 . . . . 0.0 114.3 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.679 HD23 ' HA ' ' A' ' 62' ' ' LYS . 4.1 mp -86.94 165.48 15.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.413 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.77 134.11 37.81 Favored Glycine 0 C--O 1.24 0.529 0 CA-C-N 115.143 -0.935 . . . . 0.0 113.028 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 2.7 p30 -95.06 -179.72 4.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.285 0.564 . . . . 0.0 111.304 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -61.39 122.72 15.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.904 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.06 4.13 90.07 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.238 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -88.56 148.42 24.11 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 117.29 0.545 . . . . 0.0 109.664 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.28 138.4 55.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.424 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.2 p -136.8 153.34 50.84 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.076 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -89.76 122.57 67.91 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -57.42 -40.2 83.24 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.897 2.398 . . . . 0.0 112.602 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.6 -36.76 81.45 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.23 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.9 m -66.27 113.13 4.36 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.221 0.534 . . . . 0.0 110.385 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -70.98 153.94 42.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.76 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 60' ' ' PRO . 57.5 mtpt -65.36 176.06 1.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.216 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.598 HG23 ' HB3' ' A' ' 10' ' ' ASP . 10.0 p -88.62 139.7 29.7 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.029 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HA ' HG23 ' A' ' 48' ' ' VAL . 89.5 Cg_endo -89.04 134.2 11.41 Favored 'Cis proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.768 -1.347 . . . . 0.0 113.055 0.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.612 ' HB2' ' NH2' ' A' ' 54' ' ' ARG . 66.1 t80 -75.29 130.82 39.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.124 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -87.65 130.01 34.94 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.66 -113.6 3.83 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.863 ' HD3' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -150.53 126.88 10.69 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.473 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.612 ' NH2' ' HB2' ' A' ' 50' ' ' TYR . 60.5 ttm-85 -85.84 102.24 13.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.157 0.504 . . . . 0.0 111.771 -177.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.863 HD23 ' HD3' ' A' ' 53' ' ' LYS . 1.3 mm? -105.33 27.04 8.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.423 0.63 . . . . 0.0 109.925 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.8 m -89.7 148.46 23.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.944 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 4.3 m -88.93 21.83 2.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.829 0.347 . . . . 0.0 111.493 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.37 136.13 14.45 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.601 ' SG ' HG13 ' A' ' 32' ' ' ILE . 1.8 m -75.54 153.04 85.59 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.499 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 64.6 Cg_endo -72.52 174.06 12.25 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.115 1.877 . . . . 0.0 110.995 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.3 m -68.66 139.29 55.45 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.557 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.679 ' HA ' HD23 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -58.4 154.1 14.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.827 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.5 m -44.59 129.17 6.82 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.611 0.569 . . . . 0.0 111.226 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.61 -38.28 3.28 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.954 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.1 mt -88.84 154.93 19.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.883 0.373 . . . . 0.0 111.618 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.0 m -135.8 139.48 43.52 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.866 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 23.2 t -72.26 128.73 36.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.763 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.7 t -150.04 156.94 42.58 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 31.9 ttpt -73.19 110.08 7.21 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.301 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.466 ' HB3' ' HD2' ' A' ' 75' ' ' LYS . 10.5 t -93.24 63.04 3.56 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.372 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.76 -93.56 1.49 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.052 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.499 ' OE2' ' HG3' ' A' ' 73' ' ' LYS . 2.0 tt0 -88.33 -54.49 4.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.477 -0.362 . . . . 0.0 111.042 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 34.7 mtmm -112.91 177.99 4.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.13 0.491 . . . . 0.0 111.58 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 8.5 m-85 -89.21 133.95 34.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.268 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.466 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 56.4 mttm -136.66 154.55 50.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.719 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 95.6 m -75.54 128.43 35.28 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.953 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.252 1.236 0 CA-C-O 117.531 -1.223 . . . . 0.0 109.152 179.934 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.884 0.373 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.4 p -150.91 140.2 15.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.39 106.58 17.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.88 0.371 . . . . 0.0 110.41 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.1 t -151.98 -38.99 0.11 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.545 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.91 123.96 1.15 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.07 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.087 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.25 -13.29 35.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.814 0.34 . . . . 0.0 111.107 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 30' ' ' PHE . 17.3 p -151.19 -152.03 0.42 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.87 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -163.59 -43.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.441 0.639 . . . . 0.0 109.362 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -106.59 133.29 51.5 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.592 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -52.73 -31.16 36.49 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.557 0.536 . . . . 0.0 111.184 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.8 t -51.61 -32.05 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.407 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -70.68 -32.73 70.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.126 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.4 m -95.23 -46.32 6.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.209 0.528 . . . . 0.0 112.228 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.89 153.19 9.57 Favored Glycine 0 C--N 1.31 -0.886 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.714 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.453 ' HA ' HG11 ' A' ' 48' ' ' VAL . 16.2 m -57.13 98.23 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.546 0.689 . . . . 0.0 110.776 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.509 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . 161.08 -31.43 0.35 Allowed Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.428 HG22 ' HA ' ' A' ' 33' ' ' PRO . 22.8 p -135.14 139.0 44.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.824 -0.688 . . . . 0.0 109.334 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -111.34 156.66 21.22 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.0 m -97.23 45.83 1.04 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.399 . . . . 0.0 111.369 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -84.79 178.38 7.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.117 0.484 . . . . 0.0 111.469 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.82 142.21 28.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.378 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.675 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -60.69 139.65 57.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.148 0.499 . . . . 0.0 111.649 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.751 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -64.17 -26.17 68.4 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -86.25 -42.37 13.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.899 0.38 . . . . 0.0 111.609 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.1 m -151.96 136.79 17.15 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.408 ' NH2' ' HB3' ' A' ' 55' ' ' LEU . 99.3 mtt180 -74.86 51.7 0.5 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -101.89 -35.38 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.841 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.675 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 53.1 mt -88.8 131.11 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.279 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 6.2 mtp180 -150.16 49.19 0.91 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.912 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 1.087 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.4 p90 -128.51 -168.86 1.97 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.582 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 33.1 m -59.21 82.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.222 0.952 . . . . 0.0 112.44 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.613 HG13 ' SG ' ' A' ' 59' ' ' CYS . 23.8 pt -104.27 143.79 27.38 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.428 ' HA ' HG22 ' A' ' 17' ' ' THR . 13.6 Cg_endo -56.57 159.22 14.11 Favored 'Trans proline' 0 CA--C 1.529 0.225 0 C-N-CA 123.197 2.598 . . . . 0.0 114.112 -177.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 95.1 mt -84.86 167.91 15.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.174 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.09 144.73 35.23 Favored Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.714 -0.676 . . . . 0.0 113.726 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.566 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 0.1 OUTLIER -118.07 -167.21 1.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.062 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.448 ' OG ' HD11 ' A' ' 65' ' ' LEU . 6.1 m -59.21 125.26 22.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.789 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.59 0.14 82.26 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.28 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -88.0 148.38 24.57 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 117.068 0.434 . . . . 0.0 110.541 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.534 ' O ' HD13 ' A' ' 58' ' ' LEU . 12.3 t70 -68.05 145.61 54.29 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.984 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.4 p -150.14 143.83 25.31 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' A' ' 44' ' ' ALA . 48.0 m80 -88.32 139.75 30.26 Favored Pre-proline 0 C--N 1.319 -0.747 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.862 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.73 38.03 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.196 2.597 . . . . 0.0 113.106 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 42' ' ' HIS . . . -172.57 33.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.384 0.674 . . . . 0.0 109.266 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -80.71 133.23 35.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.433 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.493 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 19.8 m170 -80.66 146.85 30.92 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -67.57 166.34 15.11 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.453 HG11 ' HA ' ' A' ' 15' ' ' SER . 58.8 t -86.33 136.99 34.88 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.435 ' HA ' HG13 ' A' ' 48' ' ' VAL . 15.7 Cg_exo -69.42 128.58 12.44 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 123.898 -1.293 . . . . 0.0 114.061 1.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 71.9 t80 -71.48 154.61 41.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.506 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.521 ' OD2' ' HG3' ' A' ' 53' ' ' LYS . 5.3 p-10 -56.33 -33.2 65.39 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.698 0.285 . . . . 0.0 111.528 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.38 34.09 67.45 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.248 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.521 ' HG3' ' OD2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -129.36 -22.76 3.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -75.24 150.6 38.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.067 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.446 ' N ' ' HD3' ' A' ' 54' ' ' ARG . 3.7 mm? -85.46 56.66 4.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.2 0.524 . . . . 0.0 111.565 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 51.3 m -89.31 128.5 35.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.27 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.751 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 15.2 m -89.67 26.61 1.71 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 40' ' ' ASP . 1.6 pp -153.97 172.16 17.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.073 0.463 . . . . 0.0 110.921 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.613 ' SG ' HG13 ' A' ' 32' ' ' ILE . 37.1 m -106.23 143.2 26.47 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.012 178.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.437 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 32.4 Cg_exo -57.14 159.52 15.08 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.539 2.159 . . . . 0.0 111.721 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 32.5 m -59.22 134.09 56.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.269 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.615 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 15.4 ptpt -70.38 163.31 26.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.251 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.0 m -47.62 124.69 7.41 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.397 0.435 . . . . 0.0 111.367 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.18 -30.07 10.56 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.11 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 36' ' ' ASN . 4.0 mm? -88.48 136.55 32.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.792 0.33 . . . . 0.0 111.006 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.5 m -116.77 124.74 50.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.467 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.5 t -71.23 125.18 26.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.7 t -150.3 158.06 43.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.836 0.35 . . . . 0.0 110.125 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.611 ' HE2' ' O ' ' A' ' 71' ' ' GLY . 85.3 tttt -71.8 105.92 3.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.257 0.551 . . . . 0.0 110.739 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 15.1 m -89.75 64.49 6.5 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.796 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.611 ' O ' ' HE2' ' A' ' 69' ' ' LYS . . . 96.16 -97.58 2.08 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.825 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.424 ' O ' ' HE3' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -91.83 -55.73 3.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.361 0.6 . . . . 0.0 110.085 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.788 ' HE3' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -100.09 171.07 8.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.332 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.589 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 9.1 m-85 -94.92 133.69 38.4 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.852 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.589 ' HD2' ' O ' ' A' ' 74' ' ' PHE . 14.1 mptt -135.58 157.1 47.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.605 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 82.5 m -76.21 118.53 19.03 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.576 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 C--O 1.253 1.256 0 CA-C-O 117.701 -1.143 . . . . 0.0 109.381 179.855 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.09 134.39 28.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.876 0.37 . . . . 0.0 110.294 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 mm -88.93 97.51 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 t -150.82 -33.34 0.16 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.184 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.46 116.24 0.64 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.491 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.052 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.96 -9.5 45.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.703 -0.248 . . . . 0.0 111.375 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 30' ' ' PHE . 12.6 p -150.69 146.37 26.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.227 0.537 . . . . 0.0 111.696 -178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.06 -42.86 12.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.992 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -121.62 145.42 48.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.218 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 50' ' ' TYR . 1.6 m-20 -54.74 -27.37 40.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.223 0.535 . . . . 0.0 110.148 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.822 HG22 ' HB2' ' A' ' 49' ' ' PRO . 77.6 t -52.47 -35.01 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.057 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -72.46 -21.93 61.15 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 97.6 m -89.09 141.4 28.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.222 0.534 . . . . 0.0 111.585 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.32 157.49 52.1 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.073 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.506 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 19.9 m -54.29 112.28 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.17 0.509 . . . . 0.0 110.312 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.467 ' C ' ' HG ' ' A' ' 34' ' ' LEU . . . 136.46 -22.84 3.33 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 p -136.01 152.24 50.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.196 -0.502 . . . . 0.0 110.232 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.6 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -135.74 162.15 33.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 59.8 m -89.07 49.28 1.75 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.641 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -82.07 163.26 22.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.98 0.419 . . . . 0.0 110.631 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.694 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -83.93 145.16 28.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.619 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.651 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -58.11 130.46 46.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.945 0.403 . . . . 0.0 110.703 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.822 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -58.4 -27.06 63.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -85.5 -38.77 18.2 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.861 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m -150.83 136.1 17.72 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.139 -0.351 . . . . 0.0 110.431 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.92 55.05 0.17 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.051 0.54 . . . . 0.0 111.823 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -114.91 -38.76 3.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.966 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.694 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 1.9 mp -88.09 133.58 30.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.81 0.338 . . . . 0.0 110.401 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.2 mmm-85 -144.63 57.18 1.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.985 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 1.052 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.0 p90 -136.1 -173.28 3.35 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.171 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.5 m -59.04 84.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 O-C-N 124.295 0.997 . . . . 0.0 113.111 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.641 HD11 ' HB3' ' A' ' 20' ' ' ALA . 38.9 pt -102.0 151.01 37.94 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.32 151.7 28.41 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.365 2.71 . . . . 0.0 114.77 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.6 HD21 ' HB3' ' A' ' 18' ' ' CYS . 80.7 mt -87.52 165.35 15.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.361 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.9 145.97 39.13 Favored Glycine 0 C--O 1.241 0.541 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.594 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 1.5 t-20 -96.82 -175.92 3.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.413 0.625 . . . . 0.0 111.253 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.8 m -60.97 129.26 40.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.555 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.99 -4.64 82.4 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.865 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.17 149.12 23.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.99 0.395 . . . . 0.0 110.519 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.631 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 1.1 t70 -63.96 141.56 58.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.357 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 74' ' ' PHE . 25.0 p -141.81 139.38 32.72 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.067 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 33.2 m170 -89.12 128.41 51.8 Favored Pre-proline 0 C--N 1.318 -0.797 0 C-N-CA 120.086 -0.645 . . . . 0.0 109.653 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 0.9 OUTLIER -44.64 -49.47 9.29 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 124.17 3.246 . . . . 0.0 114.608 -177.318 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.42 31.56 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.89 0.376 . . . . 0.0 111.821 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.423 ' O ' ' HD3' ' A' ' 54' ' ' ARG . 14.5 m -90.72 -20.23 22.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.135 0.493 . . . . 0.0 110.469 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.763 ' HD2' ' HB2' ' A' ' 56' ' ' SER . 3.7 m-70 -169.36 125.89 0.9 Allowed 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.739 ' H ' ' HB2' ' A' ' 50' ' ' TYR . 9.2 mmmm -140.39 177.74 7.79 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 61.4 t -125.95 107.7 25.23 Favored Pre-proline 0 C--N 1.32 -0.7 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.224 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.822 ' HB2' HG22 ' A' ' 11' ' ' VAL . 59.0 Cg_endo -96.49 129.46 3.38 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.483 -1.049 . . . . 0.0 112.79 -0.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.739 ' HB2' ' H ' ' A' ' 47' ' ' LYS . 1.3 t80 -82.74 124.12 29.94 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -76.83 -38.4 53.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.67 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.53 -167.75 29.56 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.549 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -152.51 140.82 20.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.593 0.235 . . . . 0.0 110.569 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 45' ' ' SER . 6.9 ptm180 -167.24 159.53 12.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.1 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.75 54.04 2.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.928 0.394 . . . . 0.0 111.912 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.763 ' HB2' ' HD2' ' A' ' 46' ' ' HIS . 50.9 m -88.31 127.19 35.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.822 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 20.8 m -88.81 44.44 1.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.4 tp -153.37 126.57 8.52 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.399 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.563 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -87.47 148.04 43.34 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.107 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 46' ' ' HIS . 42.1 Cg_endo -66.96 -177.99 1.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.488 2.125 . . . . 0.0 111.715 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 81.6 m -69.81 141.33 53.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.767 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.511 ' HA ' HD12 ' A' ' 34' ' ' LEU . 9.6 ptmm? -62.35 148.64 44.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.775 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.506 ' OG ' ' HB3' ' A' ' 15' ' ' SER . 10.2 m -46.33 130.92 10.74 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 123.44 0.463 . . . . 0.0 111.274 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.41 -30.23 10.21 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.774 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.9 mt -91.4 147.56 22.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.747 0.308 . . . . 0.0 111.464 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -108.41 126.49 52.94 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.323 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.422 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 54.1 t -83.59 116.21 22.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.0 t -137.48 157.9 45.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.765 0.316 . . . . 0.0 110.185 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 84.1 tttt -69.25 105.44 2.52 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.358 0.599 . . . . 0.0 111.198 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -92.92 77.14 4.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.746 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.452 ' O ' ' HE2' ' A' ' 69' ' ' LYS . . . 87.42 -102.52 2.8 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.579 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.548 ' O ' ' HE3' ' A' ' 69' ' ' LYS . 5.2 tm-20 -91.28 -53.08 4.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.739 0.304 . . . . 0.0 110.634 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.428 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 45.2 mmtm -98.21 171.2 8.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.073 0.463 . . . . 0.0 111.241 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 6.3 m-85 -92.19 138.34 31.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.462 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.631 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 48.8 mttp -143.92 155.08 43.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.23 0.538 . . . . 0.0 110.439 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 59.8 m -70.96 135.67 48.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.942 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.3 m . . . . . 0 C--O 1.255 1.364 0 CA-C-O 117.557 -1.211 . . . . 0.0 108.888 179.548 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 121.803 0.811 . . . . 0.0 110.008 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.19 128.16 1.08 Allowed Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.878 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.722 ' HB3' ' HA ' ' A' ' 30' ' ' PHE . . . -90.57 -33.73 15.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.279 0.562 . . . . 0.0 110.158 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 5.0 p -152.0 -165.0 2.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.152 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.461 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 27.4 t70 -141.72 -40.45 0.37 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.311 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -105.61 128.41 53.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.436 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' A' ' 49' ' ' PRO . 12.9 m-20 -54.84 -24.56 23.58 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.591 0.557 . . . . 0.0 111.069 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.53 -31.42 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.834 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -69.27 -29.59 67.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.287 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.451 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 59.7 m -93.49 -119.09 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.048 0.451 . . . . 0.0 110.545 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.96 157.8 30.39 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 m -53.39 117.29 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.068 0.461 . . . . 0.0 110.481 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.22 -23.98 5.41 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.9 p -128.34 142.13 51.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.601 -0.3 . . . . 0.0 110.211 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.69 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -123.05 154.48 38.47 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.2 m -91.51 38.58 0.98 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.932 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -88.69 -173.02 3.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.766 0.317 . . . . 0.0 110.558 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.639 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.33 140.56 29.58 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.466 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 93.6 p -67.75 144.46 55.4 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.467 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.07 65.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.354 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 41.7 p90 -87.65 -32.21 19.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.477 ' HB2' HD13 ' A' ' 28' ' ' ILE . 67.4 m -149.93 127.38 11.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.401 0.619 . . . . 0.0 112.287 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.457 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -69.85 5.34 1.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.725 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -88.58 -24.68 22.8 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.323 0.582 . . . . 0.0 109.895 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.639 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.4 mp -87.38 122.89 39.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.534 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 31.9 mtp180 -140.64 46.08 1.8 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.269 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.722 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 0.3 OUTLIER -98.53 -172.91 2.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 38.3 m -71.67 78.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.664 HG13 ' SG ' ' A' ' 59' ' ' CYS . 17.0 pt -88.75 142.7 30.9 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.739 0.304 . . . . 0.0 110.583 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.79 150.33 71.81 Favored 'Trans proline' 0 N--CA 1.475 0.409 0 C-N-CA 123.413 2.742 . . . . 0.0 114.834 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.69 HD11 ' HB3' ' A' ' 18' ' ' CYS . 8.1 mp -87.11 167.3 14.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.164 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.98 141.2 32.52 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.882 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 68.9 m-80 -102.46 -168.13 1.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.856 0.36 . . . . 0.0 110.893 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 m -62.2 125.59 24.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.056 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.18 1.68 86.24 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.569 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 20.8 mm-40 -88.92 150.44 22.85 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.853 0.359 . . . . 0.0 110.748 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.501 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -73.64 139.39 45.42 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.371 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.9 p -138.4 148.44 44.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.275 0.56 . . . . 0.0 110.388 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -89.25 122.63 68.45 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.76 -31.56 95.28 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.825 2.35 . . . . 0.0 111.929 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.447 ' HB1' HH22 ' A' ' 54' ' ' ARG . . . -70.83 -22.3 62.34 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.641 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.48 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 46.7 m -79.9 125.79 30.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.907 0.384 . . . . 0.0 110.219 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.412 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 34.9 m170 -86.41 168.92 13.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.477 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -57.83 149.0 23.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 49' ' ' PRO . 42.7 t -87.71 136.65 32.53 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.057 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HA ' HG13 ' A' ' 48' ' ' VAL . 15.9 Cg_exo -69.31 136.98 40.51 Favored 'Cis proline' 0 C--N 1.35 0.623 0 C-N-CA 123.871 -1.304 . . . . 0.0 112.819 0.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 53.9 t80 -63.72 127.96 33.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.866 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.16 58.03 1.95 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.373 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 158.92 -143.05 8.85 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.026 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -136.19 136.72 40.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.451 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 1.7 tpt180 -157.85 126.62 5.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.0 mp -89.1 52.89 2.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.337 0.589 . . . . 0.0 110.764 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.449 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 54.7 m -88.82 138.64 31.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.399 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 13.4 m -89.92 32.35 0.91 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.457 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.6 tp -154.62 127.81 8.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.985 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.664 ' SG ' HG13 ' A' ' 32' ' ' ILE . 54.8 m -74.97 145.03 80.5 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 17.0 Cg_exo -67.59 -168.34 0.18 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.496 2.131 . . . . 0.0 111.704 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 81.5 m -72.17 140.46 48.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.651 0.262 . . . . 0.0 111.04 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.452 ' HG3' HD12 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -63.97 152.89 38.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.073 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.9 m -49.28 123.95 8.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.51 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.05 -32.4 6.73 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.261 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.452 HD12 ' HG3' ' A' ' 62' ' ' LYS . 28.3 mt -89.8 151.39 21.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.068 0.461 . . . . 0.0 112.147 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -111.63 134.45 53.2 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.388 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.501 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 46.2 t -88.45 120.07 29.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.6 t -150.44 155.86 40.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 32.8 ttpt -61.63 114.38 3.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.08 0.467 . . . . 0.0 110.015 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 14.7 m -123.74 50.15 1.65 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.296 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.1 -112.29 0.84 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.66 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.859 ' HG2' ' HG3' ' A' ' 73' ' ' LYS . 2.7 pm0 -86.68 -37.63 17.79 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.29 0.567 . . . . 0.0 109.912 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.859 ' HG3' ' HG2' ' A' ' 72' ' ' GLU . 9.8 mtmp? -131.31 -165.02 1.51 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.987 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 3.5 m-85 -89.67 139.45 30.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.672 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.54 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 51.0 mttp -137.9 154.92 49.39 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 63.2 m -78.94 134.41 36.85 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.72 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.0 m . . . . . 0 C--O 1.245 0.835 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.354 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 121.744 0.783 . . . . 0.0 109.919 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.85 97.66 0.68 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.375 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.048 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -78.0 -12.31 59.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.836 0.35 . . . . 0.0 111.573 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 p -150.83 152.12 33.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.928 0.394 . . . . 0.0 111.524 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.451 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 7.6 t70 -106.23 -50.2 3.21 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -89.66 130.34 35.96 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.521 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 34.4 t70 -55.51 -28.46 54.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.619 0.724 . . . . 0.0 110.081 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.613 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 42.9 t -54.79 -29.35 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.24 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -65.59 -26.71 67.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.463 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 76.7 m -89.95 132.5 35.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.128 0.49 . . . . 0.0 111.175 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.37 158.78 53.42 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.911 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.1 m -52.95 107.92 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.307 0.575 . . . . 0.0 110.995 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.06 -30.88 2.0 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 35.5 p -132.35 149.25 52.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.291 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.859 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -136.03 162.81 31.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.861 0.3 . . . . 0.0 110.807 -178.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.521 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 65.3 m -87.82 85.99 7.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.043 0.449 . . . . 0.0 110.031 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.551 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -130.97 157.45 42.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.562 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -85.81 144.34 27.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.295 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.717 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -65.58 140.89 58.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.035 0.445 . . . . 0.0 111.003 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -66.81 -24.67 66.2 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -87.06 -36.08 18.36 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.1 m -151.53 138.93 19.44 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -80.31 35.29 0.33 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.919 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -89.86 -38.47 13.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.266 0.555 . . . . 0.0 109.885 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.717 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.4 mp -88.33 126.77 41.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.451 ' NH2' ' HA ' ' A' ' 8' ' ' ASP . 0.8 OUTLIER -150.93 57.17 0.91 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 1.048 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.6 p90 -138.69 -169.32 2.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.234 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.8 m -58.47 98.16 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 O-C-N 124.028 0.83 . . . . 0.0 112.236 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.616 HG13 ' SG ' ' A' ' 59' ' ' CYS . 33.1 pt -116.68 149.48 43.98 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.74 144.63 53.19 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.629 2.886 . . . . 0.0 115.434 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.859 HD11 ' HB3' ' A' ' 18' ' ' CYS . 7.4 mp -88.11 173.85 8.59 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.915 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.01 143.54 23.2 Favored Glycine 0 C--O 1.239 0.429 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.771 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.562 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 71.4 m-80 -99.65 -169.77 1.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.909 0.385 . . . . 0.0 111.057 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.7 m -61.0 128.06 34.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.101 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.26 8.77 85.65 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.834 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 2.2 mm-40 -88.89 161.64 16.57 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.807 0.337 . . . . 0.0 110.972 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -71.3 137.36 48.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.909 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.83 142.56 28.96 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -89.95 124.23 64.09 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -56.36 -39.95 87.91 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.794 2.33 . . . . 0.0 112.147 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.56 -38.98 77.65 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.373 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.4 m -66.29 101.37 0.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.325 0.583 . . . . 0.0 109.954 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 66.0 m-70 -68.6 148.27 50.73 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.053 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 63' ' ' SER . 52.0 tttm -54.15 163.72 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.493 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.511 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 44.5 t -85.01 143.08 39.35 Favored Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.629 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.613 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 18.9 Cg_endo -91.99 129.85 6.53 Favored 'Cis proline' 0 N--CA 1.461 -0.415 0 C-N-CA 124.013 -1.245 . . . . 0.0 114.495 1.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.518 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 20.4 t80 -87.15 128.57 35.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.838 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -82.69 61.56 5.85 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.463 -0.773 . . . . 0.0 110.789 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.13 176.62 44.48 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.459 ' H ' ' HD2' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -89.81 126.05 35.54 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.408 HH12 ' CG ' ' A' ' 10' ' ' ASP . 22.6 ttm105 -75.19 120.24 20.42 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.3 -2.19 58.44 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.223 0.535 . . . . 0.0 110.594 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.4 m -87.31 142.73 27.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.579 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 30.2 m -88.0 34.76 0.73 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.901 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.7 tp -154.31 130.73 10.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.709 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.616 ' SG ' HG13 ' A' ' 32' ' ' ILE . 9.8 m -76.06 148.79 81.83 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -72.92 -166.15 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.425 2.083 . . . . 0.0 111.792 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 72.2 m -76.46 140.59 41.32 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.335 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.587 ' HA ' HD23 ' A' ' 34' ' ' LEU . 11.1 ptmm? -60.88 148.17 40.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.997 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.527 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 68.1 m -51.04 131.77 27.26 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.142 0.496 . . . . 0.0 110.551 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.95 -28.68 10.18 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 mt -102.51 150.58 23.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.359 -0.42 . . . . 0.0 110.871 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.9 m -118.92 131.64 56.05 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.23 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 52.5 t -78.14 125.67 29.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.889 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.8 t -150.52 155.99 40.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 80.7 tttt -65.79 123.17 19.04 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.989 0.423 . . . . 0.0 110.266 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 15.6 m -128.0 41.6 3.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.255 0.55 . . . . 0.0 110.24 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 144.97 -112.72 0.67 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.03 -45.65 10.0 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.104 0.478 . . . . 0.0 109.748 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -110.98 -158.64 0.65 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.162 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 5.4 m-85 -107.38 137.24 45.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.81 0.338 . . . . 0.0 110.949 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 5.5 mptp? -126.83 159.44 33.87 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 70.1 m -81.17 131.99 35.33 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.824 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.244 0.783 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.842 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.714 0.292 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.82 124.77 0.76 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.009 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.094 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.88 -13.22 34.06 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.0 p -150.97 -159.92 1.1 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.784 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -153.15 -53.31 0.11 Allowed 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 52' ' ' GLY . 29.9 mmtp -89.83 132.97 34.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 50' ' ' TYR . 45.1 m-20 -53.86 -30.66 46.67 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.551 0.532 . . . . 0.0 110.622 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.1 t -54.94 -31.47 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.794 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.461 ' NE2' ' H ' ' A' ' 9' ' ' LYS . 73.6 mt-30 -67.26 -27.78 67.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.407 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 75.4 m -89.67 138.51 31.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.019 0.437 . . . . 0.0 111.171 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.99 154.15 52.82 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.056 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 m -49.49 108.66 0.21 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.033 0.49 . . . . 0.0 110.755 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.22 -18.37 4.21 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.304 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.5 p -135.11 161.46 35.26 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.385 0.274 . . . . 0.0 110.934 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.802 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -145.87 167.63 22.77 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.1 m -88.91 58.63 4.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.02 0.438 . . . . 0.0 111.268 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.839 ' HA ' ' HB2' ' A' ' 54' ' ' ARG . . . -90.08 152.81 20.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.26 0.552 . . . . 0.0 111.871 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -82.91 147.69 28.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.833 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.541 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -63.22 137.76 58.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.028 0.442 . . . . 0.0 111.092 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.622 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -67.09 -22.99 65.8 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -87.38 -40.03 14.78 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.89 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.0 m -152.32 148.42 27.5 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -78.09 48.36 0.73 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.936 0.398 . . . . 0.0 111.522 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -98.27 -43.14 7.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.417 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.8 mp -88.18 131.87 34.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.818 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -148.6 55.67 1.02 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 1.094 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.4 p90 -138.43 -173.8 3.64 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.2 m -57.6 98.31 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.915 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.782 HD11 ' HB3' ' A' ' 20' ' ' ALA . 44.8 pt -119.13 155.59 53.22 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 32' ' ' ILE . 10.1 Cg_endo -52.0 143.59 39.88 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.409 2.739 . . . . 0.0 115.152 -177.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.844 HD23 ' HB3' ' A' ' 59' ' ' CYS . 70.0 mt -87.19 159.74 18.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.689 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -52.98 141.53 29.11 Favored Glycine 0 C--O 1.242 0.614 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.268 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.643 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 66.1 m-20 -95.65 176.37 6.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.322 -0.439 . . . . 0.0 110.997 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.5 m -64.38 128.11 34.38 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.17 5.52 90.02 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.357 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.528 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 3.2 mm-40 -92.56 152.81 19.42 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.833 0.349 . . . . 0.0 111.497 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -68.72 145.1 54.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.426 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.45 179.0 7.05 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 37.7 m170 -116.12 122.75 31.82 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 3.7 Cg_endo -47.9 -44.12 28.03 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.425 2.75 . . . . 0.0 113.407 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.94 80.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.281 0.563 . . . . 0.0 110.984 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.528 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 19.6 m -78.17 83.15 4.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.172 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.412 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 97.1 m-70 -61.59 146.47 48.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.957 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.8 143.21 10.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.796 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' A' ' 49' ' ' PRO . 99.7 t -87.93 144.3 34.56 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.938 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.585 ' HA ' HG13 ' A' ' 48' ' ' VAL . 34.4 Cg_exo -62.53 142.45 40.82 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 124.634 -0.986 . . . . 0.0 114.144 1.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 87.8 t80 -166.36 137.59 3.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.621 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -84.66 113.82 21.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.687 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' LYS . . . 169.7 -174.2 43.95 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.225 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.86 142.58 49.01 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.839 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . 3.6 mmp_? -86.67 110.53 19.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.247 0.546 . . . . 0.0 112.076 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.42 -21.94 23.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.6 m -88.7 153.82 20.79 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.27 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.622 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 43.6 m -87.69 46.04 1.34 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.044 0.45 . . . . 0.0 111.044 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.6 tp -153.08 127.0 8.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.078 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.844 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.6 m -77.86 141.58 64.02 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.262 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.528 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 20.4 Cg_exo -65.57 -178.31 0.9 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.677 2.251 . . . . 0.0 111.499 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 72.7 m -62.4 140.43 58.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.313 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -64.11 155.56 31.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.073 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.4 m -51.78 127.4 20.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.211 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.72 -30.48 9.06 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.695 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.633 HD12 ' HG2' ' A' ' 62' ' ' LYS . 26.3 mt -88.98 145.77 25.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.109 0.481 . . . . 0.0 112.081 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.2 m -119.85 125.02 47.5 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.791 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 4.4 t -81.82 135.55 35.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.858 0.361 . . . . 0.0 111.242 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.4 m -137.53 148.33 45.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.438 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 72' ' ' GLU . 16.0 ttmt -64.54 114.26 4.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.471 0.653 . . . . 0.0 110.962 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.505 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 11.1 m -97.75 83.37 3.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.985 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.07 -62.47 4.17 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.486 ' OE1' ' HA ' ' A' ' 72' ' ' GLU . 35.6 tp10 -150.11 -43.67 0.13 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.928 0.394 . . . . 0.0 109.957 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -87.79 153.68 21.15 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.58 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 11.8 m-85 -89.39 129.57 35.89 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.89 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 45.8 mttm -125.81 150.28 47.94 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.137 0.494 . . . . 0.0 110.027 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 67' ' ' CYS . 59.2 m -75.03 141.33 43.9 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.125 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.253 1.241 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.214 179.6 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.2 t . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 121.673 0.749 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . 167.91 69.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.142 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.85 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -71.3 -17.33 62.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.7 p -150.06 144.99 26.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.826 0.345 . . . . 0.0 111.192 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.574 ' O ' ' HD2' ' A' ' 53' ' ' LYS . 11.6 t70 -86.91 -47.7 8.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.672 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 36.7 mttm -117.88 146.41 43.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.573 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.607 ' OD1' ' HA ' ' A' ' 53' ' ' LYS . 1.8 m-20 -51.24 -28.17 10.98 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.873 0.733 . . . . 0.0 111.529 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.854 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 22.0 t -55.25 -31.17 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.763 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.459 HE22 ' HB3' ' A' ' 8' ' ' ASP . 54.5 mt-30 -69.94 -17.98 63.34 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.1 m -89.42 -139.61 0.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.7 -141.84 4.77 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 119.395 -1.383 . . . . 0.0 113.777 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m -50.68 115.71 1.61 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.913 -0.644 . . . . 0.0 112.646 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 33' ' ' PRO . . . 60.45 31.45 74.36 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 114.928 -1.033 . . . . 0.0 114.907 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.565 ' O ' HG11 ' A' ' 48' ' ' VAL . 6.0 p -148.57 143.06 26.36 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.149 0.974 . . . . 0.0 111.685 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.743 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -142.43 167.67 21.55 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.2 m -89.67 45.19 1.26 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.61 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -79.81 159.87 26.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.405 0.621 . . . . 0.0 111.407 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -88.27 152.68 21.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.945 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.641 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -63.33 136.5 57.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.048 0.452 . . . . 0.0 110.694 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.704 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -66.91 -22.43 65.96 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -86.99 -37.36 17.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.895 0.379 . . . . 0.0 111.674 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.0 m -152.01 145.92 25.18 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -80.14 38.84 0.42 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.47 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -89.93 -41.66 11.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.511 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.641 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.0 mp -87.35 130.76 36.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.572 ' O ' ' HA2' ' A' ' 5' ' ' GLY . 88.4 mtm180 -148.44 65.63 1.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.86 0.725 . . . . 0.0 109.304 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.85 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.4 p90 -150.84 -170.6 3.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.816 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 94.6 m -58.76 102.8 0.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.804 0.69 . . . . 0.0 112.539 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.61 HD11 ' HB3' ' A' ' 20' ' ' ALA . 47.1 pt -123.85 157.62 62.57 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 14.4 Cg_endo -56.0 147.7 62.13 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.235 2.623 . . . . 0.0 115.061 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.808 HD23 ' HB3' ' A' ' 59' ' ' CYS . 78.5 mt -87.15 160.43 18.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.501 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.74 144.76 45.85 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 114.156 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.455 ' H ' ' CD ' ' A' ' 39' ' ' GLU . 35.1 m-80 -99.69 159.89 14.71 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.34 0.656 . . . . 0.0 110.685 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.2 m -56.39 128.58 36.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.883 0.373 . . . . 0.0 110.437 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.5 -21.69 36.31 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.966 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 36' ' ' ASN . 7.2 pt-20 -96.44 155.34 16.81 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 117.561 0.68 . . . . 0.0 110.648 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.71 145.32 49.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.998 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.2 p -144.7 156.13 43.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.079 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.462 ' CD2' ' HB3' ' A' ' 58' ' ' LEU . 84.0 m-70 -90.61 126.9 54.54 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.93 -34.67 99.21 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.708 2.272 . . . . 0.0 112.387 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.93 98.95 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.543 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.637 ' HB2' ' HB3' ' A' ' 60' ' ' PRO . 3.4 p -74.31 133.39 42.58 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -112.88 -150.31 0.46 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.947 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.623 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -70.02 155.19 40.95 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -179.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.595 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 92.0 t -111.99 137.77 21.49 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.114 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.854 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 37.9 Cg_exo -59.13 126.26 2.5 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 124.193 -1.17 . . . . 0.0 113.383 1.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.588 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 57.2 t80 -75.16 146.65 41.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.732 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.51 56.31 0.67 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.266 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.15 -136.54 6.38 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.667 ' HE3' HD21 ' A' ' 55' ' ' LEU . 29.7 pttt -150.38 138.24 20.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.731 0.3 . . . . 0.0 110.256 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.437 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 29.9 mmt180 -114.87 115.3 26.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.059 0.457 . . . . 0.0 111.224 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.667 HD21 ' HE3' ' A' ' 53' ' ' LYS . 3.1 mm? -89.23 32.75 0.82 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.931 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 p -89.2 157.38 18.28 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.703 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.704 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 68.0 m -88.02 30.21 0.87 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.044 0.45 . . . . 0.0 111.595 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.462 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 60.9 tp -154.5 123.65 6.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.382 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.808 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -73.94 146.75 85.51 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.637 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 57.0 Cg_endo -70.16 -173.31 0.75 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.843 1.695 . . . . 0.0 111.339 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . 80.0 m -67.69 142.35 56.37 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.995 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . 46.8 mtpt -55.24 145.41 21.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.182 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.8 m -47.16 117.39 1.71 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.427 0.454 . . . . 0.0 110.966 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.26 -27.53 8.93 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.496 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 61' ' ' CYS . 56.2 mt -88.3 156.64 19.07 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.781 0.324 . . . . 0.0 111.04 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.7 m -123.15 130.57 52.94 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.496 -0.482 . . . . 0.0 112.163 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 35.6 t -78.06 119.23 21.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.5 m -131.99 145.02 51.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.638 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 54.2 tttp -65.37 107.8 1.75 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.277 0.56 . . . . 0.0 110.332 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 14.4 m -95.02 83.73 3.99 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.855 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.51 -69.75 3.27 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.473 ' OE1' ' HA ' ' A' ' 72' ' ' GLU . 36.4 tp10 -135.58 -49.46 0.71 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -88.15 157.87 18.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.445 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 12.8 m-85 -89.83 130.83 36.02 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.677 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.457 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 34.5 mttp -131.39 150.62 52.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.247 0.546 . . . . 0.0 109.906 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 62.1 m -67.23 134.29 51.38 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.983 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.254 1.295 0 CA-C-O 117.747 -1.12 . . . . 0.0 108.54 179.092 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 15.4 t . . . . . 0 CA--C 1.532 0.284 0 CA-C-O 120.638 0.256 . . . . 0.0 111.426 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.5 117.55 0.4 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.046 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.71 -7.93 51.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.709 0.29 . . . . 0.0 111.776 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.514 ' SG ' ' HA ' ' A' ' 30' ' ' PHE . 6.0 p -132.3 139.13 48.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.024 0.44 . . . . 0.0 111.801 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.536 ' HB3' ' NE2' ' A' ' 12' ' ' GLN . 0.2 OUTLIER -71.55 -46.01 60.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.697 178.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -139.87 153.99 47.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.996 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.481 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 6.6 t70 -50.09 -30.87 11.9 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.155 0.91 . . . . 0.0 111.688 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.584 ' HA ' ' CB ' ' A' ' 49' ' ' PRO . 46.3 t -53.94 -30.15 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.512 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.536 ' NE2' ' HB3' ' A' ' 8' ' ' ASP . 72.3 mt-30 -76.36 -15.17 60.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 92.0 m -89.32 132.14 35.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.128 0.49 . . . . 0.0 111.088 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.51 156.83 51.39 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.095 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.1 m -52.14 108.9 0.32 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.135 0.493 . . . . 0.0 110.632 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.31 -21.18 3.3 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.1 p -136.3 156.34 48.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.136 -0.532 . . . . 0.0 110.077 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.703 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -145.17 161.69 38.9 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.325 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 62.1 m -87.01 59.41 5.62 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.078 0.465 . . . . 0.0 111.26 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.554 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -93.33 144.5 25.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.97 0.414 . . . . 0.0 110.821 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -78.6 143.12 36.72 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.651 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 66.0 m -65.46 133.66 51.76 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.883 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.62 -24.71 67.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.901 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -86.68 -37.08 18.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 110.623 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.64 ' O ' ' HB2' ' A' ' 22' ' ' SER . 23.1 t -152.06 128.1 10.39 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.476 ' HD3' ' N ' ' A' ' 26' ' ' ARG . 1.7 mpp_? -77.22 37.87 0.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 4' ' ' THR . 13.4 p-10 -89.23 -37.69 14.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.651 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 42.9 mt -89.02 124.33 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.6 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -145.99 53.74 1.15 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 1.046 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.6 p90 -131.51 -171.0 2.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.478 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.7 m -61.56 77.3 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.19 0.931 . . . . 0.0 113.266 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' A' ' 20' ' ' ALA . 44.7 pt -93.54 154.6 41.17 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -55.29 151.63 35.37 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.222 2.615 . . . . 0.0 114.442 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 18' ' ' CYS . 75.7 mt -86.91 159.68 18.96 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.12 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.53 138.25 44.17 Favored Glycine 0 C--O 1.238 0.353 0 O-C-N 124.059 0.849 . . . . 0.0 114.145 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.501 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 44.7 m-80 -105.75 162.51 13.48 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.238 0.615 . . . . 0.0 110.161 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.4 m -55.95 121.02 8.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.729 0.3 . . . . 0.0 110.63 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.77 -25.84 13.94 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.422 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 13.6 pt-20 -93.71 152.89 18.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.873 0.836 . . . . 0.0 110.769 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 67.6 m-20 -59.69 153.64 19.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.551 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 27.2 p -144.72 154.85 43.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.775 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 56.8 m170 -90.2 126.14 57.87 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.536 ' HG3' ' CG ' ' A' ' 74' ' ' PHE . 36.5 Cg_exo -59.52 -53.45 3.39 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 123.15 2.566 . . . . 0.0 113.721 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.41 30.62 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.1 t -90.54 120.86 31.98 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.57 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 83.8 m-70 -68.65 144.32 54.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.186 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.57 ' HE3' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -54.16 154.98 3.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.969 -178.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.462 HG22 HH12 ' A' ' 54' ' ' ARG . 95.8 t -88.71 135.46 32.22 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.584 ' CB ' ' HA ' ' A' ' 11' ' ' VAL . 60.7 Cg_endo -73.21 140.77 69.08 Favored 'Cis proline' 0 C--O 1.237 0.469 0 C-N-CA 123.881 -1.3 . . . . 0.0 113.08 0.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.57 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 68.7 t80 -62.25 133.75 55.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.112 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.04 60.22 1.39 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.725 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.72 -133.9 4.26 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.92 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -117.89 124.76 49.08 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.462 HH12 HG22 ' A' ' 48' ' ' VAL . 25.4 ttm180 -90.63 111.91 23.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.215 0.531 . . . . 0.0 112.181 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 55' ' ' LEU . 4.0 mm? -111.65 18.43 19.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.14 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -89.34 142.3 27.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.37 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 15.8 m -89.25 30.51 0.97 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.7 tp -154.46 130.22 10.05 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.263 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.628 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -80.51 140.31 51.81 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.35 171.06 11.01 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.539 2.159 . . . . 0.0 111.139 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.3 m -60.35 139.91 57.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.772 0.32 . . . . 0.0 110.937 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.506 ' HG2' HD12 ' A' ' 65' ' ' LEU . 14.6 ptmt -62.37 153.14 32.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.482 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.6 m -47.81 124.68 7.63 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.417 0.448 . . . . 0.0 111.294 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.18 -32.04 6.98 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.506 HD12 ' HG2' ' A' ' 62' ' ' LYS . 28.2 mt -89.29 156.9 18.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 0.0 111.565 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.1 m -124.87 133.28 53.14 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.332 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 48.1 t -79.16 122.49 26.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 m -151.0 151.98 32.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.658 0.266 . . . . 0.0 111.08 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 83.0 tttt -62.25 116.29 4.88 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.7 m -115.97 49.02 1.15 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.775 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.429 ' O ' ' HE2' ' A' ' 69' ' ' LYS . . . 131.26 -102.59 0.52 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.039 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.17 -49.61 7.17 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.062 0.458 . . . . 0.0 110.683 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -121.42 -167.29 1.49 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.673 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.619 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 5.5 m-85 -91.38 134.96 34.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.889 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 40' ' ' ASP . 51.0 mttm -133.75 155.83 49.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 60.6 m -75.61 137.64 40.89 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.946 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.667 -0.683 . . . . 0.0 109.158 179.684 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.473 ' O ' ' HD2' ' A' ' 29' ' ' ARG . 3.1 t . . . . . 0 CA--C 1.534 0.333 0 CA-C-O 121.577 0.704 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.811 ' HA2' ' HB2' ' A' ' 29' ' ' ARG . . . 132.03 126.55 2.75 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.463 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.616 ' HB3' ' HA ' ' A' ' 30' ' ' PHE . . . -91.71 -35.67 14.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.224 0.535 . . . . 0.0 110.597 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -127.58 150.02 49.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.064 -177.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -77.1 -44.03 32.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.842 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 1.006 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 32.0 mttm -131.48 152.04 51.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.816 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . 41.8 m-20 -54.87 -22.68 15.47 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.723 0.639 . . . . 0.0 110.586 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.967 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 2.2 p -54.22 -28.4 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.956 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -77.55 -24.13 49.93 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 73.4 m -89.55 136.94 32.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.941 0.4 . . . . 0.0 110.979 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.63 154.86 53.39 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.869 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -53.66 100.34 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.141 0.496 . . . . 0.0 110.966 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.33 -23.71 1.55 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.3 p -133.41 147.88 51.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.639 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.655 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -134.87 167.97 19.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.994 0.361 . . . . 0.0 110.186 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 20.7 m -89.83 31.83 0.93 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.99 148.67 41.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.974 0.416 . . . . 0.0 110.936 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.74 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -76.7 132.19 39.21 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.509 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 78.3 p -60.04 138.95 57.75 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.927 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.53 -24.73 63.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.375 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.3 p90 -87.39 -27.32 22.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.45 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.433 ' HB2' HD13 ' A' ' 28' ' ' ILE . 67.9 m -150.8 122.8 8.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.038 0.447 . . . . 0.0 110.904 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.409 ' HE ' ' HB3' ' A' ' 21' ' ' ALA . 46.1 mmm-85 -74.75 10.94 1.18 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.78 0.324 . . . . 0.0 110.92 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -89.75 -26.37 20.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.694 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.74 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.2 mp -85.97 115.95 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.811 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 62.0 mtt180 -140.52 43.8 1.86 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.616 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 0.8 OUTLIER -101.83 -178.12 3.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.99 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 89.1 m -68.64 79.64 0.28 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.573 0.546 . . . . 0.0 110.918 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.433 HG13 ' SG ' ' A' ' 59' ' ' CYS . 43.9 pt -89.18 150.54 45.2 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.06 151.72 40.88 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.54 2.827 . . . . 0.0 114.896 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.655 HD11 ' HB3' ' A' ' 18' ' ' CYS . 5.2 mp -87.99 166.5 14.44 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.958 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.93 142.41 47.41 Favored Glycine 0 C--O 1.245 0.838 0 CA-C-N 114.714 -1.13 . . . . 0.0 114.496 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.501 ' O ' ' HB3' ' A' ' 39' ' ' GLU . 57.1 m-80 -91.23 173.08 8.12 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.396 -0.902 . . . . 0.0 111.316 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.6 m -63.0 128.83 37.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.395 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.57 11.38 85.27 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.651 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 36' ' ' ASN . 15.4 tt0 -100.56 155.35 17.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.4 ' O ' HD21 ' A' ' 58' ' ' LEU . 8.3 t70 -63.43 140.23 58.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.175 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.7 p -143.12 145.5 32.9 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 52.7 m170 -89.5 123.5 66.59 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 9.6 Cg_endo -54.14 -34.11 77.13 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.244 2.629 . . . . 0.0 112.513 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.95 85.72 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.861 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 m -72.11 136.62 46.61 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -119.58 -142.21 0.35 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.639 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -68.49 166.37 17.05 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.604 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 72.3 t -133.8 130.63 20.74 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.967 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 52.4 Cg_exo -57.03 131.24 4.63 Favored 'Cis proline' 0 C--N 1.348 0.529 0 C-N-CA 124.278 -1.134 . . . . 0.0 113.197 0.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.816 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 69.1 t80 -77.57 150.93 34.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.226 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -74.17 52.06 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.096 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.53 -135.13 5.63 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 1.006 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 3.6 pptp? -151.48 127.73 10.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.988 0.394 . . . . 0.0 110.132 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -86.4 125.67 33.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.951 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.72 24.09 4.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.592 0.711 . . . . 0.0 109.395 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 m -89.84 158.79 17.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.476 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.693 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 4.6 m -89.24 24.34 2.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.726 0.298 . . . . 0.0 111.303 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.4 HD21 ' O ' ' A' ' 40' ' ' ASP . 56.1 tp -154.07 130.15 10.31 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.79 -0.186 . . . . 0.0 111.42 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.477 ' HB3' HD12 ' A' ' 34' ' ' LEU . 16.7 m -76.26 156.7 83.57 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.72 -166.75 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 121.728 1.619 . . . . 0.0 111.229 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.416 ' O ' HD23 ' A' ' 34' ' ' LEU . 73.2 m -74.16 140.02 44.89 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.604 0.24 . . . . 0.0 111.296 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.599 ' HG2' HD12 ' A' ' 65' ' ' LEU . 17.6 ptpt -64.55 157.64 26.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.715 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.9 m -44.05 125.26 4.3 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.736 0.647 . . . . 0.0 112.08 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.26 -30.58 10.07 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.514 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.599 HD12 ' HG2' ' A' ' 62' ' ' LYS . 24.6 mt -89.12 140.98 28.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.095 0.474 . . . . 0.0 112.13 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.0 m -107.25 131.73 53.86 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.818 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 45.2 t -85.06 117.74 24.21 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.2 t -150.57 154.01 36.77 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 15.7 ttpp -65.4 119.67 11.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.945 0.402 . . . . 0.0 110.801 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -137.12 45.39 2.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 122.08 0.943 . . . . 0.0 108.921 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.7 -121.17 1.02 Allowed Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.5 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.18 -44.04 12.52 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -120.06 -161.01 0.85 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.593 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 3.5 m-85 -89.75 141.6 28.47 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.885 0.374 . . . . 0.0 111.196 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 74' ' ' PHE . 14.5 mptt -131.02 160.14 35.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.274 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.464 ' HB3' HD13 ' A' ' 65' ' ' LEU . 81.7 m -84.76 129.2 34.86 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.715 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 C--O 1.252 1.192 0 CA-C-O 117.626 -1.178 . . . . 0.0 109.367 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.971 0.415 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.27 116.47 0.69 Allowed Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.779 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.08 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -89.89 -11.66 41.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.506 -0.347 . . . . 0.0 111.437 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.2 p -151.03 159.41 44.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.765 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.424 ' HB3' HE22 ' A' ' 12' ' ' GLN . 12.0 t70 -104.53 -54.69 2.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.309 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.596 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 21.9 ttmm -108.03 146.01 33.15 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.279 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.488 ' OD2' ' HB3' ' A' ' 50' ' ' TYR . 76.7 m-20 -51.41 -22.43 2.99 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.947 0.779 . . . . 0.0 110.731 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.706 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -57.11 -27.2 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.501 179.273 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.424 HE22 ' HB3' ' A' ' 8' ' ' ASP . 53.0 mt-30 -81.11 -19.62 43.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.811 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.4 m -89.95 -138.26 0.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.115 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.3 -138.24 3.62 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 119.676 -1.25 . . . . 0.0 113.3 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 m -49.86 112.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.991 -0.604 . . . . 0.0 112.582 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 33' ' ' PRO . . . 57.52 34.32 68.9 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.017 -0.992 . . . . 0.0 114.83 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.479 ' N ' HD13 ' A' ' 34' ' ' LEU . 4.3 p -145.44 140.56 27.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.914 0.857 . . . . 0.0 111.113 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.726 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -145.03 162.18 37.58 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.7 m -88.32 57.58 4.32 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.169 0.509 . . . . 0.0 111.73 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.74 ' HB2' HH12 ' A' ' 54' ' ' ARG . . . -93.19 168.95 10.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.006 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -85.16 152.04 23.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.938 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.524 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -59.44 134.35 56.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.524 0.202 . . . . 0.0 111.068 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.91 37.2 0.08 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -151.48 -36.68 0.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.008 0.433 . . . . 0.0 110.485 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.7 m -151.05 149.54 29.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -83.4 43.99 0.93 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.342 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -97.35 -45.05 6.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.067 0.46 . . . . 0.0 110.231 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.613 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.6 mp -89.39 135.44 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.772 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.67 54.58 0.89 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 1.08 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.4 p90 -130.74 -166.91 1.75 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.986 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.2 m -62.08 80.69 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.988 0.805 . . . . 0.0 112.959 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 20' ' ' ALA . 48.8 pt -96.74 154.21 38.46 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 25.3 Cg_endo -62.46 151.82 80.74 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 122.785 2.323 . . . . 0.0 114.528 -177.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 18' ' ' CYS . 5.8 mp -87.23 164.34 16.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.874 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.9 140.01 26.09 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.111 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 58.2 m-80 -95.63 -164.64 1.18 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.181 0.515 . . . . 0.0 111.124 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 m -61.43 123.79 18.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.315 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.1 -6.56 82.58 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.465 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.78 150.96 22.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.376 0.588 . . . . 0.0 111.343 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.13 146.86 49.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.533 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.547 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 24.5 p -143.58 145.45 32.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.093 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 39.9 m170 -90.11 122.68 67.38 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 9.9 Cg_endo -54.15 -38.78 87.78 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.219 2.613 . . . . 0.0 112.904 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.53 65.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.86 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.546 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 17.2 m -81.33 121.01 25.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.915 0.388 . . . . 0.0 110.47 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -93.05 -172.31 2.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.196 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -72.69 165.65 24.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.512 HG13 ' HA ' ' A' ' 49' ' ' PRO . 60.4 t -87.09 139.92 32.54 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.706 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 2.6 Cg_exo -77.12 133.11 29.61 Favored 'Cis proline' 0 C--N 1.346 0.415 0 C-N-CA 123.845 -1.314 . . . . 0.0 113.505 1.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.488 ' HB3' ' OD2' ' A' ' 10' ' ' ASP . 48.8 t80 -113.64 149.25 34.88 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.596 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 25.8 t70 -58.63 -23.67 59.52 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.394 0.616 . . . . 0.0 111.3 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.13 33.31 57.57 Favored Glycine 0 C--N 1.318 -0.426 0 N-CA-C 115.409 0.924 . . . . 0.0 115.409 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.2 pttm -88.3 56.74 3.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.035 0.917 . . . . 0.0 109.739 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.74 HH12 ' HB2' ' A' ' 20' ' ' ALA . 4.0 ppt_? -150.32 130.04 13.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.619 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.8 mt -88.48 50.34 1.95 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.439 0.638 . . . . 0.0 110.145 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 m -89.1 137.56 32.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.779 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 p -88.68 34.75 0.77 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.201 0.524 . . . . 0.0 110.598 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.9 tp -153.28 132.16 12.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.772 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.624 ' HB3' HD12 ' A' ' 34' ' ' LEU . 2.5 m -83.3 159.85 61.03 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.546 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 6.3 Cg_exo -71.83 -161.68 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.288 1.992 . . . . 0.0 111.723 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.571 ' O ' HD23 ' A' ' 34' ' ' LEU . 74.4 m -79.01 137.86 37.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.887 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HD2' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -66.86 153.46 43.39 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.1 m -46.28 113.1 0.57 Allowed 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.571 0.545 . . . . 0.0 111.6 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.37 -32.58 4.64 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.262 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 76' ' ' CYS . 3.6 mm? -89.72 143.12 27.07 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.2 m -110.5 128.14 55.49 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.599 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 20.8 t -72.96 119.2 16.87 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.9 m -131.22 144.33 51.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.991 0.424 . . . . 0.0 111.408 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.544 ' NZ ' ' HA ' ' A' ' 72' ' ' GLU . 53.2 tttm -67.3 109.11 2.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.379 0.609 . . . . 0.0 110.38 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.9 m -88.95 76.53 7.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.664 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.94 -69.67 3.2 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.544 ' HA ' ' NZ ' ' A' ' 69' ' ' LYS . 33.9 tp10 -130.57 -41.53 1.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.753 0.311 . . . . 0.0 110.489 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -86.56 -172.79 4.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.7 128.84 47.32 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -135.14 150.32 50.15 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.556 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 68.9 m -70.83 133.9 46.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.945 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.9 m . . . . . 0 C--O 1.254 1.294 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.192 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 121.654 0.74 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . -171.01 72.36 0.11 Allowed Glycine 0 C--O 1.226 -0.368 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.027 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -81.35 -23.6 37.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.464 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 18.6 p -151.13 154.92 37.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -92.03 -60.77 1.77 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.611 0.719 . . . . 0.0 110.236 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -101.35 139.32 37.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.798 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.592 ' OD2' ' HB2' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -46.68 -33.19 4.07 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.32 1.012 . . . . 0.0 111.797 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.8 t -49.55 -32.4 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.631 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -66.03 -30.19 70.69 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.464 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 66.6 m -89.88 159.84 16.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.118 0.485 . . . . 0.0 111.378 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.99 166.49 54.9 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.48 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.456 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 56.9 m -63.79 67.13 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.71 0.804 . . . . 0.0 112.125 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.35 -26.44 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.404 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 13' ' ' CYS . 26.5 p -124.39 142.73 51.07 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.691 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -119.74 154.19 34.53 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 60.4 m -89.52 48.52 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 0.0 111.961 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -95.54 -170.09 2.09 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.821 ' HB1' ' HA ' ' A' ' 26' ' ' ARG . . . -90.11 141.34 28.78 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.425 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 88.2 p -63.46 142.98 58.19 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.108 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.705 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -55.93 -26.38 47.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -87.97 -32.23 18.96 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.419 ' C ' ' H ' ' A' ' 27' ' ' ASN . 68.1 m -151.67 135.87 16.7 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.914 -0.492 . . . . 0.0 111.538 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.821 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 59.7 mtm180 -78.46 20.55 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.128 0.489 . . . . 0.0 110.785 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 25' ' ' SER . 74.2 m-20 -92.55 -31.32 15.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.605 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 1.8 mp -85.39 120.81 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 89.2 mtt180 -139.14 77.44 1.62 Allowed 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.914 0.759 . . . . 0.0 109.717 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 1.027 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.0 OUTLIER -150.83 -167.08 2.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.565 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 84.2 m -60.34 77.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.672 HG13 ' SG ' ' A' ' 59' ' ' CYS . 34.0 pt -97.99 146.37 31.37 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -57.01 151.39 50.21 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.267 2.644 . . . . 0.0 115.084 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.691 HD11 ' HB3' ' A' ' 18' ' ' CYS . 5.1 mp -87.11 168.79 12.96 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.769 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.74 147.07 37.9 Favored Glycine 0 C--O 1.239 0.436 0 CA-C-N 115.246 -0.888 . . . . 0.0 114.02 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 72.5 m-80 -100.85 -178.98 3.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.163 -0.518 . . . . 0.0 109.799 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.3 m -62.86 129.51 40.75 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.07 -6.76 76.32 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.179 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -88.2 154.56 20.34 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.897 0.379 . . . . 0.0 111.029 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -67.6 142.82 56.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.821 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.511 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 31.6 p -146.01 150.15 35.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.207 0.527 . . . . 0.0 110.688 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -95.4 126.94 43.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.56 -40.83 77.64 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.092 2.528 . . . . 0.0 112.907 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.46 -33.86 76.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.134 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.632 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 17.7 m -73.31 138.82 45.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.362 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -129.29 175.46 8.72 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 7.7 ptmt -59.69 150.88 26.43 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.445 0.466 . . . . 0.0 111.6 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 49' ' ' PRO . 60.3 t -87.14 142.56 33.77 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.651 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HA ' HG13 ' A' ' 48' ' ' VAL . 33.5 Cg_exo -63.07 138.46 28.27 Favored 'Cis proline' 0 C--N 1.351 0.683 0 C-N-CA 124.392 -1.087 . . . . 0.0 113.73 1.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.491 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 34.5 t80 -146.57 141.79 27.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.703 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -74.13 79.46 1.75 Allowed 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.546 ' HA3' ' OD1' ' A' ' 10' ' ' ASP . . . -89.48 131.84 10.93 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.783 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.18 37.46 0.55 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.324 0.583 . . . . 0.0 109.432 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.44 ' H ' ' NE ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -115.88 139.9 49.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.915 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.68 48.53 1.6 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.223 0.535 . . . . 0.0 110.463 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.7 m -103.04 143.38 32.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.39 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.705 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 72.7 m -88.86 47.92 1.56 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.57 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 53.9 tp -152.51 124.14 7.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.726 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.672 ' SG ' HG13 ' A' ' 32' ' ' ILE . 3.7 m -84.14 153.94 63.29 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.718 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.632 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 12.3 Cg_exo -69.44 -169.96 0.34 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.497 2.132 . . . . 0.0 111.642 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 82.5 m -77.75 139.37 39.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.67 0.271 . . . . 0.0 111.248 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.474 ' HA ' HD23 ' A' ' 34' ' ' LEU . 19.1 ptmt -62.13 154.12 28.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.22 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 15' ' ' SER . 17.6 m -51.03 125.27 13.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.312 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.54 -29.67 9.7 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.415 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.46 HD12 ' HG2' ' A' ' 62' ' ' LYS . 22.6 mt -88.91 152.7 21.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.025 0.44 . . . . 0.0 111.936 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -113.26 128.13 56.38 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.998 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.545 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 53.8 t -84.69 119.67 25.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.1 t -150.97 158.97 44.81 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 23.8 ttpp -65.82 102.4 0.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.245 0.545 . . . . 0.0 109.824 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.536 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 12.1 m -101.6 43.46 1.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.182 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.4 -105.6 0.47 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.322 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.507 ' CD ' ' HG2' ' A' ' 73' ' ' LYS . 1.1 pm0 -86.08 -40.51 15.65 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 122.776 0.43 . . . . 0.0 110.406 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.507 ' HG2' ' CD ' ' A' ' 72' ' ' GLU . 25.0 pttt -133.23 -164.26 1.46 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.902 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 5.1 m-85 -90.09 134.4 34.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.148 0.499 . . . . 0.0 111.468 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 46.4 mttp -135.86 154.33 51.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.063 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.511 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 73.0 m -75.39 126.44 31.01 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.469 -178.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.249 1.065 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.677 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.67 108.39 0.35 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.043 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.027 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -91.17 -14.19 31.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 p -147.7 145.82 29.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.087 0.47 . . . . 0.0 111.904 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 53' ' ' LYS . 17.6 t70 -88.23 -44.79 10.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.42 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.546 ' HG3' ' OD2' ' A' ' 8' ' ' ASP . 61.6 mttp -121.49 144.88 48.46 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 108.962 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.679 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 37.8 t0 -55.31 -18.8 7.03 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.838 0.711 . . . . 0.0 111.005 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.7 p -55.49 -25.33 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.802 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -82.13 -16.76 48.76 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 68.8 m -89.8 -129.79 0.08 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.784 0.326 . . . . 0.0 110.678 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.86 169.88 35.92 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.507 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.4 m -51.96 105.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.125 0.488 . . . . 0.0 111.364 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.63 -35.22 1.89 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.6 p -139.75 143.58 37.04 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.745 0.418 . . . . 0.0 110.08 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.653 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -128.13 159.51 34.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.679 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 67.9 m -85.78 105.09 16.05 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.192 0.52 . . . . 0.0 109.689 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' A' ' 54' ' ' ARG . . . -159.58 173.36 16.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.07 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -82.27 138.07 34.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.298 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.662 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -66.03 137.37 57.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.865 0.364 . . . . 0.0 110.881 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.03 -24.73 66.4 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -86.78 -34.82 19.47 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.416 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 27' ' ' ASN . 28.2 m -151.59 124.88 8.78 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.471 ' HD3' ' N ' ' A' ' 26' ' ' ARG . 1.6 mpp_? -76.29 30.0 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.019 0.438 . . . . 0.0 111.834 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' A' ' 25' ' ' SER . 5.6 m120 -90.03 -37.26 14.42 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.662 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.0 mp -89.58 125.76 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.198 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.505 ' HD3' ' C ' ' A' ' 28' ' ' ILE . 1.3 mpp_? -136.84 68.19 1.43 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 1.027 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.1 p90 -147.29 -161.09 1.26 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.495 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 82.9 m -60.87 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.966 0.791 . . . . 0.0 111.911 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.556 HG13 ' SG ' ' A' ' 59' ' ' CYS . 43.4 pt -100.84 150.54 37.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.48 148.14 27.59 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 123.41 2.74 . . . . 0.0 114.67 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.74 HD23 ' HB3' ' A' ' 59' ' ' CYS . 90.8 mt -85.53 163.84 18.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.979 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.516 ' O ' ' HG3' ' A' ' 62' ' ' LYS . . . -59.67 137.41 49.76 Favored Glycine 0 C--O 1.24 0.509 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.91 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -88.88 165.6 14.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.172 0.589 . . . . 0.0 110.289 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.6 t -62.52 133.77 55.44 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.498 ' O ' ' HD3' ' A' ' 75' ' ' LYS . . . 87.96 -12.08 65.07 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.548 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -88.59 159.79 17.72 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 117.107 0.453 . . . . 0.0 111.861 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.551 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 0.3 OUTLIER -65.65 147.73 52.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.091 -178.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.3 p -149.83 142.52 24.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.273 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 41.1 m170 -88.0 124.8 66.22 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 8.2 Cg_endo -51.7 -38.98 67.38 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.47 2.78 . . . . 0.0 113.795 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.65 25.67 0.42 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . 49.5 m -90.64 122.36 33.36 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.915 -0.491 . . . . 0.0 110.372 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.533 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 19.3 m170 -77.46 149.24 35.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -55.39 149.65 12.85 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.631 0.582 . . . . 0.0 111.298 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 49' ' ' PRO . 84.9 t -85.87 138.3 35.3 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.891 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.531 ' HA ' HG13 ' A' ' 48' ' ' VAL . 8.2 Cg_exo -73.58 135.18 38.83 Favored 'Cis proline' 0 C--N 1.344 0.296 0 C-N-CA 123.603 -1.415 . . . . 0.0 112.88 1.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.533 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 89.1 t80 -64.32 143.05 58.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.421 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.58 44.82 0.13 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.06 -139.75 6.9 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.801 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -121.49 134.27 55.06 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.515 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 61.4 mtp85 -88.08 124.07 33.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.845 0.355 . . . . 0.0 111.209 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -88.94 -5.87 57.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.299 0.571 . . . . 0.0 109.946 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m -87.85 146.43 25.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.459 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 13.3 m -87.41 42.82 1.06 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.983 0.42 . . . . 0.0 111.387 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.1 tp -153.62 121.99 6.22 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.379 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.74 ' HB3' HD23 ' A' ' 34' ' ' LEU . 3.4 m -81.0 148.19 63.62 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 37.3 Cg_endo -67.41 173.39 8.8 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 121.849 1.7 . . . . 0.0 111.46 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.8 m -59.34 144.37 46.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.121 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.659 ' HG2' ' HB2' ' A' ' 34' ' ' LEU . 60.2 mttm -56.17 143.96 31.39 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -51.56 110.3 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.17 0.51 . . . . 0.0 110.543 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.75 -30.06 3.65 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 65' ' ' LEU . 24.7 mt -88.83 147.19 24.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.698 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.3 m -109.91 126.78 54.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.017 0.437 . . . . 0.0 111.481 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.4 t -78.53 116.23 18.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.0 t -134.46 158.68 43.28 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.902 0.382 . . . . 0.0 110.416 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 41.5 ttmt -71.63 112.04 7.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.5 t -91.34 56.94 3.23 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.18 -92.43 1.77 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.226 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -91.02 -46.39 8.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.052 0.453 . . . . 0.0 111.257 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.56 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -107.22 167.06 10.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.711 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 13.4 m-85 -95.38 132.16 40.72 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 55.1 mttm -138.75 153.36 48.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.379 0.609 . . . . 0.0 111.013 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 70.7 m -66.33 132.51 48.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.364 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 C--O 1.253 1.266 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.129 179.701 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.59 0.71 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.56 129.72 4.06 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.674 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.008 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.4 -10.24 44.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.637 0.256 . . . . 0.0 111.571 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 18.8 p -150.76 150.67 31.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.973 0.416 . . . . 0.0 111.409 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.429 ' HB3' HE22 ' A' ' 12' ' ' GLN . 11.9 t70 -97.41 -46.22 6.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.117 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.427 ' H ' ' NE2' ' A' ' 12' ' ' GLN . 95.0 mttt -114.33 145.08 42.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.439 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.835 ' HB2' ' H ' ' A' ' 50' ' ' TYR . 88.2 m-20 -57.35 -26.85 61.63 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.509 0.505 . . . . 0.0 111.417 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -57.39 -29.15 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.898 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.429 HE22 ' HB3' ' A' ' 8' ' ' ASP . 45.2 mt-30 -70.23 -26.05 63.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.491 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 58.0 m -90.69 -122.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.119 0.485 . . . . 0.0 110.784 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.33 157.08 28.14 Favored Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.8 m -55.67 101.0 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.297 0.57 . . . . 0.0 110.846 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.03 -28.08 1.13 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.6 p -135.27 139.49 44.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.15 -0.525 . . . . 0.0 109.833 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.507 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -123.83 159.64 29.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.0 m -88.06 51.22 2.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.89 0.376 . . . . 0.0 111.539 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.758 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -79.62 160.79 26.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.043 0.449 . . . . 0.0 110.998 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.694 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -90.4 144.5 25.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.422 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.646 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -64.58 135.45 55.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.972 0.415 . . . . 0.0 110.395 179.179 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -64.87 -23.06 67.12 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.0 p90 -87.94 -37.68 16.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.4 m -151.74 152.63 32.98 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.19 -0.318 . . . . 0.0 110.162 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -81.75 41.4 0.64 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.775 0.322 . . . . 0.0 111.453 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -97.07 -39.43 9.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.951 0.405 . . . . 0.0 110.828 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.646 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 53.2 mt -88.86 125.63 41.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.918 0.39 . . . . 0.0 110.297 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.3 mmm-85 -150.95 41.03 0.74 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.865 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 1.008 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.4 p90 -121.64 -172.77 2.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.971 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.4 m -61.15 82.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 O-C-N 124.369 1.043 . . . . 0.0 112.609 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 20' ' ' ALA . 30.4 pt -97.86 147.13 32.62 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.07 152.5 36.95 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.388 2.725 . . . . 0.0 114.663 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.549 HD23 ' O ' ' A' ' 61' ' ' CYS . 3.8 mp -87.38 164.73 16.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.317 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.596 ' O ' ' HG3' ' A' ' 62' ' ' LYS . . . -75.4 154.89 46.5 Favored Glycine 0 C--O 1.237 0.335 0 CA-C-N 115.116 -0.947 . . . . 0.0 114.291 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 1.3 p30 -109.18 169.56 8.61 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.131 0.491 . . . . 0.0 110.991 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.7 m -54.59 121.91 9.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.287 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.12 -24.38 16.42 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.04 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 10.7 pt-20 -100.53 153.02 19.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.365 0.582 . . . . 0.0 110.958 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 1.2 m-20 -58.45 150.71 21.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.299 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 13.3 p -149.23 154.47 39.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.787 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -90.97 128.54 47.46 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.45 -60.07 0.8 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.5 2.8 . . . . 0.0 114.207 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.35 26.79 0.3 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.189 0.518 . . . . 0.0 110.551 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -81.98 2.63 29.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.761 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.548 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -178.18 36.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.621 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.564 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -68.33 136.14 52.95 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.603 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.6 t -86.44 128.39 57.26 Favored Pre-proline 0 C--N 1.315 -0.906 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.94 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -91.13 131.03 7.72 Favored 'Cis proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.797 -1.335 . . . . 0.0 112.855 0.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.835 ' H ' ' HB2' ' A' ' 10' ' ' ASP . 12.1 t80 -109.12 120.46 42.61 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.266 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -84.15 63.8 7.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.909 0.861 . . . . 0.0 108.838 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.15 142.62 7.32 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.881 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.449 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -101.49 52.2 0.83 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.292 0.568 . . . . 0.0 110.126 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.4 tpt85 -57.73 139.46 53.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.079 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.46 61.68 6.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.797 0.808 . . . . 0.0 110.391 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.5 m -102.17 129.41 48.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.471 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.694 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 7.0 m -89.24 28.39 1.24 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.849 0.357 . . . . 0.0 111.496 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.1 tp -153.9 129.09 9.69 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.342 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.527 ' SG ' HG13 ' A' ' 32' ' ' ILE . 3.8 m -78.77 164.44 55.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.844 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.508 ' HG3' ' HA ' ' A' ' 47' ' ' LYS . 94.7 Cg_endo -78.5 -157.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.305 2.003 . . . . 0.0 111.508 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.549 ' O ' HD23 ' A' ' 34' ' ' LEU . 90.4 m -87.14 145.5 26.4 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.399 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 29.5 mtpp -57.46 153.44 12.72 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.678 0.611 . . . . 0.0 110.236 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.8 m -49.39 121.73 5.35 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.229 0.331 . . . . 0.0 111.178 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.6 -24.34 28.91 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 65' ' ' LEU . 42.3 mt -88.27 152.13 22.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.845 0.355 . . . . 0.0 111.396 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.2 m -115.59 129.51 56.54 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.132 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.0 t -81.65 116.2 21.27 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 m -132.72 146.05 51.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.708 0.289 . . . . 0.0 110.663 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 34.8 ttpt -70.33 108.03 4.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.116 0.484 . . . . 0.0 110.887 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.886 ' HB3' ' HD3' ' A' ' 75' ' ' LYS . 19.6 t -94.38 76.85 3.9 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.54 -102.1 2.86 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.104 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.532 ' OE1' ' HG3' ' A' ' 73' ' ' LYS . 2.8 tt0 -89.01 -56.46 3.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.518 -0.341 . . . . 0.0 111.503 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HG3' ' OE1' ' A' ' 72' ' ' GLU . 64.5 mttp -102.8 172.46 6.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.17 0.509 . . . . 0.0 111.953 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.696 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 10.1 m-85 -89.48 132.05 35.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.352 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.886 ' HD3' ' HB3' ' A' ' 70' ' ' SER . 1.6 mptp? -130.95 150.05 52.29 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 62.5 m -69.64 144.98 52.77 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.699 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--O 1.248 0.981 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.398 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.32 121.42 0.64 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.454 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.109 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -91.34 -14.84 30.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.2 p -150.66 167.47 27.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.923 0.392 . . . . 0.0 111.49 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.24 -44.0 2.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.186 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 46.3 mmtm -104.09 138.16 41.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.734 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.416 ' OD2' ' HG2' ' A' ' 54' ' ' ARG . 70.4 m-20 -57.96 -28.58 64.48 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.347 0.594 . . . . 0.0 109.847 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.4 t -56.74 -29.87 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 114.827 -1.078 . . . . 0.0 111.486 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -69.11 -22.77 63.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.636 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.8 m -89.48 -126.44 0.07 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.138 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.39 -177.8 43.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.127 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.5 m -67.63 66.18 0.08 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.435 0.636 . . . . 0.0 111.488 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 176.58 -24.2 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.341 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.1 p -139.55 147.89 41.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.023 0.129 . . . . 0.0 110.655 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.503 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -136.16 160.27 39.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.4 m -87.6 51.82 2.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.136 0.493 . . . . 0.0 111.762 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.597 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -86.75 164.19 16.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.805 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.683 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -86.06 144.59 27.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.102 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.657 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -64.76 134.07 53.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.932 0.396 . . . . 0.0 111.146 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.784 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -65.7 -21.23 66.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -87.57 -35.15 18.28 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 m -151.84 144.06 23.98 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.079 -0.388 . . . . 0.0 110.524 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.94 33.79 0.18 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.955 0.407 . . . . 0.0 111.627 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -98.18 -40.83 8.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.755 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.657 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.8 mp -88.08 127.23 41.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.961 0.41 . . . . 0.0 110.918 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HD3' ' C ' ' A' ' 28' ' ' ILE . 1.1 mpp_? -143.34 68.49 1.29 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.863 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 1.109 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.5 p90 -145.76 -170.52 3.49 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.763 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.2 m -60.92 75.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.288 0.992 . . . . 0.0 112.946 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 20' ' ' ALA . 43.9 pt -89.83 153.05 47.34 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.78 151.54 47.54 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.137 2.558 . . . . 0.0 114.691 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.732 HD23 ' HA ' ' A' ' 62' ' ' LYS . 3.6 mp -87.09 170.82 11.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.936 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.54 133.28 25.47 Favored Glycine 0 C--O 1.243 0.696 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.483 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -89.75 167.83 12.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.191 -0.505 . . . . 0.0 110.36 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 m -59.97 128.1 35.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.767 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.8 -5.2 84.5 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.145 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.555 ' HA ' ' HZ2' ' A' ' 75' ' ' LYS . 5.9 mm-40 -99.21 162.44 13.05 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 117.411 0.606 . . . . 0.0 111.8 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.559 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 41.3 p-10 -63.59 151.82 40.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.251 1.024 . . . . 0.0 113.217 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 21.5 p -151.08 143.65 24.33 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.331 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.486 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 43.4 m170 -89.45 121.65 69.09 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 4.5 Cg_endo -48.54 -40.25 37.28 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.775 2.984 . . . . 0.0 113.738 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.28 -28.39 68.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.121 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 53.9 m -73.82 137.07 43.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.889 0.376 . . . . 0.0 110.587 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -123.0 145.89 48.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.87 144.12 1.9 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.556 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 21.9 t -88.25 143.21 32.35 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.052 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.556 ' C ' ' HA ' ' A' ' 48' ' ' VAL . 19.1 Cg_endo -60.75 131.8 8.24 Favored 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.402 -1.082 . . . . 0.0 114.185 1.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -115.73 137.76 51.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.176 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -69.62 109.87 4.54 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.21 -133.78 11.5 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -152.5 152.42 31.91 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 23.1 mmm180 -85.41 107.19 17.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.143 0.497 . . . . 0.0 111.906 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.75 61.49 6.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 t -144.66 163.39 34.11 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.598 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.784 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 6.6 m -88.02 21.98 2.55 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.5 tp -154.08 127.82 8.76 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 121.168 -0.213 . . . . 0.0 111.299 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.559 ' SG ' HG13 ' A' ' 32' ' ' ILE . 13.3 m -74.76 154.29 87.18 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.066 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.53 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 57.0 Cg_endo -69.76 178.28 4.73 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.475 2.117 . . . . 0.0 111.973 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 71.4 m -70.27 143.1 52.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.732 ' HA ' HD23 ' A' ' 34' ' ' LEU . 9.8 ptmm? -60.66 146.91 43.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.1 m -45.52 128.88 8.47 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.078 0.466 . . . . 0.0 111.381 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.99 -28.97 10.86 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.585 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.531 HD12 ' HG2' ' A' ' 62' ' ' LYS . 22.2 mt -89.85 145.28 25.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.955 0.407 . . . . 0.0 111.735 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.9 m -108.59 126.44 52.94 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.955 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 48.1 t -81.01 126.58 31.58 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.6 p -149.46 149.15 30.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.752 0.31 . . . . 0.0 111.231 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.884 ' HE3' ' HA ' ' A' ' 72' ' ' GLU . 46.8 tttt -66.92 105.58 1.66 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.376 0.608 . . . . 0.0 110.984 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 6.8 m -89.83 82.7 6.2 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.833 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.91 -64.09 3.96 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.274 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.884 ' HA ' ' HE3' ' A' ' 69' ' ' LYS . 0.8 OUTLIER -141.02 -47.27 0.4 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.999 0.428 . . . . 0.0 110.028 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -94.77 158.47 15.49 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 15.2 m-85 -88.37 130.08 35.24 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.45 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 37.2 mttm -134.85 155.52 50.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.315 0.579 . . . . 0.0 110.141 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.456 ' HB3' HD13 ' A' ' 65' ' ' LEU . 64.3 m -73.86 137.16 43.57 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.373 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.244 0.805 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.413 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.2 p . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.041 0.448 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.19 122.7 0.28 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.435 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.069 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -82.56 -6.53 59.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.722 0.296 . . . . 0.0 111.614 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 p -149.89 146.25 26.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.954 0.406 . . . . 0.0 111.739 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.455 ' OD1' ' HG2' ' A' ' 9' ' ' LYS . 3.2 t70 -95.37 -57.01 2.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.455 ' HG2' ' OD1' ' A' ' 8' ' ' ASP . 23.6 mmtp -93.99 141.5 28.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.746 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.2 -31.03 66.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.538 0.685 . . . . 0.0 109.881 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.865 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 47.8 t -55.97 -27.16 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.943 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.43 ' NE2' ' H ' ' A' ' 9' ' ' LYS . 55.3 mt-30 -67.08 -25.56 66.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.605 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 71.3 m -89.61 138.27 31.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.03 0.443 . . . . 0.0 111.331 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.17 151.2 49.74 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.631 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.412 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 18.4 m -51.48 113.02 0.85 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.187 0.517 . . . . 0.0 110.741 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.13 -27.86 3.1 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.4 p -128.87 144.87 51.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.965 -0.618 . . . . 0.0 109.535 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.77 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -128.96 166.51 19.03 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 72.3 m -88.02 52.77 2.55 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.797 0.332 . . . . 0.0 111.678 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.597 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -89.81 156.6 18.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.11 0.481 . . . . 0.0 111.336 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.26 145.88 24.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.463 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.597 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -66.0 128.0 34.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.086 0.469 . . . . 0.0 110.883 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.69 -20.13 65.91 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -86.81 -36.17 18.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.811 0.338 . . . . 0.0 111.441 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.8 m -152.0 138.79 18.89 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.442 ' HD3' ' N ' ' A' ' 26' ' ' ARG . 1.6 mpp_? -76.7 48.26 0.55 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.639 0.257 . . . . 0.0 111.547 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -103.95 -41.03 5.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.856 0.36 . . . . 0.0 110.379 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.597 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 69.5 mt -89.6 131.02 37.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.816 0.341 . . . . 0.0 110.335 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -151.73 52.63 0.82 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 1.069 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.9 p90 -140.45 -168.49 2.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.871 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 67.0 m -57.62 99.06 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 O-C-N 124.11 0.881 . . . . 0.0 112.378 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 20' ' ' ALA . 46.1 pt -120.74 149.9 51.53 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.39 147.52 67.43 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.408 2.739 . . . . 0.0 115.125 -177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.77 HD11 ' HB3' ' A' ' 18' ' ' CYS . 7.1 mp -88.34 164.5 15.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.359 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.77 149.29 26.79 Favored Glycine 0 C--O 1.238 0.348 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.252 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 49.6 m-80 -103.34 -168.12 1.47 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.999 0.428 . . . . 0.0 110.922 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 m -61.61 129.95 43.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.626 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.421 ' O ' ' HE3' ' A' ' 75' ' ' LYS . . . 93.11 -12.24 70.28 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.323 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 36' ' ' ASN . 49.1 mt-10 -90.86 144.8 25.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.29 0.566 . . . . 0.0 111.293 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.58 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 11.6 m-20 -62.38 145.63 53.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.301 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -135.52 179.91 6.04 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -116.76 122.12 31.99 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -57.77 -34.79 98.71 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.771 2.314 . . . . 0.0 112.492 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.52 -26.46 62.67 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.565 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.59 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 40.6 m -78.35 129.94 35.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.419 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -88.35 -152.25 0.22 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.698 ' HD2' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -88.2 146.57 25.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.501 HG13 ' HA ' ' A' ' 49' ' ' PRO . 70.8 t -88.65 136.72 30.8 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 123.436 0.46 . . . . 0.0 110.191 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.865 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 16.7 Cg_exo -68.82 128.25 11.3 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.863 -1.307 . . . . 0.0 113.115 0.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.5 ' CE2' ' HG2' ' A' ' 54' ' ' ARG . 80.5 t80 -65.26 145.86 55.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.111 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.93 49.9 0.25 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.23 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.61 -143.51 9.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.955 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -150.4 59.45 0.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.1 0.476 . . . . 0.0 111.37 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.5 ' HG2' ' CE2' ' A' ' 50' ' ' TYR . 22.0 mmt85 -59.39 140.55 56.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.29 57.76 4.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.416 0.627 . . . . 0.0 110.311 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.2 m -88.84 141.78 28.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.253 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 4.1 p -89.13 17.6 5.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.955 0.407 . . . . 0.0 111.698 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.9 tp -154.18 129.88 10.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.724 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.526 ' SG ' HG13 ' A' ' 32' ' ' ILE . 9.0 m -73.37 149.49 88.96 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.59 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 7.5 Cg_exo -72.11 -160.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.396 2.064 . . . . 0.0 111.762 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.857 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 44.1 m -75.72 139.31 41.82 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.992 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.418 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -60.79 150.11 33.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.835 179.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.412 ' OG ' ' HB3' ' A' ' 15' ' ' SER . 13.8 m -49.67 125.29 11.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.625 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.86 -33.72 5.74 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.917 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 65' ' ' LEU . 39.5 mt -89.95 163.59 14.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.922 0.391 . . . . 0.0 111.817 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -133.64 137.75 45.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.08 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.857 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 10.5 t -92.53 148.99 21.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.785 0.326 . . . . 0.0 111.039 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.6 t -147.94 156.6 42.85 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -73.79 111.99 9.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.381 0.61 . . . . 0.0 110.302 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.8 m -89.55 66.88 7.42 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.94 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.16 -60.4 1.94 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.169 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -142.17 -46.15 0.34 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -88.24 160.46 17.68 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.475 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 25.4 m-85 -99.28 122.38 42.36 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.477 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.58 ' HD2' ' HA ' ' A' ' 40' ' ' ASP . 19.6 mmmt -123.2 144.07 49.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 67' ' ' CYS . 95.1 m -73.42 149.84 42.16 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.237 -0.887 . . . . 0.0 109.382 179.426 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 C--O 1.237 0.408 0 CA-C-O 121.739 0.781 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.518 ' CA ' ' HB2' ' A' ' 29' ' ' ARG . . . 107.25 132.17 6.87 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.465 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 30' ' ' PHE . . . -76.97 -20.39 56.15 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.171 0.51 . . . . 0.0 110.542 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 p -137.08 158.85 43.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.876 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -83.17 -51.05 7.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.602 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.941 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 28.1 mttm -126.11 147.3 49.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.737 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . 40.8 m-20 -51.41 -28.72 13.56 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.01 0.819 . . . . 0.0 111.33 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 t -53.74 -32.67 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.049 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -69.18 -25.47 64.36 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.3 m -89.3 135.19 33.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.903 0.383 . . . . 0.0 110.409 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.04 156.05 50.19 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.4 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.4 m -52.71 104.12 0.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.288 0.566 . . . . 0.0 110.442 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.17 -19.66 1.92 Allowed Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.0 p -137.56 157.1 47.26 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.284 -0.458 . . . . 0.0 110.55 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.796 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -140.85 162.3 35.78 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.7 m -91.09 35.52 0.91 Allowed 'General case' 0 C--O 1.239 0.528 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.71 169.34 15.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.909 0.385 . . . . 0.0 110.639 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.739 ' HB1' ' HA ' ' A' ' 26' ' ' ARG . . . -78.96 135.92 37.08 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.8 p -66.47 146.24 54.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.39 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.41 -26.12 66.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.358 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 35.8 p90 -88.02 -29.6 20.59 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.731 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.498 ' HB2' HD13 ' A' ' 28' ' ' ILE . 69.3 m -150.99 122.7 8.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.244 0.545 . . . . 0.0 110.937 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.739 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 99.2 mtt180 -72.32 3.04 5.09 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.495 ' OD1' HD12 ' A' ' 28' ' ' ILE . 20.6 p30 -89.27 -17.04 29.79 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.0 mp -87.48 121.11 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.518 ' HB2' ' CA ' ' A' ' 5' ' ' GLY . 12.7 mtm105 -141.88 39.85 1.66 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.552 ' CD2' HG23 ' A' ' 28' ' ' ILE . 2.2 m-85 -89.57 -175.68 4.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 91.3 m -69.09 79.1 0.34 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.644 HG13 ' SG ' ' A' ' 59' ' ' CYS . 31.1 pt -89.25 146.01 35.3 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.12 144.79 45.55 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.832 3.021 . . . . 0.0 115.042 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.845 HD23 ' HB3' ' A' ' 59' ' ' CYS . 94.8 mt -87.33 160.48 18.37 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.986 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 62' ' ' LYS . . . -61.12 151.38 42.28 Favored Glycine 0 C--O 1.238 0.392 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.1 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 16.3 p30 -118.93 -167.72 1.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 m -62.85 117.59 6.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.873 0.368 . . . . 0.0 111.259 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.53 1.65 68.45 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.759 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 36' ' ' ASN . 18.3 mm-40 -88.38 152.31 22.0 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.678 0.275 . . . . 0.0 111.228 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.468 ' CG ' ' HZ3' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -67.76 143.91 55.64 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.356 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.7 p -147.12 144.4 29.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.986 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.43 ' HB2' ' OG ' ' A' ' 45' ' ' SER . 50.3 m170 -89.46 129.42 47.31 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.82 -41.3 39.06 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.291 2.66 . . . . 0.0 114.236 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.4 12.78 3.38 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.683 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . 5.7 m -91.25 122.54 33.96 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.016 -0.428 . . . . 0.0 110.212 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.586 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 27.6 m170 -88.56 153.71 20.92 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.24 149.3 20.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.54 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.584 HG13 ' HA ' ' A' ' 49' ' ' PRO . 78.3 t -88.91 139.22 29.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.78 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.584 ' HA ' HG13 ' A' ' 48' ' ' VAL . 29.9 Cg_endo -64.17 125.28 4.57 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 123.615 -1.411 . . . . 0.0 113.326 1.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 90.8 t80 -72.77 145.95 46.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.212 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.79 55.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.547 0.689 . . . . 0.0 111.315 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.67 -129.54 3.24 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.941 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 2.6 pptp? -150.72 129.75 12.61 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -77.3 128.45 34.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.277 0.56 . . . . 0.0 112.277 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.1 mt -101.44 15.72 27.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.766 0.793 . . . . 0.0 109.399 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.3 m -89.73 157.58 17.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.657 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 8.1 m -88.34 30.89 0.84 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.186 0.517 . . . . 0.0 110.511 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.3 tp -154.9 127.77 8.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.912 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.845 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -76.35 142.37 71.27 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.683 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 41.9 Cg_endo -68.17 -176.35 1.04 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.039 1.826 . . . . 0.0 112.096 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.0 m -67.15 139.09 57.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.331 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.606 ' HA ' HD13 ' A' ' 34' ' ' LEU . 6.2 ptpp? -67.49 151.5 47.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.8 m -48.34 109.25 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.599 0.562 . . . . 0.0 110.911 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.04 -34.3 2.76 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 76' ' ' CYS . 3.9 mm? -89.16 139.12 30.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.797 0.332 . . . . 0.0 110.809 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -106.12 129.54 54.18 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.957 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 41.9 t -78.34 126.04 30.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.7 t -145.66 156.12 43.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.874 0.368 . . . . 0.0 110.479 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -71.44 107.69 4.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.339 0.59 . . . . 0.0 110.846 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.985 ' HB3' ' HD3' ' A' ' 75' ' ' LYS . 47.7 t -98.4 70.91 2.01 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.871 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.15 -106.02 3.33 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.119 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.617 ' OE1' ' HG2' ' A' ' 73' ' ' LYS . 11.6 tm-20 -89.31 -51.21 5.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.624 0.212 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.617 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 43.7 mmtm -94.76 178.68 5.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.942 0.401 . . . . 0.0 111.141 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -103.88 131.87 50.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.433 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.985 ' HD3' ' HB3' ' A' ' 70' ' ' SER . 3.6 mptp? -130.13 154.63 47.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.029 0.442 . . . . 0.0 110.314 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 61.6 m -77.8 136.22 38.08 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.388 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.723 -1.132 . . . . 0.0 109.365 179.912 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 121.239 0.542 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.08 124.45 1.31 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.76 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.06 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -81.22 -12.14 59.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.9 p -141.74 157.04 45.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.09 0.471 . . . . 0.0 111.514 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.752 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 26.7 t70 -105.18 -44.35 4.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.033 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -111.98 139.43 47.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.854 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -53.63 -32.9 53.18 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.725 0.64 . . . . 0.0 111.474 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.3 t -52.7 -28.9 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.314 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -68.23 -29.38 68.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 71.3 m -90.41 140.21 29.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.137 0.494 . . . . 0.0 111.499 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.21 154.58 50.8 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.963 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.9 m -53.46 105.83 0.15 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.353 0.597 . . . . 0.0 110.784 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.39 -28.55 1.79 Allowed Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.6 p -127.62 142.79 51.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.801 -0.7 . . . . 0.0 109.229 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.768 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -125.64 158.84 33.72 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.354 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 81.1 m -88.16 47.94 1.57 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 56' ' ' SER . . . -92.0 162.49 14.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.815 0.341 . . . . 0.0 110.493 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -83.87 134.49 34.69 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.476 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 81.2 p -72.41 137.19 46.32 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.705 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.14 -24.46 67.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.567 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.6 p90 -88.32 -20.03 25.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.878 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.479 ' HB2' HD13 ' A' ' 28' ' ' ILE . 59.9 m -149.24 117.4 6.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.197 0.523 . . . . 0.0 110.955 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -69.07 -13.68 62.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.226 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.446 ' OD1' ' HB3' ' A' ' 25' ' ' SER . 16.1 p-10 -88.29 -15.81 34.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.694 0.283 . . . . 0.0 111.204 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 1.7 mp -88.13 118.78 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.752 ' NH2' ' HA ' ' A' ' 8' ' ' ASP . 28.4 ttp180 -150.43 50.77 0.89 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 1.06 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.1 p90 -117.44 -166.17 1.16 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.637 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.6 m -62.04 76.97 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.077 0.861 . . . . 0.0 112.606 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.694 HG13 ' SG ' ' A' ' 59' ' ' CYS . 39.0 pt -93.31 145.43 30.01 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.89 149.86 75.81 Favored 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 123.243 2.629 . . . . 0.0 114.774 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.768 HD11 ' HB3' ' A' ' 18' ' ' CYS . 7.4 mp -88.09 166.08 14.68 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.059 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.62 151.93 25.79 Favored Glycine 0 C--O 1.239 0.412 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.023 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 5.0 p30 -112.0 -176.38 2.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.8 m -55.18 126.85 26.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.191 0.519 . . . . 0.0 111.783 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.55 -20.62 48.86 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.368 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -89.56 149.25 22.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.709 0.29 . . . . 0.0 110.598 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -68.71 148.37 50.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.794 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.514 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 12.6 p -139.44 147.86 41.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.822 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.442 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 50.2 m170 -89.42 121.0 69.7 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 10.6 Cg_endo -54.99 -36.5 92.62 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.15 2.567 . . . . 0.0 112.66 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.61 -30.79 71.15 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.377 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.8 m -75.68 128.87 36.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.798 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -101.01 166.73 10.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.374 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -55.79 148.76 15.95 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.676 0.61 . . . . 0.0 112.13 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.59 HG13 ' HA ' ' A' ' 49' ' ' PRO . 74.2 t -87.17 140.89 32.56 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.345 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.59 ' HA ' HG13 ' A' ' 48' ' ' VAL . 72.7 Cg_endo -78.03 128.53 16.81 Favored 'Cis proline' 0 C--N 1.346 0.445 0 C-N-CA 123.499 -1.459 . . . . 0.0 113.764 0.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -75.53 134.24 40.81 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.882 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.4 114.47 7.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.64 -133.47 11.74 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.996 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -150.37 141.11 22.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.838 0.351 . . . . 0.0 110.149 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -118.91 137.25 53.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.392 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.72 47.33 1.49 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.501 0.667 . . . . 0.0 109.794 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.409 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 45.7 t -89.66 140.2 29.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.952 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 5.6 m -89.12 13.42 13.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.217 0.532 . . . . 0.0 110.842 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.3 tp -153.93 132.22 11.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.731 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.694 ' SG ' HG13 ' A' ' 32' ' ' ILE . 7.4 m -71.24 150.94 94.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.23 -165.2 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.083 1.855 . . . . 0.0 111.675 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 68.4 m -76.76 141.98 40.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.706 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.559 ' HA ' HD23 ' A' ' 34' ' ' LEU . 19.8 ptmt -57.54 146.24 30.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.065 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.5 m -49.73 120.1 4.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 119.52 -33.18 4.75 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.743 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.3 mt -89.26 165.0 14.7 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.008 0.432 . . . . 0.0 111.964 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.7 m -120.44 132.51 55.26 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.872 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 53.2 t -89.14 125.77 35.18 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.5 t -150.36 155.97 40.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.723 0.297 . . . . 0.0 110.469 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.632 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 36.1 ttpt -69.05 106.03 2.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.293 0.568 . . . . 0.0 110.584 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.514 ' HB2' ' HD3' ' A' ' 75' ' ' LYS . 13.3 m -92.13 58.19 3.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.553 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.07 -100.7 1.33 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.299 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -89.75 -55.69 3.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.945 0.403 . . . . 0.0 110.912 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -100.34 170.76 8.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.314 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 13.1 m-85 -88.68 128.26 35.6 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.514 ' HD3' ' HB2' ' A' ' 70' ' ' SER . 24.2 mtpp -132.7 152.18 51.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.145 0.498 . . . . 0.0 109.694 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.514 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 98.4 m -71.47 134.94 46.92 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.795 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.248 0.978 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.82 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 8.7 t . . . . . 0 CA--C 1.532 0.258 0 CA-C-O 120.632 0.253 . . . . 0.0 111.466 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.95 118.01 0.63 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.302 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.064 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -91.21 -8.19 49.22 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.1 p -148.6 145.24 27.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.204 0.526 . . . . 0.0 112.368 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.629 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 14.4 t70 -90.21 -32.23 16.69 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.732 0.777 . . . . 0.0 109.325 178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.536 ' HG2' ' H ' ' A' ' 52' ' ' GLY . 55.0 mttp -135.8 139.74 43.72 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.777 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.62 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 41.9 t0 -55.98 -25.49 44.23 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.77 0.669 . . . . 0.0 110.571 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 t -55.03 -29.85 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.688 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.416 HE22 ' HB3' ' A' ' 8' ' ' ASP . 29.5 mt-30 -72.95 -19.6 61.21 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.683 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.451 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 59.1 m -89.53 -120.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.341 . . . . 0.0 110.702 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.28 156.11 15.28 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.736 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.4 m -51.3 104.29 0.08 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.222 0.534 . . . . 0.0 111.016 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.06 -32.96 1.39 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.5 p -138.53 135.7 35.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.824 -0.688 . . . . 0.0 109.173 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.667 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -120.31 162.85 18.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.62 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 62.5 m -87.02 110.55 20.14 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -164.09 172.52 13.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.929 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -74.49 138.13 42.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.054 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.534 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 81.4 p -75.61 141.8 42.78 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.178 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -62.29 -24.11 67.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.882 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -88.27 -25.54 22.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.556 ' HB2' HD13 ' A' ' 28' ' ' ILE . 71.4 m -150.93 130.48 13.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.276 0.56 . . . . 0.0 111.872 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -74.32 -0.06 15.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.689 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 4' ' ' THR . 30.8 m-20 -87.99 -26.76 22.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.883 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.3 mp -87.94 126.95 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 98.9 mtt180 -146.62 67.97 1.17 Allowed 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.687 0.617 . . . . 0.0 109.475 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 1.064 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.0 OUTLIER -142.39 -160.95 1.16 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.165 -179.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 24.3 m -61.54 85.22 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.845 0.716 . . . . 0.0 111.668 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.502 HG13 ' SG ' ' A' ' 59' ' ' CYS . 41.4 pt -104.84 149.29 37.36 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.6 148.5 20.8 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.844 3.03 . . . . 0.0 115.035 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.689 HD23 ' HB3' ' A' ' 59' ' ' CYS . 98.6 mt -87.5 159.63 18.56 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.52 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.15 137.64 38.33 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.829 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 68.0 m-80 -95.11 176.06 6.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.026 0.441 . . . . 0.0 110.713 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.9 m -61.24 127.93 33.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.91 -6.59 82.83 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.931 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.8 146.85 24.75 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 120.85 0.357 . . . . 0.0 110.405 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.431 ' O ' HD21 ' A' ' 58' ' ' LEU . 1.6 m-20 -61.29 139.4 58.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.926 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.472 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 25.0 p -135.07 142.4 46.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.19 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 44.2 m170 -88.39 125.38 63.78 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 2.5 Cg_endo -47.37 -36.54 23.44 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.83 3.02 . . . . 0.0 113.304 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.27 37.27 0.2 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.297 0.57 . . . . 0.0 112.031 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.598 ' HB2' ' HB3' ' A' ' 60' ' ' PRO . 6.2 p -92.05 155.89 17.77 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.929 0.395 . . . . 0.0 110.198 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.443 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 58.5 m-70 -133.26 143.57 49.19 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -55.34 152.95 7.8 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.566 HG13 ' HA ' ' A' ' 49' ' ' PRO . 95.4 t -87.01 141.56 33.29 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.509 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' HG13 ' A' ' 48' ' ' VAL . 71.8 Cg_endo -78.83 132.21 25.41 Favored 'Cis proline' 0 C--O 1.235 0.355 0 C-N-CA 123.454 -1.477 . . . . 0.0 113.818 1.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.565 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 54.6 t80 -77.72 134.44 38.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.069 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -82.35 119.13 23.76 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.572 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.536 ' H ' ' HG2' ' A' ' 9' ' ' LYS . . . 94.76 -149.82 19.5 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -178.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.629 ' HG3' ' O ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -144.32 133.24 22.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.119 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.469 ' HB2' ' CB ' ' A' ' 20' ' ' ALA . 40.6 mtp85 -70.3 136.47 49.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.367 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.28 -7.64 57.63 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 t -88.38 148.8 24.06 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.462 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.671 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 18.1 m -86.43 44.27 1.13 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.431 HD21 ' O ' ' A' ' 40' ' ' ASP . 24.3 tp -154.41 121.44 5.61 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.689 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -80.09 157.84 73.04 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.496 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.598 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 12.5 Cg_exo -68.28 177.46 4.51 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.066 1.844 . . . . 0.0 111.18 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 77.7 m -68.25 142.28 55.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.491 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.576 ' HG2' HD12 ' A' ' 65' ' ' LEU . 16.5 ptmt -61.71 151.57 33.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.349 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.5 m -45.94 125.84 6.71 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.56 0.538 . . . . 0.0 111.671 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.76 -32.71 6.86 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.83 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.576 HD12 ' HG2' ' A' ' 62' ' ' LYS . 36.0 mt -89.15 155.67 19.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.951 0.405 . . . . 0.0 111.637 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.1 m -127.47 129.29 47.18 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.373 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 48.3 t -71.42 124.81 25.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.3 t -142.98 155.53 44.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.112 0.482 . . . . 0.0 110.753 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -72.43 105.7 4.24 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.418 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.993 ' HB2' ' HD3' ' A' ' 75' ' ' LYS . 13.4 m -98.19 81.08 2.74 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.03 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.69 -109.01 3.29 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.665 ' OE1' ' HG2' ' A' ' 73' ' ' LYS . 1.3 tm-20 -89.24 -49.16 6.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.661 0.231 . . . . 0.0 111.579 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.665 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 43.9 mmtm -92.81 -172.47 3.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.157 0.503 . . . . 0.0 111.396 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -112.21 130.4 55.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.993 ' HD3' ' HB2' ' A' ' 70' ' ' SER . 1.7 mptp? -132.79 152.19 51.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.074 0.464 . . . . 0.0 109.798 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 89.2 m -70.1 118.59 13.13 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.942 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.522 -0.752 . . . . 0.0 109.271 179.37 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.539 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 9.1 t . . . . . 0 CA--C 1.532 0.253 0 CA-C-O 121.026 0.441 . . . . 0.0 110.728 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.41 114.5 0.31 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.046 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.82 -12.99 34.68 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.0 p -141.36 145.22 35.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.548 0.69 . . . . 0.0 112.578 -178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.16 -38.61 9.25 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.231 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HD2' ' OD1' ' A' ' 51' ' ' ASP . 14.0 mmtp -115.43 132.54 56.59 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.992 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.673 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 33.0 t70 -56.57 -25.32 52.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.991 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.8 HG22 ' HB2' ' A' ' 49' ' ' PRO . 22.0 t -58.04 -28.28 33.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.351 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -69.93 -20.28 63.35 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.002 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 70.0 m -89.18 129.59 35.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.126 0.489 . . . . 0.0 111.093 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.11 160.28 47.98 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.809 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.6 m -50.17 115.21 1.33 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.361 0.601 . . . . 0.0 110.868 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.625 ' H ' HD12 ' A' ' 34' ' ' LEU . . . 131.74 -28.25 3.58 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.7 p -132.63 158.44 42.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.084 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.659 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -147.57 164.24 34.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.673 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 77.0 m -86.13 112.79 21.63 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -161.34 166.74 27.03 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.146 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.647 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -85.83 149.48 25.21 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.46 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.597 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -67.67 137.37 55.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.835 0.35 . . . . 0.0 110.686 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.757 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -66.04 -24.0 66.65 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.4 p90 -86.98 -36.8 18.07 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.0 m -151.82 142.89 23.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -79.02 40.91 0.42 Allowed 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.06 -0.4 . . . . 0.0 111.511 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -96.28 -38.91 9.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.853 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 3.2 mp -89.72 131.94 35.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.539 ' HD3' ' O ' ' A' ' 4' ' ' THR . 1.6 mpt_? -143.07 65.2 1.34 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 1.046 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.1 p90 -150.46 -163.27 1.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.9 m -62.17 87.29 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 O-C-N 124.063 0.852 . . . . 0.0 112.187 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.555 HG13 ' SG ' ' A' ' 59' ' ' CYS . 45.0 pt -103.06 158.27 32.1 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 32' ' ' ILE . 11.8 Cg_endo -53.9 142.52 63.59 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.243 2.629 . . . . 0.0 114.502 -177.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.893 HD13 ' HA ' ' A' ' 62' ' ' LYS . 30.5 mt -86.87 158.85 19.24 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.674 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.81 150.13 37.37 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.047 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 3.7 p-10 -117.69 176.95 4.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.674 0.273 . . . . 0.0 110.82 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.3 m -52.38 131.14 32.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.833 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.0 -14.92 61.17 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.245 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.539 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 3.9 mm-40 -106.82 158.4 17.02 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.563 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 42.5 t0 -58.75 149.49 26.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.313 -1.767 . . . . 0.0 113.067 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.77 145.96 26.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -90.81 116.44 66.43 Favored Pre-proline 0 C--N 1.317 -0.821 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.705 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HD3' ' HB2' ' A' ' 74' ' ' PHE . 15.9 Cg_endo -58.46 -42.35 56.01 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.234 2.623 . . . . 0.0 112.927 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.6 -34.71 77.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.466 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.619 ' HB3' ' HD2' ' A' ' 54' ' ' ARG . 19.9 m -72.83 119.36 16.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.307 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.438 ' HB2' ' HD2' ' A' ' 50' ' ' TYR . 11.7 m170 -69.86 144.87 52.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HD3' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -63.68 -172.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.561 0.696 . . . . 0.0 111.603 -179.173 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.5 t -85.79 138.18 35.53 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.744 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.8 ' HB2' HG22 ' A' ' 11' ' ' VAL . 72.4 Cg_endo -96.79 135.13 3.9 Favored 'Cis proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.72 -1.367 . . . . 0.0 113.79 1.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.509 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 51.1 t80 -91.67 139.32 30.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.406 178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.433 ' OD1' ' HD2' ' A' ' 9' ' ' LYS . 49.0 t0 -77.03 59.02 1.6 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.861 0.838 . . . . 0.0 110.408 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 153.3 -139.43 6.9 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.83 128.77 20.68 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.619 ' HD2' ' HB3' ' A' ' 45' ' ' SER . 31.9 mtm-85 -70.14 137.1 50.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.315 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.8 58.68 5.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.851 0.834 . . . . 0.0 109.485 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.9 m -143.95 144.2 31.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.348 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.757 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 62.1 m -88.24 41.0 0.98 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.942 0.401 . . . . 0.0 111.21 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.4 tp -153.69 127.11 8.6 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.655 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.841 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.6 m -81.05 141.03 50.03 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.424 ' HD2' ' SG ' ' A' ' 18' ' ' CYS . 49.4 Cg_endo -69.36 -166.97 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.111 1.874 . . . . 0.0 111.821 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.749 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 34.6 m -69.34 137.35 52.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.705 0.288 . . . . 0.0 111.17 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.893 ' HA ' HD13 ' A' ' 34' ' ' LEU . 11.8 ptpt -66.19 148.52 51.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.87 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.6 m -45.61 122.52 3.68 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 123.487 0.492 . . . . 0.0 111.909 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.22 -32.99 5.5 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.09 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.0 mt -89.19 154.71 19.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.934 0.397 . . . . 0.0 111.816 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.0 m -121.89 131.91 54.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.225 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.749 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 9.7 t -91.9 143.17 26.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.798 0.333 . . . . 0.0 110.885 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t -141.22 159.24 42.63 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 27.5 ttpp -69.14 104.34 2.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.312 0.577 . . . . 0.0 110.941 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 10.5 t -89.67 75.96 7.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.478 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.85 -98.27 2.2 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.32 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.45 -56.86 3.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.029 0.443 . . . . 0.0 111.104 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.445 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 14.3 ptpt -98.17 -165.9 1.31 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.82 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.499 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 8.9 m-85 -109.7 133.98 52.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.148 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.563 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 21.8 mttt -132.42 146.8 52.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.535 0.683 . . . . 0.0 110.427 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 67' ' ' CYS . 73.5 m -68.32 150.44 48.21 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.745 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 C--O 1.248 0.984 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.321 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 120.748 0.309 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.33 125.58 0.95 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.329 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.076 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -84.18 -8.81 58.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.713 0.292 . . . . 0.0 111.457 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.6 p -148.32 145.96 28.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.762 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.3 -48.38 5.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.242 0.544 . . . . 0.0 109.58 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -102.97 139.54 38.41 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.778 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -55.25 -25.7 35.22 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.76 0.662 . . . . 0.0 111.429 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.427 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 22.0 t -54.16 -31.7 22.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.957 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -67.8 -28.02 67.24 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.3 m -89.58 138.92 31.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.074 0.464 . . . . 0.0 111.458 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.7 164.07 50.26 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.723 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.7 m -57.39 97.83 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.4 0.619 . . . . 0.0 110.763 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 153.64 -24.74 0.74 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.553 ' O ' HG11 ' A' ' 48' ' ' VAL . 25.7 p -137.39 155.24 49.6 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.17 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.786 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -139.09 167.24 22.5 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.1 m -89.3 49.49 1.77 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.965 0.412 . . . . 0.0 111.869 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.621 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -83.98 150.62 25.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.211 0.529 . . . . 0.0 111.101 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -86.6 142.3 28.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.525 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.517 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -61.42 126.05 25.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.981 0.42 . . . . 0.0 110.613 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.45 -21.61 65.57 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -86.99 -32.82 19.85 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.896 -0.321 . . . . 0.0 111.309 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.1 m -151.65 130.69 12.61 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -76.21 56.96 1.08 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.282 0.563 . . . . 0.0 111.189 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -118.5 -43.34 2.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.501 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 3.0 mp -88.97 128.16 41.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.313 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -152.07 58.65 0.85 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.763 0.792 . . . . 0.0 109.816 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 1.076 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.2 p90 -126.96 -170.95 2.3 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.533 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.7 m -60.43 79.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.061 0.85 . . . . 0.0 112.947 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.621 HD11 ' HB3' ' A' ' 20' ' ' ALA . 40.9 pt -95.83 151.93 38.71 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.05 148.54 38.89 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.331 2.687 . . . . 0.0 114.507 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.786 HD21 ' HB3' ' A' ' 18' ' ' CYS . 92.5 mt -86.93 171.05 11.09 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.509 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.64 145.29 32.58 Favored Glycine 0 C--O 1.241 0.553 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.88 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -88.79 -177.27 5.48 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.189 0.596 . . . . 0.0 110.948 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -61.72 132.33 52.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.036 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.519 ' O ' ' HD3' ' A' ' 75' ' ' LYS . . . 81.94 -3.97 77.54 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.259 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.543 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -88.91 157.32 18.46 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 117.448 0.624 . . . . 0.0 112.039 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.634 ' HB3' HD21 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -60.89 144.43 52.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.733 -178.312 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.4 p -150.53 145.36 25.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.535 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.527 ' HB2' ' OG ' ' A' ' 45' ' ' SER . 56.7 m170 -89.51 128.92 49.04 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.02 -39.61 90.07 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.918 2.412 . . . . 0.0 112.962 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.83 97.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.464 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.713 ' HB2' ' HG3' ' A' ' 60' ' ' PRO . 10.8 p -76.98 132.6 39.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -109.13 -160.93 0.74 Allowed 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.301 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.51 146.19 42.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.032 0.444 . . . . 0.0 111.382 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.553 HG11 ' O ' ' A' ' 17' ' ' THR . 40.8 t -88.34 143.38 32.44 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.847 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.551 ' HA ' ' CG1' ' A' ' 48' ' ' VAL . 16.4 Cg_exo -69.04 124.51 7.32 Favored 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 124.128 -1.197 . . . . 0.0 113.717 0.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.434 ' N ' ' HA ' ' A' ' 48' ' ' VAL . 79.9 t80 -89.06 133.4 34.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.761 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.22 111.46 10.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.036 0.446 . . . . 0.0 109.84 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 122.83 -157.86 17.42 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.582 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -152.68 132.83 13.5 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -130.01 153.41 48.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.898 0.38 . . . . 0.0 111.03 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.51 45.02 0.98 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.217 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.0 m -89.52 138.42 31.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.978 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 20.4 m -89.98 30.3 1.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.32 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.634 HD21 ' HB3' ' A' ' 40' ' ' ASP . 60.9 tp -153.55 125.35 7.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.756 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.764 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -76.38 141.29 69.72 Favored Pre-proline 0 C--N 1.327 -0.377 0 O-C-N 123.26 0.35 . . . . 0.0 110.423 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.713 ' HG3' ' HB2' ' A' ' 45' ' ' SER . 6.5 Cg_exo -70.93 -167.22 0.26 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.515 2.143 . . . . 0.0 112.329 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 61.5 m -70.55 138.86 51.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.045 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 15.5 ptpt -76.4 -179.15 4.97 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.563 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.7 m -52.91 131.28 35.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.839 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.25 -31.03 6.61 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.913 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 61' ' ' CYS . 3.6 mm? -88.9 144.86 25.91 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.373 0.606 . . . . 0.0 112.302 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.3 m -121.97 132.59 54.61 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.295 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.9 t -76.56 130.61 38.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.209 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t -149.77 159.83 44.04 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.478 ' NZ ' ' HA ' ' A' ' 72' ' ' GLU . 47.0 tttm -71.8 104.01 3.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.298 0.571 . . . . 0.0 110.043 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 t -92.59 80.87 4.79 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.57 -101.88 2.5 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.505 ' OE1' ' HA ' ' A' ' 72' ' ' GLU . 36.5 tp10 -98.15 -50.88 4.2 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.531 -0.468 . . . . 0.0 112.006 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.53 -174.55 3.52 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.513 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -104.53 133.46 49.35 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.045 0.45 . . . . 0.0 110.897 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 47.8 mttm -141.42 155.78 45.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.94 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 67.5 m -69.15 140.42 54.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.284 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 C--O 1.244 0.771 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.191 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 120.591 0.234 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.68 130.75 1.85 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.0 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.511 ' HB3' ' HA ' ' A' ' 30' ' ' PHE . . . -90.48 -23.7 20.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.947 0.403 . . . . 0.0 110.658 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.57 -142.93 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.069 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -164.16 -45.14 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.2 0.524 . . . . 0.0 110.857 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -109.33 135.41 50.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.78 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.598 ' HB3' HG23 ' A' ' 48' ' ' VAL . 56.7 m-20 -46.28 -38.28 8.42 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.019 0.824 . . . . 0.0 112.09 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.7 t -48.15 -35.09 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.565 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -68.34 -33.2 73.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.444 ' HB3' ' OG1' ' A' ' 17' ' ' THR . 37.8 m -93.45 -31.91 14.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.201 0.524 . . . . 0.0 111.946 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.0 159.63 34.3 Favored Glycine 0 C--N 1.314 -0.641 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.409 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -61.1 80.5 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.496 0.665 . . . . 0.0 111.835 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 177.67 -33.55 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 13' ' ' CYS . 7.5 p -137.21 147.33 45.77 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.531 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -130.59 159.11 38.15 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.08 -178.448 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.4 m -89.54 46.37 1.36 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.581 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.42 159.38 18.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.913 0.387 . . . . 0.0 110.946 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.754 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -78.57 131.63 36.83 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.477 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 89.6 p -61.64 139.38 58.29 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.621 -178.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.1 -24.68 63.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.294 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -87.98 -27.25 22.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.684 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.601 ' HB3' HD13 ' A' ' 28' ' ' ILE . 8.6 t -151.24 126.62 10.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.148 0.499 . . . . 0.0 111.042 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -73.23 4.72 4.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.392 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -88.91 -19.55 25.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.029 0.443 . . . . 0.0 110.479 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.754 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.5 mp -87.98 120.13 36.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 45.0 mtp85 -141.59 42.52 1.73 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 123.761 0.663 . . . . 0.0 109.454 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.691 ' CD2' HG23 ' A' ' 28' ' ' ILE . 1.3 m-85 -97.67 -175.07 3.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 99.8 m -72.62 80.43 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.416 0.448 . . . . 0.0 110.237 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.601 HG13 ' SG ' ' A' ' 59' ' ' CYS . 39.3 pt -89.03 148.42 41.01 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.3 156.15 26.84 Favored 'Trans proline' 0 N--CA 1.473 0.29 0 C-N-CA 123.329 2.686 . . . . 0.0 114.3 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.679 HD23 ' HA ' ' A' ' 62' ' ' LYS . 4.1 mp -86.94 165.48 15.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.413 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.77 134.11 37.81 Favored Glycine 0 C--O 1.24 0.529 0 CA-C-N 115.143 -0.935 . . . . 0.0 113.028 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 2.7 p30 -95.06 -179.72 4.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.285 0.564 . . . . 0.0 111.304 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -61.39 122.72 15.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.904 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.06 4.13 90.07 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.238 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -88.56 148.42 24.11 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 117.29 0.545 . . . . 0.0 109.664 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.28 138.4 55.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.424 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.2 p -136.8 153.34 50.84 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.076 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -89.76 122.57 67.91 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -57.42 -40.2 83.24 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.897 2.398 . . . . 0.0 112.602 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.6 -36.76 81.45 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.23 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.9 m -66.27 113.13 4.36 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.221 0.534 . . . . 0.0 110.385 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -70.98 153.94 42.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.76 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 60' ' ' PRO . 57.5 mtpt -65.36 176.06 1.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.216 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.598 HG23 ' HB3' ' A' ' 10' ' ' ASP . 10.0 p -88.62 139.7 29.7 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.029 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HA ' HG23 ' A' ' 48' ' ' VAL . 89.5 Cg_endo -89.04 134.2 11.41 Favored 'Cis proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.768 -1.347 . . . . 0.0 113.055 0.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.612 ' HB2' ' NH2' ' A' ' 54' ' ' ARG . 66.1 t80 -75.29 130.82 39.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.124 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -87.65 130.01 34.94 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.66 -113.6 3.83 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.863 ' HD3' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -150.53 126.88 10.69 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.612 ' NH2' ' HB2' ' A' ' 50' ' ' TYR . 60.5 ttm-85 -85.84 102.24 13.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.157 0.504 . . . . 0.0 111.771 -177.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.863 HD23 ' HD3' ' A' ' 53' ' ' LYS . 1.3 mm? -105.33 27.04 8.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.423 0.63 . . . . 0.0 109.925 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.8 m -89.7 148.46 23.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.944 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 4.3 m -88.93 21.83 2.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.829 0.347 . . . . 0.0 111.493 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.37 136.13 14.45 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.601 ' SG ' HG13 ' A' ' 32' ' ' ILE . 1.8 m -75.54 153.04 85.59 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.499 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 64.6 Cg_endo -72.52 174.06 12.25 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.115 1.877 . . . . 0.0 110.995 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.3 m -68.66 139.29 55.45 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.557 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.679 ' HA ' HD23 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -58.4 154.1 14.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.827 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.5 m -44.59 129.17 6.82 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.611 0.569 . . . . 0.0 111.226 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.61 -38.28 3.28 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.954 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.1 mt -88.84 154.93 19.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.883 0.373 . . . . 0.0 111.618 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.0 m -135.8 139.48 43.52 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.866 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 23.2 t -72.26 128.73 36.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.763 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.7 t -150.04 156.94 42.58 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 31.9 ttpt -73.19 110.08 7.21 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.301 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.466 ' HB3' ' HD2' ' A' ' 75' ' ' LYS . 10.5 t -93.24 63.04 3.56 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.372 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.76 -93.56 1.49 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.052 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.499 ' OE2' ' HG3' ' A' ' 73' ' ' LYS . 2.0 tt0 -88.33 -54.49 4.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.477 -0.362 . . . . 0.0 111.042 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 34.7 mtmm -112.91 177.99 4.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.13 0.491 . . . . 0.0 111.58 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 8.5 m-85 -89.21 133.95 34.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.268 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.466 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 56.4 mttm -136.66 154.55 50.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.719 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 95.6 m -75.54 128.43 35.28 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.953 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.252 1.236 0 CA-C-O 117.531 -1.223 . . . . 0.0 109.152 179.934 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 120.944 0.402 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.91 123.96 1.15 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.07 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.087 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.25 -13.29 35.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.814 0.34 . . . . 0.0 111.107 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 30' ' ' PHE . 17.3 p -151.19 -152.03 0.42 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.87 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -163.59 -43.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.441 0.639 . . . . 0.0 109.362 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -106.59 133.29 51.5 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.592 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -52.73 -31.16 36.49 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.557 0.536 . . . . 0.0 111.184 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.8 t -51.61 -32.05 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.407 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -70.68 -32.73 70.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.126 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.4 m -95.23 -46.32 6.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.209 0.528 . . . . 0.0 112.228 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.89 153.19 9.57 Favored Glycine 0 C--N 1.31 -0.886 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.714 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.453 ' HA ' HG11 ' A' ' 48' ' ' VAL . 16.2 m -57.13 98.23 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.546 0.689 . . . . 0.0 110.776 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.509 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . 161.08 -31.43 0.35 Allowed Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.428 HG22 ' HA ' ' A' ' 33' ' ' PRO . 22.8 p -135.14 139.0 44.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.824 -0.688 . . . . 0.0 109.334 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -111.34 156.66 21.22 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.0 m -97.23 45.83 1.04 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.399 . . . . 0.0 111.369 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -84.79 178.38 7.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.117 0.484 . . . . 0.0 111.469 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.82 142.21 28.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.378 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.675 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -60.69 139.65 57.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.148 0.499 . . . . 0.0 111.649 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.751 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -64.17 -26.17 68.4 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -86.25 -42.37 13.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.899 0.38 . . . . 0.0 111.609 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.1 m -151.96 136.79 17.15 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.408 ' NH2' ' HB3' ' A' ' 55' ' ' LEU . 99.3 mtt180 -74.86 51.7 0.5 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -101.89 -35.38 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.841 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.675 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 53.1 mt -88.8 131.11 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.279 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 6.2 mtp180 -150.16 49.19 0.91 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.912 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 1.087 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.4 p90 -128.51 -168.86 1.97 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.582 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 33.1 m -59.21 82.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.222 0.952 . . . . 0.0 112.44 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.613 HG13 ' SG ' ' A' ' 59' ' ' CYS . 23.8 pt -104.27 143.79 27.38 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.428 ' HA ' HG22 ' A' ' 17' ' ' THR . 13.6 Cg_endo -56.57 159.22 14.11 Favored 'Trans proline' 0 CA--C 1.529 0.225 0 C-N-CA 123.197 2.598 . . . . 0.0 114.112 -177.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 95.1 mt -84.86 167.91 15.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.174 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.09 144.73 35.23 Favored Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.714 -0.676 . . . . 0.0 113.726 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.566 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 0.1 OUTLIER -118.07 -167.21 1.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.062 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.448 ' OG ' HD11 ' A' ' 65' ' ' LEU . 6.1 m -59.21 125.26 22.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.789 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.59 0.14 82.26 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.28 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -88.0 148.38 24.57 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 117.068 0.434 . . . . 0.0 110.541 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.534 ' O ' HD13 ' A' ' 58' ' ' LEU . 12.3 t70 -68.05 145.61 54.29 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.984 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.4 p -150.14 143.83 25.31 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.416 ' CD2' HD21 ' A' ' 58' ' ' LEU . 90.0 m-70 -88.32 139.75 30.26 Favored Pre-proline 0 C--N 1.319 -0.747 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.862 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.73 38.03 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.196 2.597 . . . . 0.0 113.106 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 42' ' ' HIS . . . -172.57 33.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.384 0.674 . . . . 0.0 109.266 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -80.71 133.23 35.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.433 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.493 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 19.8 m170 -80.66 146.85 30.92 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -67.57 166.34 15.11 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.453 HG11 ' HA ' ' A' ' 15' ' ' SER . 58.8 t -86.33 136.99 34.88 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.435 ' HA ' HG13 ' A' ' 48' ' ' VAL . 15.7 Cg_exo -69.42 128.58 12.44 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 123.898 -1.293 . . . . 0.0 114.061 1.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 71.9 t80 -71.48 154.61 41.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.506 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.521 ' OD2' ' HG3' ' A' ' 53' ' ' LYS . 5.3 p-10 -56.33 -33.2 65.39 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.698 0.285 . . . . 0.0 111.528 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.38 34.09 67.45 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.248 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.521 ' HG3' ' OD2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -129.36 -22.76 3.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -75.24 150.6 38.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.067 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.446 ' N ' ' HD3' ' A' ' 54' ' ' ARG . 3.7 mm? -85.46 56.66 4.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.2 0.524 . . . . 0.0 111.565 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 51.3 m -89.31 128.5 35.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.27 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.751 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 15.2 m -89.67 26.61 1.71 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 40' ' ' ASP . 1.6 pp -153.97 172.16 17.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.073 0.463 . . . . 0.0 110.921 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.613 ' SG ' HG13 ' A' ' 32' ' ' ILE . 37.1 m -106.23 143.2 26.47 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.012 178.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.437 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 32.4 Cg_exo -57.14 159.52 15.08 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.539 2.159 . . . . 0.0 111.721 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 32.5 m -59.22 134.09 56.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.269 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.615 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 15.4 ptpt -70.38 163.31 26.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.251 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.0 m -47.62 124.69 7.41 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.397 0.435 . . . . 0.0 111.367 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.18 -30.07 10.56 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.11 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 36' ' ' ASN . 4.0 mm? -88.48 136.55 32.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.792 0.33 . . . . 0.0 111.006 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.5 m -116.77 124.74 50.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.467 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.5 t -71.23 125.18 26.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.7 t -150.3 158.06 43.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.836 0.35 . . . . 0.0 110.125 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.611 ' HE2' ' O ' ' A' ' 71' ' ' GLY . 85.3 tttt -71.8 105.92 3.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.257 0.551 . . . . 0.0 110.739 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 15.1 m -89.75 64.49 6.5 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.796 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.611 ' O ' ' HE2' ' A' ' 69' ' ' LYS . . . 96.16 -97.58 2.08 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.825 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.424 ' O ' ' HE3' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -91.83 -55.73 3.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.361 0.6 . . . . 0.0 110.085 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.788 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -100.09 171.07 8.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.332 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.589 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 9.1 m-85 -94.92 133.69 38.4 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.852 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.589 ' HD2' ' O ' ' A' ' 74' ' ' PHE . 14.1 mptt -135.58 157.1 47.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.605 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 82.5 m -76.21 118.53 19.03 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.576 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 C--O 1.253 1.256 0 CA-C-O 117.701 -1.143 . . . . 0.0 109.381 179.855 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.223 -0.326 0 CA-C-O 120.5 0.19 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.46 116.24 0.64 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.491 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.052 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.96 -9.5 45.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.703 -0.248 . . . . 0.0 111.375 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 30' ' ' PHE . 12.6 p -150.69 146.37 26.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.227 0.537 . . . . 0.0 111.696 -178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.06 -42.86 12.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.992 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -121.62 145.42 48.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.218 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 50' ' ' TYR . 1.6 m-20 -54.74 -27.37 40.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.223 0.535 . . . . 0.0 110.148 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.822 HG22 ' HB2' ' A' ' 49' ' ' PRO . 77.6 t -52.47 -35.01 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.057 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -72.46 -21.93 61.15 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 97.6 m -89.09 141.4 28.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.222 0.534 . . . . 0.0 111.585 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.32 157.49 52.1 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.073 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.506 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 19.9 m -54.29 112.28 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.17 0.509 . . . . 0.0 110.312 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.467 ' C ' ' HG ' ' A' ' 34' ' ' LEU . . . 136.46 -22.84 3.33 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 p -136.01 152.24 50.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.196 -0.502 . . . . 0.0 110.232 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.6 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -135.74 162.15 33.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 59.8 m -89.07 49.28 1.75 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.641 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -82.07 163.26 22.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.98 0.419 . . . . 0.0 110.631 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.694 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -83.93 145.16 28.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.619 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.651 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -58.11 130.46 46.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.945 0.403 . . . . 0.0 110.703 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.822 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -58.4 -27.06 63.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -85.5 -38.77 18.2 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.861 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m -150.83 136.1 17.72 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.139 -0.351 . . . . 0.0 110.431 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.92 55.05 0.17 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.051 0.54 . . . . 0.0 111.823 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -114.91 -38.76 3.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.966 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.694 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 1.9 mp -88.09 133.58 30.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.81 0.338 . . . . 0.0 110.401 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.2 mmm-85 -144.63 57.18 1.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.985 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 1.052 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.0 p90 -136.1 -173.28 3.35 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.171 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.5 m -59.04 84.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 O-C-N 124.295 0.997 . . . . 0.0 113.111 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.641 HD11 ' HB3' ' A' ' 20' ' ' ALA . 38.9 pt -102.0 151.01 37.94 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.32 151.7 28.41 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.365 2.71 . . . . 0.0 114.77 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.6 HD21 ' HB3' ' A' ' 18' ' ' CYS . 80.7 mt -87.52 165.35 15.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.361 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.9 145.97 39.13 Favored Glycine 0 C--O 1.241 0.541 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.594 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 1.5 t-20 -96.82 -175.92 3.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.413 0.625 . . . . 0.0 111.253 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.8 m -60.97 129.26 40.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.555 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.99 -4.64 82.4 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.865 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.17 149.12 23.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.99 0.395 . . . . 0.0 110.519 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.631 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 1.1 t70 -63.96 141.56 58.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.357 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 74' ' ' PHE . 25.0 p -141.81 139.38 32.72 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.067 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 33.2 m170 -89.12 128.41 51.8 Favored Pre-proline 0 C--N 1.318 -0.797 0 C-N-CA 120.086 -0.645 . . . . 0.0 109.653 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 0.9 OUTLIER -44.64 -49.47 9.29 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 124.17 3.246 . . . . 0.0 114.608 -177.318 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.42 31.56 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.89 0.376 . . . . 0.0 111.821 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.423 ' O ' ' HD3' ' A' ' 54' ' ' ARG . 14.5 m -90.72 -20.23 22.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.135 0.493 . . . . 0.0 110.469 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.763 ' HD2' ' HB2' ' A' ' 56' ' ' SER . 3.7 m-70 -169.36 125.89 0.9 Allowed 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.739 ' H ' ' HB2' ' A' ' 50' ' ' TYR . 9.2 mmmm -140.39 177.74 7.79 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 61.4 t -125.95 107.7 25.23 Favored Pre-proline 0 C--N 1.32 -0.7 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.224 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.822 ' HB2' HG22 ' A' ' 11' ' ' VAL . 59.0 Cg_endo -96.49 129.46 3.38 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.483 -1.049 . . . . 0.0 112.79 -0.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.739 ' HB2' ' H ' ' A' ' 47' ' ' LYS . 1.3 t80 -82.74 124.12 29.94 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -76.83 -38.4 53.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.67 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.53 -167.75 29.56 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.549 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -152.51 140.82 20.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.593 0.235 . . . . 0.0 110.569 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 45' ' ' SER . 6.9 ptm180 -167.24 159.53 12.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.1 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.75 54.04 2.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.928 0.394 . . . . 0.0 111.912 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.763 ' HB2' ' HD2' ' A' ' 46' ' ' HIS . 50.9 m -88.31 127.19 35.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.822 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 20.8 m -88.81 44.44 1.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.4 tp -153.37 126.57 8.52 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.399 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.563 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -87.47 148.04 43.34 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.107 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 46' ' ' HIS . 42.1 Cg_endo -66.96 -177.99 1.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.488 2.125 . . . . 0.0 111.715 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 81.6 m -69.81 141.33 53.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.767 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.511 ' HA ' HD12 ' A' ' 34' ' ' LEU . 9.6 ptmm? -62.35 148.64 44.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.775 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.506 ' OG ' ' HB3' ' A' ' 15' ' ' SER . 10.2 m -46.33 130.92 10.74 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 123.44 0.463 . . . . 0.0 111.274 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.41 -30.23 10.21 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.774 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.9 mt -91.4 147.56 22.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.747 0.308 . . . . 0.0 111.464 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -108.41 126.49 52.94 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.323 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.422 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 54.1 t -83.59 116.21 22.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.0 t -137.48 157.9 45.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.765 0.316 . . . . 0.0 110.185 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 84.1 tttt -69.25 105.44 2.52 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.358 0.599 . . . . 0.0 111.198 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -92.92 77.14 4.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.746 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.452 ' O ' ' HE2' ' A' ' 69' ' ' LYS . . . 87.42 -102.52 2.8 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.579 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.548 ' O ' ' HE3' ' A' ' 69' ' ' LYS . 5.2 tm-20 -91.28 -53.08 4.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.739 0.304 . . . . 0.0 110.634 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.428 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 45.2 mmtm -98.21 171.2 8.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.073 0.463 . . . . 0.0 111.241 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 6.3 m-85 -92.19 138.34 31.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.462 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.631 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 48.8 mttp -143.92 155.08 43.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.23 0.538 . . . . 0.0 110.439 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 59.8 m -70.96 135.67 48.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.942 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.3 m . . . . . 0 C--O 1.255 1.364 0 CA-C-O 117.557 -1.211 . . . . 0.0 108.888 179.548 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.99 133.58 30.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.749 0.309 . . . . 0.0 110.254 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.417 HG22 ' CE1' ' A' ' 30' ' ' PHE . 45.4 mm -94.67 115.12 32.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 t -140.18 26.51 2.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.803 0.811 . . . . 0.0 110.008 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.19 128.16 1.08 Allowed Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.878 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.722 ' HB3' ' HA ' ' A' ' 30' ' ' PHE . . . -90.57 -33.73 15.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.279 0.562 . . . . 0.0 110.158 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 5.0 p -152.0 -165.0 2.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.152 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.461 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 27.4 t70 -141.72 -40.45 0.37 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.311 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -105.61 128.41 53.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.436 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' A' ' 49' ' ' PRO . 12.9 m-20 -54.84 -24.56 23.58 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.591 0.557 . . . . 0.0 111.069 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.53 -31.42 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.834 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -69.27 -29.59 67.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.287 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.451 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 59.7 m -93.49 -119.09 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.048 0.451 . . . . 0.0 110.545 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.96 157.8 30.39 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 m -53.39 117.29 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.068 0.461 . . . . 0.0 110.481 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.22 -23.98 5.41 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.9 p -128.34 142.13 51.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.601 -0.3 . . . . 0.0 110.211 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.69 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -123.05 154.48 38.47 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.2 m -91.51 38.58 0.98 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.932 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -88.69 -173.02 3.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.766 0.317 . . . . 0.0 110.558 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.639 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.33 140.56 29.58 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.466 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 93.6 p -67.75 144.46 55.4 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.467 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.07 65.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.354 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 41.7 p90 -87.65 -32.21 19.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.477 ' HB2' HD13 ' A' ' 28' ' ' ILE . 67.4 m -149.93 127.38 11.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.401 0.619 . . . . 0.0 112.287 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.457 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -69.85 5.34 1.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.725 179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -88.58 -24.68 22.8 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.323 0.582 . . . . 0.0 109.895 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.639 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.4 mp -87.38 122.89 39.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.534 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 31.9 mtp180 -140.64 46.08 1.8 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.269 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.722 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 0.3 OUTLIER -98.53 -172.91 2.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 38.3 m -71.67 78.83 0.83 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.664 HG13 ' SG ' ' A' ' 59' ' ' CYS . 17.0 pt -88.75 142.7 30.9 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.739 0.304 . . . . 0.0 110.583 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.79 150.33 71.81 Favored 'Trans proline' 0 N--CA 1.475 0.409 0 C-N-CA 123.413 2.742 . . . . 0.0 114.834 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.69 HD11 ' HB3' ' A' ' 18' ' ' CYS . 8.1 mp -87.11 167.3 14.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.164 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.98 141.2 32.52 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.882 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 68.9 m-80 -102.46 -168.13 1.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.856 0.36 . . . . 0.0 110.893 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 m -62.2 125.59 24.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.056 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.18 1.68 86.24 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.569 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 20.8 mm-40 -88.92 150.44 22.85 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.853 0.359 . . . . 0.0 110.748 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.501 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -73.64 139.39 45.42 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.371 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.9 p -138.4 148.44 44.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.275 0.56 . . . . 0.0 110.388 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -89.25 122.63 68.45 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.76 -31.56 95.28 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.825 2.35 . . . . 0.0 111.929 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.447 ' HB1' HH22 ' A' ' 54' ' ' ARG . . . -70.83 -22.3 62.34 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.641 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.48 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 46.7 m -79.9 125.79 30.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.907 0.384 . . . . 0.0 110.219 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.412 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 34.9 m170 -86.41 168.92 13.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.477 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -57.83 149.0 23.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 49' ' ' PRO . 42.7 t -87.71 136.65 32.53 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.057 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HA ' HG13 ' A' ' 48' ' ' VAL . 15.9 Cg_exo -69.31 136.98 40.51 Favored 'Cis proline' 0 C--N 1.35 0.623 0 C-N-CA 123.871 -1.304 . . . . 0.0 112.819 0.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 53.9 t80 -63.72 127.96 33.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.866 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.16 58.03 1.95 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.373 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 158.92 -143.05 8.85 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.026 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -136.19 136.72 40.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.451 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 1.7 tpt180 -157.85 126.62 5.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.0 mp -89.1 52.89 2.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.337 0.589 . . . . 0.0 110.764 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.449 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 54.7 m -88.82 138.64 31.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.399 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 13.4 m -89.92 32.35 0.91 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.457 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.6 tp -154.62 127.81 8.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.985 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.664 ' SG ' HG13 ' A' ' 32' ' ' ILE . 54.8 m -74.97 145.03 80.5 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 17.0 Cg_exo -67.59 -168.34 0.18 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.496 2.131 . . . . 0.0 111.704 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 81.5 m -72.17 140.46 48.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.651 0.262 . . . . 0.0 111.04 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.452 ' HG3' HD12 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -63.97 152.89 38.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.073 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.9 m -49.28 123.95 8.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.51 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.05 -32.4 6.73 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.261 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.452 HD12 ' HG3' ' A' ' 62' ' ' LYS . 28.3 mt -89.8 151.39 21.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.068 0.461 . . . . 0.0 112.147 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -111.63 134.45 53.2 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.388 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.501 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 46.2 t -88.45 120.07 29.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.6 t -150.44 155.86 40.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 32.8 ttpt -61.63 114.38 3.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.08 0.467 . . . . 0.0 110.015 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 14.7 m -123.74 50.15 1.65 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.296 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.1 -112.29 0.84 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.66 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.859 ' HG2' ' HG3' ' A' ' 73' ' ' LYS . 2.7 pm0 -86.68 -37.63 17.79 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.29 0.567 . . . . 0.0 109.912 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.859 ' HG3' ' HG2' ' A' ' 72' ' ' GLU . 9.8 mtmp? -131.31 -165.02 1.51 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.987 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 3.5 m-85 -89.67 139.45 30.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.672 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.54 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 51.0 mttp -137.9 154.92 49.39 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 63.2 m -78.94 134.41 36.85 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.72 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.0 m . . . . . 0 C--O 1.245 0.835 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.354 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p -150.63 141.33 16.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.3 mm -89.14 65.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.099 0.476 . . . . 0.0 111.293 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.8 t -150.7 31.76 0.64 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.744 0.783 . . . . 0.0 109.919 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.85 97.66 0.68 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.375 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.048 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -78.0 -12.31 59.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.836 0.35 . . . . 0.0 111.573 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 p -150.83 152.12 33.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.928 0.394 . . . . 0.0 111.524 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.451 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 7.6 t70 -106.23 -50.2 3.21 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -89.66 130.34 35.96 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.521 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 34.4 t70 -55.51 -28.46 54.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.619 0.724 . . . . 0.0 110.081 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.613 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 42.9 t -54.79 -29.35 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.24 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -65.59 -26.71 67.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.463 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 76.7 m -89.95 132.5 35.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.128 0.49 . . . . 0.0 111.175 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.37 158.78 53.42 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.911 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.1 m -52.95 107.92 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.307 0.575 . . . . 0.0 110.995 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.06 -30.88 2.0 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 35.5 p -132.35 149.25 52.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.291 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.859 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -136.03 162.81 31.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.861 0.3 . . . . 0.0 110.807 -178.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.521 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 65.3 m -87.82 85.99 7.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.043 0.449 . . . . 0.0 110.031 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.551 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -130.97 157.45 42.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.562 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -85.81 144.34 27.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.295 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.717 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -65.58 140.89 58.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.035 0.445 . . . . 0.0 111.003 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -66.81 -24.67 66.2 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -87.06 -36.08 18.36 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.1 m -151.53 138.93 19.44 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -80.31 35.29 0.33 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.919 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -89.86 -38.47 13.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.266 0.555 . . . . 0.0 109.885 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.717 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.4 mp -88.33 126.77 41.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.451 ' NH2' ' HA ' ' A' ' 8' ' ' ASP . 0.8 OUTLIER -150.93 57.17 0.91 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 1.048 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.6 p90 -138.69 -169.32 2.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.234 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.8 m -58.47 98.16 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 O-C-N 124.028 0.83 . . . . 0.0 112.236 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.616 HG13 ' SG ' ' A' ' 59' ' ' CYS . 33.1 pt -116.68 149.48 43.98 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.74 144.63 53.19 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.629 2.886 . . . . 0.0 115.434 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.859 HD11 ' HB3' ' A' ' 18' ' ' CYS . 7.4 mp -88.11 173.85 8.59 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.915 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.01 143.54 23.2 Favored Glycine 0 C--O 1.239 0.429 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.771 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.562 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 71.4 m-80 -99.65 -169.77 1.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.909 0.385 . . . . 0.0 111.057 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.7 m -61.0 128.06 34.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.101 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.26 8.77 85.65 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.834 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 2.2 mm-40 -88.89 161.64 16.57 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.807 0.337 . . . . 0.0 110.972 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -71.3 137.36 48.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.909 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.83 142.56 28.96 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -89.95 124.23 64.09 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -56.36 -39.95 87.91 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.794 2.33 . . . . 0.0 112.147 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.56 -38.98 77.65 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.373 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.4 m -66.29 101.37 0.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.325 0.583 . . . . 0.0 109.954 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 66.0 m-70 -68.6 148.27 50.73 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.053 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 63' ' ' SER . 52.0 tttm -54.15 163.72 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.493 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.511 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 44.5 t -85.01 143.08 39.35 Favored Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.629 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.613 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 18.9 Cg_endo -91.99 129.85 6.53 Favored 'Cis proline' 0 N--CA 1.461 -0.415 0 C-N-CA 124.013 -1.245 . . . . 0.0 114.495 1.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.518 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 20.4 t80 -87.15 128.57 35.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.838 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -82.69 61.56 5.85 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.463 -0.773 . . . . 0.0 110.789 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.13 176.62 44.48 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.459 ' H ' ' HD2' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -89.81 126.05 35.54 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.408 HH12 ' CG ' ' A' ' 10' ' ' ASP . 22.6 ttm105 -75.19 120.24 20.42 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.3 -2.19 58.44 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.223 0.535 . . . . 0.0 110.594 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.4 m -87.31 142.73 27.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.579 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 30.2 m -88.0 34.76 0.73 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.901 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.7 tp -154.31 130.73 10.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.709 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.616 ' SG ' HG13 ' A' ' 32' ' ' ILE . 9.8 m -76.06 148.79 81.83 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -72.92 -166.15 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.425 2.083 . . . . 0.0 111.792 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 72.2 m -76.46 140.59 41.32 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.335 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.587 ' HA ' HD23 ' A' ' 34' ' ' LEU . 11.1 ptmm? -60.88 148.17 40.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.997 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.527 ' HA ' ' HE2' ' A' ' 47' ' ' LYS . 68.1 m -51.04 131.77 27.26 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.142 0.496 . . . . 0.0 110.551 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.95 -28.68 10.18 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 mt -102.51 150.58 23.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.359 -0.42 . . . . 0.0 110.871 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.9 m -118.92 131.64 56.05 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.23 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 52.5 t -78.14 125.67 29.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.889 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.8 t -150.52 155.99 40.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 80.7 tttt -65.79 123.17 19.04 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.989 0.423 . . . . 0.0 110.266 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 15.6 m -128.0 41.6 3.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.255 0.55 . . . . 0.0 110.24 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 144.97 -112.72 0.67 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.03 -45.65 10.0 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.104 0.478 . . . . 0.0 109.748 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -110.98 -158.64 0.65 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.162 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 5.4 m-85 -107.38 137.24 45.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.81 0.338 . . . . 0.0 110.949 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 5.5 mptp? -126.83 159.44 33.87 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 70.1 m -81.17 131.99 35.33 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.824 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.244 0.783 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.842 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.55 137.86 13.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.8 mm -89.18 103.63 14.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.968 0.413 . . . . 0.0 110.303 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.0 t -151.93 -38.33 0.12 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.039 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.82 124.77 0.76 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.009 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.094 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.88 -13.22 34.06 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.0 p -150.97 -159.92 1.1 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.784 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -153.15 -53.31 0.11 Allowed 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 52' ' ' GLY . 29.9 mmtp -89.83 132.97 34.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 50' ' ' TYR . 45.1 m-20 -53.86 -30.66 46.67 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.551 0.532 . . . . 0.0 110.622 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.1 t -54.94 -31.47 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.794 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.461 ' NE2' ' H ' ' A' ' 9' ' ' LYS . 73.6 mt-30 -67.26 -27.78 67.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.407 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 75.4 m -89.67 138.51 31.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.019 0.437 . . . . 0.0 111.171 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.99 154.15 52.82 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.056 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 m -49.49 108.66 0.21 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.033 0.49 . . . . 0.0 110.755 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.22 -18.37 4.21 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.304 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.5 p -135.11 161.46 35.26 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.385 0.274 . . . . 0.0 110.934 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.802 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -145.87 167.63 22.77 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.1 m -88.91 58.63 4.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.02 0.438 . . . . 0.0 111.268 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.839 ' HA ' ' HB2' ' A' ' 54' ' ' ARG . . . -90.08 152.81 20.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.26 0.552 . . . . 0.0 111.871 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -82.91 147.69 28.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.833 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.541 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -63.22 137.76 58.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.028 0.442 . . . . 0.0 111.092 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.622 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -67.09 -22.99 65.8 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -87.38 -40.03 14.78 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.89 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.0 m -152.32 148.42 27.5 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -78.09 48.36 0.73 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.936 0.398 . . . . 0.0 111.522 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -98.27 -43.14 7.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.417 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.8 mp -88.18 131.87 34.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.818 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -148.6 55.67 1.02 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 1.094 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.4 p90 -138.43 -173.8 3.64 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.2 m -57.6 98.31 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.915 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.782 HD11 ' HB3' ' A' ' 20' ' ' ALA . 44.8 pt -119.13 155.59 53.22 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 32' ' ' ILE . 10.1 Cg_endo -52.0 143.59 39.88 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.409 2.739 . . . . 0.0 115.152 -177.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.844 HD23 ' HB3' ' A' ' 59' ' ' CYS . 70.0 mt -87.19 159.74 18.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.689 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -52.98 141.53 29.11 Favored Glycine 0 C--O 1.242 0.614 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.268 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.643 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 66.1 m-20 -95.65 176.37 6.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.322 -0.439 . . . . 0.0 110.997 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.5 m -64.38 128.11 34.38 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.17 5.52 90.02 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.357 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.528 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 3.2 mm-40 -92.56 152.81 19.42 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.833 0.349 . . . . 0.0 111.497 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -68.72 145.1 54.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.426 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.45 179.0 7.05 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 37.7 m170 -116.12 122.75 31.82 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 3.7 Cg_endo -47.9 -44.12 28.03 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.425 2.75 . . . . 0.0 113.407 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.94 80.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.281 0.563 . . . . 0.0 110.984 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.528 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 19.6 m -78.17 83.15 4.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.172 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.412 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 97.1 m-70 -61.59 146.47 48.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.957 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.8 143.21 10.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.796 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' A' ' 49' ' ' PRO . 99.7 t -87.93 144.3 34.56 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.938 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.585 ' HA ' HG13 ' A' ' 48' ' ' VAL . 34.4 Cg_exo -62.53 142.45 40.82 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 124.634 -0.986 . . . . 0.0 114.144 1.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 87.8 t80 -166.36 137.59 3.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.621 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -84.66 113.82 21.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.687 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' LYS . . . 169.7 -174.2 43.95 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.225 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.86 142.58 49.01 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.839 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . 3.6 mmp_? -86.67 110.53 19.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.247 0.546 . . . . 0.0 112.076 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.42 -21.94 23.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.6 m -88.7 153.82 20.79 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.27 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.622 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 43.6 m -87.69 46.04 1.34 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.044 0.45 . . . . 0.0 111.044 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.6 tp -153.08 127.0 8.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.078 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.844 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.6 m -77.86 141.58 64.02 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.262 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.528 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 20.4 Cg_exo -65.57 -178.31 0.9 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.677 2.251 . . . . 0.0 111.499 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 72.7 m -62.4 140.43 58.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.313 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -64.11 155.56 31.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.073 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.4 m -51.78 127.4 20.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.211 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.72 -30.48 9.06 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.695 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.633 HD12 ' HG2' ' A' ' 62' ' ' LYS . 26.3 mt -88.98 145.77 25.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.109 0.481 . . . . 0.0 112.081 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.2 m -119.85 125.02 47.5 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.791 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 4.4 t -81.82 135.55 35.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.858 0.361 . . . . 0.0 111.242 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.4 m -137.53 148.33 45.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.438 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 72' ' ' GLU . 16.0 ttmt -64.54 114.26 4.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.471 0.653 . . . . 0.0 110.962 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.505 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 11.1 m -97.75 83.37 3.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.985 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.07 -62.47 4.17 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.486 ' OE1' ' HA ' ' A' ' 72' ' ' GLU . 35.6 tp10 -150.11 -43.67 0.13 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.928 0.394 . . . . 0.0 109.957 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -87.79 153.68 21.15 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.58 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 11.8 m-85 -89.39 129.57 35.89 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.89 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 45.8 mttm -125.81 150.28 47.94 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.137 0.494 . . . . 0.0 110.027 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 67' ' ' CYS . 59.2 m -75.03 141.33 43.9 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.125 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.253 1.241 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.214 179.6 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.13 135.87 24.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.861 0.363 . . . . 0.0 110.217 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.9 mm -88.59 81.93 2.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.215 0.531 . . . . 0.0 110.467 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.2 t -150.08 29.26 0.73 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.673 0.749 . . . . 0.0 110.105 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . 167.91 69.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.142 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.85 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -71.3 -17.33 62.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.7 p -150.06 144.99 26.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.826 0.345 . . . . 0.0 111.192 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.574 ' O ' ' HD2' ' A' ' 53' ' ' LYS . 11.6 t70 -86.91 -47.7 8.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.672 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 36.7 mttm -117.88 146.41 43.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.573 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.607 ' OD1' ' HA ' ' A' ' 53' ' ' LYS . 1.8 m-20 -51.24 -28.17 10.98 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.873 0.733 . . . . 0.0 111.529 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.854 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 22.0 t -55.25 -31.17 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.763 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.459 HE22 ' HB3' ' A' ' 8' ' ' ASP . 54.5 mt-30 -69.94 -17.98 63.34 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.1 m -89.42 -139.61 0.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.7 -141.84 4.77 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 119.395 -1.383 . . . . 0.0 113.777 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m -50.68 115.71 1.61 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.913 -0.644 . . . . 0.0 112.646 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 33' ' ' PRO . . . 60.45 31.45 74.36 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 114.928 -1.033 . . . . 0.0 114.907 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.565 ' O ' HG11 ' A' ' 48' ' ' VAL . 6.0 p -148.57 143.06 26.36 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.149 0.974 . . . . 0.0 111.685 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.743 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -142.43 167.67 21.55 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.2 m -89.67 45.19 1.26 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.61 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -79.81 159.87 26.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.405 0.621 . . . . 0.0 111.407 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -88.27 152.68 21.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.945 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.641 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -63.33 136.5 57.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.048 0.452 . . . . 0.0 110.694 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.704 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -66.91 -22.43 65.96 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -86.99 -37.36 17.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.895 0.379 . . . . 0.0 111.674 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.0 m -152.01 145.92 25.18 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -80.14 38.84 0.42 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.47 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -89.93 -41.66 11.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.511 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.641 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.0 mp -87.35 130.76 36.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.572 ' O ' ' HA2' ' A' ' 5' ' ' GLY . 88.4 mtm180 -148.44 65.63 1.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.86 0.725 . . . . 0.0 109.304 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.85 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.4 p90 -150.84 -170.6 3.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.816 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 94.6 m -58.76 102.8 0.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.804 0.69 . . . . 0.0 112.539 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.61 HD11 ' HB3' ' A' ' 20' ' ' ALA . 47.1 pt -123.85 157.62 62.57 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 14.4 Cg_endo -56.0 147.7 62.13 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.235 2.623 . . . . 0.0 115.061 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.808 HD23 ' HB3' ' A' ' 59' ' ' CYS . 78.5 mt -87.15 160.43 18.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.501 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.74 144.76 45.85 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 114.156 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.455 ' H ' ' CD ' ' A' ' 39' ' ' GLU . 35.1 m-80 -99.69 159.89 14.71 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.34 0.656 . . . . 0.0 110.685 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.2 m -56.39 128.58 36.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.883 0.373 . . . . 0.0 110.437 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.5 -21.69 36.31 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.966 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 36' ' ' ASN . 7.2 pt-20 -96.44 155.34 16.81 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 117.561 0.68 . . . . 0.0 110.648 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.71 145.32 49.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.998 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.2 p -144.7 156.13 43.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.079 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.462 ' CD2' ' HB3' ' A' ' 58' ' ' LEU . 84.0 m-70 -90.61 126.9 54.54 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.93 -34.67 99.21 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.708 2.272 . . . . 0.0 112.387 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.93 98.95 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.543 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.637 ' HB2' ' HB3' ' A' ' 60' ' ' PRO . 3.4 p -74.31 133.39 42.58 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -112.88 -150.31 0.46 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.947 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.623 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -70.02 155.19 40.95 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -179.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.595 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 92.0 t -111.99 137.77 21.49 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.114 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.854 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 37.9 Cg_exo -59.13 126.26 2.5 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 124.193 -1.17 . . . . 0.0 113.383 1.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.588 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 57.2 t80 -75.16 146.65 41.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.732 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.51 56.31 0.67 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.266 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.15 -136.54 6.38 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.667 ' HE3' HD21 ' A' ' 55' ' ' LEU . 29.7 pttt -150.38 138.24 20.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.731 0.3 . . . . 0.0 110.256 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.437 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 29.9 mmt180 -114.87 115.3 26.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.059 0.457 . . . . 0.0 111.224 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.667 HD21 ' HE3' ' A' ' 53' ' ' LYS . 3.1 mm? -89.23 32.75 0.82 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.931 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 p -89.2 157.38 18.28 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.703 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.704 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 68.0 m -88.02 30.21 0.87 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.044 0.45 . . . . 0.0 111.595 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.462 ' HB3' ' CD2' ' A' ' 42' ' ' HIS . 60.9 tp -154.5 123.65 6.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.382 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.808 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -73.94 146.75 85.51 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.637 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 57.0 Cg_endo -70.16 -173.31 0.75 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.843 1.695 . . . . 0.0 111.339 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . 80.0 m -67.69 142.35 56.37 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.995 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . 46.8 mtpt -55.24 145.41 21.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.182 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.8 m -47.16 117.39 1.71 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.427 0.454 . . . . 0.0 110.966 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.26 -27.53 8.93 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.496 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 61' ' ' CYS . 56.2 mt -88.3 156.64 19.07 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.781 0.324 . . . . 0.0 111.04 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.7 m -123.15 130.57 52.94 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.496 -0.482 . . . . 0.0 112.163 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 35.6 t -78.06 119.23 21.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.5 m -131.99 145.02 51.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.638 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 54.2 tttp -65.37 107.8 1.75 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.277 0.56 . . . . 0.0 110.332 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 14.4 m -95.02 83.73 3.99 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.855 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.51 -69.75 3.27 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.473 ' OE1' ' HA ' ' A' ' 72' ' ' GLU . 36.4 tp10 -135.58 -49.46 0.71 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -88.15 157.87 18.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.445 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 12.8 m-85 -89.83 130.83 36.02 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.677 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.457 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 34.5 mttp -131.39 150.62 52.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.247 0.546 . . . . 0.0 109.906 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 62.1 m -67.23 134.29 51.38 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.983 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.254 1.295 0 CA-C-O 117.747 -1.12 . . . . 0.0 108.54 179.092 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.65 137.35 12.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 110.118 -0.326 . . . . 0.0 110.118 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 mm -88.9 99.58 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.931 0.396 . . . . 0.0 110.04 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 15.4 t -151.24 -30.21 0.18 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.426 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.5 117.55 0.4 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.046 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.71 -7.93 51.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.709 0.29 . . . . 0.0 111.776 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.514 ' SG ' ' HA ' ' A' ' 30' ' ' PHE . 6.0 p -132.3 139.13 48.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.024 0.44 . . . . 0.0 111.801 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.536 ' HB3' ' NE2' ' A' ' 12' ' ' GLN . 0.2 OUTLIER -71.55 -46.01 60.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.697 178.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -139.87 153.99 47.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.996 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.481 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 6.6 t70 -50.09 -30.87 11.9 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.155 0.91 . . . . 0.0 111.688 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.584 ' HA ' ' CB ' ' A' ' 49' ' ' PRO . 46.3 t -53.94 -30.15 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.512 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.536 ' NE2' ' HB3' ' A' ' 8' ' ' ASP . 72.3 mt-30 -76.36 -15.17 60.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 92.0 m -89.32 132.14 35.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.128 0.49 . . . . 0.0 111.088 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.51 156.83 51.39 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.095 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.1 m -52.14 108.9 0.32 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.135 0.493 . . . . 0.0 110.632 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.31 -21.18 3.3 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.1 p -136.3 156.34 48.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.136 -0.532 . . . . 0.0 110.077 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.703 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -145.17 161.69 38.9 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.325 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 62.1 m -87.01 59.41 5.62 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.078 0.465 . . . . 0.0 111.26 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.554 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -93.33 144.5 25.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.97 0.414 . . . . 0.0 110.821 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -78.6 143.12 36.72 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.651 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 66.0 m -65.46 133.66 51.76 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.883 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.62 -24.71 67.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.901 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -86.68 -37.08 18.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 110.623 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.64 ' O ' ' HB2' ' A' ' 22' ' ' SER . 23.1 t -152.06 128.1 10.39 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.476 ' HD3' ' N ' ' A' ' 26' ' ' ARG . 1.7 mpp_? -77.22 37.87 0.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 4' ' ' THR . 13.4 p-10 -89.23 -37.69 14.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.651 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 42.9 mt -89.02 124.33 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.6 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -145.99 53.74 1.15 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 1.046 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.6 p90 -131.51 -171.0 2.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.478 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.7 m -61.56 77.3 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.19 0.931 . . . . 0.0 113.266 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' A' ' 20' ' ' ALA . 44.7 pt -93.54 154.6 41.17 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -55.29 151.63 35.37 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.222 2.615 . . . . 0.0 114.442 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 18' ' ' CYS . 75.7 mt -86.91 159.68 18.96 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.12 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.53 138.25 44.17 Favored Glycine 0 C--O 1.238 0.353 0 O-C-N 124.059 0.849 . . . . 0.0 114.145 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.501 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 44.7 m-80 -105.75 162.51 13.48 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.238 0.615 . . . . 0.0 110.161 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.4 m -55.95 121.02 8.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.729 0.3 . . . . 0.0 110.63 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.77 -25.84 13.94 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.422 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 13.6 pt-20 -93.71 152.89 18.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.873 0.836 . . . . 0.0 110.769 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 67.6 m-20 -59.69 153.64 19.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.551 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 27.2 p -144.72 154.85 43.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.775 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 56.8 m170 -90.2 126.14 57.87 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.536 ' HG3' ' CG ' ' A' ' 74' ' ' PHE . 36.5 Cg_exo -59.52 -53.45 3.39 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 123.15 2.566 . . . . 0.0 113.721 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.41 30.62 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.1 t -90.54 120.86 31.98 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.57 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 83.8 m-70 -68.65 144.32 54.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.186 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.57 ' HE3' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -54.16 154.98 3.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.969 -178.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.462 HG22 HH12 ' A' ' 54' ' ' ARG . 95.8 t -88.71 135.46 32.22 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.584 ' CB ' ' HA ' ' A' ' 11' ' ' VAL . 60.7 Cg_endo -73.21 140.77 69.08 Favored 'Cis proline' 0 C--O 1.237 0.469 0 C-N-CA 123.881 -1.3 . . . . 0.0 113.08 0.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.57 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 68.7 t80 -62.25 133.75 55.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.112 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.04 60.22 1.39 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.725 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.72 -133.9 4.26 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.92 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -117.89 124.76 49.08 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.462 HH12 HG22 ' A' ' 48' ' ' VAL . 25.4 ttm180 -90.63 111.91 23.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.215 0.531 . . . . 0.0 112.181 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 55' ' ' LEU . 4.0 mm? -111.65 18.43 19.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.14 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -89.34 142.3 27.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.37 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 15.8 m -89.25 30.51 0.97 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.7 tp -154.46 130.22 10.05 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.263 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.628 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -80.51 140.31 51.81 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.35 171.06 11.01 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.539 2.159 . . . . 0.0 111.139 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.3 m -60.35 139.91 57.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.772 0.32 . . . . 0.0 110.937 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.506 ' HG2' HD12 ' A' ' 65' ' ' LEU . 14.6 ptmt -62.37 153.14 32.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.482 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.6 m -47.81 124.68 7.63 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.417 0.448 . . . . 0.0 111.294 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.18 -32.04 6.98 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.506 HD12 ' HG2' ' A' ' 62' ' ' LYS . 28.2 mt -89.29 156.9 18.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 0.0 111.565 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.1 m -124.87 133.28 53.14 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.332 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 48.1 t -79.16 122.49 26.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 m -151.0 151.98 32.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.658 0.266 . . . . 0.0 111.08 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 83.0 tttt -62.25 116.29 4.88 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.7 m -115.97 49.02 1.15 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.775 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.429 ' O ' ' HE2' ' A' ' 69' ' ' LYS . . . 131.26 -102.59 0.52 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.039 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.17 -49.61 7.17 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.062 0.458 . . . . 0.0 110.683 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -121.42 -167.29 1.49 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.673 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.619 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 5.5 m-85 -91.38 134.96 34.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.889 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 40' ' ' ASP . 51.0 mttm -133.75 155.83 49.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 60.6 m -75.61 137.64 40.89 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.946 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.667 -0.683 . . . . 0.0 109.158 179.684 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p -150.89 144.86 16.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.8 mm -88.02 57.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.69 0.757 . . . . 0.0 110.823 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.473 ' O ' ' HD2' ' A' ' 29' ' ' ARG . 3.1 t -151.73 15.54 0.67 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.827 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.811 ' HA2' ' HB2' ' A' ' 29' ' ' ARG . . . 132.03 126.55 2.75 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.463 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.616 ' HB3' ' HA ' ' A' ' 30' ' ' PHE . . . -91.71 -35.67 14.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.224 0.535 . . . . 0.0 110.597 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -127.58 150.02 49.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.064 -177.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -77.1 -44.03 32.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.842 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 1.006 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 32.0 mttm -131.48 152.04 51.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.816 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . 41.8 m-20 -54.87 -22.68 15.47 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.723 0.639 . . . . 0.0 110.586 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.967 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 2.2 p -54.22 -28.4 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.956 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -77.55 -24.13 49.93 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 73.4 m -89.55 136.94 32.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.941 0.4 . . . . 0.0 110.979 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.63 154.86 53.39 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.869 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -53.66 100.34 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.141 0.496 . . . . 0.0 110.966 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.33 -23.71 1.55 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.3 p -133.41 147.88 51.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.639 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.655 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -134.87 167.97 19.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.994 0.361 . . . . 0.0 110.186 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 20.7 m -89.83 31.83 0.93 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.99 148.67 41.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.974 0.416 . . . . 0.0 110.936 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.74 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -76.7 132.19 39.21 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.509 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 78.3 p -60.04 138.95 57.75 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.927 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.53 -24.73 63.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.375 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.3 p90 -87.39 -27.32 22.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.45 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.433 ' HB2' HD13 ' A' ' 28' ' ' ILE . 67.9 m -150.8 122.8 8.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.038 0.447 . . . . 0.0 110.904 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.409 ' HE ' ' HB3' ' A' ' 21' ' ' ALA . 46.1 mmm-85 -74.75 10.94 1.18 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.78 0.324 . . . . 0.0 110.92 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -89.75 -26.37 20.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.694 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.74 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.2 mp -85.97 115.95 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.811 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 62.0 mtt180 -140.52 43.8 1.86 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.616 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 0.8 OUTLIER -101.83 -178.12 3.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.99 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 89.1 m -68.64 79.64 0.28 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.573 0.546 . . . . 0.0 110.918 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.433 HG13 ' SG ' ' A' ' 59' ' ' CYS . 43.9 pt -89.18 150.54 45.2 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.06 151.72 40.88 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.54 2.827 . . . . 0.0 114.896 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.655 HD11 ' HB3' ' A' ' 18' ' ' CYS . 5.2 mp -87.99 166.5 14.44 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.958 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.93 142.41 47.41 Favored Glycine 0 C--O 1.245 0.838 0 CA-C-N 114.714 -1.13 . . . . 0.0 114.496 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.501 ' O ' ' HB3' ' A' ' 39' ' ' GLU . 57.1 m-80 -91.23 173.08 8.12 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.396 -0.902 . . . . 0.0 111.316 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.6 m -63.0 128.83 37.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.395 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.57 11.38 85.27 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.651 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 36' ' ' ASN . 15.4 tt0 -100.56 155.35 17.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.4 ' O ' HD21 ' A' ' 58' ' ' LEU . 8.3 t70 -63.43 140.23 58.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.175 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.7 p -143.12 145.5 32.9 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 52.7 m170 -89.5 123.5 66.59 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 9.6 Cg_endo -54.14 -34.11 77.13 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.244 2.629 . . . . 0.0 112.513 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.95 85.72 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.861 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 m -72.11 136.62 46.61 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -119.58 -142.21 0.35 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.639 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -68.49 166.37 17.05 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.604 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 72.3 t -133.8 130.63 20.74 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.967 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 52.4 Cg_exo -57.03 131.24 4.63 Favored 'Cis proline' 0 C--N 1.348 0.529 0 C-N-CA 124.278 -1.134 . . . . 0.0 113.197 0.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.816 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 69.1 t80 -77.57 150.93 34.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.226 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -74.17 52.06 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.096 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.53 -135.13 5.63 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 1.006 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 3.6 pptp? -151.48 127.73 10.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.988 0.394 . . . . 0.0 110.132 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -86.4 125.67 33.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.951 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.72 24.09 4.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.592 0.711 . . . . 0.0 109.395 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 m -89.84 158.79 17.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.476 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.693 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 4.6 m -89.24 24.34 2.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.726 0.298 . . . . 0.0 111.303 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.4 HD21 ' O ' ' A' ' 40' ' ' ASP . 56.1 tp -154.07 130.15 10.31 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.79 -0.186 . . . . 0.0 111.42 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.477 ' HB3' HD12 ' A' ' 34' ' ' LEU . 16.7 m -76.26 156.7 83.57 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.72 -166.75 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 121.728 1.619 . . . . 0.0 111.229 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.416 ' O ' HD23 ' A' ' 34' ' ' LEU . 73.2 m -74.16 140.02 44.89 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.604 0.24 . . . . 0.0 111.296 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.599 ' HG2' HD12 ' A' ' 65' ' ' LEU . 17.6 ptpt -64.55 157.64 26.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.715 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.9 m -44.05 125.26 4.3 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.736 0.647 . . . . 0.0 112.08 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.26 -30.58 10.07 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.514 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.599 HD12 ' HG2' ' A' ' 62' ' ' LYS . 24.6 mt -89.12 140.98 28.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.095 0.474 . . . . 0.0 112.13 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.0 m -107.25 131.73 53.86 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.818 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 45.2 t -85.06 117.74 24.21 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.2 t -150.57 154.01 36.77 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 15.7 ttpp -65.4 119.67 11.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.945 0.402 . . . . 0.0 110.801 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -137.12 45.39 2.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 122.08 0.943 . . . . 0.0 108.921 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.7 -121.17 1.02 Allowed Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.5 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.18 -44.04 12.52 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -120.06 -161.01 0.85 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.593 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 3.5 m-85 -89.75 141.6 28.47 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.885 0.374 . . . . 0.0 111.196 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 74' ' ' PHE . 14.5 mptt -131.02 160.14 35.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.274 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.464 ' HB3' HD13 ' A' ' 65' ' ' LEU . 81.7 m -84.76 129.2 34.86 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.715 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 C--O 1.252 1.192 0 CA-C-O 117.626 -1.178 . . . . 0.0 109.367 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.868 0.366 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.74 135.88 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.9 mm -89.12 60.18 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.561 0.696 . . . . 0.0 110.365 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.2 t -89.67 -29.54 18.71 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.594 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.27 116.47 0.69 Allowed Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.779 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.08 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -89.89 -11.66 41.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.506 -0.347 . . . . 0.0 111.437 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.2 p -151.03 159.41 44.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.765 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.424 ' HB3' HE22 ' A' ' 12' ' ' GLN . 12.0 t70 -104.53 -54.69 2.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.309 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.596 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 21.9 ttmm -108.03 146.01 33.15 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.279 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.488 ' OD2' ' HB3' ' A' ' 50' ' ' TYR . 76.7 m-20 -51.41 -22.43 2.99 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.947 0.779 . . . . 0.0 110.731 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.706 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -57.11 -27.2 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.501 179.273 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.424 HE22 ' HB3' ' A' ' 8' ' ' ASP . 53.0 mt-30 -81.11 -19.62 43.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.811 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.4 m -89.95 -138.26 0.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.115 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.3 -138.24 3.62 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 119.676 -1.25 . . . . 0.0 113.3 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.0 m -49.86 112.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.991 -0.604 . . . . 0.0 112.582 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 33' ' ' PRO . . . 57.52 34.32 68.9 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.017 -0.992 . . . . 0.0 114.83 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.479 ' N ' HD13 ' A' ' 34' ' ' LEU . 4.3 p -145.44 140.56 27.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.914 0.857 . . . . 0.0 111.113 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.726 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -145.03 162.18 37.58 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.7 m -88.32 57.58 4.32 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.169 0.509 . . . . 0.0 111.73 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.74 ' HB2' HH12 ' A' ' 54' ' ' ARG . . . -93.19 168.95 10.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.006 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -85.16 152.04 23.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.938 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.524 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -59.44 134.35 56.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.524 0.202 . . . . 0.0 111.068 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.91 37.2 0.08 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -151.48 -36.68 0.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.008 0.433 . . . . 0.0 110.485 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.7 m -151.05 149.54 29.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -83.4 43.99 0.93 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.342 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -97.35 -45.05 6.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.067 0.46 . . . . 0.0 110.231 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.613 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.6 mp -89.39 135.44 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.772 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.67 54.58 0.89 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 1.08 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.4 p90 -130.74 -166.91 1.75 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.986 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.2 m -62.08 80.69 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.988 0.805 . . . . 0.0 112.959 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 20' ' ' ALA . 48.8 pt -96.74 154.21 38.46 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 25.3 Cg_endo -62.46 151.82 80.74 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 122.785 2.323 . . . . 0.0 114.528 -177.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 18' ' ' CYS . 5.8 mp -87.23 164.34 16.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.874 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.9 140.01 26.09 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.111 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 58.2 m-80 -95.63 -164.64 1.18 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.181 0.515 . . . . 0.0 111.124 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 m -61.43 123.79 18.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.315 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.1 -6.56 82.58 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.465 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.78 150.96 22.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.376 0.588 . . . . 0.0 111.343 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.13 146.86 49.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.533 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.547 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 24.5 p -143.58 145.45 32.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.093 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 39.9 m170 -90.11 122.68 67.38 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 9.9 Cg_endo -54.15 -38.78 87.78 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.219 2.613 . . . . 0.0 112.904 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.53 65.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.86 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.546 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 17.2 m -81.33 121.01 25.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.915 0.388 . . . . 0.0 110.47 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -93.05 -172.31 2.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.196 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -72.69 165.65 24.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.512 HG13 ' HA ' ' A' ' 49' ' ' PRO . 60.4 t -87.09 139.92 32.54 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.706 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 2.6 Cg_exo -77.12 133.11 29.61 Favored 'Cis proline' 0 C--N 1.346 0.415 0 C-N-CA 123.845 -1.314 . . . . 0.0 113.505 1.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.488 ' HB3' ' OD2' ' A' ' 10' ' ' ASP . 48.8 t80 -113.64 149.25 34.88 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.596 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 25.8 t70 -58.63 -23.67 59.52 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.394 0.616 . . . . 0.0 111.3 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 55.13 33.31 57.57 Favored Glycine 0 C--N 1.318 -0.426 0 N-CA-C 115.409 0.924 . . . . 0.0 115.409 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.2 pttm -88.3 56.74 3.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.035 0.917 . . . . 0.0 109.739 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.74 HH12 ' HB2' ' A' ' 20' ' ' ALA . 4.0 ppt_? -150.32 130.04 13.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.619 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.8 mt -88.48 50.34 1.95 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.439 0.638 . . . . 0.0 110.145 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 m -89.1 137.56 32.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.779 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 p -88.68 34.75 0.77 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.201 0.524 . . . . 0.0 110.598 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.9 tp -153.28 132.16 12.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.772 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.624 ' HB3' HD12 ' A' ' 34' ' ' LEU . 2.5 m -83.3 159.85 61.03 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.546 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 6.3 Cg_exo -71.83 -161.68 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.288 1.992 . . . . 0.0 111.723 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.571 ' O ' HD23 ' A' ' 34' ' ' LEU . 74.4 m -79.01 137.86 37.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.887 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HD2' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -66.86 153.46 43.39 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.1 m -46.28 113.1 0.57 Allowed 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.571 0.545 . . . . 0.0 111.6 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.37 -32.58 4.64 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.262 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 76' ' ' CYS . 3.6 mm? -89.72 143.12 27.07 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.2 m -110.5 128.14 55.49 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.599 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 20.8 t -72.96 119.2 16.87 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.9 m -131.22 144.33 51.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.991 0.424 . . . . 0.0 111.408 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.544 ' NZ ' ' HA ' ' A' ' 72' ' ' GLU . 53.2 tttm -67.3 109.11 2.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.379 0.609 . . . . 0.0 110.38 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.9 m -88.95 76.53 7.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.664 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.94 -69.67 3.2 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.544 ' HA ' ' NZ ' ' A' ' 69' ' ' LYS . 33.9 tp10 -130.57 -41.53 1.2 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.753 0.311 . . . . 0.0 110.489 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -86.56 -172.79 4.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.7 128.84 47.32 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -135.14 150.32 50.15 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.556 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 68.9 m -70.83 133.9 46.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.945 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.9 m . . . . . 0 C--O 1.254 1.294 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.192 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.03 132.18 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.949 0.405 . . . . 0.0 110.266 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 51.2 mm -93.24 119.16 40.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.138 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.6 t -150.4 18.11 0.83 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.654 0.74 . . . . 0.0 110.054 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 29' ' ' ARG . . . -171.01 72.36 0.11 Allowed Glycine 0 C--O 1.226 -0.368 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.027 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -81.35 -23.6 37.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.464 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 18.6 p -151.13 154.92 37.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -92.03 -60.77 1.77 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.611 0.719 . . . . 0.0 110.236 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -101.35 139.32 37.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.798 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.592 ' OD2' ' HB2' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -46.68 -33.19 4.07 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.32 1.012 . . . . 0.0 111.797 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.8 t -49.55 -32.4 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.631 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -66.03 -30.19 70.69 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.464 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 66.6 m -89.88 159.84 16.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.118 0.485 . . . . 0.0 111.378 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.99 166.49 54.9 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.48 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.456 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 56.9 m -63.79 67.13 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.71 0.804 . . . . 0.0 112.125 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.35 -26.44 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.404 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 13' ' ' CYS . 26.5 p -124.39 142.73 51.07 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.691 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -119.74 154.19 34.53 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 60.4 m -89.52 48.52 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 0.0 111.961 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -95.54 -170.09 2.09 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.821 ' HB1' ' HA ' ' A' ' 26' ' ' ARG . . . -90.11 141.34 28.78 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.425 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 88.2 p -63.46 142.98 58.19 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.108 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.705 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -55.93 -26.38 47.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -87.97 -32.23 18.96 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.419 ' C ' ' H ' ' A' ' 27' ' ' ASN . 68.1 m -151.67 135.87 16.7 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.914 -0.492 . . . . 0.0 111.538 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.821 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 59.7 mtm180 -78.46 20.55 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.128 0.489 . . . . 0.0 110.785 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 25' ' ' SER . 74.2 m-20 -92.55 -31.32 15.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.605 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 1.8 mp -85.39 120.81 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 89.2 mtt180 -139.14 77.44 1.62 Allowed 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.914 0.759 . . . . 0.0 109.717 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 1.027 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.0 OUTLIER -150.83 -167.08 2.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.565 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 84.2 m -60.34 77.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.672 HG13 ' SG ' ' A' ' 59' ' ' CYS . 34.0 pt -97.99 146.37 31.37 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -57.01 151.39 50.21 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.267 2.644 . . . . 0.0 115.084 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.691 HD11 ' HB3' ' A' ' 18' ' ' CYS . 5.1 mp -87.11 168.79 12.96 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.769 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.74 147.07 37.9 Favored Glycine 0 C--O 1.239 0.436 0 CA-C-N 115.246 -0.888 . . . . 0.0 114.02 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 72.5 m-80 -100.85 -178.98 3.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.163 -0.518 . . . . 0.0 109.799 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.3 m -62.86 129.51 40.75 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.07 -6.76 76.32 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.179 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -88.2 154.56 20.34 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.897 0.379 . . . . 0.0 111.029 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -67.6 142.82 56.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.821 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.511 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 31.6 p -146.01 150.15 35.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.207 0.527 . . . . 0.0 110.688 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -95.4 126.94 43.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.56 -40.83 77.64 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.092 2.528 . . . . 0.0 112.907 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.46 -33.86 76.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.134 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.632 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 17.7 m -73.31 138.82 45.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.362 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -129.29 175.46 8.72 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 7.7 ptmt -59.69 150.88 26.43 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.445 0.466 . . . . 0.0 111.6 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 49' ' ' PRO . 60.3 t -87.14 142.56 33.77 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.651 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HA ' HG13 ' A' ' 48' ' ' VAL . 33.5 Cg_exo -63.07 138.46 28.27 Favored 'Cis proline' 0 C--N 1.351 0.683 0 C-N-CA 124.392 -1.087 . . . . 0.0 113.73 1.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.491 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 34.5 t80 -146.57 141.79 27.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.703 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -74.13 79.46 1.75 Allowed 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.546 ' HA3' ' OD1' ' A' ' 10' ' ' ASP . . . -89.48 131.84 10.93 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.783 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.18 37.46 0.55 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.324 0.583 . . . . 0.0 109.432 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.44 ' H ' ' NE ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -115.88 139.9 49.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.915 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.68 48.53 1.6 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.223 0.535 . . . . 0.0 110.463 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.7 m -103.04 143.38 32.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.39 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.705 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 72.7 m -88.86 47.92 1.56 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.57 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 53.9 tp -152.51 124.14 7.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.726 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.672 ' SG ' HG13 ' A' ' 32' ' ' ILE . 3.7 m -84.14 153.94 63.29 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.718 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.632 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 12.3 Cg_exo -69.44 -169.96 0.34 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.497 2.132 . . . . 0.0 111.642 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 82.5 m -77.75 139.37 39.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.67 0.271 . . . . 0.0 111.248 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.474 ' HA ' HD23 ' A' ' 34' ' ' LEU . 19.1 ptmt -62.13 154.12 28.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.22 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 15' ' ' SER . 17.6 m -51.03 125.27 13.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.312 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.54 -29.67 9.7 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.415 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.46 HD12 ' HG2' ' A' ' 62' ' ' LYS . 22.6 mt -88.91 152.7 21.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.025 0.44 . . . . 0.0 111.936 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -113.26 128.13 56.38 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.998 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.545 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 53.8 t -84.69 119.67 25.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.1 t -150.97 158.97 44.81 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 23.8 ttpp -65.82 102.4 0.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.245 0.545 . . . . 0.0 109.824 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.536 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 12.1 m -101.6 43.46 1.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.182 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.4 -105.6 0.47 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.322 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.507 ' CD ' ' HG2' ' A' ' 73' ' ' LYS . 1.1 pm0 -86.08 -40.51 15.65 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 122.776 0.43 . . . . 0.0 110.406 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.507 ' HG2' ' CD ' ' A' ' 72' ' ' GLU . 25.0 pttt -133.23 -164.26 1.46 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.902 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 5.1 m-85 -90.09 134.4 34.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.148 0.499 . . . . 0.0 111.468 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 70' ' ' SER . 46.4 mttp -135.86 154.33 51.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.063 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.511 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 73.0 m -75.39 126.44 31.01 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.469 -178.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.249 1.065 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.677 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.82 138.53 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.8 mm -88.56 90.68 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.195 0.522 . . . . 0.0 110.064 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.5 t -150.41 -29.3 0.22 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.396 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.67 108.39 0.35 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.043 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.027 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -91.17 -14.19 31.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 p -147.7 145.82 29.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.087 0.47 . . . . 0.0 111.904 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 53' ' ' LYS . 17.6 t70 -88.23 -44.79 10.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.42 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.546 ' HG3' ' OD2' ' A' ' 8' ' ' ASP . 61.6 mttp -121.49 144.88 48.46 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.511 -0.768 . . . . 0.0 108.962 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.679 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 37.8 t0 -55.31 -18.8 7.03 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.838 0.711 . . . . 0.0 111.005 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.7 p -55.49 -25.33 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.802 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -82.13 -16.76 48.76 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 68.8 m -89.8 -129.79 0.08 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.784 0.326 . . . . 0.0 110.678 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.86 169.88 35.92 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.507 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.4 m -51.96 105.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.125 0.488 . . . . 0.0 111.364 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.63 -35.22 1.89 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.6 p -139.75 143.58 37.04 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.745 0.418 . . . . 0.0 110.08 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.653 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -128.13 159.51 34.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.679 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 67.9 m -85.78 105.09 16.05 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.192 0.52 . . . . 0.0 109.689 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' A' ' 54' ' ' ARG . . . -159.58 173.36 16.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.07 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -82.27 138.07 34.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.298 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.662 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -66.03 137.37 57.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.865 0.364 . . . . 0.0 110.881 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.03 -24.73 66.4 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -86.78 -34.82 19.47 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.416 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 27' ' ' ASN . 28.2 m -151.59 124.88 8.78 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.471 ' HD3' ' N ' ' A' ' 26' ' ' ARG . 1.6 mpp_? -76.29 30.0 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.019 0.438 . . . . 0.0 111.834 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' A' ' 25' ' ' SER . 5.6 m120 -90.03 -37.26 14.42 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.662 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.0 mp -89.58 125.76 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.198 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.505 ' HD3' ' C ' ' A' ' 28' ' ' ILE . 1.3 mpp_? -136.84 68.19 1.43 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 1.027 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.1 p90 -147.29 -161.09 1.26 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.495 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 82.9 m -60.87 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.966 0.791 . . . . 0.0 111.911 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.556 HG13 ' SG ' ' A' ' 59' ' ' CYS . 43.4 pt -100.84 150.54 37.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.48 148.14 27.59 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 123.41 2.74 . . . . 0.0 114.67 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.74 HD23 ' HB3' ' A' ' 59' ' ' CYS . 90.8 mt -85.53 163.84 18.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.979 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.516 ' O ' ' HG3' ' A' ' 62' ' ' LYS . . . -59.67 137.41 49.76 Favored Glycine 0 C--O 1.24 0.509 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.91 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -88.88 165.6 14.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.172 0.589 . . . . 0.0 110.289 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.6 t -62.52 133.77 55.44 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.498 ' O ' ' HD3' ' A' ' 75' ' ' LYS . . . 87.96 -12.08 65.07 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.548 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -88.59 159.79 17.72 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 117.107 0.453 . . . . 0.0 111.861 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.551 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 0.3 OUTLIER -65.65 147.73 52.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.091 -178.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.3 p -149.83 142.52 24.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.273 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 41.1 m170 -88.0 124.8 66.22 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 8.2 Cg_endo -51.7 -38.98 67.38 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.47 2.78 . . . . 0.0 113.795 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.65 25.67 0.42 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . 49.5 m -90.64 122.36 33.36 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.915 -0.491 . . . . 0.0 110.372 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.533 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 19.3 m170 -77.46 149.24 35.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -55.39 149.65 12.85 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.631 0.582 . . . . 0.0 111.298 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 49' ' ' PRO . 84.9 t -85.87 138.3 35.3 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.891 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.531 ' HA ' HG13 ' A' ' 48' ' ' VAL . 8.2 Cg_exo -73.58 135.18 38.83 Favored 'Cis proline' 0 C--N 1.344 0.296 0 C-N-CA 123.603 -1.415 . . . . 0.0 112.88 1.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.533 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 89.1 t80 -64.32 143.05 58.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.421 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.58 44.82 0.13 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.06 -139.75 6.9 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.801 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -121.49 134.27 55.06 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.515 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 61.4 mtp85 -88.08 124.07 33.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.845 0.355 . . . . 0.0 111.209 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -88.94 -5.87 57.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.299 0.571 . . . . 0.0 109.946 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m -87.85 146.43 25.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.459 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 13.3 m -87.41 42.82 1.06 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.983 0.42 . . . . 0.0 111.387 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.1 tp -153.62 121.99 6.22 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.379 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.74 ' HB3' HD23 ' A' ' 34' ' ' LEU . 3.4 m -81.0 148.19 63.62 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 37.3 Cg_endo -67.41 173.39 8.8 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 121.849 1.7 . . . . 0.0 111.46 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.8 m -59.34 144.37 46.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.121 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.659 ' HG2' ' HB2' ' A' ' 34' ' ' LEU . 60.2 mttm -56.17 143.96 31.39 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -51.56 110.3 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.17 0.51 . . . . 0.0 110.543 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.75 -30.06 3.65 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 65' ' ' LEU . 24.7 mt -88.83 147.19 24.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.698 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.3 m -109.91 126.78 54.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.017 0.437 . . . . 0.0 111.481 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.4 t -78.53 116.23 18.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.0 t -134.46 158.68 43.28 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.902 0.382 . . . . 0.0 110.416 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 41.5 ttmt -71.63 112.04 7.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.5 t -91.34 56.94 3.23 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.18 -92.43 1.77 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.226 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -91.02 -46.39 8.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.052 0.453 . . . . 0.0 111.257 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.56 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -107.22 167.06 10.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.711 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 13.4 m-85 -95.38 132.16 40.72 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 55.1 mttm -138.75 153.36 48.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.379 0.609 . . . . 0.0 111.013 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 70.7 m -66.33 132.51 48.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.364 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 C--O 1.253 1.266 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.129 179.701 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -88.96 135.56 25.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 123.177 0.298 . . . . 0.0 110.237 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 51.4 mm -96.82 119.81 45.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.171 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 t -150.3 26.5 0.77 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.59 0.71 . . . . 0.0 110.171 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.56 129.72 4.06 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.674 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.008 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.4 -10.24 44.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.637 0.256 . . . . 0.0 111.571 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 18.8 p -150.76 150.67 31.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.973 0.416 . . . . 0.0 111.409 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.429 ' HB3' HE22 ' A' ' 12' ' ' GLN . 11.9 t70 -97.41 -46.22 6.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.117 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.427 ' H ' ' NE2' ' A' ' 12' ' ' GLN . 95.0 mttt -114.33 145.08 42.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.439 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.835 ' HB2' ' H ' ' A' ' 50' ' ' TYR . 88.2 m-20 -57.35 -26.85 61.63 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.509 0.505 . . . . 0.0 111.417 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -57.39 -29.15 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.898 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.429 HE22 ' HB3' ' A' ' 8' ' ' ASP . 45.2 mt-30 -70.23 -26.05 63.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.491 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 58.0 m -90.69 -122.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.119 0.485 . . . . 0.0 110.784 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.33 157.08 28.14 Favored Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.8 m -55.67 101.0 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.297 0.57 . . . . 0.0 110.846 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.03 -28.08 1.13 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.6 p -135.27 139.49 44.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.15 -0.525 . . . . 0.0 109.833 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.507 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -123.83 159.64 29.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.0 m -88.06 51.22 2.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.89 0.376 . . . . 0.0 111.539 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.758 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -79.62 160.79 26.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.043 0.449 . . . . 0.0 110.998 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.694 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -90.4 144.5 25.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.422 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.646 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -64.58 135.45 55.99 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.972 0.415 . . . . 0.0 110.395 179.179 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -64.87 -23.06 67.12 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.0 p90 -87.94 -37.68 16.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.4 m -151.74 152.63 32.98 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.19 -0.318 . . . . 0.0 110.162 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -81.75 41.4 0.64 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.775 0.322 . . . . 0.0 111.453 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -97.07 -39.43 9.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.951 0.405 . . . . 0.0 110.828 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.646 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 53.2 mt -88.86 125.63 41.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.918 0.39 . . . . 0.0 110.297 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.3 mmm-85 -150.95 41.03 0.74 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.865 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 1.008 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.4 p90 -121.64 -172.77 2.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.971 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.4 m -61.15 82.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 O-C-N 124.369 1.043 . . . . 0.0 112.609 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 20' ' ' ALA . 30.4 pt -97.86 147.13 32.62 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.07 152.5 36.95 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.388 2.725 . . . . 0.0 114.663 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.549 HD23 ' O ' ' A' ' 61' ' ' CYS . 3.8 mp -87.38 164.73 16.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.317 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.596 ' O ' ' HG3' ' A' ' 62' ' ' LYS . . . -75.4 154.89 46.5 Favored Glycine 0 C--O 1.237 0.335 0 CA-C-N 115.116 -0.947 . . . . 0.0 114.291 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 1.3 p30 -109.18 169.56 8.61 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.131 0.491 . . . . 0.0 110.991 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.7 m -54.59 121.91 9.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.287 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.12 -24.38 16.42 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.04 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 10.7 pt-20 -100.53 153.02 19.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.365 0.582 . . . . 0.0 110.958 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 1.2 m-20 -58.45 150.71 21.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.299 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 13.3 p -149.23 154.47 39.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.787 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -90.97 128.54 47.46 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.45 -60.07 0.8 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.5 2.8 . . . . 0.0 114.207 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.35 26.79 0.3 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.189 0.518 . . . . 0.0 110.551 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -81.98 2.63 29.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.761 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.548 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -178.18 36.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.621 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.564 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -68.33 136.14 52.95 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.603 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.6 t -86.44 128.39 57.26 Favored Pre-proline 0 C--N 1.315 -0.906 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.94 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -91.13 131.03 7.72 Favored 'Cis proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.797 -1.335 . . . . 0.0 112.855 0.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.835 ' H ' ' HB2' ' A' ' 10' ' ' ASP . 12.1 t80 -109.12 120.46 42.61 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.266 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -84.15 63.8 7.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.909 0.861 . . . . 0.0 108.838 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.15 142.62 7.32 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.881 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.449 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -101.49 52.2 0.83 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.292 0.568 . . . . 0.0 110.126 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.4 tpt85 -57.73 139.46 53.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.079 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.46 61.68 6.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.797 0.808 . . . . 0.0 110.391 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.5 m -102.17 129.41 48.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.471 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.694 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 7.0 m -89.24 28.39 1.24 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.849 0.357 . . . . 0.0 111.496 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.1 tp -153.9 129.09 9.69 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.342 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.527 ' SG ' HG13 ' A' ' 32' ' ' ILE . 3.8 m -78.77 164.44 55.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.844 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.508 ' HG3' ' HA ' ' A' ' 47' ' ' LYS . 94.7 Cg_endo -78.5 -157.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.305 2.003 . . . . 0.0 111.508 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.549 ' O ' HD23 ' A' ' 34' ' ' LEU . 90.4 m -87.14 145.5 26.4 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.399 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 29.5 mtpp -57.46 153.44 12.72 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.678 0.611 . . . . 0.0 110.236 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.8 m -49.39 121.73 5.35 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.229 0.331 . . . . 0.0 111.178 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.6 -24.34 28.91 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 65' ' ' LEU . 42.3 mt -88.27 152.13 22.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.845 0.355 . . . . 0.0 111.396 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.2 m -115.59 129.51 56.54 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.132 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.0 t -81.65 116.2 21.27 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 m -132.72 146.05 51.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.708 0.289 . . . . 0.0 110.663 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 34.8 ttpt -70.33 108.03 4.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.116 0.484 . . . . 0.0 110.887 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.886 ' HB3' ' HD3' ' A' ' 75' ' ' LYS . 19.6 t -94.38 76.85 3.9 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.54 -102.1 2.86 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.104 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.532 ' OE1' ' HG3' ' A' ' 73' ' ' LYS . 2.8 tt0 -89.01 -56.46 3.28 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.518 -0.341 . . . . 0.0 111.503 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HG3' ' OE1' ' A' ' 72' ' ' GLU . 64.5 mttp -102.8 172.46 6.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.17 0.509 . . . . 0.0 111.953 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.696 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 10.1 m-85 -89.48 132.05 35.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.352 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.886 ' HD3' ' HB3' ' A' ' 70' ' ' SER . 1.6 mptp? -130.95 150.05 52.29 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 62.5 m -69.64 144.98 52.77 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.699 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--O 1.248 0.981 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.398 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.12 131.93 35.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.936 0.398 . . . . 0.0 110.436 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.6 mm -93.6 123.4 45.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.9 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 t -151.01 -42.53 0.12 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.564 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.32 121.42 0.64 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.454 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.109 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -91.34 -14.84 30.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.2 p -150.66 167.47 27.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.923 0.392 . . . . 0.0 111.49 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.24 -44.0 2.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.186 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 46.3 mmtm -104.09 138.16 41.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.734 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.416 ' OD2' ' HG2' ' A' ' 54' ' ' ARG . 70.4 m-20 -57.96 -28.58 64.48 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.347 0.594 . . . . 0.0 109.847 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.4 t -56.74 -29.87 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 114.827 -1.078 . . . . 0.0 111.486 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -69.11 -22.77 63.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.636 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.8 m -89.48 -126.44 0.07 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.138 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.39 -177.8 43.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.127 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.5 m -67.63 66.18 0.08 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.435 0.636 . . . . 0.0 111.488 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 176.58 -24.2 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.341 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.1 p -139.55 147.89 41.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.023 0.129 . . . . 0.0 110.655 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.503 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -136.16 160.27 39.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.4 m -87.6 51.82 2.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.136 0.493 . . . . 0.0 111.762 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.597 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -86.75 164.19 16.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.805 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.683 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -86.06 144.59 27.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.102 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.657 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -64.76 134.07 53.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.932 0.396 . . . . 0.0 111.146 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.784 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -65.7 -21.23 66.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -87.57 -35.15 18.28 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 m -151.84 144.06 23.98 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.079 -0.388 . . . . 0.0 110.524 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.94 33.79 0.18 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.955 0.407 . . . . 0.0 111.627 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -98.18 -40.83 8.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.755 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.657 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 2.8 mp -88.08 127.23 41.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.961 0.41 . . . . 0.0 110.918 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HD3' ' C ' ' A' ' 28' ' ' ILE . 1.1 mpp_? -143.34 68.49 1.29 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.863 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 1.109 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.5 p90 -145.76 -170.52 3.49 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.763 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.2 m -60.92 75.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.288 0.992 . . . . 0.0 112.946 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 20' ' ' ALA . 43.9 pt -89.83 153.05 47.34 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.78 151.54 47.54 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.137 2.558 . . . . 0.0 114.691 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.732 HD23 ' HA ' ' A' ' 62' ' ' LYS . 3.6 mp -87.09 170.82 11.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.936 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.54 133.28 25.47 Favored Glycine 0 C--O 1.243 0.696 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.483 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -89.75 167.83 12.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.191 -0.505 . . . . 0.0 110.36 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 m -59.97 128.1 35.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.767 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.8 -5.2 84.5 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.145 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.555 ' HA ' ' HZ2' ' A' ' 75' ' ' LYS . 5.9 mm-40 -99.21 162.44 13.05 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 117.411 0.606 . . . . 0.0 111.8 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.559 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 41.3 p-10 -63.59 151.82 40.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.251 1.024 . . . . 0.0 113.217 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 21.5 p -151.08 143.65 24.33 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.331 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.486 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 43.4 m170 -89.45 121.65 69.09 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 4.5 Cg_endo -48.54 -40.25 37.28 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.775 2.984 . . . . 0.0 113.738 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.28 -28.39 68.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.121 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 53.9 m -73.82 137.07 43.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.889 0.376 . . . . 0.0 110.587 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -123.0 145.89 48.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.87 144.12 1.9 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.556 ' HA ' ' C ' ' A' ' 49' ' ' PRO . 21.9 t -88.25 143.21 32.35 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.052 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.556 ' C ' ' HA ' ' A' ' 48' ' ' VAL . 19.1 Cg_endo -60.75 131.8 8.24 Favored 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.402 -1.082 . . . . 0.0 114.185 1.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -115.73 137.76 51.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.176 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -69.62 109.87 4.54 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.21 -133.78 11.5 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -152.5 152.42 31.91 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 23.1 mmm180 -85.41 107.19 17.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.143 0.497 . . . . 0.0 111.906 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.75 61.49 6.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 t -144.66 163.39 34.11 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.598 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.784 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 6.6 m -88.02 21.98 2.55 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.5 tp -154.08 127.82 8.76 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 121.168 -0.213 . . . . 0.0 111.299 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.559 ' SG ' HG13 ' A' ' 32' ' ' ILE . 13.3 m -74.76 154.29 87.18 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.066 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.53 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 57.0 Cg_endo -69.76 178.28 4.73 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.475 2.117 . . . . 0.0 111.973 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 71.4 m -70.27 143.1 52.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.732 ' HA ' HD23 ' A' ' 34' ' ' LEU . 9.8 ptmm? -60.66 146.91 43.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.1 m -45.52 128.88 8.47 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.078 0.466 . . . . 0.0 111.381 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.99 -28.97 10.86 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.585 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.531 HD12 ' HG2' ' A' ' 62' ' ' LYS . 22.2 mt -89.85 145.28 25.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.955 0.407 . . . . 0.0 111.735 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.9 m -108.59 126.44 52.94 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.955 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 48.1 t -81.01 126.58 31.58 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.6 p -149.46 149.15 30.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.752 0.31 . . . . 0.0 111.231 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.884 ' HE3' ' HA ' ' A' ' 72' ' ' GLU . 46.8 tttt -66.92 105.58 1.66 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.376 0.608 . . . . 0.0 110.984 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 6.8 m -89.83 82.7 6.2 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.833 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.91 -64.09 3.96 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.274 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.884 ' HA ' ' HE3' ' A' ' 69' ' ' LYS . 0.8 OUTLIER -141.02 -47.27 0.4 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.999 0.428 . . . . 0.0 110.028 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -94.77 158.47 15.49 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 15.2 m-85 -88.37 130.08 35.24 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.45 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 37.2 mttm -134.85 155.52 50.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.315 0.579 . . . . 0.0 110.141 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.456 ' HB3' HD13 ' A' ' 65' ' ' LEU . 64.3 m -73.86 137.16 43.57 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.373 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.244 0.805 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.413 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.11 136.56 23.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.6 mm -96.94 119.79 45.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.29 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.2 p -120.96 30.5 6.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.041 0.448 . . . . 0.0 110.57 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.19 122.7 0.28 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.435 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.069 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -82.56 -6.53 59.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.722 0.296 . . . . 0.0 111.614 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 p -149.89 146.25 26.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.954 0.406 . . . . 0.0 111.739 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.455 ' OD1' ' HG2' ' A' ' 9' ' ' LYS . 3.2 t70 -95.37 -57.01 2.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.455 ' HG2' ' OD1' ' A' ' 8' ' ' ASP . 23.6 mmtp -93.99 141.5 28.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.746 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.2 -31.03 66.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.538 0.685 . . . . 0.0 109.881 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.865 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 47.8 t -55.97 -27.16 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.943 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.43 ' NE2' ' H ' ' A' ' 9' ' ' LYS . 55.3 mt-30 -67.08 -25.56 66.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.605 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 71.3 m -89.61 138.27 31.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.03 0.443 . . . . 0.0 111.331 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.17 151.2 49.74 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.631 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.412 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 18.4 m -51.48 113.02 0.85 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.187 0.517 . . . . 0.0 110.741 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.13 -27.86 3.1 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.4 p -128.87 144.87 51.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.965 -0.618 . . . . 0.0 109.535 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.77 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -128.96 166.51 19.03 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 72.3 m -88.02 52.77 2.55 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.797 0.332 . . . . 0.0 111.678 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.597 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -89.81 156.6 18.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.11 0.481 . . . . 0.0 111.336 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.26 145.88 24.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.463 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.597 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -66.0 128.0 34.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.086 0.469 . . . . 0.0 110.883 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.69 -20.13 65.91 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -86.81 -36.17 18.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.811 0.338 . . . . 0.0 111.441 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.8 m -152.0 138.79 18.89 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.442 ' HD3' ' N ' ' A' ' 26' ' ' ARG . 1.6 mpp_? -76.7 48.26 0.55 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.639 0.257 . . . . 0.0 111.547 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -103.95 -41.03 5.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.856 0.36 . . . . 0.0 110.379 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.597 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 69.5 mt -89.6 131.02 37.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.816 0.341 . . . . 0.0 110.335 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -151.73 52.63 0.82 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 1.069 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.9 p90 -140.45 -168.49 2.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.871 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 67.0 m -57.62 99.06 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 O-C-N 124.11 0.881 . . . . 0.0 112.378 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 20' ' ' ALA . 46.1 pt -120.74 149.9 51.53 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.39 147.52 67.43 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.408 2.739 . . . . 0.0 115.125 -177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.77 HD11 ' HB3' ' A' ' 18' ' ' CYS . 7.1 mp -88.34 164.5 15.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.359 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.77 149.29 26.79 Favored Glycine 0 C--O 1.238 0.348 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.252 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 49.6 m-80 -103.34 -168.12 1.47 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.999 0.428 . . . . 0.0 110.922 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 m -61.61 129.95 43.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.626 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.421 ' O ' ' HE3' ' A' ' 75' ' ' LYS . . . 93.11 -12.24 70.28 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.323 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 36' ' ' ASN . 49.1 mt-10 -90.86 144.8 25.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.29 0.566 . . . . 0.0 111.293 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.58 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 11.6 m-20 -62.38 145.63 53.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.301 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -135.52 179.91 6.04 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -116.76 122.12 31.99 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -57.77 -34.79 98.71 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.771 2.314 . . . . 0.0 112.492 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.52 -26.46 62.67 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.565 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.59 ' HB3' ' HG3' ' A' ' 60' ' ' PRO . 40.6 m -78.35 129.94 35.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.419 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -88.35 -152.25 0.22 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.698 ' HD2' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -88.2 146.57 25.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.501 HG13 ' HA ' ' A' ' 49' ' ' PRO . 70.8 t -88.65 136.72 30.8 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 123.436 0.46 . . . . 0.0 110.191 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.865 ' HB3' ' HA ' ' A' ' 11' ' ' VAL . 16.7 Cg_exo -68.82 128.25 11.3 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.863 -1.307 . . . . 0.0 113.115 0.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.5 ' CE2' ' HG2' ' A' ' 54' ' ' ARG . 80.5 t80 -65.26 145.86 55.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.111 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.93 49.9 0.25 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.23 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.61 -143.51 9.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.955 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -150.4 59.45 0.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.1 0.476 . . . . 0.0 111.37 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.5 ' HG2' ' CE2' ' A' ' 50' ' ' TYR . 22.0 mmt85 -59.39 140.55 56.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.29 57.76 4.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.416 0.627 . . . . 0.0 110.311 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.2 m -88.84 141.78 28.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.253 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 4.1 p -89.13 17.6 5.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.955 0.407 . . . . 0.0 111.698 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.9 tp -154.18 129.88 10.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.724 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.526 ' SG ' HG13 ' A' ' 32' ' ' ILE . 9.0 m -73.37 149.49 88.96 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.59 ' HG3' ' HB3' ' A' ' 45' ' ' SER . 7.5 Cg_exo -72.11 -160.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.396 2.064 . . . . 0.0 111.762 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.857 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 44.1 m -75.72 139.31 41.82 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.992 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.418 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -60.79 150.11 33.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.835 179.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.412 ' OG ' ' HB3' ' A' ' 15' ' ' SER . 13.8 m -49.67 125.29 11.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.625 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.86 -33.72 5.74 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.917 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 65' ' ' LEU . 39.5 mt -89.95 163.59 14.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.922 0.391 . . . . 0.0 111.817 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -133.64 137.75 45.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.08 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.857 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 10.5 t -92.53 148.99 21.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.785 0.326 . . . . 0.0 111.039 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.6 t -147.94 156.6 42.85 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -73.79 111.99 9.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.381 0.61 . . . . 0.0 110.302 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.8 m -89.55 66.88 7.42 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.94 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.16 -60.4 1.94 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.169 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -142.17 -46.15 0.34 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -88.24 160.46 17.68 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.475 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 25.4 m-85 -99.28 122.38 42.36 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.477 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.58 ' HD2' ' HA ' ' A' ' 40' ' ' ASP . 19.6 mmmt -123.2 144.07 49.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 67' ' ' CYS . 95.1 m -73.42 149.84 42.16 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.237 -0.887 . . . . 0.0 109.382 179.426 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.15 135.44 25.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 123.262 0.351 . . . . 0.0 110.281 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.5 mm -88.98 95.18 5.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.993 0.425 . . . . 0.0 110.108 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 t -150.6 27.8 0.72 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.739 0.781 . . . . 0.0 110.155 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.518 ' CA ' ' HB2' ' A' ' 29' ' ' ARG . . . 107.25 132.17 6.87 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.465 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 30' ' ' PHE . . . -76.97 -20.39 56.15 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.171 0.51 . . . . 0.0 110.542 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 p -137.08 158.85 43.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.876 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -83.17 -51.05 7.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.602 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.941 ' HA ' ' HB3' ' A' ' 53' ' ' LYS . 28.1 mttm -126.11 147.3 49.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.737 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . 40.8 m-20 -51.41 -28.72 13.56 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.01 0.819 . . . . 0.0 111.33 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 t -53.74 -32.67 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.049 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -69.18 -25.47 64.36 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 72.3 m -89.3 135.19 33.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.903 0.383 . . . . 0.0 110.409 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.04 156.05 50.19 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.4 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.4 m -52.71 104.12 0.08 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.288 0.566 . . . . 0.0 110.442 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.17 -19.66 1.92 Allowed Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.0 p -137.56 157.1 47.26 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.284 -0.458 . . . . 0.0 110.55 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.796 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -140.85 162.3 35.78 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.7 m -91.09 35.52 0.91 Allowed 'General case' 0 C--O 1.239 0.528 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.71 169.34 15.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.909 0.385 . . . . 0.0 110.639 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.739 ' HB1' ' HA ' ' A' ' 26' ' ' ARG . . . -78.96 135.92 37.08 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.8 p -66.47 146.24 54.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.39 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.41 -26.12 66.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.358 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 35.8 p90 -88.02 -29.6 20.59 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.731 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.498 ' HB2' HD13 ' A' ' 28' ' ' ILE . 69.3 m -150.99 122.7 8.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.244 0.545 . . . . 0.0 110.937 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.739 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 99.2 mtt180 -72.32 3.04 5.09 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.495 ' OD1' HD12 ' A' ' 28' ' ' ILE . 20.6 p30 -89.27 -17.04 29.79 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.0 mp -87.48 121.11 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.518 ' HB2' ' CA ' ' A' ' 5' ' ' GLY . 12.7 mtm105 -141.88 39.85 1.66 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.552 ' CD2' HG23 ' A' ' 28' ' ' ILE . 2.2 m-85 -89.57 -175.68 4.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 91.3 m -69.09 79.1 0.34 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.644 HG13 ' SG ' ' A' ' 59' ' ' CYS . 31.1 pt -89.25 146.01 35.3 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.12 144.79 45.55 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.832 3.021 . . . . 0.0 115.042 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.845 HD23 ' HB3' ' A' ' 59' ' ' CYS . 94.8 mt -87.33 160.48 18.37 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.986 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 62' ' ' LYS . . . -61.12 151.38 42.28 Favored Glycine 0 C--O 1.238 0.392 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.1 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 16.3 p30 -118.93 -167.72 1.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 m -62.85 117.59 6.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.873 0.368 . . . . 0.0 111.259 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.53 1.65 68.45 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.759 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 36' ' ' ASN . 18.3 mm-40 -88.38 152.31 22.0 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.678 0.275 . . . . 0.0 111.228 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.468 ' CG ' ' HZ3' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -67.76 143.91 55.64 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.356 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.7 p -147.12 144.4 29.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.986 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.43 ' HB2' ' OG ' ' A' ' 45' ' ' SER . 50.3 m170 -89.46 129.42 47.31 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.82 -41.3 39.06 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.291 2.66 . . . . 0.0 114.236 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.4 12.78 3.38 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.683 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . 5.7 m -91.25 122.54 33.96 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.016 -0.428 . . . . 0.0 110.212 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.586 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 27.6 m170 -88.56 153.71 20.92 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.24 149.3 20.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.54 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.584 HG13 ' HA ' ' A' ' 49' ' ' PRO . 78.3 t -88.91 139.22 29.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.78 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.584 ' HA ' HG13 ' A' ' 48' ' ' VAL . 29.9 Cg_endo -64.17 125.28 4.57 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 123.615 -1.411 . . . . 0.0 113.326 1.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 90.8 t80 -72.77 145.95 46.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.212 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.79 55.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.547 0.689 . . . . 0.0 111.315 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.67 -129.54 3.24 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.941 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . 2.6 pptp? -150.72 129.75 12.61 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -77.3 128.45 34.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.277 0.56 . . . . 0.0 112.277 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.1 mt -101.44 15.72 27.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.766 0.793 . . . . 0.0 109.399 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.3 m -89.73 157.58 17.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.657 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 8.1 m -88.34 30.89 0.84 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.186 0.517 . . . . 0.0 110.511 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.3 tp -154.9 127.77 8.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.912 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.845 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -76.35 142.37 71.27 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.683 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 41.9 Cg_endo -68.17 -176.35 1.04 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.039 1.826 . . . . 0.0 112.096 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.0 m -67.15 139.09 57.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.331 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.606 ' HA ' HD13 ' A' ' 34' ' ' LEU . 6.2 ptpp? -67.49 151.5 47.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.8 m -48.34 109.25 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.599 0.562 . . . . 0.0 110.911 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.04 -34.3 2.76 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 76' ' ' CYS . 3.9 mm? -89.16 139.12 30.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.797 0.332 . . . . 0.0 110.809 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -106.12 129.54 54.18 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.957 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 41.9 t -78.34 126.04 30.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.7 t -145.66 156.12 43.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.874 0.368 . . . . 0.0 110.479 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -71.44 107.69 4.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.339 0.59 . . . . 0.0 110.846 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.985 ' HB3' ' HD3' ' A' ' 75' ' ' LYS . 47.7 t -98.4 70.91 2.01 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.871 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.15 -106.02 3.33 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.119 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.617 ' OE1' ' HG2' ' A' ' 73' ' ' LYS . 11.6 tm-20 -89.31 -51.21 5.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.624 0.212 . . . . 0.0 111.125 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.617 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 43.7 mmtm -94.76 178.68 5.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.942 0.401 . . . . 0.0 111.141 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -103.88 131.87 50.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.433 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.985 ' HD3' ' HB3' ' A' ' 70' ' ' SER . 3.6 mptp? -130.13 154.63 47.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.029 0.442 . . . . 0.0 110.314 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 61.6 m -77.8 136.22 38.08 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.388 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.723 -1.132 . . . . 0.0 109.365 179.912 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.16 135.26 26.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 110.11 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.3 mm -90.35 118.88 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.367 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.2 p -130.29 35.76 4.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.239 0.542 . . . . 0.0 110.638 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.08 124.45 1.31 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.76 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.06 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -81.22 -12.14 59.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.9 p -141.74 157.04 45.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.09 0.471 . . . . 0.0 111.514 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.752 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 26.7 t70 -105.18 -44.35 4.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.033 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -111.98 139.43 47.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.854 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -53.63 -32.9 53.18 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.725 0.64 . . . . 0.0 111.474 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.3 t -52.7 -28.9 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.314 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -68.23 -29.38 68.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 71.3 m -90.41 140.21 29.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.137 0.494 . . . . 0.0 111.499 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.21 154.58 50.8 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.963 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.9 m -53.46 105.83 0.15 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.353 0.597 . . . . 0.0 110.784 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.39 -28.55 1.79 Allowed Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.6 p -127.62 142.79 51.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.801 -0.7 . . . . 0.0 109.229 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.768 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -125.64 158.84 33.72 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.354 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 81.1 m -88.16 47.94 1.57 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 56' ' ' SER . . . -92.0 162.49 14.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.815 0.341 . . . . 0.0 110.493 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -83.87 134.49 34.69 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.476 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 81.2 p -72.41 137.19 46.32 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.705 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.14 -24.46 67.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.567 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.6 p90 -88.32 -20.03 25.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.878 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.479 ' HB2' HD13 ' A' ' 28' ' ' ILE . 59.9 m -149.24 117.4 6.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.197 0.523 . . . . 0.0 110.955 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -69.07 -13.68 62.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.226 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.446 ' OD1' ' HB3' ' A' ' 25' ' ' SER . 16.1 p-10 -88.29 -15.81 34.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.694 0.283 . . . . 0.0 111.204 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 1.7 mp -88.13 118.78 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.752 ' NH2' ' HA ' ' A' ' 8' ' ' ASP . 28.4 ttp180 -150.43 50.77 0.89 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 1.06 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.1 p90 -117.44 -166.17 1.16 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.637 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.6 m -62.04 76.97 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.077 0.861 . . . . 0.0 112.606 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.694 HG13 ' SG ' ' A' ' 59' ' ' CYS . 39.0 pt -93.31 145.43 30.01 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.89 149.86 75.81 Favored 'Trans proline' 0 N--CA 1.475 0.423 0 C-N-CA 123.243 2.629 . . . . 0.0 114.774 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.768 HD11 ' HB3' ' A' ' 18' ' ' CYS . 7.4 mp -88.09 166.08 14.68 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.059 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.62 151.93 25.79 Favored Glycine 0 C--O 1.239 0.412 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.023 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 5.0 p30 -112.0 -176.38 2.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.8 m -55.18 126.85 26.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.191 0.519 . . . . 0.0 111.783 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.55 -20.62 48.86 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.368 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -89.56 149.25 22.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.709 0.29 . . . . 0.0 110.598 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -68.71 148.37 50.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.794 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.514 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 12.6 p -139.44 147.86 41.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.822 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.442 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 50.2 m170 -89.42 121.0 69.7 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 10.6 Cg_endo -54.99 -36.5 92.62 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.15 2.567 . . . . 0.0 112.66 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.61 -30.79 71.15 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.377 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.8 m -75.68 128.87 36.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.798 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -101.01 166.73 10.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.374 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -55.79 148.76 15.95 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.676 0.61 . . . . 0.0 112.13 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.59 HG13 ' HA ' ' A' ' 49' ' ' PRO . 74.2 t -87.17 140.89 32.56 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.345 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.59 ' HA ' HG13 ' A' ' 48' ' ' VAL . 72.7 Cg_endo -78.03 128.53 16.81 Favored 'Cis proline' 0 C--N 1.346 0.445 0 C-N-CA 123.499 -1.459 . . . . 0.0 113.764 0.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -75.53 134.24 40.81 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.882 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.4 114.47 7.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.64 -133.47 11.74 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.996 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -150.37 141.11 22.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.838 0.351 . . . . 0.0 110.149 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -118.91 137.25 53.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.392 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.72 47.33 1.49 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.501 0.667 . . . . 0.0 109.794 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.409 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 45.7 t -89.66 140.2 29.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.952 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 5.6 m -89.12 13.42 13.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.217 0.532 . . . . 0.0 110.842 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.3 tp -153.93 132.22 11.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.731 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.694 ' SG ' HG13 ' A' ' 32' ' ' ILE . 7.4 m -71.24 150.94 94.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.23 -165.2 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.083 1.855 . . . . 0.0 111.675 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 68.4 m -76.76 141.98 40.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.706 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.559 ' HA ' HD23 ' A' ' 34' ' ' LEU . 19.8 ptmt -57.54 146.24 30.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.065 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.5 m -49.73 120.1 4.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 119.52 -33.18 4.75 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.743 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.3 mt -89.26 165.0 14.7 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.008 0.432 . . . . 0.0 111.964 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.7 m -120.44 132.51 55.26 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.872 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 53.2 t -89.14 125.77 35.18 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.5 t -150.36 155.97 40.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.723 0.297 . . . . 0.0 110.469 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.632 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 36.1 ttpt -69.05 106.03 2.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.293 0.568 . . . . 0.0 110.584 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.514 ' HB2' ' HD3' ' A' ' 75' ' ' LYS . 13.3 m -92.13 58.19 3.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.553 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.07 -100.7 1.33 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.299 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -89.75 -55.69 3.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.945 0.403 . . . . 0.0 110.912 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -100.34 170.76 8.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.314 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 13.1 m-85 -88.68 128.26 35.6 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.514 ' HD3' ' HB2' ' A' ' 70' ' ' SER . 24.2 mtpp -132.7 152.18 51.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.145 0.498 . . . . 0.0 109.694 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.514 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 98.4 m -71.47 134.94 46.92 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.795 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.248 0.978 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.82 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.61 135.19 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 123.287 0.367 . . . . 0.0 110.037 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.4 mm -91.35 118.67 37.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.109 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 8.7 t -151.01 -38.81 0.13 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.466 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.95 118.01 0.63 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.302 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.064 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -91.21 -8.19 49.22 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.1 p -148.6 145.24 27.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.204 0.526 . . . . 0.0 112.368 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.629 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 14.4 t70 -90.21 -32.23 16.69 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.732 0.777 . . . . 0.0 109.325 178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.536 ' HG2' ' H ' ' A' ' 52' ' ' GLY . 55.0 mttp -135.8 139.74 43.72 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.777 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.62 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 41.9 t0 -55.98 -25.49 44.23 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.77 0.669 . . . . 0.0 110.571 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 t -55.03 -29.85 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.688 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.416 HE22 ' HB3' ' A' ' 8' ' ' ASP . 29.5 mt-30 -72.95 -19.6 61.21 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.683 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.451 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 59.1 m -89.53 -120.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.341 . . . . 0.0 110.702 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.28 156.11 15.28 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.736 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.4 m -51.3 104.29 0.08 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.222 0.534 . . . . 0.0 111.016 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.06 -32.96 1.39 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.5 p -138.53 135.7 35.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.824 -0.688 . . . . 0.0 109.173 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.667 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -120.31 162.85 18.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.62 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 62.5 m -87.02 110.55 20.14 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -164.09 172.52 13.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.929 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -74.49 138.13 42.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.054 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.534 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 81.4 p -75.61 141.8 42.78 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.178 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -62.29 -24.11 67.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.882 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -88.27 -25.54 22.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.556 ' HB2' HD13 ' A' ' 28' ' ' ILE . 71.4 m -150.93 130.48 13.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.276 0.56 . . . . 0.0 111.872 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -74.32 -0.06 15.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.689 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 4' ' ' THR . 30.8 m-20 -87.99 -26.76 22.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.883 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.3 mp -87.94 126.95 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 98.9 mtt180 -146.62 67.97 1.17 Allowed 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.687 0.617 . . . . 0.0 109.475 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 1.064 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.0 OUTLIER -142.39 -160.95 1.16 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.165 -179.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 24.3 m -61.54 85.22 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.845 0.716 . . . . 0.0 111.668 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.502 HG13 ' SG ' ' A' ' 59' ' ' CYS . 41.4 pt -104.84 149.29 37.36 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.6 148.5 20.8 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.844 3.03 . . . . 0.0 115.035 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.689 HD23 ' HB3' ' A' ' 59' ' ' CYS . 98.6 mt -87.5 159.63 18.56 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.52 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.15 137.64 38.33 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.829 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 68.0 m-80 -95.11 176.06 6.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.026 0.441 . . . . 0.0 110.713 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.9 m -61.24 127.93 33.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.91 -6.59 82.83 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.931 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.8 146.85 24.75 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 120.85 0.357 . . . . 0.0 110.405 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.431 ' O ' HD21 ' A' ' 58' ' ' LEU . 1.6 m-20 -61.29 139.4 58.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.926 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.472 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 25.0 p -135.07 142.4 46.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.19 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 44.2 m170 -88.39 125.38 63.78 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 2.5 Cg_endo -47.37 -36.54 23.44 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.83 3.02 . . . . 0.0 113.304 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.27 37.27 0.2 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.297 0.57 . . . . 0.0 112.031 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.598 ' HB2' ' HB3' ' A' ' 60' ' ' PRO . 6.2 p -92.05 155.89 17.77 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.929 0.395 . . . . 0.0 110.198 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.443 ' HB2' ' CD2' ' A' ' 50' ' ' TYR . 58.5 m-70 -133.26 143.57 49.19 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -55.34 152.95 7.8 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.566 HG13 ' HA ' ' A' ' 49' ' ' PRO . 95.4 t -87.01 141.56 33.29 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.509 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' HG13 ' A' ' 48' ' ' VAL . 71.8 Cg_endo -78.83 132.21 25.41 Favored 'Cis proline' 0 C--O 1.235 0.355 0 C-N-CA 123.454 -1.477 . . . . 0.0 113.818 1.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.565 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 54.6 t80 -77.72 134.44 38.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.069 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -82.35 119.13 23.76 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.572 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.536 ' H ' ' HG2' ' A' ' 9' ' ' LYS . . . 94.76 -149.82 19.5 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -178.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.629 ' HG3' ' O ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -144.32 133.24 22.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.119 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.469 ' HB2' ' CB ' ' A' ' 20' ' ' ALA . 40.6 mtp85 -70.3 136.47 49.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.367 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.28 -7.64 57.63 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 t -88.38 148.8 24.06 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.462 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.671 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 18.1 m -86.43 44.27 1.13 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.431 HD21 ' O ' ' A' ' 40' ' ' ASP . 24.3 tp -154.41 121.44 5.61 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.689 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -80.09 157.84 73.04 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.496 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.598 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 12.5 Cg_exo -68.28 177.46 4.51 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.066 1.844 . . . . 0.0 111.18 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 77.7 m -68.25 142.28 55.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.491 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.576 ' HG2' HD12 ' A' ' 65' ' ' LEU . 16.5 ptmt -61.71 151.57 33.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.349 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.5 m -45.94 125.84 6.71 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.56 0.538 . . . . 0.0 111.671 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.76 -32.71 6.86 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.83 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.576 HD12 ' HG2' ' A' ' 62' ' ' LYS . 36.0 mt -89.15 155.67 19.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.951 0.405 . . . . 0.0 111.637 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.1 m -127.47 129.29 47.18 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.373 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 48.3 t -71.42 124.81 25.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.3 t -142.98 155.53 44.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.112 0.482 . . . . 0.0 110.753 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -72.43 105.7 4.24 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.418 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.993 ' HB2' ' HD3' ' A' ' 75' ' ' LYS . 13.4 m -98.19 81.08 2.74 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.03 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.69 -109.01 3.29 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.665 ' OE1' ' HG2' ' A' ' 73' ' ' LYS . 1.3 tm-20 -89.24 -49.16 6.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.661 0.231 . . . . 0.0 111.579 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.665 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 43.9 mmtm -92.81 -172.47 3.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.157 0.503 . . . . 0.0 111.396 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -112.21 130.4 55.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.993 ' HD3' ' HB2' ' A' ' 70' ' ' SER . 1.7 mptp? -132.79 152.19 51.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.074 0.464 . . . . 0.0 109.798 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 89.2 m -70.1 118.59 13.13 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.942 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.522 -0.752 . . . . 0.0 109.271 179.37 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.19 133.7 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.81 0.338 . . . . 0.0 110.275 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.684 HG21 HG13 ' A' ' 28' ' ' ILE . 3.9 mp -89.76 116.94 32.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.294 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.539 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 9.1 t -152.08 -36.61 0.12 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.728 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.41 114.5 0.31 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.046 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.82 -12.99 34.68 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.0 p -141.36 145.22 35.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.548 0.69 . . . . 0.0 112.578 -178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.16 -38.61 9.25 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.231 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HD2' ' OD1' ' A' ' 51' ' ' ASP . 14.0 mmtp -115.43 132.54 56.59 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.992 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.673 ' HA ' ' SG ' ' A' ' 19' ' ' CYS . 33.0 t70 -56.57 -25.32 52.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.991 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.8 HG22 ' HB2' ' A' ' 49' ' ' PRO . 22.0 t -58.04 -28.28 33.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.351 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -69.93 -20.28 63.35 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.002 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 70.0 m -89.18 129.59 35.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.126 0.489 . . . . 0.0 111.093 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.11 160.28 47.98 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.809 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.6 m -50.17 115.21 1.33 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.361 0.601 . . . . 0.0 110.868 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.625 ' H ' HD12 ' A' ' 34' ' ' LEU . . . 131.74 -28.25 3.58 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.7 p -132.63 158.44 42.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.084 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.659 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -147.57 164.24 34.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.673 ' SG ' ' HA ' ' A' ' 10' ' ' ASP . 77.0 m -86.13 112.79 21.63 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -161.34 166.74 27.03 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.146 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.647 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -85.83 149.48 25.21 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.46 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.597 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -67.67 137.37 55.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.835 0.35 . . . . 0.0 110.686 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.757 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -66.04 -24.0 66.65 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.4 p90 -86.98 -36.8 18.07 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.0 m -151.82 142.89 23.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -79.02 40.91 0.42 Allowed 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.06 -0.4 . . . . 0.0 111.511 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -96.28 -38.91 9.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.853 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.684 HG13 HG21 ' A' ' 3' ' ' ILE . 3.2 mp -89.72 131.94 35.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.539 ' HD3' ' O ' ' A' ' 4' ' ' THR . 1.6 mpt_? -143.07 65.2 1.34 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 1.046 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 1.1 p90 -150.46 -163.27 1.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.9 m -62.17 87.29 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 O-C-N 124.063 0.852 . . . . 0.0 112.187 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.555 HG13 ' SG ' ' A' ' 59' ' ' CYS . 45.0 pt -103.06 158.27 32.1 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 32' ' ' ILE . 11.8 Cg_endo -53.9 142.52 63.59 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.243 2.629 . . . . 0.0 114.502 -177.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.893 HD13 ' HA ' ' A' ' 62' ' ' LYS . 30.5 mt -86.87 158.85 19.24 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.674 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.81 150.13 37.37 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.047 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 3.7 p-10 -117.69 176.95 4.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.674 0.273 . . . . 0.0 110.82 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.3 m -52.38 131.14 32.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.833 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.0 -14.92 61.17 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.245 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.539 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 3.9 mm-40 -106.82 158.4 17.02 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.563 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 42.5 t0 -58.75 149.49 26.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.313 -1.767 . . . . 0.0 113.067 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.77 145.96 26.92 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -90.81 116.44 66.43 Favored Pre-proline 0 C--N 1.317 -0.821 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.705 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HD3' ' HB2' ' A' ' 74' ' ' PHE . 15.9 Cg_endo -58.46 -42.35 56.01 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.234 2.623 . . . . 0.0 112.927 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.6 -34.71 77.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.466 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.619 ' HB3' ' HD2' ' A' ' 54' ' ' ARG . 19.9 m -72.83 119.36 16.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.307 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.438 ' HB2' ' HD2' ' A' ' 50' ' ' TYR . 11.7 m170 -69.86 144.87 52.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HD3' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -63.68 -172.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.561 0.696 . . . . 0.0 111.603 -179.173 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.5 t -85.79 138.18 35.53 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.744 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.8 ' HB2' HG22 ' A' ' 11' ' ' VAL . 72.4 Cg_endo -96.79 135.13 3.9 Favored 'Cis proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.72 -1.367 . . . . 0.0 113.79 1.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.509 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 51.1 t80 -91.67 139.32 30.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.406 178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.433 ' OD1' ' HD2' ' A' ' 9' ' ' LYS . 49.0 t0 -77.03 59.02 1.6 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.861 0.838 . . . . 0.0 110.408 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 153.3 -139.43 6.9 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.83 128.77 20.68 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.619 ' HD2' ' HB3' ' A' ' 45' ' ' SER . 31.9 mtm-85 -70.14 137.1 50.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.315 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.8 58.68 5.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.851 0.834 . . . . 0.0 109.485 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.9 m -143.95 144.2 31.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.348 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.757 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 62.1 m -88.24 41.0 0.98 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.942 0.401 . . . . 0.0 111.21 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.4 tp -153.69 127.11 8.6 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.655 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.841 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.6 m -81.05 141.03 50.03 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.424 ' HD2' ' SG ' ' A' ' 18' ' ' CYS . 49.4 Cg_endo -69.36 -166.97 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.111 1.874 . . . . 0.0 111.821 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.749 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 34.6 m -69.34 137.35 52.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.705 0.288 . . . . 0.0 111.17 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.893 ' HA ' HD13 ' A' ' 34' ' ' LEU . 11.8 ptpt -66.19 148.52 51.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.87 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.6 m -45.61 122.52 3.68 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 123.487 0.492 . . . . 0.0 111.909 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.22 -32.99 5.5 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.09 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.0 mt -89.19 154.71 19.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.934 0.397 . . . . 0.0 111.816 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.0 m -121.89 131.91 54.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.225 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.749 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 9.7 t -91.9 143.17 26.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.798 0.333 . . . . 0.0 110.885 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t -141.22 159.24 42.63 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 27.5 ttpp -69.14 104.34 2.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.312 0.577 . . . . 0.0 110.941 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 10.5 t -89.67 75.96 7.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.478 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.85 -98.27 2.2 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.32 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.45 -56.86 3.14 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.029 0.443 . . . . 0.0 111.104 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.445 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 14.3 ptpt -98.17 -165.9 1.31 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.82 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.499 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 8.9 m-85 -109.7 133.98 52.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.148 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.563 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 21.8 mttt -132.42 146.8 52.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.535 0.683 . . . . 0.0 110.427 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 67' ' ' CYS . 73.5 m -68.32 150.44 48.21 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.745 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 C--O 1.248 0.984 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.321 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.01 137.75 20.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.4 mm -88.99 115.66 29.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.838 0.351 . . . . 0.0 110.26 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 t -151.1 -36.14 0.14 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.857 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.33 125.58 0.95 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.329 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.076 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -84.18 -8.81 58.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.713 0.292 . . . . 0.0 111.457 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.6 p -148.32 145.96 28.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.762 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.3 -48.38 5.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.242 0.544 . . . . 0.0 109.58 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -102.97 139.54 38.41 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.778 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -55.25 -25.7 35.22 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.76 0.662 . . . . 0.0 111.429 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.427 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 22.0 t -54.16 -31.7 22.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.957 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -67.8 -28.02 67.24 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.3 m -89.58 138.92 31.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.074 0.464 . . . . 0.0 111.458 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.7 164.07 50.26 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.723 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.7 m -57.39 97.83 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.4 0.619 . . . . 0.0 110.763 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 153.64 -24.74 0.74 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.553 ' O ' HG11 ' A' ' 48' ' ' VAL . 25.7 p -137.39 155.24 49.6 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.17 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.786 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -139.09 167.24 22.5 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 61.1 m -89.3 49.49 1.77 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.965 0.412 . . . . 0.0 111.869 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.621 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -83.98 150.62 25.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.211 0.529 . . . . 0.0 111.101 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -86.6 142.3 28.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.525 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.517 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -61.42 126.05 25.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.981 0.42 . . . . 0.0 110.613 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.45 -21.61 65.57 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -86.99 -32.82 19.85 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.896 -0.321 . . . . 0.0 111.309 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.1 m -151.65 130.69 12.61 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -76.21 56.96 1.08 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.282 0.563 . . . . 0.0 111.189 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -118.5 -43.34 2.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.501 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 3.0 mp -88.97 128.16 41.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.313 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -152.07 58.65 0.85 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.763 0.792 . . . . 0.0 109.816 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 1.076 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.2 p90 -126.96 -170.95 2.3 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.533 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.7 m -60.43 79.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.061 0.85 . . . . 0.0 112.947 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.621 HD11 ' HB3' ' A' ' 20' ' ' ALA . 40.9 pt -95.83 151.93 38.71 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.05 148.54 38.89 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.331 2.687 . . . . 0.0 114.507 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.786 HD21 ' HB3' ' A' ' 18' ' ' CYS . 92.5 mt -86.93 171.05 11.09 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.509 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.64 145.29 32.58 Favored Glycine 0 C--O 1.241 0.553 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.88 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -88.79 -177.27 5.48 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.189 0.596 . . . . 0.0 110.948 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -61.72 132.33 52.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.036 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.519 ' O ' ' HD3' ' A' ' 75' ' ' LYS . . . 81.94 -3.97 77.54 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.259 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.543 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -88.91 157.32 18.46 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 117.448 0.624 . . . . 0.0 112.039 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.634 ' HB3' HD21 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -60.89 144.43 52.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.733 -178.312 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.4 p -150.53 145.36 25.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.535 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.527 ' HB2' ' OG ' ' A' ' 45' ' ' SER . 56.7 m170 -89.51 128.92 49.04 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.02 -39.61 90.07 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.918 2.412 . . . . 0.0 112.962 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.83 97.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.464 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.713 ' HB2' ' HG3' ' A' ' 60' ' ' PRO . 10.8 p -76.98 132.6 39.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -109.13 -160.93 0.74 Allowed 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.301 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.51 146.19 42.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.032 0.444 . . . . 0.0 111.382 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.553 HG11 ' O ' ' A' ' 17' ' ' THR . 40.8 t -88.34 143.38 32.44 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.847 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.551 ' HA ' ' CG1' ' A' ' 48' ' ' VAL . 16.4 Cg_exo -69.04 124.51 7.32 Favored 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 124.128 -1.197 . . . . 0.0 113.717 0.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.434 ' N ' ' HA ' ' A' ' 48' ' ' VAL . 79.9 t80 -89.06 133.4 34.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.761 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.22 111.46 10.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.036 0.446 . . . . 0.0 109.84 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 122.83 -157.86 17.42 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.582 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -152.68 132.83 13.5 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -130.01 153.41 48.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.898 0.38 . . . . 0.0 111.03 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.51 45.02 0.98 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.217 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.0 m -89.52 138.42 31.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.978 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 20.4 m -89.98 30.3 1.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.32 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.634 HD21 ' HB3' ' A' ' 40' ' ' ASP . 60.9 tp -153.55 125.35 7.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.756 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.764 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -76.38 141.29 69.72 Favored Pre-proline 0 C--N 1.327 -0.377 0 O-C-N 123.26 0.35 . . . . 0.0 110.423 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.713 ' HG3' ' HB2' ' A' ' 45' ' ' SER . 6.5 Cg_exo -70.93 -167.22 0.26 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.515 2.143 . . . . 0.0 112.329 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 61.5 m -70.55 138.86 51.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.045 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 15.5 ptpt -76.4 -179.15 4.97 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.563 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.7 m -52.91 131.28 35.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.839 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.25 -31.03 6.61 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.913 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 61' ' ' CYS . 3.6 mm? -88.9 144.86 25.91 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.373 0.606 . . . . 0.0 112.302 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.3 m -121.97 132.59 54.61 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.295 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.9 t -76.56 130.61 38.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.209 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t -149.77 159.83 44.04 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' NZ ' ' HA ' ' A' ' 72' ' ' GLU . 47.0 tttm -71.8 104.01 3.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.298 0.571 . . . . 0.0 110.043 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 t -92.59 80.87 4.79 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.57 -101.88 2.5 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.505 ' OE1' ' HA ' ' A' ' 72' ' ' GLU . 36.5 tp10 -98.15 -50.88 4.2 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.531 -0.468 . . . . 0.0 112.006 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.53 -174.55 3.52 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.513 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -104.53 133.46 49.35 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.045 0.45 . . . . 0.0 110.897 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 47.8 mttm -141.42 155.78 45.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.94 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 67.5 m -69.15 140.42 54.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.284 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 C--O 1.244 0.771 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.191 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.17 128.8 41.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.158 0.504 . . . . 0.0 110.484 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.8 mm -89.75 91.42 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.136 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -151.21 -32.55 0.16 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.444 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.68 130.75 1.85 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.0 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.511 ' HB3' ' HA ' ' A' ' 30' ' ' PHE . . . -90.48 -23.7 20.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.947 0.403 . . . . 0.0 110.658 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.57 -142.93 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.069 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -164.16 -45.14 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.2 0.524 . . . . 0.0 110.857 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -109.33 135.41 50.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.78 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.598 ' HB3' HG23 ' A' ' 48' ' ' VAL . 56.7 m-20 -46.28 -38.28 8.42 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.019 0.824 . . . . 0.0 112.09 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.7 t -48.15 -35.09 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.565 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -68.34 -33.2 73.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.444 ' HB3' ' OG1' ' A' ' 17' ' ' THR . 37.8 m -93.45 -31.91 14.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.201 0.524 . . . . 0.0 111.946 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.0 159.63 34.3 Favored Glycine 0 C--N 1.314 -0.641 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.409 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -61.1 80.5 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.496 0.665 . . . . 0.0 111.835 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 177.67 -33.55 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 13' ' ' CYS . 7.5 p -137.21 147.33 45.77 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.531 ' HB3' HD11 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -130.59 159.11 38.15 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.08 -178.448 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.4 m -89.54 46.37 1.36 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.581 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.42 159.38 18.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.913 0.387 . . . . 0.0 110.946 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.754 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -78.57 131.63 36.83 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.477 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 89.6 p -61.64 139.38 58.29 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.621 -178.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.1 -24.68 63.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.294 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -87.98 -27.25 22.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.684 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.601 ' HB3' HD13 ' A' ' 28' ' ' ILE . 8.6 t -151.24 126.62 10.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.148 0.499 . . . . 0.0 111.042 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -73.23 4.72 4.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.392 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -88.91 -19.55 25.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.029 0.443 . . . . 0.0 110.479 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.754 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 2.5 mp -87.98 120.13 36.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 45.0 mtp85 -141.59 42.52 1.73 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 123.761 0.663 . . . . 0.0 109.454 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.691 ' CD2' HG23 ' A' ' 28' ' ' ILE . 1.3 m-85 -97.67 -175.07 3.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 99.8 m -72.62 80.43 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.416 0.448 . . . . 0.0 110.237 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.601 HG13 ' SG ' ' A' ' 59' ' ' CYS . 39.3 pt -89.03 148.42 41.01 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.3 156.15 26.84 Favored 'Trans proline' 0 N--CA 1.473 0.29 0 C-N-CA 123.329 2.686 . . . . 0.0 114.3 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.679 HD23 ' HA ' ' A' ' 62' ' ' LYS . 4.1 mp -86.94 165.48 15.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.413 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.77 134.11 37.81 Favored Glycine 0 C--O 1.24 0.529 0 CA-C-N 115.143 -0.935 . . . . 0.0 113.028 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 2.7 p30 -95.06 -179.72 4.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.285 0.564 . . . . 0.0 111.304 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -61.39 122.72 15.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.904 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.06 4.13 90.07 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.238 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -88.56 148.42 24.11 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 117.29 0.545 . . . . 0.0 109.664 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.28 138.4 55.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.424 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.2 p -136.8 153.34 50.84 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.076 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -89.76 122.57 67.91 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -57.42 -40.2 83.24 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.897 2.398 . . . . 0.0 112.602 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.6 -36.76 81.45 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.23 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.9 m -66.27 113.13 4.36 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.221 0.534 . . . . 0.0 110.385 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -70.98 153.94 42.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.76 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 60' ' ' PRO . 57.5 mtpt -65.36 176.06 1.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.216 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.598 HG23 ' HB3' ' A' ' 10' ' ' ASP . 10.0 p -88.62 139.7 29.7 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.029 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HA ' HG23 ' A' ' 48' ' ' VAL . 89.5 Cg_endo -89.04 134.2 11.41 Favored 'Cis proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.768 -1.347 . . . . 0.0 113.055 0.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.612 ' HB2' ' NH2' ' A' ' 54' ' ' ARG . 66.1 t80 -75.29 130.82 39.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.124 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -87.65 130.01 34.94 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.66 -113.6 3.83 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.863 ' HD3' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -150.53 126.88 10.69 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.612 ' NH2' ' HB2' ' A' ' 50' ' ' TYR . 60.5 ttm-85 -85.84 102.24 13.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.157 0.504 . . . . 0.0 111.771 -177.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.863 HD23 ' HD3' ' A' ' 53' ' ' LYS . 1.3 mm? -105.33 27.04 8.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.423 0.63 . . . . 0.0 109.925 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.8 m -89.7 148.46 23.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.944 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 4.3 m -88.93 21.83 2.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.829 0.347 . . . . 0.0 111.493 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.37 136.13 14.45 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.601 ' SG ' HG13 ' A' ' 32' ' ' ILE . 1.8 m -75.54 153.04 85.59 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.499 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 64.6 Cg_endo -72.52 174.06 12.25 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.115 1.877 . . . . 0.0 110.995 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.3 m -68.66 139.29 55.45 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.557 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.679 ' HA ' HD23 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -58.4 154.1 14.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.827 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.5 m -44.59 129.17 6.82 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.611 0.569 . . . . 0.0 111.226 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.61 -38.28 3.28 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.954 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.1 mt -88.84 154.93 19.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.883 0.373 . . . . 0.0 111.618 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.0 m -135.8 139.48 43.52 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.866 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 74' ' ' PHE . 23.2 t -72.26 128.73 36.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.763 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.7 t -150.04 156.94 42.58 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 31.9 ttpt -73.19 110.08 7.21 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.301 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.466 ' HB3' ' HD2' ' A' ' 75' ' ' LYS . 10.5 t -93.24 63.04 3.56 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.372 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.76 -93.56 1.49 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.052 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.499 ' OE2' ' HG3' ' A' ' 73' ' ' LYS . 2.0 tt0 -88.33 -54.49 4.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.477 -0.362 . . . . 0.0 111.042 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 34.7 mtmm -112.91 177.99 4.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.13 0.491 . . . . 0.0 111.58 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 8.5 m-85 -89.21 133.95 34.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.268 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.466 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 56.4 mttm -136.66 154.55 50.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.719 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 95.6 m -75.54 128.43 35.28 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.953 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.252 1.236 0 CA-C-O 117.531 -1.223 . . . . 0.0 109.152 179.934 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.884 0.373 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.4 p -150.91 140.2 15.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.39 106.58 17.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.88 0.371 . . . . 0.0 110.41 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.1 t -151.98 -38.99 0.11 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.545 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.91 123.96 1.15 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.07 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.087 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.25 -13.29 35.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.814 0.34 . . . . 0.0 111.107 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 30' ' ' PHE . 17.3 p -151.19 -152.03 0.42 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.87 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -163.59 -43.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.441 0.639 . . . . 0.0 109.362 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -106.59 133.29 51.5 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.592 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -52.73 -31.16 36.49 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.557 0.536 . . . . 0.0 111.184 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.8 t -51.61 -32.05 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.407 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -70.68 -32.73 70.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.126 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.4 m -95.23 -46.32 6.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.209 0.528 . . . . 0.0 112.228 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.89 153.19 9.57 Favored Glycine 0 C--N 1.31 -0.886 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.714 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.453 ' HA ' HG11 ' A' ' 48' ' ' VAL . 16.2 m -57.13 98.23 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.546 0.689 . . . . 0.0 110.776 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.509 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . 161.08 -31.43 0.35 Allowed Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.428 HG22 ' HA ' ' A' ' 33' ' ' PRO . 22.8 p -135.14 139.0 44.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.824 -0.688 . . . . 0.0 109.334 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -111.34 156.66 21.22 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.0 m -97.23 45.83 1.04 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.399 . . . . 0.0 111.369 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 29' ' ' ARG . . . -84.79 178.38 7.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.117 0.484 . . . . 0.0 111.469 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -90.82 142.21 28.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.378 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.675 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -60.69 139.65 57.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.148 0.499 . . . . 0.0 111.649 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.751 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -64.17 -26.17 68.4 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -86.25 -42.37 13.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.899 0.38 . . . . 0.0 111.609 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.1 m -151.96 136.79 17.15 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.408 ' NH2' ' HB3' ' A' ' 55' ' ' LEU . 99.3 mtt180 -74.86 51.7 0.5 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -101.89 -35.38 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.841 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.675 ' HB ' ' OG ' ' A' ' 22' ' ' SER . 53.1 mt -88.8 131.11 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.279 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 6.2 mtp180 -150.16 49.19 0.91 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.912 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 1.087 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.4 p90 -128.51 -168.86 1.97 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.582 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 33.1 m -59.21 82.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.222 0.952 . . . . 0.0 112.44 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.613 HG13 ' SG ' ' A' ' 59' ' ' CYS . 23.8 pt -104.27 143.79 27.38 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.428 ' HA ' HG22 ' A' ' 17' ' ' THR . 13.6 Cg_endo -56.57 159.22 14.11 Favored 'Trans proline' 0 CA--C 1.529 0.225 0 C-N-CA 123.197 2.598 . . . . 0.0 114.112 -177.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 95.1 mt -84.86 167.91 15.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.174 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.09 144.73 35.23 Favored Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.714 -0.676 . . . . 0.0 113.726 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.566 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 0.1 OUTLIER -118.07 -167.21 1.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.062 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.448 ' OG ' HD11 ' A' ' 65' ' ' LEU . 6.1 m -59.21 125.26 22.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.789 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.59 0.14 82.26 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.28 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -88.0 148.38 24.57 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 117.068 0.434 . . . . 0.0 110.541 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.534 ' O ' HD13 ' A' ' 58' ' ' LEU . 12.3 t70 -68.05 145.61 54.29 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.984 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.4 p -150.14 143.83 25.31 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.416 ' CD2' HD21 ' A' ' 58' ' ' LEU . 90.0 m-70 -88.32 139.75 30.26 Favored Pre-proline 0 C--N 1.319 -0.747 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.862 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.73 38.03 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.196 2.597 . . . . 0.0 113.106 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 42' ' ' HIS . . . -172.57 33.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.384 0.674 . . . . 0.0 109.266 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -80.71 133.23 35.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.433 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.493 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 19.8 m170 -80.66 146.85 30.92 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -67.57 166.34 15.11 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.453 HG11 ' HA ' ' A' ' 15' ' ' SER . 58.8 t -86.33 136.99 34.88 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.435 ' HA ' HG13 ' A' ' 48' ' ' VAL . 15.7 Cg_exo -69.42 128.58 12.44 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 123.898 -1.293 . . . . 0.0 114.061 1.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 46' ' ' HIS . 71.9 t80 -71.48 154.61 41.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.506 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.521 ' OD2' ' HG3' ' A' ' 53' ' ' LYS . 5.3 p-10 -56.33 -33.2 65.39 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.698 0.285 . . . . 0.0 111.528 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.38 34.09 67.45 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.248 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.521 ' HG3' ' OD2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -129.36 -22.76 3.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -75.24 150.6 38.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.067 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.446 ' N ' ' HD3' ' A' ' 54' ' ' ARG . 3.7 mm? -85.46 56.66 4.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.2 0.524 . . . . 0.0 111.565 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 51.3 m -89.31 128.5 35.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.27 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.751 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 15.2 m -89.67 26.61 1.71 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 40' ' ' ASP . 1.6 pp -153.97 172.16 17.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.073 0.463 . . . . 0.0 110.921 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.613 ' SG ' HG13 ' A' ' 32' ' ' ILE . 37.1 m -106.23 143.2 26.47 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.012 178.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.437 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 32.4 Cg_exo -57.14 159.52 15.08 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.539 2.159 . . . . 0.0 111.721 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 32.5 m -59.22 134.09 56.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.269 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.615 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 15.4 ptpt -70.38 163.31 26.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.251 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.0 m -47.62 124.69 7.41 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.397 0.435 . . . . 0.0 111.367 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.18 -30.07 10.56 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.11 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 36' ' ' ASN . 4.0 mm? -88.48 136.55 32.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.792 0.33 . . . . 0.0 111.006 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.5 m -116.77 124.74 50.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.467 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.5 t -71.23 125.18 26.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.7 t -150.3 158.06 43.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.836 0.35 . . . . 0.0 110.125 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.611 ' HE2' ' O ' ' A' ' 71' ' ' GLY . 85.3 tttt -71.8 105.92 3.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.257 0.551 . . . . 0.0 110.739 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 75' ' ' LYS . 15.1 m -89.75 64.49 6.5 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.796 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.611 ' O ' ' HE2' ' A' ' 69' ' ' LYS . . . 96.16 -97.58 2.08 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.825 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.424 ' O ' ' HE3' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -91.83 -55.73 3.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.361 0.6 . . . . 0.0 110.085 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.788 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -100.09 171.07 8.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.332 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.589 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 9.1 m-85 -94.92 133.69 38.4 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.852 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.589 ' HD2' ' O ' ' A' ' 74' ' ' PHE . 14.1 mptt -135.58 157.1 47.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.605 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 82.5 m -76.21 118.53 19.03 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.576 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 C--O 1.253 1.256 0 CA-C-O 117.701 -1.143 . . . . 0.0 109.381 179.855 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.09 134.39 28.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.876 0.37 . . . . 0.0 110.294 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 mm -88.93 97.51 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 t -150.82 -33.34 0.16 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.184 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.46 116.24 0.64 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.491 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.052 ' H ' ' HB3' ' A' ' 30' ' ' PHE . . . -90.96 -9.5 45.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.703 -0.248 . . . . 0.0 111.375 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 30' ' ' PHE . 12.6 p -150.69 146.37 26.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.227 0.537 . . . . 0.0 111.696 -178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.06 -42.86 12.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.992 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -121.62 145.42 48.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.218 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 50' ' ' TYR . 1.6 m-20 -54.74 -27.37 40.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.223 0.535 . . . . 0.0 110.148 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.822 HG22 ' HB2' ' A' ' 49' ' ' PRO . 77.6 t -52.47 -35.01 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.057 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -72.46 -21.93 61.15 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 97.6 m -89.09 141.4 28.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.222 0.534 . . . . 0.0 111.585 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.32 157.49 52.1 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.073 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.506 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 19.9 m -54.29 112.28 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.17 0.509 . . . . 0.0 110.312 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.467 ' C ' ' HG ' ' A' ' 34' ' ' LEU . . . 136.46 -22.84 3.33 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 p -136.01 152.24 50.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.196 -0.502 . . . . 0.0 110.232 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.6 ' HB3' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -135.74 162.15 33.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 59.8 m -89.07 49.28 1.75 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.641 ' HB3' HD11 ' A' ' 32' ' ' ILE . . . -82.07 163.26 22.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.98 0.419 . . . . 0.0 110.631 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.694 ' HA ' ' O ' ' A' ' 28' ' ' ILE . . . -83.93 145.16 28.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.619 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.651 ' OG ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -58.11 130.46 46.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.945 0.403 . . . . 0.0 110.703 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.822 ' HA ' ' HB3' ' A' ' 57' ' ' SER . . . -58.4 -27.06 63.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -85.5 -38.77 18.2 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.861 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m -150.83 136.1 17.72 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.139 -0.351 . . . . 0.0 110.431 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.92 55.05 0.17 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.051 0.54 . . . . 0.0 111.823 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -114.91 -38.76 3.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.966 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.694 ' O ' ' HA ' ' A' ' 21' ' ' ALA . 1.9 mp -88.09 133.58 30.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.81 0.338 . . . . 0.0 110.401 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.2 mmm-85 -144.63 57.18 1.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.985 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 1.052 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 2.0 p90 -136.1 -173.28 3.35 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.171 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.5 m -59.04 84.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 O-C-N 124.295 0.997 . . . . 0.0 113.111 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.641 HD11 ' HB3' ' A' ' 20' ' ' ALA . 38.9 pt -102.0 151.01 37.94 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.32 151.7 28.41 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.365 2.71 . . . . 0.0 114.77 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.6 HD21 ' HB3' ' A' ' 18' ' ' CYS . 80.7 mt -87.52 165.35 15.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.361 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.9 145.97 39.13 Favored Glycine 0 C--O 1.241 0.541 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.594 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 1.5 t-20 -96.82 -175.92 3.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.413 0.625 . . . . 0.0 111.253 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.8 m -60.97 129.26 40.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.555 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.99 -4.64 82.4 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.865 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.17 149.12 23.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.99 0.395 . . . . 0.0 110.519 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.631 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 1.1 t70 -63.96 141.56 58.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.357 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 74' ' ' PHE . 25.0 p -141.81 139.38 32.72 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.067 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 33.2 m170 -89.12 128.41 51.8 Favored Pre-proline 0 C--N 1.318 -0.797 0 C-N-CA 120.086 -0.645 . . . . 0.0 109.653 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 42' ' ' HIS . 0.9 OUTLIER -44.64 -49.47 9.29 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 124.17 3.246 . . . . 0.0 114.608 -177.318 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.42 31.56 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.89 0.376 . . . . 0.0 111.821 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.423 ' O ' ' HD3' ' A' ' 54' ' ' ARG . 14.5 m -90.72 -20.23 22.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.135 0.493 . . . . 0.0 110.469 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.763 ' HD2' ' HB2' ' A' ' 56' ' ' SER . 3.7 m-70 -169.36 125.89 0.9 Allowed 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.739 ' H ' ' HB2' ' A' ' 50' ' ' TYR . 9.2 mmmm -140.39 177.74 7.79 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 61.4 t -125.95 107.7 25.23 Favored Pre-proline 0 C--N 1.32 -0.7 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.224 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.822 ' HB2' HG22 ' A' ' 11' ' ' VAL . 59.0 Cg_endo -96.49 129.46 3.38 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.483 -1.049 . . . . 0.0 112.79 -0.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.739 ' HB2' ' H ' ' A' ' 47' ' ' LYS . 1.3 t80 -82.74 124.12 29.94 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -76.83 -38.4 53.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.67 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.53 -167.75 29.56 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.549 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -152.51 140.82 20.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.593 0.235 . . . . 0.0 110.569 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 45' ' ' SER . 6.9 ptm180 -167.24 159.53 12.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.1 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.75 54.04 2.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.928 0.394 . . . . 0.0 111.912 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.763 ' HB2' ' HD2' ' A' ' 46' ' ' HIS . 50.9 m -88.31 127.19 35.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.822 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 20.8 m -88.81 44.44 1.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.4 tp -153.37 126.57 8.52 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.399 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.563 ' HB3' HD23 ' A' ' 34' ' ' LEU . 1.7 m -87.47 148.04 43.34 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.107 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 46' ' ' HIS . 42.1 Cg_endo -66.96 -177.99 1.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.488 2.125 . . . . 0.0 111.715 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 67' ' ' CYS . 81.6 m -69.81 141.33 53.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.767 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.511 ' HA ' HD12 ' A' ' 34' ' ' LEU . 9.6 ptmm? -62.35 148.64 44.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.775 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.506 ' OG ' ' HB3' ' A' ' 15' ' ' SER . 10.2 m -46.33 130.92 10.74 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 123.44 0.463 . . . . 0.0 111.274 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.41 -30.23 10.21 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.774 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.9 mt -91.4 147.56 22.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.747 0.308 . . . . 0.0 111.464 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -108.41 126.49 52.94 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.323 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.422 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 54.1 t -83.59 116.21 22.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.0 t -137.48 157.9 45.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.765 0.316 . . . . 0.0 110.185 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . 84.1 tttt -69.25 105.44 2.52 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.358 0.599 . . . . 0.0 111.198 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -92.92 77.14 4.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.746 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.452 ' O ' ' HE2' ' A' ' 69' ' ' LYS . . . 87.42 -102.52 2.8 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.579 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.548 ' O ' ' HE3' ' A' ' 69' ' ' LYS . 5.2 tm-20 -91.28 -53.08 4.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.739 0.304 . . . . 0.0 110.634 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.428 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 45.2 mmtm -98.21 171.2 8.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.073 0.463 . . . . 0.0 111.241 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 6.3 m-85 -92.19 138.34 31.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.462 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.631 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 48.8 mttp -143.92 155.08 43.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.23 0.538 . . . . 0.0 110.439 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 36' ' ' ASN . 59.8 m -70.96 135.67 48.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.942 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.3 m . . . . . 0 C--O 1.255 1.364 0 CA-C-O 117.557 -1.211 . . . . 0.0 108.888 179.548 . . . . . . . . 0 0 . 1 stop_ save_